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Summary {#efs25306-sec-0001}
=======

For the preparation of the 50th session of the Codex Committee on Pesticide Residues (CCPR meeting), the European Commission asked EFSA to provide comments on the individual active substances assessed in the 2017 Joint FAO/WHO Meeting on Pesticide Residues (JMPR), in particular on the recommended toxicological reference values and the proposed maximum residue limits (MRLs) at steps 3 and 6 of the Codex procedure.

In 2017, JMPR evaluated 15 active substances regarding the setting of toxicological reference values to be used in consumer risk assessment (bicyclopyrone, chlormequat, cyclaniliprole, fenazaquin, fenpropimorph, fenpyrazamine, fenpyroximate, fosetyl Al, isoprothiolane, natamycin, oxamyl, phosphonic acid, propylene oxide, thiophanate‐methyl, triflumezopyrim). EFSA compared the acceptable daily intake (ADI) and acute reference dose (ARfD) values derived by JMPR with the values derived at European Union (EU) level and, in case differences were identified, European Food Safety Authority (EFSA) provided further explanations for the reasons of the differences.

Regarding the setting of MRLs, JMPR assessed 36 substances for deriving MRL proposals (acetamiprid, azoxystrobin, bicyclopyrone, captan, chlormequat, cyclaniliprole, cyprodinil, 2,4‐D, difenoconazole, fenazaquin, fenpropimorph, fenpyrazamine, fenpyroximate, flonicamid, fluensulfone, fluopyram, flupyradifurone, fosetyl Al, imazamox, imazapyr, imidacloprid, isoprothiolane, isopyrazam, natamycin, oxamyl, phosphonic acid, picoxystrobin, propiconazole, propylene oxide, prothioconazole, quinclorac, saflufenacil, spinetoram, tebuconazole, trifloxystrobin, triflumezopyrim). EFSA provided comments on the proposed Codex MRLs as well as on active substances that were reassessed by JMPR following specific concerns raised in the previous years (quinclorac, abamectin, acetamiprid) and on general issues discussed in the 2017 JMPR meeting.

It is highlighted that the JMPR report summarising the recommendations of the 2017 JMPR meeting was published on 8 January 2018. The full evaluations were published on 6 March 2018. Thus, due to the limited details available and the short timelines for providing the comments, an in‐depth analysis taking into account the detailed information provided in the JMPR evaluation could not always be performed. The conclusions reached in this report should be considered as indicative and might have to be reconsidered in a more detailed assessment when needed. The comments presented in this report have to be seen in the context of the currently applicable guidance documents and the MRL legislation applicable at the time of commenting. The comments may not be valid any more or may have to be modified if the legal or scientific framework changes.

1. Introduction {#efs25306-sec-0003}
===============

1.1. Background {#efs25306-sec-0004}
---------------

Manufacturers of pesticides who are interested in the setting of Codex Maximum Residue Limits (CXLs) submit data to the Joint Meeting on Pesticide Residues (JMPR) for assessment in accordance with the procedures established in the Codex Alimentarius (Codex Alimentarius, [2016](#efs25306-bib-0002){ref-type="ref"}). The most recent Joint FAO/WHO meeting on pesticide residues (JMPR) evaluations of the toxicological data and the residue studies are summarised in the JMPR Report 2017 (FAO, [2017](#efs25306-bib-0152){ref-type="ref"}). It comprises in total 38 active substances: 16 of them were assessed for both toxicological reference values and residues, 21 active substances were assessed in view of setting new CXLs and 3 active substances were assessed for specific concerns raised in previous Codex Committee on Pesticide Residues (CCPR) meetings by delegations.

On 14 November 2017, the European Commission requested European Food Safety Authority (EFSA) to provide support for the preparation of the European Union (EU)‐coordinated position for the 50th session of the CCPR in April 2018 in China. In particular, EFSA was asked to give advice and to provide comments on the recommendations of the 2017 JMPR and on the proposed Codex maximum residue limits (MRLs) in support of the CCPR in April 2018. Additionally, the European Commission requested EFSA to give its comments on other proposed Codex MRLs that were retained in the step procedure in previous years and may not have been covered by the 2017 JMPR report but by (an) earlier JMPR report(s).

Furthermore, the European Commission asked for comments on the general chapters of the JMPR 2017 report, where relevant for risk assessment as well as on the proposed crop groupings, the JMPR priority list and documents related to the revision of the IESTI equation, if any.

For reasons of transparency and traceability, EFSA has created separate questions for each of the active substances covered by the mandate in the EFSA Register of Questions with the following reference numbers and subjects:

Question numberSubject1.EFSA‐Q‐2017‐00763Abamectin -- EFSA comments on the toxicological reference values evaluated by JMPR in 20172.EFSA‐Q‐2017‐00764Acetamiprid -- EFSA comments on the toxicological reference values evaluated by JMPR in 20173.EFSA‐Q‐2017‐00765Azoxystrobin -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 20174.EFSA‐Q‐2017‐00766Bicyclopyrone -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 20175.EFSA‐Q‐2017‐00767Captan -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 20176.EFSA‐Q‐2017‐00768Chlormequat -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 20177.EFSA‐Q‐2017‐00769Cyclaniliprole -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 20178.EFSA‐Q‐2017‐00770Cyprodinil -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 20179.EFSA‐Q‐2017‐007712,4‐D -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201710.EFSA‐Q‐2017‐00772Difenoconazole -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201711.EFSA‐Q‐2017‐00773Fenazaquin -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201712.EFSA‐Q‐2017‐00774Fenpropimorph -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201713.EFSA‐Q‐2017‐00775Fenpyrazamine -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201714.EFSA‐Q‐2017‐00776Fenpyroximate -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201715.EFSA‐Q‐2017‐00777Flonicamid -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201716.EFSA‐Q‐2017‐00778Fluensulfone -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201717.EFSA‐Q‐2017‐00779Fluopyram -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201718.EFSA‐Q‐2017‐00780Flupyradifurone -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201719.EFSA‐Q‐2017‐00781Fosetyl Al -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201720.EFSA‐Q‐2017‐00782Imazamox -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201721.EFSA‐Q‐2017‐00783Imazapyr -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201722.EFSA‐Q‐2017‐00784Imidacloprid -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201723.EFSA‐Q‐2017‐00785Isoprothiolane -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201724.EFSA‐Q‐2017‐00786Isopyrazam -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201725.EFSA‐Q‐2017‐00787Natamycin -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201726.EFSA‐Q‐2017‐00788Oxamyl -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201727.EFSA‐Q‐2017‐00789Phosphonic acid -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201728.EFSA‐Q‐2017‐00790Picoxystrobin -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201729.EFSA‐Q‐2017‐00791Propiconazole -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201730.EFSA‐Q‐2017‐00792Propylene oxide -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201731.EFSA‐Q‐2017‐00793Prothioconazole -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201732.EFSA‐Q‐2017‐00794Quinclorac -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201733.EFSA‐Q‐2017‐00795Saflufenacil -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201734.EFSA‐Q‐2017‐00796Spinetoram -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201735.EFSA‐Q‐2017‐00797Tebuconazole -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201736.EFSA‐Q‐2017‐00798Thiophanate‐methyl -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201737.EFSA‐Q‐2017‐00799Trifloxystrobin -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 201738.EFSA‐Q‐2017‐00800Triflumezopyrim -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 201739.EFSA‐Q‐2017‐00804EFSA comments on the general considerations provided by JMPR in 2017

1.2. Terms of Reference {#efs25306-sec-0005}
-----------------------

The requested advice and comments on the recommendations of the JMPR and, where appropriate, on other proposed Codex MRLs, retained in the step procedure and reviewed by JMPR in previous years, should contain the following information: Background information on all active substances under discussion regarding the status of the active substance at EU level (approval status of the active substance, availability of EFSA conclusions and availability of EFSA‐reasoned opinions on MRL applications or MRL review).In case new toxicological reference values are proposed by JMPR, a comparison of the proposed reference values with agreed EU reference values and an evaluation of the reasons for possible differences.As regards the proposed draft Codex MRLs for discussion in CCPR 2018, EFSA should provide any relevant comments on the proposed MRLs and specifically address the following questions:--Whether the residue definitions derived by JMPR are comparable with the existing EU residue definitions;--Whether the proposed draft Codex MRLs are comparable with the existing EU MRLs;--Whether the proposed draft Codex MRLs are sufficiently supported by data;--Whether the proposed draft Codex MRLs are appropriate in terms of the data that have been used to establish them and in terms of the method used for their calculation;--Whether the proposed draft Codex MRLs are safe for European consumers with regard to chronic and, where relevant, acute exposure.

The requested comments to the general chapters of the JMPR 2017 report, where relevant for risk assessment, as well as comments on the proposed crop groupings and the JMPR priority list can be provided as contributions to the EU‐coordinated positions when these are discussed with the Member States and do not need to be covered by a scientific report.

*(Terms of reference as provided by the European Commission in the Mandate of 14 November 2017)*

EFSA agreed with the European Commission to respond to this request with a scientific report and to share the first draft of the scientific report containing comments on the active substances with all Member States and the European Commission by end of February 2018, inviting Member States to provide comments. Considering the short timelines, the first draft report did not cover yet all active substances (the detailed assessment was missing for three a.s.).

The final draft report addressing the Member State comments was completed on 9 March 2018; this document was intended to be used for discussions in the first Council Working Party scheduled for 16 March 2018.

It was agreed with the requestor to publish the final report before 31 July 2018.

The comments provided by Member States during the commenting period were addressed either directly in the final EFSA scientific report or though discussion during the Council Working Party meetings for the preparation of the 50th Session of the CCPRs.

2. Assessment {#efs25306-sec-0006}
=============

For each of the substances under consideration, EFSA provided the requested background information (first bullet point); in addition, the toxicological reference values (second bullet point of the Terms of Reference) derived by JMPR and at EU level were reported, comparing the assessments performed by JMPR and in the EU under Regulation (EC) No 1107/2009[1](#efs25306-note-2001){ref-type="fn"}. The sources of information used are the EFSA conclusions available for the active substances under consideration, the Review Reports, Draft Assessment Reports (DAR) prepared by the Rapporteur Member States and other sources of information if available.

For deriving the comments on the Codex MRL proposals (third bullet point in the Terms of Reference), EFSA compared the levels of the Codex MRL proposals and the enforcement residue definition derived by JMPR with the MRLs and the residue definition established in the EU legislation (Regulation (EC) No 396/2005) or the legislation under preparation. The EU residue definitions for risk assessment were retrieved from the EFSA conclusions, EFSA‐reasoned opinions on MRL review under Article 12 of Regulation 396/2005[2](#efs25306-note-1004){ref-type="fn"} or, where these documents are not available, the reports prepared by the European Commission in the framework of the peer review of active substances or Member State evaluations in DAR. The comparison of the existing EU MRLs and the proposed Codex MRLs is presented in tabular form. Codex MRL proposals that are higher than the existing EU MRLs are printed in bold. In line with the presentation of MRLs in the EU legislation, limit of quantification (LOQ) MRLs are indicated by adding an asterisk ('\*') after the value. A detailed assessment of the analytical methods to be used for enforcement purpose was not performed.

For assessing whether the draft Codex MRL proposals are sufficiently supported by data, EFSA took into account the currently valid EU guidance documents for consumer risk assessment and the agreed EU policies (European Commission, [1996](#efs25306-bib-0127){ref-type="ref"}, [1997a](#efs25306-bib-0128){ref-type="ref"}, [1997b](#efs25306-bib-0129){ref-type="ref"}, [1997c](#efs25306-bib-0130){ref-type="ref"}, [1997d](#efs25306-bib-0131){ref-type="ref"}, [1997e](#efs25306-bib-0132){ref-type="ref"}, [1997f](#efs25306-bib-0133){ref-type="ref"}--[g](#efs25306-bib-0134){ref-type="ref"}, [2000](#efs25306-bib-0135){ref-type="ref"}, [2010a](#efs25306-bib-0139){ref-type="ref"}, [2017a](#efs25306-bib-0147){ref-type="ref"}; OECD, [2011](#efs25306-bib-0154){ref-type="ref"}, [2013](#efs25306-bib-0155){ref-type="ref"}). It is noted that due to the different data requirements and policies in JMPR (FAO, [2017](#efs25306-bib-0152){ref-type="ref"}), the assessment of identical residue data sets submitted in support of a EU MRL and Codex MRL request may result in different recommendations at EU level and by JMPR. In this report, EFSA provides background information on the reasons for these differences. For calculating the numerical MRL value, EFSA used the same methodology as JMPR (OECD calculator) (OECD, [2011](#efs25306-bib-0154){ref-type="ref"}).

For the assessment of the safety of the draft Codex MRL proposals, EFSA used the EFSA PRIMo rev. 2 (EFSA, [2007a](#efs25306-bib-0006){ref-type="ref"}). For assessing the acute consumer risk, EFSA applied the standard EU methodology, including the agreed EU variability factors and the acute reference dose (ARfD) agreed at EU level. For the assessment of the long‐term consumer risk, EFSA calculated the exposure resulting from the existing EU MRLs, taking into account the most recent information on supervised trials median residues (STMRs) and including the STMR values derived by JMPR for commodities where the proposed Codex MRLs are higher than the existing EU MRLs. It is noted that this approach is likely to overestimate the actual exposure because it is quite unlikely that each food item consumed contains residues at the maximum level allowed in the European legislation, but it is a sufficiently conservative risk assessment screening. For active substances where the MRL review has not yet been completed, a less refined calculation was performed for the commodities where the EU MRL is higher than the proposed Codex MRL, using the EU MRL as input values for the risk assessment. The contribution of the individual crops under consideration in the CCPR meeting was calculated separately. The exposure assessments are usually based on the EU toxicological reference values unless it is specifically mentioned that the JMPR values were used. For draft Codex MRL proposals for food of animal origin, EFSA focussed mainly on the consumer risk assessment and the validity of feeding studies and animal metabolism studies. For draft Codex MRL proposals for animal commodities, a full assessment of the expected dietary burden at EU level is not possible in the framework of this report because relevant information are not available to EFSA (e.g. use of the active substance on all feed items in the EU and in Third Countries). For pesticides where the EU and JMPR residue definitions for risk assessment are not comparable, EFSA calculated tentative risk assessment scenarios. The assumptions and uncertainties of these scenarios are described individually.

It is highlighted that the JMPR report summarising the recommendations of the 2017 JMPR meeting was published on 8 January 2018. The full evaluations were published on 6 March 2018. Thus, due to the limited time available for providing the comments, an in‐depth analysis could not always be performed. Thus, the conclusions reached in this report should be considered as indicative and might have to be reconsidered in a more detailed assessment, when needed. The comments presented in this report have to be seen in the context of the currently applicable guidance documents and the MRL legislation valid at the time of commenting. Thus, the comments may not be valid any more or may have to be modified if the legal or scientific framework changes.

3. EFSA Comments on JMPR report chapter 2 (General considerations), 3.1 (Concerns raised by the Codex Committee on Pesticide Residues) and 3.2 (Other matters of interest) {#efs25306-sec-0007}
==========================================================================================================================================================================

3.1. Harmonisation of the dietary exposure methodologies for compounds used both as pesticides and veterinary drugs -- Special studies on microbiological effects of pesticide residues in foods {#efs25306-sec-0008}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

EFSA welcomes the initiative of JMPR to carry out microbiological assessments of pesticides residues\' adverse chronic and acute effects on the microorganisms in the human gastrointestinal tract similarly to the assessments already routinely done by JECFA for veterinary drug residues.

For chemical active substances used as pesticides, specific studies investigating the potential adverse effects of pesticide residues on the microorganisms in the human gastrointestinal tract (human microbiome are not part of the EU data requirements). In the literature reviews which have to be submitted since 1 January 2014 in addition to the studies defined in the data requirements, adverse effects of pesticide residues on the microorganisms in the human gastrointestinal tract have not been reported so far.

3.2. Historical control data {#efs25306-sec-0009}
----------------------------

The recommendation to update the document 'Principles and Methods for the Risk Assessment of Chemical in Food' (EHC 240) is welcome. The interpretation of statistical evaluations and historical control data often is a reason for discussion leading to divergent views of experts and it would be desirable to find a common approach.

3.3. Further consideration of the process for establishing group MRLs, update on use of the revised commodity classification for vegetables {#efs25306-sec-0010}
-------------------------------------------------------------------------------------------------------------------------------------------

EFSA shares the observation of JMPR that the shape/size or surface/weight ratio of a crop is an important parameter that influences the magnitude of residues. It may be less important for systemic substances or soil applications, but for foliar uses of pesticides close to harvest residue an extrapolation to crops with different morphological features may lead to inappropriate MRLs.

JMPR decided that based on residue trial in tomatoes, maximum residue levels will be derived only for cherry tomatoes (VO 2700) and tomatoes (VO 0448), but not for other crops listed in the subgroup 12A Tomatoes, e.g. to currant tomatoes, goji berries, tomatillos. Similarly, when data are available for Bell and non‐bell peppers, JMPR decided to present maximum residue levels only for subgroup of peppers, exempting okra, martynia and roselle.

In the EU, MRLs established for tomatoes are also applicable to cherry tomatoes and to a number of minor crops, such as Cape gooseberries, tomatillos, goji berries, tomatillos and some other minor crops.

As regards peppers, the MRLs established for bell peppers would be equally applied to chili peppers, but not automatically to okra (okra are classified separately from peppers). However, an extrapolation from peppers to okra is allowed in the EU, provided that the same good agricultural practice (GAP) applies. Roselle and martynia are not explicitly listed in the EU food classification.

The MRLs derived with the OECD calculator usually accommodate for variations, but in certain cases, the MRLs might not be sufficient for small‐sized crops listed in the crop classification in the same category as a comparably larger crop.

The uncertainty resulting from the application of MRLs that were established for major crops like tomatoes or peppers to the related minor crops was considered acceptable by risk managers, taking into account that these commodities are usually consumed in lower amounts, and usually no specific residue trials are available that would allow to establish separate MRLs.

3.4. Field use pattern anticipated residue comparison model {#efs25306-sec-0011}
-----------------------------------------------------------

JMPR developed a model/tool that estimates residues at harvest resulting for a certain GAP based on residue trials that are not exactly matching with the critical GAP, but differ in application rates, retreatment intervals (RTI) and preharvest intervals (PHI). Crop‐specific half‐lives were estimated from a limited number of decline studies. This tool was used for deriving MRL proposals for cyclaniliprole.

Such a model/tool can be useful to decide if the results of supervised trials differing in one or several parameters are representative for the GAPs for which MRLs are requested. It might allow a more harmonised and objective evaluation of such GAPs by different assessment bodies.

However, before using this approach in a regulatory decision‐making process, it is necessary that the model is validated to ensure that the derived MRL proposals are appropriate. The EU, therefore, requests that (1) a full description of the algorithms implemented in the model should be provided in the JMPR report and (2) a model validation is performed, comparing the outcome of an assessment based on trials matching the GAP with assessments based on residue trials that deviate in different parameters from the GAP to be assessed. Based on the results of the validation, a decision can be taken on the cases/scenarios where the tool can be used and the limitations of the tool (e.g. for residues with a complex degradation behaviour). Given these uncertainties resulting from the lack of a model validation, the EU will reserve its position for MRL proposals that were derived with this tool for the time being. The EU is ready to provide further detailed technical comments on its analysis of the model.

3.5. Update of the IESTI Model used for the calculation of dietary exposure: New Large Portion data {#efs25306-sec-0012}
---------------------------------------------------------------------------------------------------

The update of the IESTI model to be used for dietary exposure calculations is welcome and regular updates should be further promoted. In future revisions, the recommendations of the international workshop on the IESTI equation should be incorporated as regards the consumption data.

EFSA would like to inform the participants of the CCPR meeting that a new revision of the European model for pesticide risk assessment (EFSA PRIMo) has been recently published, including new diets.

3.6. Quinclorac (287) {#efs25306-sec-0013}
---------------------

Following the 49th CCPR Meeting, the EU submitted a concern form asking JMPR to reconsider the residue definition for enforcement, since the more toxic metabolite (i.e. quinclorac methyl ester) was included in the residue definitions for compliance established by the US EPA and Health Canada, while it was not included in the residue definition for enforcement derived by JMPR.

JMPR confirmed that quinclorac is a suitable marker for compliance in all commodities and did not revise the previously derived residue definition. It was noted by JMPR that quinclorac methyl ester is included only in the residue definition for enforcement for specific crops/crop groups, i.e. in the USA for rapeseed and in Canada for pulses and oilseeds.

Further details on the new MRL proposals derived by JMPR in 2017 are presented in Section [4.29](#efs25306-sec-0190){ref-type="sec"}.

The concern of the EU is not fully addressed. Considering that, in 2017, JMPR assessed the setting of MRLs for rape seed, a crop where the methyl ester occurred in higher concentrations than expected from the metabolism studies, i.e. up to 400% of the parent compound, it would be more appropriate to include the more toxic metabolite as additional marker substance in the residue definition for enforcement. Further discussions with risk managers are recommended to decide on the EU position on the residue definition for quinclorac.

3.7. Abamectin (177) {#efs25306-sec-0014}
--------------------

JMPR received information on some new studies and published papers on abamectin. However, JMPR did not find it appropriate to re‐evaluate abamectin. Since no detailed information is reported in the JMPR report, EFSA is not in a position to provide any comments.

3.8. Acetamiprid (246) {#efs25306-sec-0015}
----------------------

Following a request from CCPR, JMPR should perform a follow‐up evaluation for toxicology. Since no relevant data were provided, JMPR did not find it appropriate to re‐evaluate acetamiprid.

At EU level, acetamiprid was recently re‐evaluated and the toxicological reference values have been lowered. The table below gives a comparison of the toxicological reference values established by JMPR and at EU level (Table [1](#efs25306-tbl-0001){ref-type="table"}).

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

                           JMPR evaluation                                                      EU evaluation   TRV comparable                                                                               
  ------------------------ -------------------------------------------------------------------- --------------- ------------------------ ------------------------------------------------------------------- ----
  **ADI**                  0.07 mg/kg bw per day                                                JMPR 2011       0.025 mg/kg bw per day   EFSA ([2016q](#efs25306-bib-0107){ref-type="ref"})                  No
  **ARfD**                 0.1 mg/kg bw                                                         JMPR 2011       0.025 mg/kg bw           European Commission ([2017d](#efs25306-bib-0150){ref-type="ref"})   No
  **Conclusion/comment**   The new EU toxicological reference values were taken note recently                                                                                                                

ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values.

John Wiley & Sons, Ltd

Following the lowering of the toxicological reference values, the existing EU MRLs and the previously accepted Codex MRLs are reconsidered. The assessment by EFSA will be finalised in April 2018.

It is recommended that an efficient procedure should be developed to share new toxicological data with JMPR to ensure that JMPR toxicological reference values are based on the same database.

3.9. Update from the Joint FAO/WHO Expert Committee on Food Additives (JECFA) {#efs25306-sec-0016}
-----------------------------------------------------------------------------

No comments from EFSA side.

3.10. Harmonisation of the dietary exposure methodologies for compounds used both as pesticides and veterinary drugs -- Harmonising/combining exposure from veterinary drug and pesticide use {#efs25306-sec-0017}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The activities to harmonise/combine dietary exposure methodologies for pesticides and veterinary drugs are welcome.

3.11. Pesticides for vector control -- New Pesticide Ingredients Developed Initially for Vector Control: Use of JMPR WHO Core Assessment Group for Pesticides {#efs25306-sec-0018}
-------------------------------------------------------------------------------------------------------------------------------------------------------------

No comments.

3.12. Other Matters of Interest: Update from the International Programme on Chemical Safety (IPCS) {#efs25306-sec-0019}
--------------------------------------------------------------------------------------------------

No comments.

3.13. Harmonisation of residue definition -- determining the level of interest in a pilot project to achieve more harmonised residue definitions {#efs25306-sec-0020}
------------------------------------------------------------------------------------------------------------------------------------------------

A representative of Bayer CropScience proposed a procedure aiming to develop residue definitions that are acceptable by national regulators which would foster the acceptance of Codex MRLs. He proposed a pilot project.

Such an initiative is supported. It is noted that recently an EFSA guidance document on the establishment of the residue definition for dietary risk assessment was published (EFSA, [2016m](#efs25306-bib-0103){ref-type="ref"}). The discussions with risk managers on the details regarding the implementation of this guidance document are currently ongoing. The new EFSA guidance document could be used in the framework of the proposed pilot project to get experience on the use of the EFSA guidance at international level.

4. EFSA comments on JMPR report chapter 5 (Individual substances assessed) {#efs25306-sec-0021}
==========================================================================

In the following sections, the active substances assessed by JMPR in the most recent assessment are presented (FAO, [2017](#efs25306-bib-0152){ref-type="ref"}, [2018](#efs25306-bib-0153){ref-type="ref"}). The terms in brackets after the name of the active substance in the header of the sections refer to the code number used by JMPR; the second parenthesis provides information whether the substance was assessed for toxicological properties (T) and/or for residues (R). The substances are sorted according to the codex number.

4.1. Captan (007) R {#efs25306-sec-0022}
-------------------

### 4.1.1. Background information (Table [2](#efs25306-tbl-0002){ref-type="table"}) {#efs25306-sec-0023}

###### 

Background information on captan

                                                      Comments, references
  ------------------------- ------------------------- ---------------------------------------------------------------------------------
  Type of JMPR evaluation   New use                   
  RMS                       AT                        Original RMS was IT
  Approval status           Renewal of the approval   Commission Directive 2007/5/EC[a](#efs25306-note-0006){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2009c](#efs25306-bib-0015){ref-type="ref"}) Ongoing conclusion (AIR III)
  MRL review                Yes, see comments         EFSA ([2014d](#efs25306-bib-0059){ref-type="ref"})
  MRL applications          No                        Ongoing in hops

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2007/5/EU: Commission Directive 2007/5/EC of 7 February 2007 amending Council Directive 91/414/EEC to include captan, folpet, formetanate and methiocarb as active substances. OJ L 35, 8.2.2007, p. 11--17.

John Wiley & Sons, Ltd

### 4.1.2. Toxicological reference values -- captan (Table [3](#efs25306-tbl-0003){ref-type="table"}) {#efs25306-sec-0024}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                 | EU evaluation                                                                                                                                                                                                                                                                                                 | TRV comparable       |                                                                                                                                                                                                   |     |
+========================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============================================================================================================================================================================================================================================================================================================+======================+===================================================================================================================================================================================================+=====+
| **ADI**                | 0.1 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                            | JMPR, 1984 confirmed by JMPR, 1995 (reproductive toxicity studies in rats and monkeys)                                                                                                                                                                                                                        | 0.1 mg/kg bw per day | European Commission ([2008](#efs25306-bib-0138){ref-type="ref"}) confirmed in the EFSA ([2009c](#efs25306-bib-0015){ref-type="ref"}) (teratogenicity study in rabbits, with safety factor of 100) | Yes |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                    | WHO, [2009](#efs25306-bib-10010){ref-type="ref"} established for women of childbearing age and unnecessary for the general population (based on NOAEL of 30 mg/kg bw per day for increased incidences of intrauterine deaths and malformations at 100 mg/kg bw per day in rabbits and a safety factor of 100) | 0.3 mg/kg bw         | European Commission ([2008](#efs25306-bib-0138){ref-type="ref"}) confirmed in the EFSA ([2009c](#efs25306-bib-0015){ref-type="ref"}) (teratogenicity study in rabbits, with safety factor of 100) | Yes |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | In the framework of AIR III, the RMS proposed a new ADI (0.25 mg/kg bw per day) and a new ARfD (0.9 mg/kg bw) for **captan**. According to the RMS, the rabbit is considered to be not the appropriate species for derivation of TRV for human risk assessment. The strong antimicrobial activity of captan is associated with secondary effects unique to the physiology of the rabbit digestive system (ingestion of caecotrophs/coprophagy). |                                                                                                                                                                                                                                                                                                               |                      |                                                                                                                                                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                               |                      |                                                                                                                                                                                                   |     |
|                        | The toxicity of the metabolite **THPI** may need to be reconsidered during the renewal under AIR 3 as proposed by the RMS AT since recent studies indicate the acute oral toxicity of THPI to be higher than that of the parent captan and significantly higher than reported in the original DAR of 2003.                                                                                                                                      |                                                                                                                                                                                                                                                                                                               |                      |                                                                                                                                                                                                   |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; TRV: toxicological reference values; DAR:draft assesment report.

John Wiley & Sons, Ltd

### 4.1.3. Residue definitions -- captan (Table [4](#efs25306-tbl-0004){ref-type="table"}) {#efs25306-sec-0025}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------+-----------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR evaluation                                                                         | EU evaluation                                       | RDs comparable |
+=========================+=============================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================================+=====================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                              | Captan                                                                                  | Reg. 396/2005:                                      | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         | Sum of captan and THPI, expressed as captan         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         | Wine grapes: captan                                 |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------+-----------------------------------------------------+----------------+
| Animal products         | Captan                                                                                                                                                                                                                                                                                                                                                                                                                                      | Reg. 396/2005:                                                                          | No                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         |                                                     |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                              | Animal matrices except honey: sum of THPI, 3‐OH THPI and 5‐OH THPI, expressed as captan |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Honey and other apiculture products: sum of captan and THPI, expressed as captan        |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             | The residue is not fat soluble                                                          |                                                     |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------+-----------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                              | Captan                                                                                  | EFSA ([2014c](#efs25306-bib-0058){ref-type="ref"}): | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         | Sum of captan and THPI, expressed as captan         |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------+-----------------------------------------------------+----------------+
| Animal products         | Captan                                                                                                                                                                                                                                                                                                                                                                                                                                      | EFSA ([2014c](#efs25306-bib-0058){ref-type="ref"}):                                     | No                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                         |                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Sum of THPI, 3‐OH THPI and 5‐OH THPI, expressed as captan                               |                                                     |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------+-----------------------------------------------------+----------------+
| **Conclusion/comments** | Footnote for EU residue definition: The EU reference laboratories identified the reference standard for 3‐OH THPI and 5‐OH THPI as commercially not available. When re‐viewing the MRL, the Commission will take into account the commercial availability of the reference standard referred to in the first sentence by 30 March 2017, or, if that reference standard is not commercially available by that date, the unavailability of it |                                                                                         |                                                     |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------+-----------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.1.4. Codex MRL proposals -- captan (Table [5](#efs25306-tbl-0005){ref-type="table"}) {#efs25306-sec-0026}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+--------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity            | Codex MRL proposal | EU MRL                                      | Comment                                                                                                                                                                                                                    |
+======================+====================+=============================================+============================================================================================================================================================================================================================+
| Ginseng              | No Codex proposal  | 0.1[\*](#efs25306-note-0599){ref-type="fn"} | Critical GAP: USA critical GAP is 3.36 kg ai/ha with a maximum of 8 applications or 27 kg ai/ha per season and a PHI of 14 days.                                                                                           |
|                      |                    |                                             |                                                                                                                                                                                                                            |
|                      |                    |                                             | Four trials conducted at 26.88 kg ai/ha per season, in accordance with the USA critical GAP.                                                                                                                               |
|                      |                    |                                             |                                                                                                                                                                                                                            |
|                      |                    |                                             | The 2017 JMPR concluded that '*there were analytical issues in the supervised field trials that precluded sufficient confidence in the representativeness of the captan residues for estimating a maximum residue level*'. |
|                      |                    |                                             |                                                                                                                                                                                                                            |
|                      |                    |                                             | In addition, it should be highlighted that metabolism studies for root crops would be required. JMPR did not report the availability of metabolism studies in root crops neither in 2017 nor in previous assessments.      |
|                      |                    |                                             |                                                                                                                                                                                                                            |
|                      |                    |                                             | The RMS informed EFSA, that in the AIR III process, a metabolism study on root crops was not provided.                                                                                                                     |
+----------------------+--------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments** | --                 |                                             |                                                                                                                                                                                                                            |
+----------------------+--------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; RMS: rapporteur Member State; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; PHI: preharvest interval.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.1.5. Consumer risk assessment -- captan {#efs25306-sec-0027}

Not relevant, since no Codex MRL proposal was derived.

4.2. Chlormequat (15) (R/T) {#efs25306-sec-0028}
---------------------------

### 4.2.1. Background information (Table [6](#efs25306-tbl-0006){ref-type="table"}) {#efs25306-sec-0029}

###### 

Background information on chlormequat

                                                      Comments, references
  ------------------------- ------------------------- --------------------------------------------------------------------------------------
  Type of JMPR evaluation   Periodic review           
  RMS                       UK                        
  Approval status           Renewal of the approval   Commission Directive 2010/2/EU[a](#efs25306-note-0011){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2009a](#efs25306-bib-0013){ref-type="ref"}) EFSA on‐going conclusion (AIR IV)
  MRL review                Yes, see comments         EFSA ([2016d](#efs25306-bib-0094){ref-type="ref"})
  MRL applications          No                        None on going
                                                      

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State**.**

2010/2/EU: Commission Directive 2010/2/EU of 27 January 2010 amending Council Directive 91/414/EEC as regards an extension of the use of the active substance chlormequat. OJ L 24, 28.1.2010, p. 11--13.

John Wiley & Sons, Ltd

### 4.2.2. Toxicological reference values -- chlormequat (Table [7](#efs25306-tbl-0007){ref-type="table"}) {#efs25306-sec-0030}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                          | EU evaluation                  | TRV comparable        |                                                                              |    |
+========================+==========================================================================================================================================================================================================================================================================================================================================+================================+=======================+==============================================================================+====+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                                                                                                                                                                                    | JMPR 2017;                     | 0.04 mg/kg bw per day | EFSA ([2009a](#efs25306-bib-0013){ref-type="ref"})Dog, 1‐year study          | No |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          | Dog, 90‐day and 1‐year studies |                       | (UF 100)                                                                     |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       | Confirmed in                                                                 |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       | European Commission ([2015](#efs25306-bib-0146){ref-type="ref"})             |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+------------------------------------------------------------------------------+----+
| **ARfD**               | 0.05 mg/kg bw                                                                                                                                                                                                                                                                                                                            | JMPR 2017;                     | 0.09 mg/kg bw         | EFSA ([2009a](#efs25306-bib-0013){ref-type="ref"})Dog, 4‐week study          | No |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          | Dog, 90‐day and 1‐year studies |                       | (UF 100)                                                                     |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       | Confirmed inEuropean Commission ([2015](#efs25306-bib-0146){ref-type="ref"}) |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+------------------------------------------------------------------------------+----+
| **Conclusion/comment** | **JMPR** confirmed the previous assessments of chlormequat, establishing the ADI and the ARfD on the basis of the overall NOAEL of 4.7 mg/kg bw per day in the 1‐year and 90‐day dog studies, and applying a safety factor of 100.                                                                                                       |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        | During the **EU** peer review, the 1‐year dog study was also considered for the derivation of the ADI, with an additional correction of the NOAEL (from 5 to 4 mg/kg bw per day) in order to take into account the analytical results during the study (the tested concentrations were 21% lower than the target values after 6 months). |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        | For the derivation of the ARfD, the acute effects observed during the 4‐week dog study were considered as an appropriate basis.                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        |                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                                              |    |
|                        | It is noted that the EU and JMPR ADI and ARfD are established for chlormequat chloride. JMPR has recalculated to TRV using the molecular weight correction factor to match with the residue definition that is expressed as chlormequat cation.                                                                                          |                                |                       |                                                                              |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+------------------------------------------------------------------------------+----+

EU: European Union; ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; NOAEL: no observed adverse effect level; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.2.3. Residue definitions -- chlormequat (Table [8](#efs25306-tbl-0008){ref-type="table"}) {#efs25306-sec-0031}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                            | JMPR evaluation                                                                                     | EU evaluation (EFSA, [2016d](#efs25306-bib-0094){ref-type="ref"})                                                          | RDs comparable          |
+=========================+============================================================================================================================================================================================================================================================================================================+=====================================================================================================+============================================================================================================================+=========================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                             | Chlormequat cation                                                                                  | EU Reg. 396/2005: Chlormequat (Sum of chlormequat and its salts, expressed as chlormequat chloride)                        | Yes (see comment below) |
|                         |                                                                                                                                                                                                                                                                                                            |                                                                                                     |                                                                                                                            |                         |
|                         |                                                                                                                                                                                                                                                                                                            |                                                                                                     | Art 12: Sum of chlormequat and its salts, expressed as chlormequat chloride (only for cereals, pears and cultivated fungi) |                         |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-------------------------+
| Animal products         | Chlormequat cation                                                                                                                                                                                                                                                                                         | EU Reg. 396/2005: Chlormequat (Sum of chlormequat and its salts, expressed as chlormequat chloride) | Yes (see comment below)                                                                                                    |                         |
|                         |                                                                                                                                                                                                                                                                                                            |                                                                                                     |                                                                                                                            |                         |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                             | Art 12: Sum of chlormequat and its salts, expressed as chlormequat chloride                         |                                                                                                                            |                         |
|                         |                                                                                                                                                                                                                                                                                                            |                                                                                                     |                                                                                                                            |                         |
|                         |                                                                                                                                                                                                                                                                                                            | The residue is not fat soluble                                                                      |                                                                                                                            |                         |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-------------------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                             | Chlormequat cation                                                                                  | Sum of chlormequat and its salts, expressed as chlormequat chloride (only for cereals, pears and cultivated fungi)         | Yes (see comment below) |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-------------------------+
| Animal products         | Chlormequat cation                                                                                                                                                                                                                                                                                         | Sum of chlormequat and its salts, expressed as chlormequat chloride                                 | Yes (see comment below)                                                                                                    |                         |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-------------------------+
| **Conclusion/comments** | Residue definitions for enforcement derived by JMPR and by EU evaluation are comparable. However, if CXLs defined for chlormequat cation are taken over in the EU, they need to be multiplied by a correction factor of 1.29 to be expressed as chlormequat chloride (molecular weight correction factor). |                                                                                                     |                                                                                                                            |                         |
|                         |                                                                                                                                                                                                                                                                                                            |                                                                                                     |                                                                                                                            |                         |
|                         | NB: the JMPR residue definition also applies to fruit crops as an additional metabolism study performed on grapes was assessed in the JMPR report. This study was not assessed in the EU evaluation                                                                                                        |                                                                                                     |                                                                                                                            |                         |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-------------------------+

CXL: Codex Maximum Residue Limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice.

John Wiley & Sons, Ltd

### 4.2.4. Codex MRL proposals -- chlormequat (Table [9](#efs25306-tbl-0009){ref-type="table"}) {#efs25306-sec-0032}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                                                                                                              | EU MRL                                              | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+===============================================+=================================================================================================================================+=====================================================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Barley                                        | 2                                                                                                                               | 3                                                   | Critical GAP: 1 x 1,650 g a.s./ha at BBCH 25‐30 (no PHI needed) (UK)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: minor deviation on the timing of applications seems acceptable to support the UK GAP. MRL proposal needs to be converted into chlormequat chloride before being compared with the EU MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is acceptable. See general comment below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder, dry                  | 50 (dw)                                                                                                                         |                                                     | Critical GAP: 1 × 1650 g a.s./ha at BBCH 25‐30 (no PHI needed) \[the most critical GAP authorised Ireland is not supported by data\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: same as for barley grain.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: Currently, no MRLs are established in the EU for feed items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pearl (pot) barley                            | 2                                                                                                                               |                                                     | PF of 0.9 is derived by JMPR. A similar PF of 0.9 was derived in the context of the MRL review                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley, malt                                  | 2                                                                                                                               |                                                     | PF of 0.9 was derived by JMPR from one processing study. A similar PF of 0.9 was derived in the context of the MRL review                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley, spent grain                           | 2                                                                                                                               |                                                     | PF of 0.02 was derived by JMPR from 4 processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley, beer                                  | 2                                                                                                                               |                                                     | A PF of 0.2 was derived by JMPR from 4 processing studies. A similar PF of 0.2 was derived in the context of the MRL review.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oats                                          | 4                                                                                                                               | 15                                                  | Critical GAP: 1 × 1650 g a.s./ha at BBCH 33 (UK)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: No, 1 trial is missing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: MRL proposal needs to be converted into chlormequat chloride before being implemented in the EU Regulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is acceptable. See general comment below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oat straw and fodder, dry                     | 7 (dw)                                                                                                                          |                                                     | Critical GAP: 1 × 1,650 g a.s./ha at BBCH 33 (UK)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes, although 1 trial is missing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: same as oat grain.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: Currently, no MRLs are established in the EU for feed items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oat kernels                                   | 4                                                                                                                               |                                                     | PF of 1 was derived by JMPR from 1 trial. No PF derived for this commodity in the MRL review.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oat flakes                                    | 4                                                                                                                               |                                                     | PF of 0.8 was derived by JMPR. A similar PF of 1 was derived in the context of the MRL review while 0.8 is derived by JMPR.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale                                     | 5                                                                                                                               | 4                                                   | Critical GAP: 1 × 1875 g a.s./ha at BBCH 31 (Ireland)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: The use of the proportionality principle was applied to scale residue trials performed on rye with different application rates compared to GAP; trials performed on wheat were not considered as they showed lower residue levels. MRL proposal needs to be converted into chlormequat chloride before being implemented in the EU Regulation. It is noted that the EU MRL for triticale is covered by the EU MRL on wheat.It is noted that the most critical GAP reported in NEU during the MRL review was 1 × 0.6 kg/ha; BBCH 49) while the GAP considered in the JMPR report also comes from EU and is more critical than the one considered in the MRL review. |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is sufficiently supported by data and is therefore acceptable. See general comment below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale straw and fodder, dry 80 (dw)       | 80 (dw)                                                                                                                         |                                                     | Critical GAP: 1 × 1875 g a.s./ha at BBCH 31 (Ireland)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 23                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: Same as triticale grain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: Currently, no MRLs are established in the EU for feed items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat                                         | 2                                                                                                                               | 4                                                   | Critical GAP: 1 × 2025 g a.s./ha at BBCH 21‐31 (Argentina) \[the most critical GAP from Japan is not clearly defined\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 25                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: The use of the proportionality principle was applied to scale up residue trials which were all performed with lower application rates compared to GAP. MRL proposal needs to be converted into chlormequat chloride before being implemented in the EU Regulation.                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is acceptable. It is noted that for triticale a higher MRL proposal was derived. In the EU triticale and wheat are normally covered by a common MRL. Therefore, the triticale CXL would be applicable to wheat as well.                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat straw and fodder, dry                   | 80 (dw)                                                                                                                         |                                                     | Critical GAP: 1 × 2,025 g a.s./ha at BBCH 21‐31 (Argentina)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 24                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: same as for wheat grain.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: Currently, no MRLs are established in the EU for feed items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| White (type 550) wheat flour                  | 2                                                                                                                               |                                                     | PF of 0.29 is derived by JMPR. A similar PF (0.3) was derived in the context of the MRL review                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat bran, unprocessed                       | 7                                                                                                                               |                                                     | PF of 3.0 is derived by JMPR. A similar PF (3.1) was derived in the context of the MRL review.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | An MRL of 6 mg/kg should be enough as the MRL on wheat grain is 2 mg/kg and the derived PF is 3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | However, currently, no MRLs are established for processed products in the EU                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wholemeal flour                               | 2                                                                                                                               |                                                     | PF of 1.2 is derived by JMPR; a similar PF of 1 was derived in the context of the MRL review                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat wholemeal bread                         | 2                                                                                                                               |                                                     | PF of 0.54 is derived by JMPR; a similar PF of 0.5 was derived in the context of the MRL review.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat wholemeal                               | 2                                                                                                                               |                                                     | It is not understood to which product the PF of 1.2 refers (wheat wholemeal?). Whole meal flour and whole meal bread are already covered in the rows above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye                                           | **6**                                                                                                                           | 4                                                   | Critical GAP: 1 × 2250 g a.s./ha at BBCH 21‐32 (Latvia)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: The use of the proportionality principle was applied to scale up residue trials which were performed with a lower application rate compared to GAP. MRL proposal needs to be converted into chlormequat chloride before being implemented in the EU Regulation. It is noted that the most critical reported in NEU during the MRL review was 1 × 1.5 kg/ha; BBCH 37) while the GAP considered in the JMPR report also comes from EU and is more critical than the one considered in the MRL review.                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is acceptable. See general comment below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye straw and fodder, dry                     | 20 (dw)                                                                                                                         |                                                     | Critical GAP: 1 × 2,250 g a.s./ha at BBCH 21‐32 (Latvia)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: Same as rye grain.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: Currently, no MRLs are established in the EU for feed items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye bran, unprocessed                         | 20                                                                                                                              |                                                     | PF of 3.2 is derived by JMPR from 1 trial only. A similar PF (3.1) was derived in the context of the MRL review                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye flour                                     | 6                                                                                                                               |                                                     | PF of 0.99 is derived by JMPR from 1 trial only. A PF of 0.3 was derived in the context of the MRL review.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye whole meal                                | 8                                                                                                                               |                                                     | PF of 1.3 is derived by JMPR from 1 trial only. A similar PF (1) was derived in the context of the MRL review for whole meal flour                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye wholemeal bread                           | 6                                                                                                                               |                                                     | PF of 0.95 is derived by JMPR from 1 trial only. A lower PF (0.5) was derived for whole meal bread in the context of the MRL review                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Straw and fodder (dry) of cereal grains       | W30                                                                                                                             |                                                     | The existing CXL is recommended for withdrawal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapes                                        | 0.04[\*](#efs25306-note-0600){ref-type="fn"}                                                                                    | 0.05 (ft) (table)                                   | Critical GAP: 3 foliar applications (1st 500 + 2nd 1,000 + 3rd 250) g a.s./ha; PHI 91 days (India))                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 | 0.01[\*](#efs25306-note-0600){ref-type="fn"} (wine) | Number of trials: 6 × \< 0.04 (according to application rate defined in the GAP) + 2 × \< 0.04 (more critical application rate) \[samplings on mature grapes are performed at PHI 120--150 days, which is longer than the PHI defined by the GAP\].                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Sufficiently supported by data: Yes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: the metabolism study for fruit crops was not assessed at EU level, but the study confirms the proposed residue definition. It is noted that, for some trials, the PHI in the residue trials was longer than the PHI defined in the GAP. Longer PHI in the residue trials is not covering the GAP with 91 days. According to 25% tolerance rule, PHI 114 d should be the maximum.                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. See also general comment below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton seed                                   | W0.5                                                                                                                            | 0.7 (ft)                                            | The existing CXL is recommended for withdrawal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rape seed                                     | W5                                                                                                                              | 7 (ft)                                              | The existing CXL is recommended for withdrawal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rape seed oil, Crude                          | W0.1                                                                                                                            |                                                     | The existing CXL is recommended for withdrawal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize fodder (dry)                            | W7                                                                                                                              | 0.01[\*](#efs25306-note-0600){ref-type="fn"}        | The existing CXL is recommended for withdrawal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | 0.2                                                                                                                             | 0.2                                                 | Maximum dietary burden was calculated for the Australian diet for beef and dairy cattle. Feeding study with highest dose level covers the max DB.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | The HR in meat is only 0.091 mg/kg; thus, a MRL proposal of 0.1 mg/kg (or 0.15) should be enough; no information is available for muscle. However, considering that the residues in meat and fat were in the same range, it is assumed that in muscle the same residue level would occur. Thus, the MRL proposal derived by JMPR for meat would be appropriate also for muscle. Before this, MRL can be taken over in the EU, it needs to be converted into chlormequat chloride (0.1 (or 0.15 mg/kg) ×1.29 = 0.15 (or 0.2 mg/kg). The MRL proposal derived after the conversion would be comparable with the existing EU MRL for muscle (expressed as chlormequat chloride).                      |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable. JMPR should be asked for a clarification for the MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | **0.1**                                                                                                                         | (swine, 0.02, rest 0.06)                            | Max Dietary burden = 100 ppm (assumed to be mg/kg DM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Feeding study with highest dose level (93 ppm) covering the max DB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | HR in fat is only 0.083 mg/kg; thus, a MRL proposal of 0.09 mg/kg should be enough. MRL proposal needs to be converted into chlormequat chloride before being compared with the EU MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable. JMPR should be asked for a clarification for the MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | **1**                                                                                                                           | 0.5 others                                          | Max Dietary burden = 100 ppm (assumed to be mg/kg DM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 | 0.15 (liver)                                        | Feeding study with highest dose level (93 ppm) covering the max DB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 | 0.5 (kidney)                                        | HR in liver/kidney is only 0.88 mg/kg; thus, a MRL proposal of 0.9 mg/kg should be enough. MRL proposal needs to be converted into chlormequat chloride before being compared with the EU MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable. JMPR should be asked for a clarification for the MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat of cattle, pigs and sheep                | W0.2                                                                                                                            | (see above 0.2)                                     | Replaced by the proposal for all 'mammals other than marine mammals'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Goat meat                                     | W0.2                                                                                                                            | 0.2                                                 | Replaced by the new proposal for all 'mammals other than marine mammals'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Liver of cattle, goats, pigs and sheep        | W0.1                                                                                                                            | 0.5 others                                          | Replaced by the proposal for all 'mammals other than marine mammals'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 | 0.15 (liver)                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 | 0.5 (kidney)                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Kidney of cattle, goats, pigs and sheep       | W0.5                                                                                                                            | 0.5 others                                          | Replaced by the proposal for all 'mammals other than marine mammals'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 | 0.15 (liver)                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 | 0.5 (kidney)                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.3                                                                                                                             | 0.5                                                 | Max Dietary burden = 66.8 ppm (assumed to be mg/kg DM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Feeding study with highest dose level (93 ppm) covering the max DB.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: MRL proposal needs to be converted into chlormequat chloride before being compared with the EU MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is acceptable. See general comments below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk of cattle, goats and sheep               | W0.5                                                                                                                            |                                                     | Replaced by the proposal for all 'milks' (see above)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                  | 0.04[\*](#efs25306-note-0600){ref-type="fn"}                                                                                    | 0.04                                                | Maximum dietary burden was calculated for European laying hens (11.4 ppm mg/kg DM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Feeding study with highest dose level (14 ppm) covering the max DB. No residues were found at any of the feeding levels (highest feeding level 4N calculated dietary burden).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | The MRL in EU should be defined for 'poultry muscle'. Since MRL at LOQ is proposed for meat and fat, it can reasonably be also transposed at an MRL of 0.04\* mg/mg in poultry muscle.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is acceptable. See general comments below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                  | **0.04** [\*](#efs25306-note-0600){ref-type="fn"}                                                                               | 0.03                                                | Max Dietary burden: 11.4 ppm (assumed to be mg/kg DM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Feeding study with highest dose level (14 ppm) covering the max DB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Specific comments/observations: MRL proposal needs to be converted into chlormequat chloride before being compared with the EU MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: The proposed Codex MRL is acceptable. See general comments below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                      | 0.1                                                                                                                             | 0.1                                                 | Max Dietary burden: 11.4 ppm (assumed to be mg/kg DM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Feeding study with highest dose level (14 ppm) covering the max DB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | HR in liver is only 0.072 mg/kg; thus, a MRL proposal of 0.08 mg/kg should be enough. MRL proposal needs to be converted into chlormequat chloride before being compared with the EU MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. JMPR should be asked for a clarification for the MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                          | 0.1                                                                                                                             | 0.1                                                 | Max Dietary burden: 11.4 ppm (assumed to be mg/kg DM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Feeding study with highest dose level (14 ppm) covering the max DB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | HR in eggs is only 0.079 mg/kg; thus, a MRL proposal of 0.08 mg/kg should be enough. MRL proposal needs to be converted into chlormequat chloride before being compared with the EU MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                               |                                                                                                                                 |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                 |                                                     | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. JMPR should be asked for a clarification for the MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| General comment:                              | Acceptable Codex MRL proposals need to be converted into chlormequat chloride before being taken over in the EU MRL legislation |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; DM: dry matter; CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice; PF: processing factor; NEU: northern European Union; HR: highest residue.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.2.5. Consumer risk assessment -- chlormequat (Table [10](#efs25306-tbl-0010){ref-type="table"}) {#efs25306-sec-0033}

###### 

Summary of the consumer risk assessment for chlormequat

+-----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                 | Chronic exposure assessment                                                                                                                                                                                                                                                              | Comments on JMPR exposure assessment                                                                         |
+===========================================================================================================================================================+==========================================================================================================================================================================================================================================================================================+==============================================================================================================+
| **RA assumptions:**                                                                                                                                       | **RA assumptions:**                                                                                                                                                                                                                                                                      | **Specific comments**                                                                                        |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| The short‐term dietary risk assessment was performed for all commodities assessed by JMPR.                                                                | The most recent long‐term risk assessment (EFSA, [2016d](#efs25306-bib-0094){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for rye grain, wheat grain, table and wine grapes and livestock commodities. | Detailed RA values can be assessed for wheat and triticale, which is not possible with the EU PRIMo.         |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| HR values derived by JMPR were multiplied by the molecular factor of 1.29 in order to express the residues as chlormequat chloride, in line with the TRV. | STMR values derived by JMPR were multiplied by the molecular factor of 1.29 in order to express the residues as chlormequat chloride, in line with the TRV.                                                                                                                              | RA values are expressed as chlormequat cation, but TRV were also converted accordingly, i.e. divided by 1.29 |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| Contribution of cereals was assessed with STMR RAC.                                                                                                       | Contribution of cereals was assessed with STMR RAC. No refinement was performed with the processing factors. For wheat, the highest STMR between wheat and triticale was considered in the calculation (i.e. STMR triticale)                                                             |                                                                                                              |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| Two scenarios were calculated, using the EU ARfD (scenario 1) and the JMPR ARfD (scenario 2)                                                              |                                                                                                                                                                                                                                                                                          |                                                                                                              |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                              | **Results:**                                                                                                                                                                                                                                                                             | **Results:**                                                                                                 |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| [Scenario 1, considering ARfD derived by EFSA ( [2009a](#efs25306-bib-0013){ref-type="ref"}):]{.ul}                                                       | [Scenario 1, considering ARfD derived by EFSA ( [2009a](#efs25306-bib-0013){ref-type="ref"}):]{.ul}                                                                                                                                                                                      | Long‐term exposure:                                                                                          |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| No short‐term exposure concern was identified (max 40% ARfD for milk).                                                                                    | The overall chronic exposure accounted for 40.4% of the ADI (DK child).                                                                                                                                                                                                                  | 1--7% of the ADI                                                                                             |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| [Scenario 2: considering ARfD derived by JMPR (FAO, [2017](#efs25306-bib-0152){ref-type="ref"}):]{.ul}                                                    | Main contributors are wheat (16.3% ADI), rye (15.7% ADI) and milk and cream (5.1% ADI).                                                                                                                                                                                                  | Short‐term exposure:                                                                                         |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
| No short‐term exposure concern was identified (max 72% ARfD for milk)                                                                                     | Considering the ADI derived by EFSA ([2009a](#efs25306-bib-0013){ref-type="ref"}), no long‐term consumer health risk was identified. As the ADI derived by JMPR is less critical, no further concern is expected                                                                         | Up to 100% ARfD (rye)                                                                                        |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          | Up to 100% ARfD (oats)                                                                                       |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          |                                                                                                              |
|                                                                                                                                                           |                                                                                                                                                                                                                                                                                          | 40% ARfD (milks)                                                                                             |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------+

RA: risk assesment; ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; HR: Highest residue; RAC: raw agricultural commodity; STMR: supervised trials median residue.
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4.3. 2,4‐D (20) (R) {#efs25306-sec-0034}
-------------------

### 4.3.1. Background information (Table [11](#efs25306-tbl-0011){ref-type="table"}) {#efs25306-sec-0035}

###### 

Background information on 2,4‐D

+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+
|                         |                         | Comments, references                                                                                    |
+=========================+=========================+=========================================================================================================+
| Type of JMPR evaluation | New uses                |                                                                                                         |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+
| RMS                     | EL                      |                                                                                                         |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+
| Approval status         | Renewal of the approval | Commission Implementing Regulation (EU) 2015/2033[a](#efs25306-note-0017){ref-type="fn"}                |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA, 2014m (corrigendum 2017)                                                                          |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments       | EFSA (2011g)                                                                                            |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments       | EFSA ([2017b](#efs25306-bib-0110){ref-type="ref"}) (import tolerance maize)                             |
|                         |                         |                                                                                                         |
|                         |                         | Application on modification of MRL in GM soya beans currently on clock‐stop (additional data requested) |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+
|                         |                         |                                                                                                         |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue limit.

2015/2033/EU: Commission Implementing Regulation (EU) 2015/2033 of 13 November 2015 renewing the approval of the active substance 2,4‐D in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 298, 14.11.2015, p. 8--11.

John Wiley & Sons, Ltd

### 4.3.2. Toxicological reference values -- 2,4‐D (Table [12](#efs25306-tbl-0012){ref-type="table"}) {#efs25306-sec-0036}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | EU evaluation | TRV comparable        |                                                                                                                    |    |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+====================================================================================================================+====+
| **ADI**                | 0.01 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR 1996     | 0.02 mg/kg bw per day | EFSA ([2014m](#efs25306-bib-0068){ref-type="ref"}) (Dog, 1‐year, safety factor 100) confirmed in                   | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       | European Commission ([2017c](#efs25306-bib-0149){ref-type="ref"})                                                  |    |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR 2001     | 0.3 mg/kg bw          | EFSA ([2014m](#efs25306-bib-0068){ref-type="ref"}) (Rat and rabbit                                                 | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       | developmental                                                                                                      |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       | toxicity studies, safety factor 100) confirmed inEuropean Commission ([2017c](#efs25306-bib-0149){ref-type="ref"}) |    |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | The last toxicological assessment of 2,4‐D by JMPR was performed in 2001, where JMPR assessed the need for setting an ARfD.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |               |                       |                                                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                    |    |
|                        | The ADI was derived in 1996.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       |                                                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                    |    |
|                        | 2,4‐dichlorophenol (2,4‐DCP) was identified in the metabolism studies performed with 2,4‐D in GM soybeans expressing the AAD‐12 protein (6% of TRR, free and conjugated). This metabolite also occurred in metabolism study with conventional root crops (4% of TRR in potato, 1% of TRR in wheat forage and straw), in livestock metabolism studies performed with 2,4‐D (up to 7.3% milk, eggs and chicken liver) and in livestock metabolism studies with 2,4‐DB (up to 40% of TRR in conjugated from).                                                                                                                    |               |                       |                                                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                    |    |
|                        | Toxicological studies on 2,4‐DCP were never assessed by JMPR.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                    |    |
|                        | At EU level, during the renewal peer review of 2,4‐D and 2,4‐DB, the toxicological properties of 2,4‐DCP were investigated (EFSA, [2014m](#efs25306-bib-0068){ref-type="ref"}, [2016k](#efs25306-bib-0101){ref-type="ref"}). Based on the available equivocal data, no firm conclusion could be drawn on the genotoxic or carcinogenic potential of metabolite 2,4‐DCP (positive results were reported *in vitro*) and on its toxicological profile (2,4‐DCP caused embryotoxicity (reduced intrauterine survival, foetal weight and ossification) in rats at maternally toxic doses (mortality and reduced body weight gain) |               |                       |                                                                                                                    |    |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union; GM: genetically modified; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRR: total radioactive residue; TRV: toxicological reference values.
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### 4.3.3. Residue definitions -- 2,4‐D (Table [13](#efs25306-tbl-0013){ref-type="table"}) {#efs25306-sec-0037}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------+----------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                         | JMPR evaluation                                                | EU evaluation                                                  | RDs comparable |
+=========================+=========================================================================================================================================================================================================================================================================================================================================================+================================================================+================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                          | Sum of 2,4‐D                                                   | 2,4‐D (sum of 2,4‐D, its salts, its esters and its conjugates, | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                |                                                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                | expressed as 2,4‐D)                                            |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------+----------------------------------------------------------------+----------------+
| Animal products         | Sum of 2,4‐D                                                                                                                                                                                                                                                                                                                                            | 2,4‐D (sum of 2,4‐D, its salts, its esters and its conjugates, | No                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                |                                                                |                |
|                         | Fat solubility not specified                                                                                                                                                                                                                                                                                                                            | expressed as 2,4‐D)                                            |                                                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                |                                                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         | The residue is not fat soluble                                 |                                                                |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------+----------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                          | Sum of 2,4‐D                                                   | Sum of 2,4‐D, its salts, esters and conjugates expressed       | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                |                                                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                | as 2,4‐D                                                       |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------+----------------------------------------------------------------+----------------+
| Animal products         | Sum of 2,4‐D                                                                                                                                                                                                                                                                                                                                            | Sum of 2,4‐D, its salts, esters and conjugates expressed       | No                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                |                                                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         | as 2,4‐D                                                       |                                                                |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------+----------------------------------------------------------------+----------------+
| **Conclusion/comments** | In GM cotton (AAD‐12 cotton), 2,4‐DCP and its conjugates were detected at similar or even at higher concentrations than parent 2,4‐D. JMPR did not consider appropriate to include this metabolite in the residue definition since it may occur in or on plants not only from the use of 2,4‐D but also from its presence in water and the environment. |                                                                |                                                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                         |                                                                |                                                                |                |
|                         | According to EFSA, before a decision on the need to include this metabolite in a residue definition related to the use of 2,4‐D containing plant protection products is taken, the toxicological profile of the metabolite need to be investigated                                                                                                      |                                                                |                                                                |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------+----------------------------------------------------------------+----------------+

EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RD‐RA: residue definition for risk assessment; RD‐ENF: residue definition for enforcement practice; GM: genetically modified.
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### 4.3.4. Codex MRL proposals -- 2,4‐D (Table [14](#efs25306-tbl-0014){ref-type="table"}) {#efs25306-sec-0038}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

  Commodity     Codex MRL proposal   EU MRL                                         Comment
  ------------- -------------------- ---------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------
  Cotton seed   **--**               0.05[\*](#efs25306-note-0601){ref-type="fn"}   Due to questionable storage stability of 2,4‐D and 2,4‐DCP in cotton seed, the trials were not assessed by JMPR and no Codex MRL proposal was derived

EU MRL: European Union maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.3.5. Consumer risk assessment -- 2,4‐D {#efs25306-sec-0039}

Not relevant, since no Codex MRL proposals were derived by JMPR.

4.4. Thiophanate‐methyl (77) (T) {#efs25306-sec-0040}
--------------------------------

### 4.4.1. Background information (Table [15](#efs25306-tbl-0015){ref-type="table"}) {#efs25306-sec-0041}

###### 

Background information on thiophanate‐methyl

                                                                         Comments, references
  ------------------------- -------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type of JMPR evaluation   Periodic review                              
  RMS                       SE                                           
  Approval status           Renewal of the approval                      Commission Implementing Regulation (EU) 2017/1511[a](#efs25306-note-0022){ref-type="fn"}
  EFSA conclusion           Yes, see comments                            EFSA (2018b)
  MRL review                Yes, see comments                            EFSA (2014s)
  MRL applications          No                                           
  EU cut‐off criteria       Lack of toxicological reference values       Since no toxicological reference values were established, based on genotoxicity concerns, the approval criteria are not met
                            Proposed classification by the peer review   The peer review proposed classification for thiophanate‐methyl as Muta 1B, H340 (falling under cut‐off criteria) while current harmonised classification is Muta 2, H341
                            Endocrine disrupting potential               The peer review considered that there is enough evidence to conclude that thiophanate‐methyl is an endocrine disruptor and that the mechanism is relevant to humans (cut‐off criteria)

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union MRL: maximum residue limit.

2017/1511/EU: Commission Implementing Regulation (EU) 2017/1511 of 30 August 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1‐methylcyclopropene, beta‐cyfluthrin, chlorothalonil, chlorotoluron, cypermethrin, daminozide, deltamethrin, dimethenamid‐p, flufenacet, flurtamone, forchlorfenuron, fosthiazate, indoxacarb, iprodione, MCPA, MCPB, silthiofam, thiophanate‐methyl and tribenuron. OJ L 224, 31.8.2017, p. 115--117.
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### 4.4.2. Toxicological reference values -- thiophanate‐methyl (Table [16](#efs25306-tbl-0016){ref-type="table"}) {#efs25306-sec-0042}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+----------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | EU evaluation | TRV comparable |                                                    |    |
+========================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+================+====================================================+====+
| **ADI**                | 0.09 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR 2017     | --             | EFSA ([2018b](#efs25306-bib-0122){ref-type="ref"}) | No |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+----------------------------------------------------+----+
| **ARfD**               | 1 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | JMPR 2017     | --             | EFSA ([2018b](#efs25306-bib-0122){ref-type="ref"}) | No |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+----------------------------------------------------+----+
| **Conclusion/comment** | Regarding the ADI, the JMPR set an ADI on the basis of a NOAEL of 8.8 mg/kg body weight (bw) per day based on reduction in body weight gain and clinical chemistry, urine analysis and histopathological changes in the kidney, thyroid, liver and adrenals in a 2‐year study in rats. This ADI is supported by the overall NOAEL of 10 mg/kg bw per day based on increased thyroid weight and histopathological changes in the thyroid observed in 3‐month, 1‐year and 2‐year toxicity studies in dogs. A safety factor of 100 was used.                                                                                                                                                                                                                                                           |               |                |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |               |                |                                                    |    |
|                        | The ARfD was established at 1 mg/kg bw on the basis of a NOAEL of 125 mg/kg bw for transient reductions in body weight gains (including body weight losses) and feed consumption in an acute neurotoxicity study in rats, using a safety factor of 100.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |               |                |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |               |                |                                                    |    |
|                        | In its 2018 review, the EU peer review considered thiophanate‐methyl a clastogenic substance (based on positive micronucleus test *in vitro* and *in vivo;* and centromeric staining showing that a high proportion (66%) of the micronuclei induced by thiophanate‐methyl did not contain a centromere, close to the proportion of 76% observed after exposure to the known clastogen mitomycin C and distinctly different from the proportion of 32% observed after exposure to the known aneugen carbendazim) for which no threshold is assumed; therefore, no ADI or ARfD was derived. In addition, a potential for aneugenicity could not be ruled out since its main metabolite, carbendazim, is a recognised aneugenic substance (classified as Muta 1B, H340 in Annex VI to Reg. 1272/2008) |               |                |                                                    |    |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+----------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; NOAEL: no observed adverse effect level; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.4.3. Residue definitions thiophanate‐methyl {#efs25306-sec-0043}

No residue assessment was performed by JMPR.

### 4.4.4. Codex MRL proposals thiophanate‐methyl {#efs25306-sec-0044}

No Codex MRL proposals were derived by JMPR.

### 4.4.5. Consumer risk assessment -- thiophanate‐methyl {#efs25306-sec-0045}

Not relevant since no Codex MRL proposals were derived by JMPR.

4.5. Oxamyl (126) (R/T) {#efs25306-sec-0046}
-----------------------

### 4.5.1. Background information (Table [17](#efs25306-tbl-0017){ref-type="table"}) {#efs25306-sec-0047}

###### 

Background information on oxamyl

                                                      Comments, references
  ------------------------- ------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type of JMPR evaluation   Periodic review           
  RMS                       IT                        
  Approval status           Renewal of the approval   Commission Implementing Regulation (EU) No 1136/2013[a](#efs25306-note-0025){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2005a](#efs25306-bib-0003){ref-type="ref"}) EFSA ongoing conclusion (AIR III)
  MRL review                Yes, see comments         EFSA ([2010h](#efs25306-bib-0024){ref-type="ref"})
  MRL applications          No                        
  General comment                                     The previous EU assessment of the toxicological properties of oxamyl is more than 12 years old. The renewal process for the approval of the a.s. is ongoing. It may reasonably be expected that in the framework of the renewal process different conclusions on toxicological properties of oxamyl and its metabolites will be derived. Therefore, the comments on the acceptability of toxicological reference values, on Codex MRL proposals and the resulting risk assessment are only tentative and may have to be revised in the light of the outcome of the peer review. If EU GAPs that were the basis of the assessment performed by JMPR will be revised as a consequence of the EU peer review, the Codex MRL proposals will have to be reconsidered

EU: European Union GAP: Good Agricultural Practice; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

1136/2013/EU: Commission Implementing Regulation (EU) No 1136/2013 of 12 November 2013 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clothianidin, dimoxystrobin, oxamyl and pethoxamid. OJ L 302, 13.11.2013, p. 34--35.

John Wiley & Sons, Ltd

### 4.5.2. Toxicological reference values -- oxamyl (Table [18](#efs25306-tbl-0018){ref-type="table"}) {#efs25306-sec-0048}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+------------------------+-------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | EU evaluation                                                              | TRV comparable         |                                                                               |    |
+========================+===================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+============================================================================+========================+===============================================================================+====+
| **ADI**                | 0.009 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | JMPR 2002, confirmed in 2017 (human volunteers study, safety factor of 10) | 0.001 mg/kg bw per day | EFSA ([2005a](#efs25306-bib-0003){ref-type="ref"})                            | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        | (Acute neurotoxicity                                                          |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        | study (rat), with a safety factor of 100)                                     |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        | confirmed by European Commission ([2011](#efs25306-bib-0141){ref-type="ref"}) |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+------------------------+-------------------------------------------------------------------------------+----+
| **ARfD**               | 0.009 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | JMPR 2002, confirmed in 2017 (human volunteers study, safety factor 10)    | 0.001 mg/kg bw         | EFSA ([2005a](#efs25306-bib-0003){ref-type="ref"})                            | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        | (Acute neurotoxicity                                                          |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        | study (rat), with a safety factor of 100)                                     |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        | confirmed by European Commission ([2011](#efs25306-bib-0141){ref-type="ref"}) |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+------------------------+-------------------------------------------------------------------------------+----+
| **Conclusion/comment** | JMPR and EU assessment considered a different study for the point of departure for setting reference values. According to Regulation EC 1107/2009 '*for ethical reasons, the assessment of an active substance or a plant protection product should not be based on tests or studies involving the deliberate administration of the active substance or plant protection product to humans with the purpose of determining a human 'no observed effect level' of an active substance. Similarly, toxicological studies carried out on humans should not be used to lower the safety margins for active substances or plant protection products.'* On this basis, EFSA supported the reference values as proposed during the European peer review. |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        | In the JMPR assessment and in the EU peer review, a number of metabolites were discussed as regards to their toxicological profiles and the need to include them in the residue definitions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        | Considering that the peer review is currently ongoing, at EU level, final conclusion on the toxicological relevance of the individual metabolites is not yet available. Thus, it is recommended to decide on the acceptability of the assessment, once the EU assessment on the renewal of the a.s. is finalised.                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                            |                        |                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                            |                        |                                                                               |    |
|                        | EFSA, however, noted inconsistency in the naming of one metabolite: IN‐N009 (also referred to as DMCF (dimethylcarbonocyanidic amide) is reported in the residue section mainly as IN‐N0079. The use of different codes in the section 'Toxicology' and 'Residue and analytical aspects' is confusing and should be avoided                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                            |                        |                                                                               |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+------------------------+-------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.5.3. Residue definitions -- oxamyl (Table [19](#efs25306-tbl-0019){ref-type="table"}) {#efs25306-sec-0049}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+---------------+----------------+
|                         | Commodity group                                                                                                                                                                                                              | JMPR evaluation                | EU evaluation | RDs comparable |
+=========================+==============================================================================================================================================================================================================================+================================+===============+================+
| **RD enf**              | Plant products                                                                                                                                                                                                               | Oxamyl                         | Oxamyl        | Yes            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+---------------+----------------+
| Animal products         | Oxamyl                                                                                                                                                                                                                       | Oxamyl                         | Yes           |                |
|                         |                                                                                                                                                                                                                              |                                |               |                |
|                         | The residue is not fat soluble                                                                                                                                                                                               | The residue is not fat soluble |               |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                               | Oxamyl                         | None required | N/A            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+---------------+----------------+
| Animal products         | Oxamyl                                                                                                                                                                                                                       | None required                  | N/A           |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+---------------+----------------+
| **Conclusion/comments** | The existing EU residue definitions will be rediscussed in the framework of the renewal. A final conclusion on the acceptability of the proposed JMPR RD assessment should be postponed until a final EU position is derived |                                |               |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+---------------+----------------+

EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RD: residue definition; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice.

John Wiley & Sons, Ltd

### 4.5.4. Codex MRL proposals -- oxamyl (Table [20](#efs25306-tbl-0020){ref-type="table"}) {#efs25306-sec-0050}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                         | Codex MRL proposal                                                                  | EU MRL                                                                                             | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+===================================================================+=====================================================================================+====================================================================================================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Apple                                                             | W (2)                                                                               | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Brussels sprouts                                                  | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | Critical GAP: NL, 1 × 4 kg a.i./ha (soil application)                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: Brussels sprouts are a category 2 crop; thus, at least 4 trials would be required.                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: Considering that the proposed MRL is at the LOQ, the limited number of trials may be acceptable                                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrot                                                            | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | Critical GAP: NEU: 1 × 0.09 g a.i./m (seed furrow application)                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: For carrots, at least 8 trials would be required.                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: Considering that the proposed MRL is at the LOQ, the limited number of trials may be acceptable                                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                     | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"} (ft)                                                  | Critical GAP: SEU, 4 soil applications with a maximum of 5 kg/ha per crop cycle, PHI 28 days.                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: Combined data set of trials in cherry tomatoes and tomatoes                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Group of citrus fruit (includes all commodities in this group)    | W (3)                                                                               | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton seed                                                       | W0.2                                                                                | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cucumber                                                          | **0.02**                                                                            | 0.01[\*](#efs25306-note-0602){ref-type="fn"} (ft)                                                  | Critical GAP: SEU, 2 soil application with a maximum of 3 kg/ha per crop cycle, PHI 50 days.                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: The number of trials is sufficient according to JMPR rules; however, at EU level, two additional trials would be required. For summer squash, a set of 6 trials was provided for the same GAP. The two data sets could be combined to derive a more robust MRL proposal for cucumber and summer squash.                                                                                                                                                             |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is not acceptable, because the number of trials is insufficient. If the trials on summer squash will be used to support the use on cucumber, an acute consumer health risk cannot be excluded                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                          | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | The proposed Codex MRL was derived from a feeding study, taking into account the expected dietary burden resulting from the uses assessed by JMPR. It was noted that no storage stability data were available for animal products.                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal of cattle, goats, horse, pigs and sheep              | W0.02[\*](#efs25306-note-0602){ref-type="fn"}                                       | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | JMPR proposed to withdraw the existing CXL and replace it with a new MRL of 0.01[\*](#efs25306-note-0602){ref-type="fn"} mg/kg                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggplant (includes all commodities in this subgroup)              | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.02 (ft)                                                                                          | Critical GAP: SEU, 4 soil applications with a maximum of 5 kg/ha per crop cycle, PHI 28 days.                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: Egg plants are a major crop, and therefore, 8 trials would be necessary. Since in the 5 available trials, the residues were \< 0.01 mg/kg, the reduced number of trials is acceptable. It is noted the JMPR derived two MRL proposals for eggplants, one for the individual crop (crop code VO0440) and a second one for the subgroup of eggplants (crop code VO2016). To avoid confusions, one of these MRL proposals should be deleted.                           |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                              | W0.02[\*](#efs25306-note-0602){ref-type="fn"}                                       | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                 | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | See the comment on the Edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                     | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | See the comment on the Edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melons, except watermelon                                         | 0.01                                                                                | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | Critical GAP: SEU, 2 application with a maximum of 3 kg/ha per crop cycle, PHI 50 days                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: Melons are a major crop, and therefore, at least 8 trials are required. Since not all residue trials are below the LOQ, it is not appropriate to derive the MRL proposal from a reduced data.                                                                                                                                                                                                                                                                       |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is not acceptable because of insufficient number of trials                                                                                                                                                                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                             | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | See the comment on the Edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Parsnip                                                           | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | The MRL proposal was derived by extrapolation from the trials on carrots.                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | See the comment on carrots                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut                                                            | W0.05                                                                               | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut fodder                                                     | W0.2 (dw)                                                                           | --                                                                                                 | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, chili (dried)                                            | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        |                                                                                                    | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                            | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                        | 0.01[\*](#efs25306-note-0602){ref-type="fn"}                                                       | Critical GAP: NEU, 1 soil application, 5.5 kg/ha, PHI 80 days                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: The origin of the trials SEU/NEU is not mentioned in the JMPR report. All the residues were \< 0.01 mg/kg, thus a limited number of trials could be acceptable to cover both EU zones.                                                                                                                                                                                                                                                                              |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                                          | W0.02[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"} | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}                 | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                      | W0.02[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"} | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}                 | JMPR proposed to withdraw the existing CXL                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Squash, summer                                                    | **0.04**                                                                            | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"} (ft)            | Critical GAP: SEU, 2 applications, with a maximum of 3 kg/ha per crop cycle, PHI 50 days.                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: The number of trials is sufficient according to JMPR rules; however at EU level, two additional trials would be required. For cucumbers, a set of 6 trials were provided for the same GAP. The two data sets could be combined to derive a more robust MRL proposal for cucumber and summer squash. Thus, a MRL of 0.03 mg/kg would be sufficient. It should be investigated why the EU MRL is set at the LOQ, while apparently quantifiable residues are expected. |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is not acceptable; a lower MRL proposal of 0.03 mg/kg would be sufficient. In addition, an acute consumer health risk was identified                                                                                                                                                                                                                                                                                                                             |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of eggplants (includes all commodities in this subgroup) | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}  | 0.02[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}(ft) (eggplants) | Critical GAP: SEU, 4 soil applications with a maximum of 5 kg/ha per crop cycle, PHI 28 days.                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: Egg plants are a major crop, and therefore, 8 trials would be necessary. Since in the 5 available trials, the residues were \< 0.01 mg/kg, the reduced number of trials is acceptable. It is noted that the JMPR derived two MRL proposals for eggplants, one for the individual crop (crop code VO0440) and a second one for the subgroup of eggplants (crop code VO2016). To avoid confusions, one of these MRL proposals should be deleted.                      |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of Peppers (except martynia, okra and roselle)           | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}  | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}                 | Critical GAP: SEU, 3 applications, with a maximum of 4 kg/ha per crop cycle, PHI 35 days.                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: Residues in all trials \< 0.01 mg/kg                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar beet                                                        | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}  | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}                 | Critical GAP:NL, 0.75--2.5 kg/ha (soil incorporation in furrow at drilling)                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: The residues in sugar beets were all below the LOD (0.005 or 0.01 mg/kg)                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                            | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}  | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"} (ft)            | Critical GAP: SEU, 4 soil applications with a maximum of 5 kg/ha per crop cycle, PHI 28 days.                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: combined data set of trials in cherry tomatoes and tomatoes, all trials \< 0.01 mg/kg.                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Watermelon                                                        | 0.01                                                                                | 0.01[[\*](#efs25306-note-0602){ref-type="fn"}](#efs25306-note-0602){ref-type="fn"}                 | Critical GAP: SEU, cycle rate 3 kg/ha, PHI 50 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Number of trials: 7 (\< 0.01 mg/kg)                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                   |                                                                                     |                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                   |                                                                                     |                                                                                                    | Specific comments/observations: Watermelons are a major crop, and therefore, at least 8 trials are required. Since all residue trials are below the LOQ, a reduced data may be acceptable                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+-------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; CXL: Codex Maximum Residue Limit; NEU: northern European Union; LOD: limit of detection; LOQ: limit of quantification; MRL: maximum residue limit; SEU: Southern European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; PHI: preharvest interval.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.5.5. Consumer risk assessment -- oxamyl (Table [21](#efs25306-tbl-0021){ref-type="table"}) {#efs25306-sec-0051}

###### 

Summary of the consumer risk assessment oxamyl

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                   | Chronic exposure assessment                                                                                                                                                                                                                                                                                                           | Comments on JMPR exposure assessment |
+=============================================================================================================================================================================================================================================================================================================================================================================================================================================+=======================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                         | **RA assumptions:**                                                                                                                                                                                                                                                                                                                   | **No comment**                       |
|                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                       |                                      |
| A risk assessment was conducted for those commodities, where the Codex MRL proposals were higher than the existing EU MRLs, using the current EU ARfD.The result of this risk assessment may change if the toxicological reference value and/or the residue definition will be revised (e.g. in the framework of the peer review that will soon start).                                                                                     | A long‐term risk assessment was conducted by updating the exposure calculation from art 12 MRL review (EFSA, [2010h](#efs25306-bib-0024){ref-type="ref"}), only for the crops assessed by JMPR and leading to higher MRLs proposals than the current EU MRLs (highlighted in bold above) using the EU toxicological reference values. |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                       |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                             | The EU ADI was used.                                                                                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                       |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                             | The result of this risk assessment may change if the toxicological reference value and/or the residue definition will be revised (e.g. in the framework of the peer review that will soon start)                                                                                                                                      |                                      |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                | **Results:**                                                                                                                                                                                                                                                                                                                          | 0--1% of ADI,                        |
|                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                       |                                      |
| A short‐term consumer health risk was identified for courgettes (102% of ARfD). For cucumbers, using the HR derived from trials on cucumbers, the exposure was close to the ARfD, and thus, a very narrow safety margin was identified (94% of ARfD). However, if the HR from the combined data set of courgettes and cucumbers is used in the risk assessment, an exceedance of the ARfD is noted for cucumbers as well (129% of the ARfD) | Considering only the exposure to parent oxamyl, no chronic consumer intake concerns was identified (max 28% of ADI)                                                                                                                                                                                                                   | 0--20% of ARfD                       |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit.
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4.6. Propiconazole (160) (R) {#efs25306-sec-0052}
----------------------------

### 4.6.1. Background information (Table [22](#efs25306-tbl-0022){ref-type="table"}) {#efs25306-sec-0053}

###### 

Background information on propiconazole

                                                      Comments, references
  ------------------------- ------------------------- ---------------------------------------------------------------------------------------------
  Type of JMPR evaluation   New use                   
  RMS                       FI                        
  Approval status           Renewal of the approval   Commission Implementing Regulation (EU) No 2016/2016[a](#efs25306-note-0031){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2017f](#efs25306-bib-0114){ref-type="ref"})
  MRL review                Yes, see comments         EFSA ([2015a](#efs25306-bib-0076){ref-type="ref"})
  MRL applications          No                        

MRL: maximum residue limit; RMS: rapporteur Member State.

2016/2016/EU: Commission Implementing Regulation (EU) 2016/2016 of 17 November 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, benzoic acid, flazasulfuron, mecoprop‐P, mepanipyrim, mesosulfuron, propineb, propoxycarbazon, propyzamide, propiconazole, Pseudomonas chlororaphis Strain: MA 342, pyraclostrobin, quinoxyfen, thiacloprid, thiram, ziram, zoxamide. OJ L 312, 18.11.2016, p. 21--23.

John Wiley & Sons, Ltd

### 4.6.2. Toxicological reference values -- propiconazole (Table [23](#efs25306-tbl-0023){ref-type="table"}) {#efs25306-sec-0054}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | EU evaluation | TRV comparable        |                                                                                                       |    |
+========================+======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+=======================================================================================================+====+
| **ADI**                | 0.07 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR 2015     | 0.04 mg/kg bw per day | EFSA ([2017f](#efs25306-bib-0114){ref-type="ref"}) (Chronic rat study with uncertainty factor of 100) | No |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR 2015     | 0.1 mg/kg bw          | EFSA ([2017f](#efs25306-bib-0114){ref-type="ref"})                                                    | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |               |                       | (Developmental study in rat with uncertainty factor of 300)                                           |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | In the framework of the renewal of the approval, the ARfD has been recently lowered in the EU (EFSA, [2017f](#efs25306-bib-0114){ref-type="ref"}); the ADI has been confirmed.                                                                                                                                                                                                                                                                                                                       |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |               |                       |                                                                                                       |    |
|                        | Propiconazole is proposed to be classified as toxic for reproduction category 1B by the RAC of ECHA, in accordance with the provisions of Regulation (EC) No 1272/2008, and toxic effects on the endocrine organs have been observed in the available data. Should the second interim provision of Annex II, Point 3.6.5 of Regulation (EC) No 1107/2009 be applicable to category 1B, propiconazole may be considered to have endocrine disrupting properties leading to a critical area of concern |               |                       |                                                                                                       |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 4.6.3. Residue definitions -- propiconazole (Table [24](#efs25306-tbl-0024){ref-type="table"}) {#efs25306-sec-0055}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                  | JMPR evaluation                                                                                                  | EU evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | RDs comparable |
+=========================+==================================================================================================================================================================================================================================================================================================================================================+==================================================================================================================+=============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                   | Propiconazole                                                                                                    | Propiconazole (sum of isomers)                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Yes            |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Propiconazole                                                                                                                                                                                                                                                                                                                                    | EU Reg. 396/2005: Propiconazole (sum of isomers)                                                                 | Yes (current RD),                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                       | Peer review: CGA91305 (free and conjugated) ((1*RS*)‐1‐(2,4‐dichlorophenyl)‐2‐(1*H*‐1,2,4‐triazol‐1‐yl) ethanol) | No (peer review proposal)                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  | The residue is fat soluble                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                   | Propiconazole plus all metabolites convertible to 2,4‐dichloro‐benzoic acid, expressed as propiconazole.         | Primary crops (For all categories of crops):                                                                                                                                                                                                                                                                                                                                                                                                                                                | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  | Propiconazole (sum of isomers)CGA 118244 (3,5‐dideoxy‐1,2‐O‐\[(1*RS*)‐1‐(2,4‐dichlorophenyl)‐2‐(1*H*‐1,2,4‐triazol‐1‐yl)ethylidene\]‐D,L‐pentitol) free and glucoside conjugated.Whether the parent compound and CGA 118244 have to be considered together or separately is pending upon the submission of toxicological data to address the toxicity profile on CGA118244).CGA142856 (TAA, 1*H*‐1,2,4‐triazol‐1‐ylacetic acid) and CGA131013 (TA, 3‐(1*H*‐1,2,4‐triazol‐1‐yl)‐D,L‐alanine) |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  | Rotational crops and processed commodities: Open (EFSA, [2017g](#efs25306-bib-0115){ref-type="ref"})                                                                                                                                                                                                                                                                                                                                                                                        |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Animal products                                                                                                                                                                                                                                                                                                                                  | Propiconazole plus all metabolites convertible to 2,4‐dichloro‐benzoic acid, expressed as propiconazole          | Propiconazole, CGA91305 (free and conjugated) and CGA118244 (The way the residue definition will be expressed is pending upon the requested toxicological profile on CGA91305 and CGA118244)CGA71019 (1,2,4‐triazole)                                                                                                                                                                                                                                                                       | No             |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | Considering that JMPR derived MRL proposals only for fruit crops and for tea, the difference in the residue definitions for risk assessment for animal products are of no relevance.                                                                                                                                                             |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         | The enforcement RD for plants established in Reg. 396/2005 is comparable with the RD of JMPR. For the risk assessment residue definitions, JMPR covers the common moiety (2,4‐dichlorobenzoic acid), while in the EU, the second residue definition covers one metabolite for which open questions on the toxicological profile were identified. |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         | JMPR did not set specific residue definitions for the TDSs (TAA and TA).                                                                                                                                                                                                                                                                         |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
|                         | Due to the different risk assessment residue definitions for plant commodities and the open questions as regards the toxicological properties of some of the metabolites, only a tentative risk assessment can be performed                                                                                                                      |                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice.

John Wiley & Sons, Ltd

### 4.6.4. Codex MRL proposals -- propiconazole (Table [25](#efs25306-tbl-0025){ref-type="table"}) {#efs25306-sec-0056}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                                                                                                                                                                                             | Codex MRL proposal | EU MRL                                            | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+=======================================================================================================================================================================================================================================================================+====================+===================================================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Subgroup of oranges, sweet,                                                                                                                                                                                                                                           | **15Po**           | 0.01[\*](#efs25306-note-0603){ref-type="fn"} (ft) | Critical GAP: USA, post‐harvest GAP: 2 × 52.7 g a.s./100L (dip/drench),                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| sour                                                                                                                                                                                                                                                                  |                    |                                                   | Number of trials: 16 (8 trials on oranges, 4 trials on mandarins and 4 trials on lemons).                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: For the post‐harvest use, the MRL proposal should be calculated as mean + 4SD. Thus, a lower MRL of 10 mg/kg would be sufficient. The CF for risk assessment was derived from residue trials in cherries. The validity of this extrapolation is not questionable. No metabolism studies are available for post‐harvest treatment.                                                                                                                                                                  |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: The proposed Codex MRL is not acceptable because it is too high. In addition, the residue trials do not provide information on the actual residue concentration compliant with the residue definition for risk assessment                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of mandarins                                                                                                                                                                                                                                                 | **15Po**           | 0.01[\*](#efs25306-note-0603){ref-type="fn"} (ft) | Critical GAP: US post‐harvest GAP: 2 × 52.7 g a.s./100L (dip/drench)                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: See assessment for the subgroup of oranges.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: The proposed Codex MRL is not acceptable (see assessment for the sub‐group of oranges)                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of lemons and limes (including citron)                                                                                                                                                                                                                       | **15Po**           | 0.01[\*](#efs25306-note-0603){ref-type="fn"}      | Critical GAP: US post‐harvest GAP: 2 × 52.7 g a.s./100L (dip/drench)                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: See assessment for the subgroup of oranges.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: The proposed Codex MRL is not acceptable (see assessment for the sub‐group of oranges)                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of pummelo and grapefruits (including Shaddock‐like hybrids)                                                                                                                                                                                                 | **6Po**            | 0.01[\*](#efs25306-note-0603){ref-type="fn"}      | Critical GAP: US post‐harvest GAP: 2 × 52.7 g a.s./100L (dip/drench)                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: For the post‐harvest use, the MRL proposal should be calculated as mean + 4SD. Thus, a lower MRL of 4 mg/kg would be sufficient. The validity of extrapolation of CF from cherries to citrus is not questionable. No metabolism studies are available for post‐harvest treatment.                                                                                                                                                                                                                  |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: The proposed Codex MRL is not acceptable because it is too high. In addition, the residue trials do not provide information on the actual residue concentration compliant with the residue definition for risk assessment                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peach                                                                                                                                                                                                                                                                 | **1.5Po**          | 0.01[\*](#efs25306-note-0603){ref-type="fn"}      | Critical GAP: US post‐harvest GAP: 1 × 0.54 g a.s./1,000 kg (in‐line aqueous/fruit‐coating spray)                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: Peaches are a category 3 crop for JMPR; therefore, at least 5 trials would be required. Considering that the GAP is a post‐harvest use, a reduced data set may be sufficient, but 3 trials are considered insufficient. For the post‐harvest use, the MRL proposal should be calculated as mean + 4SD. Thus, a lower MRL of 0.7 mg/kg would be sufficient. It is noted that the proposed MRL is approximately 3 times the application rate.                                                        |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: The proposed Codex MRL is not acceptable as the number of residue trials is insufficient and the calculated MRL proposal is too high                                                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of cherries (includes all commodities in this subgroup)                                                                                                                                                                                                      | **3Po**            | 0.01[\*](#efs25306-note-0603){ref-type="fn"}      | Critical GAP: US post‐harvest GAP: 1 × 12.9 g a.s./100 L (in‐line dip/drench).                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: To be discussed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: Cherries are a major crop according the JMPR. Thus, additional residue trials would be required. However, considering that the GAP is a post‐harvest use and that the residue trials gave a very homogeneous picture (0.67--1.4 mg/kg), the number of trials may be considered sufficient.                                                                                                                                                                                                         |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable as regards the number of residue trials                                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of plum including prunes) (includes allcommodities in this subgroup)                                                                                                                                                                                         | **0.5Po**          | 0.01[\*](#efs25306-note-0603){ref-type="fn"}      | Critical GAP: US post‐harvest GAP: 1 × 0.54 g a.s./1,000 kg (in‐line aqueous/fruit‐coating spray)                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: For the post‐harvest use, the MRL proposal should be calculated as mean + 4SD. Thus, a lower MRL of 0.4 mg/kg would be sufficient.                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: The proposed Codex MRL is not acceptable; a lower MRL of 0.4 mg/kg would be appropriate                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple                                                                                                                                                                                                                                                             | **4Po**            | 0.02[\*](#efs25306-note-0603){ref-type="fn"}      | Critical GAP: US post‐harvest GAP: 1 × 25.8 g a.s./100 L (drench) + 1 × 25.8 g a.s./100 L (directed peduncle spray).                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Sufficiently supported by data: To be discussed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Specific comments/observations: According the JMPR, pineapples are a category 3 crop, thus, at least 5 residue trials would be required. Considering that it is a post‐harvest use and that the residue levels measured in the trials are all in the same range (0.92--1.2 mg/kg), 4 trials might be sufficient. For the post‐harvest use, the MRL proposal should be calculated as mean + 4SD. Thus, a lower MRL of 2 mg/kg would be sufficient. It is noted that no metabolism studies are available for post‐harvest treatment. |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   | Conclusion: The proposed Codex MRL is not acceptable; a lower MRL of 2 mg/kg would be appropriate. To be discussed with RM whether the number of trials is sufficient                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange oil                                                                                                                                                                                                                                                            | 2800               |                                                   | A single‐processing study is available (PF 185)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange juice                                                                                                                                                                                                                                                          | None               |                                                   | A single‐processing study is available (PF \< 0.011)                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple juice                                                                                                                                                                                                                                                       | none               |                                                   | A single‐processing residue trial analysing for the [total propiconazole]{.ul} residues was submitted. A PF \< 0.12 was derived for pineapple pulp and for juice                                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| General comments: No metabolism studies are available for post‐harvest uses to derive conclusions on the nature of residues in the crops concerned.                                                                                                                   |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                       |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| JMPR did not update the calculation of the dietary burden for livestock because it was assumed that post‐harvest treated products are not fed to livestock. According to EFSAs view, this argument is not valid, since it cannot be excluded that citrus fruit pomace |                    |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

EU MRL: European Union maximum residue limit; GAP: Good Agricultural Practice; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; PF: processing factor.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.6.5. Consumer risk assessment -- propiconazole (Table [26](#efs25306-tbl-0026){ref-type="table"}) {#efs25306-sec-0057}

###### 

Summary of the consumer risk assessment for propiconazole:

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                          | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                 | Comments on JMPR exposure assessment |
+====================================================================================================================================================================================================================================================================================================================================================================================================================================================+=============================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                | **RA assumptions:**                                                                                                                                                                                                                                                                                                                         | **Specific comments**                |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             |                                      |
| A tentative short‐term dietary risk assessment was performed for parent propiconazole for citrus fruits, cherries, peaches, plums and pineapples using the HR~pulp~ value for citrus fruit, the HR~whole~ fruit for peaches, cherries and plums and the HR‐P for pineapple.                                                                                                                                                                        | The most recent long‐term risk assessment for parent propiconazole (EFSA, [2015a](#efs25306-bib-0076){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR~pulp~ values derived by JMPR for citrus fruits, the STMR~whole\ fruit~ cherries, peaches, plums and the STMR‐P for pineapple. | --                                   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             |                                      |
| The EU ARfD was used.                                                                                                                                                                                                                                                                                                                                                                                                                              | The EU ADI was used.                                                                                                                                                                                                                                                                                                                        |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             |                                      |
| The risk assessment is considered tentative, because of the difference of residue definitions established at EU level and by JMPR. Additional uncertainties in the risk assessment are resulting from the lack of data on the residue concentration compliant with the residue definition for risk assessment for citrus and the lack of information on the possible impact of plant and livestock metabolism on the isomer ratio of propiconazole | The risk assessment is considered tentative, because of the difference of residue definitions established at EU level and by JMPR                                                                                                                                                                                                           |                                      |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                       | **Results:**                                                                                                                                                                                                                                                                                                                                | **Results:**                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             |                                      |
| No short‐term exposure concern was identified (57% of the ARfD for oranges) in the tentative risk assessment.                                                                                                                                                                                                                                                                                                                                      | No long‐term consumer health risk was identified in the tentative risk assessment.                                                                                                                                                                                                                                                          | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    | The overall chronic exposure accounted for 14.6% of the ADI (WHO Cluster diet B)                                                                                                                                                                                                                                                            | 0.8--6.4% of the ADI                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                             | 0--10% of the ARfD (children)        |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union; HR: highest residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue.

John Wiley & Sons, Ltd

4.7. Abamectin (177) (T) {#efs25306-sec-0058}
------------------------

### 4.7.1. Background information (Table [27](#efs25306-tbl-0027){ref-type="table"}) {#efs25306-sec-0059}

###### 

Background information on abamectin

+-------------------------+-------------------------------+-----------------------------------------------------------------------------------------------------+
|                         |                               | Comments, references                                                                                |
+=========================+===============================+=====================================================================================================+
| Type of JMPR evaluation | Other evaluation, see comment | Assessment of new studies and published papers regarding the toxicological properties of abamectin. |
+-------------------------+-------------------------------+-----------------------------------------------------------------------------------------------------+
| RMS                     | AT                            |                                                                                                     |
+-------------------------+-------------------------------+-----------------------------------------------------------------------------------------------------+
| Approval status         | Renewal of the approval       | Commission Implementing Regulation (EU) No 2017/438[a](#efs25306-note-0037){ref-type="fn"}          |
+-------------------------+-------------------------------+-----------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments             | EFSA ([2008b](#efs25306-bib-0009){ref-type="ref"})                                                  |
|                         |                               |                                                                                                     |
|                         |                               | EFSA ([2016j](#efs25306-bib-0100){ref-type="ref"})                                                  |
|                         |                               |                                                                                                     |
|                         |                               | EFSA conclusions ongoing (AIR IV)                                                                   |
+-------------------------+-------------------------------+-----------------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments             | EFSA ([2014n](#efs25306-bib-0069){ref-type="ref"})                                                  |
+-------------------------+-------------------------------+-----------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments             | EFSA ([2017j](#efs25306-bib-0118){ref-type="ref"}) (banana)                                         |
|                         |                               |                                                                                                     |
|                         |                               | EFSA ([2015i](#efs25306-bib-0084){ref-type="ref"}) (various crop)                                   |
|                         |                               |                                                                                                     |
|                         |                               | Citrus (Additional data request)celery and fennel (Additional data request)                         |
+-------------------------+-------------------------------+-----------------------------------------------------------------------------------------------------+

MRL: maximum residue limit.

2017/438/EU: Commission Implementing Regulation (EU) 2017/438 of 13 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance abamectin. OJ L 67, 14.3.2017, p. 67--69.

John Wiley & Sons, Ltd

### 4.7.2. Toxicological reference values -- abamectin (Table [28](#efs25306-tbl-0028){ref-type="table"}) {#efs25306-sec-0060}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------------+----------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | EU evaluation                                   | TRV comparable          |                                                    |    |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================================+=========================+====================================================+====+
| **ADI**                | 0.001 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR 2016 (developmental neurotoxicity in rats) | 0.0025 mg/kg bw per day | EFSA ([2008b](#efs25306-bib-0009){ref-type="ref"}) | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                 |                         |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                 |                         | (18‐ and 53‐wk dog study UF 100)                   |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------------+----------------------------------------------------+----+
| **ARfD**               | 0.003 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR 2016                                       | 0.005 mg/kg bw          | EFSA ([2008b](#efs25306-bib-0009){ref-type="ref"}) | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                 |                         |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | (first week of treatment in dog studies)        |                         | (acute neurotoxicity rat UF 100)                   |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------------+----------------------------------------------------+----+
| **Conclusion/comment** | The toxicological reference values derived by JMPR are lower than the ones derived at EU level. It is noted that the ADI/ARfD of JMPR applies also to the 8,9‐Z‐isomer and the 24‐hydroxymethyl metabolite of abamectin.                                                                                                                                                                                                                                                                                      |                                                 |                         |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                 |                         |                                                    |    |
|                        | The developmental neurotoxicity study in rats was not peer reviewed by EFSA ([2008b](#efs25306-bib-0009){ref-type="ref"}). EFSA would consider appropriate to use this study as a point of departure for setting the ADI. The use of the dog studies for setting the ARfD would also be consider appropriate since the effects described by JMPR were observed during the first week of treatment.                                                                                                            |                                                 |                         |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                 |                         |                                                    |    |
|                        | Regarding metabolites, EFSA ([2008b](#efs25306-bib-0009){ref-type="ref"}) also concluded that 8,9‐Z‐isomer showed a similar profile to abamectin. EFSA ([2008b](#efs25306-bib-0009){ref-type="ref"}) did not discuss the toxicological profile of 24‐hydroxymethyl metabolite of abamectin; however, being a major rat metabolite as described by JMPR, EFSA would support the view that it could be considered covered by parent, and then, the reference values of abamectin would apply to this metabolite |                                                 |                         |                                                    |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------------+----------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.7.3. Residue definitions -- abamectin (Table [29](#efs25306-tbl-0029){ref-type="table"}) {#efs25306-sec-0061}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                     | JMPR evaluation                                                                                       | EU evaluation                                                                                                         | RDs comparable |
+=========================+=====================================================================================================+=======================================================================================================+=======================================================================================================================+================+
| **RD enf**              | Plant products                                                                                      | Avermectin B1a                                                                                        | Reg. 396/2005:                                                                                                        | No             |
|                         |                                                                                                     |                                                                                                       |                                                                                                                       |                |
|                         |                                                                                                     |                                                                                                       | Abamectin (sum of avermectin B1a, avermectin B1b and delta‐8,9 isomer of avermectin B1a, expressed as avermectin B1a) |                |
|                         |                                                                                                     |                                                                                                       |                                                                                                                       |                |
|                         |                                                                                                     |                                                                                                       | Peer review:                                                                                                          |                |
|                         |                                                                                                     |                                                                                                       |                                                                                                                       |                |
|                         |                                                                                                     |                                                                                                       | Sum of avermectin B1a, avermectin B1a 8,9‐Z isomer, and avermectin B1b, expressed as avermectin B1a                   |                |
+-------------------------+-----------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Avermectin B1a                                                                                      | EU Reg. 396/2005: Abamectin B1a                                                                       | Yes                                                                                                                   |                |
|                         |                                                                                                     |                                                                                                       |                                                                                                                       |                |
|                         | The residue is fat soluble                                                                          | Peer review: Not necessary -- covered by legal provisions in force for abamectin from veterinary uses |                                                                                                                       |                |
|                         |                                                                                                     |                                                                                                       |                                                                                                                       |                |
|                         |                                                                                                     | The residue is fat soluble                                                                            |                                                                                                                       |                |
+-------------------------+-----------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                      | Avermectin B1a                                                                                        | Sum of avermectin B1a, avermectin B1a 8,9‐Z isomer, and avermectin B1b, expressed as avermectin B1a                   | No             |
+-------------------------+-----------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Avermectin B1a                                                                                      | Not necessary -- covered by legal provisions in force for abamectin from veterinary uses              | No                                                                                                                    |                |
+-------------------------+-----------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for plant products derived by JMPR and at EU level are not fully compatible |                                                                                                       |                                                                                                                       |                |
+-------------------------+-----------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+

EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 4.7.4. Codex MRL proposals -- abamectin {#efs25306-sec-0062}

No Codex MRL proposals.

### 4.7.5. Consumer risk assessment -- abamectin {#efs25306-sec-0063}

Not relevant.

4.8. Fenpropimorph (188) (R/T) {#efs25306-sec-0064}
------------------------------

### 4.8.1. Background information (Table [30](#efs25306-tbl-0030){ref-type="table"}) {#efs25306-sec-0065}

###### 

Background information on fenpropimorph

                                                Comments, references
  ------------------------- ------------------- ------------------------------------------------------------------------------------------
  Type of JMPR evaluation   Periodic review     
  RMS                       LV                  
  Approval status           Approved            Commission Implementing Regulation No 2008/107/EC[a](#efs25306-note-0041){ref-type="fn"}
  EFSA conclusion           Yes, see comments   EFSA ([2008c](#efs25306-bib-0010){ref-type="ref"})
  MRL review                Yes, see comments   EFSA ([2015f](#efs25306-bib-0081){ref-type="ref"})
  MRL applications          No                  None open

MRL: maximum residue limit.

2008/107/EC: Commission Directive 2008/107/EC of 25 November 2008 amending Council Directive 91/414/EEC to include abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as active substances. OJ L 316, 26.11.2008, p. 4--11.

John Wiley & Sons, Ltd

### 4.8.2. Toxicological reference values -- fenpropimorph (Table [31](#efs25306-tbl-0031){ref-type="table"}) {#efs25306-sec-0066}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+---------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                    | EU evaluation | TRV comparable         |                                                                                 |    |
+========================+====================================================================================================================================================================================================================+===============+========================+=================================================================================+====+
| **ADI**                | 0.004 mg/kg bw per day                                                                                                                                                                                             | JMPR 2016     | 0.003 mg/kg bw per day | EFSA ([2008c](#efs25306-bib-0010){ref-type="ref"})                              | No |
|                        |                                                                                                                                                                                                                    |               |                        |                                                                                 |    |
|                        |                                                                                                                                                                                                                    |               |                        | (Rat, 2‐year, with uncertainty                                                  |    |
|                        |                                                                                                                                                                                                                    |               |                        |                                                                                 |    |
|                        |                                                                                                                                                                                                                    |               |                        | factor of 100)                                                                  |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+---------------------------------------------------------------------------------+----+
| **ARfD**               | 0.1 mg/kg bw                                                                                                                                                                                                       | JMPR 2016     | 0.03 mg/kg bw          | EFSA ([2008c](#efs25306-bib-0010){ref-type="ref"}) (Rabbit, developmental, with | No |
|                        |                                                                                                                                                                                                                    |               |                        |                                                                                 |    |
|                        | (women of childbearing age)                                                                                                                                                                                        |               |                        | uncertainty factor of 500)                                                      |    |
|                        |                                                                                                                                                                                                                    |               |                        |                                                                                 |    |
|                        | 0.4 mg/kg bw (General population)                                                                                                                                                                                  |               |                        |                                                                                 |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+---------------------------------------------------------------------------------+----+
| **Conclusion/comment** | EFSA comments on the toxicological reference values were provided in the EFSA CCPR Report, ([2017h](#efs25306-bib-0116){ref-type="ref"})                                                                           |               |                        |                                                                                 |    |
|                        |                                                                                                                                                                                                                    |               |                        |                                                                                 |    |
|                        | Metabolite BF 421‐2: no information on the toxicological profile of this metabolite is reported in the toxicological evaluation of fenpropimorph (FAO, [2016](#efs25306-bib-0151){ref-type="ref"}).                |               |                        |                                                                                 |    |
|                        |                                                                                                                                                                                                                    |               |                        |                                                                                 |    |
|                        | Metabolite BF 421‐10 (cis‐2,6‐dimethylmorpholine), a major metabolite in rats and in plants, was tested in an adequate range of *in vitro* and *in vivo* genotoxicity tests. No evidence of genotoxicity was found |               |                        |                                                                                 |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+---------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.8.3. Residue definitions -- fenpropimorph (Table [32](#efs25306-tbl-0032){ref-type="table"}) {#efs25306-sec-0067}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                   | JMPR evaluation                                                                                                            | EU evaluation                                                                                                                                                   | RDs comparable |
+=========================+===================================================================================================================================================================================================================================================================================+============================================================================================================================+=================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                    | Fenpropimorph                                                                                                              | Fenpropimorph (sum of isomers)                                                                                                                                  | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fenpropimorph and fenpropimorph carboxylic acid (BF 421‐2), expressed as fenpropimorph (p. 161 of JMPR report)                                                                                                                                                             | Reg. 396/2005:                                                                                                             | No                                                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         | or                                                                                                                                                                                                                                                                                | Fenpropimorph carboxylic acid (BF 421‐2) expressed as fenpropimorph                                                        |                                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         | 2‐methyl‐2‐{4‐\[2‐methyl‐3‐(cis‐2,6‐dimethylmorpholin‐4‐yl)propyl\]phenyl} propionic acid (p. 431 of JMPR report)                                                                                                                                                                 | MRL review: Sum of fenpropimorph and fenpropimorph carboxylic acid (BF 421‐2), expressed as fenpropimorph (sum of isomers) |                                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                    | The residue is fat soluble                                                                                                 |                                                                                                                                                                 |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                    | Sum of fenpropimorph, BF421‐1 (free and conjugated) and BF421‐10, expressed as fenpropimorph (p. 161 of JMPR report)       | Sum of fenpropimorph, fenpropimorph alcohol (BF 421‐1, free and conjugated) and 2,6‐dimethylmorpholine (BF 421‐10), expressed as fenpropimorph (sum of isomers) | Yes            |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                   | Fenpropimorph (p. 431 of JMPR report, Annex 1)                                                                             |                                                                                                                                                                 |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fenpropimorph and fenpropimorph carboxylic acid (BF 421‐2), expressed as fenpropimorph (p. 161 of JMPR report)                                                                                                                                                             | Sum of fenpropimorph and fenpropimorph carboxylic acid (BF 421‐2), expressed as fenpropimorph (sum of isomers)             | Yes                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         | or                                                                                                                                                                                                                                                                                |                                                                                                                            |                                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         | 2‐methyl‐2‐{4‐\[2‐methyl‐3‐(cis‐2,6‐dimethylmorpholin‐4‐yl)propyl\]phenyl} propionic acid (p. 461 of JMPR report, Annex 1)                                                                                                                                                        |                                                                                                                            |                                                                                                                                                                 |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | It is noted that different RDs were reported in the JMPR report (body text, p. 161) and in the Annex 1 of JMPR summary report (p. 431). It is assumed that the RDs reported on p. 161 are the correct ones. However, confirmation by JMPR would be desirable.                     |                                                                                                                            |                                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         | Parent fenpropimorph is included in the residue definition for animals (in addition to BF 421‐2). However, the parent compound was not found in any animal tissues and milk of ruminants. Thus, the different RD for animal products (enforcement) would not have a major impact. |                                                                                                                            |                                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                            |                                                                                                                                                                 |                |
|                         | For poultry, parent fenpropimorph was found in metabolism studies                                                                                                                                                                                                                 |                                                                                                                            |                                                                                                                                                                 |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice.

John Wiley & Sons, Ltd

### 4.8.4. Codex MRL proposals -- fenpropimorph (Table [33](#efs25306-tbl-0033){ref-type="table"}) {#efs25306-sec-0068}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                            | EU MRL                                                                                    | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+===============================================+===============================================+===========================================================================================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Banana                                        | **2**                                         | 0.6                                                                                       | Critical GAP: Colombia, up to 0.6 kg a.s./ha, PHI: 0 day, number of applications and interval between applications not specified.                                                                                                                                                                                                                                                                                                                                                                       |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| (unbagged)                                    |                                               |                                                                                           | Number of trials: 18                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Specific comments/observations: Trials in unbagged banana were used to derive the MRL proposal. The samples have not been analysed for the full RD RA, but instead a CF of 1 was derived from the metabolism study. For 11 trials on unbagged banana, fenpropimorph residues were analysed in the pulp ranging from \< 0.05 to 0.43 mg/kg. For bagged banana, residues in pulp were lower and ranged from \< 0.05 to 0.2 mg/kg, but the individual residue values were not provided in the JMPR report. |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: An acute intake concern was identified when the EU ARfD is used (120% of the ARfD, details see below).                                                                                                                                                                                                                                                                                                                                                                                      |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | The proposed Codex MRL is not acceptable due to intake concerns                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley                                        | 0.2                                           | 0.4                                                                                       | Critical GAP: Belgium: 2 × 0.75 kg a.s./ha, PHI: 28 days.                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Number of trials: 15 trials (performed in Belgium and Brazil)                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Specific comments/observations: The samples have not been analysed for the RD RA, but instead, a CF of 1.7. In the EU assessment, a CF of 1 was derived. The EU MRL was derived for a slightly more critical Swedish GAP (NEU, 2× 0.75 kg, PHI 35 days).                                                                                                                                                                                                                                                |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable. The manufacturer should be encouraged to submit the critical EU GAP to JMPR                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder, dry                  | 0.5                                           |                                                                                           | The residue data sets on barley and wheat straw were merged to derive the MRL proposal. Overall, 16 residue trials were available                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | **0.7**                                       | 0.3 in swine for the rest is 3 Kidney: 0.5 except swine 0.05 Liver: 3 except swine is 0.3 | Critical DB was identified for the Australian diet.                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | An acceptable cow‐feeding study dosed with fenpropimorph and BF 421‐2 at dosing levels of 2, 6 and 20 mg/kg DM and covering therefore the estimated maximum dietary burden, i.e. 2.7 mg/kg DM for beef and dairy, cattle was assessed.                                                                                                                                                                                                                                                                  |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: Although the residue definitions derived at EU level and by Codex, the proposed MRL are different, the MRL might be acceptable, considering the fact that in metabolism studies in ruminants' parent fenpropimorph was not found                                                                                                                                                                                                                                                            |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                          | 0.005[\*](#efs25306-note-0604){ref-type="fn"} | 0.01[\*](#efs25306-note-0604){ref-type="fn"}                                              | Critical DB for EU diet (layers). The proposed Codex MRLs were derived from the poultry metabolism study.                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable. The different residue definition is of no relevance, since the existing EU MRL is higher                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Kidney of cattle, goats, pigs and sheep       | W 0.05                                        | All 0.5 except pigs: 0.05                                                                 | The previous CXL is withdrawn                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Liver of cattle, goats, pigs and sheep        | W 0.3                                         | All 3 except pig with 0.3                                                                 | The previous CXL is withdrawn                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | 0.05                                          | All 0.2 except pig with 0.01[\*](#efs25306-note-0604){ref-type="fn"}                      | Conclusion: The proposed Codex MRL is acceptable. The different residue definition is of no relevance, since the existing EU MRL is higher                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | 0.04                                          | All 0.15 except pig with 0.02                                                             | Conclusion: The proposed Codex MRL is acceptable. The different residue definition is of minor relevance, since the existing EU MRL is higher and the parent compound included in the EU RD is unlikely to occur                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.01                                          | 0.015                                                                                     | Conclusion: The proposed Codex MRL is acceptable. The different residue definition is of minor relevance, since the existing EU MRL is higher and the parent compound included in the EU RD is unlikely to occur                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oats                                          | 0.2                                           | 0.4                                                                                       | Critical GAP: Not provided.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | The Codex MRL proposal was derived by extrapolation from the residue data set on barley.                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oats straw and fodder, dry                    | 0.5                                           |                                                                                           | Extrapolation from the combined residue data sets on barley and wheat straw                                                                                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                  | 0.005[\*](#efs25306-note-0604){ref-type="fn"} | 0.01[\*](#efs25306-note-0604){ref-type="fn"}                                              | A poultry feeding study is not available and not required since based on the poultry metabolism study and at the estimated maximum dietary burden (0.25 mg/kg DM), residues of fenpropimorph and BF 421‐2 are expected to be below the LOQ of the method.                                                                                                                                                                                                                                               |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable. The different residue definition is of no relevance, since the existing EU MRL is higher                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                  | 0.005[\*](#efs25306-note-0604){ref-type="fn"} | 0.01[\*](#efs25306-note-0604){ref-type="fn"}                                              | The proposed Codex MRL was derived from a poultry metabolism study which covers the calculated dietary burden (0.25 mg/kg DM); residues of fenpropimorph and BF 421‐2 are expected to be below the LOQ of the method.                                                                                                                                                                                                                                                                                   |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable. It is noted that in the EU MRLs are established for poultry muscle, instead of meat. The different residue definition is of no relevance, since the existing EU MRL is higher                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                      | 0.005[\*](#efs25306-note-0604){ref-type="fn"} | 0.01[\*](#efs25306-note-0604){ref-type="fn"}                                              | The proposed Codex MRL was derived from a poultry feeding study which covers the calculated dietary burden (0.25 mg/kg DM); residues of fenpropimorph and BF 421‐2 are expected to be below the LOQ of the method.                                                                                                                                                                                                                                                                                      |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable. The different residue definition is of no relevance, since the existing EU MRL is higher                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye                                           | 0.07                                          | 0.15                                                                                      | Critical GAP: Not reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Specific comments/observations: The Codex MRL proposal was derived by extrapolation from wheat.                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye straw and fodder, dry                     | 0.5                                           |                                                                                           | Extrapolation from the combined residue data sets on barley and wheat straw                                                                                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar beet                                    | 0.03                                          | 0.01[\*](#efs25306-note-0604){ref-type="fn"}                                              | Critical GAP: Poland: 1 × 0.25 kg a.s./ha, BBCH 39‐49; PHI: 35 days.                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Specific comments/observations: The proportionality approach was applied to the submitted residue trials that were performed at an application rate of 0.75 kg a.s./ha. It is noted that only the residues of fenpropimorph have been analysed for. A CF of 1.3 was derived by JMPR for the dietary intake assessment.                                                                                                                                                                                  |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | It is noted that in the Art. 12 MRL review, a tentative MRL proposal of 0.15 mg/kg was derived (4 overdosed trial from NEU, no scaling applied). However, this MRL has not been taken over in the EU MRL legislation.                                                                                                                                                                                                                                                                                   |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fodder beet leaves or tops                    | W1                                            |                                                                                           | JMPR proposed the withdrawal of 1 mg/kg on fodder beet leaves and tops since this is a commodity that is not traded. It is noted that residue trials were provided; the results were used for the dietary burden calculation                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar beet pulp, dry                          | 0.1                                           |                                                                                           | 2 processing trials, CF for residue definition 1.3                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale                                     | 0.07                                          | 0.15 (wheat)                                                                              | Extrapolation from wheat.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | See comments on wheat.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale straw and fodder, dry               | 0.5                                           |                                                                                           | Extrapolation from the combined residue data sets on barley and wheat straw provided the same use patterns on barley, wheat and triticale                                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat                                         | 0.07                                          | 0.15                                                                                      | Critical GAP: BE, 2 × 0.75 kg a.s./ha, PHI: 28 days                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Specific comments/observations: 7 residue trials conducted in Europe have been submitted. As a major crop in the NEU zone, one additional trial compliant with the BE GAP is in principle required. The existing EU MRL was derived for a slightly more critical GAP (SE, 2 × 0.75 kg/ha, PHI 35 days)                                                                                                                                                                                                  |
|                                               |                                               |                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                               |                                                                                           | Conclusion: The proposed Codex MRL might be considered acceptable although one additional trial would be required. The manufacturer should be encouraged to submit the critical EU GAP to JMPR                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat bran, unprocessed                       | 0.2                                           |                                                                                           | 3 processing trials, PF 2.9, CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat germ                                    | 0.3                                           |                                                                                           | 2 processing trials, PF 3.3, CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat straw and fodder, dry                   | 0.5                                           |                                                                                           | See barley straw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat wholemeal                               | 0.1                                           |                                                                                           | 3 processing trials, PF 1.4, CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Beer                                          | none                                          |                                                                                           | 4 processing trials, PF 0.004, CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pot Barley                                    | none                                          |                                                                                           | 4 processing trials, PF 0.9, CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley flour                                  | none                                          |                                                                                           | 2 processing trials, PF 2.5 CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat flour                                   | none                                          |                                                                                           | 3 processing trials, PF 0.35, CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oat flakes                                    | none                                          |                                                                                           | 3 processing trials, PF 0.8, CF for residue definition 1.7                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar beet molasses                           | none                                          |                                                                                           | 2 processing trials, PF 0.05, CF for residue definition 1.3                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar, refined                                | none                                          |                                                                                           | 2 processing trials, PF 0.05, CF for residue definition 1.3                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------+-----------------------------------------------+-------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; ADI: acceptable daily intake; ARfD: acute reference dose; PF: processing factor; CF: conversion factor; GAP: Good Agricultural Practice; LOQ: limit of quantification; CXL: Codex Maximum Residue Limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.8.5. Consumer risk assessment -- fenpropimorph (Table [34](#efs25306-tbl-0034){ref-type="table"}) {#efs25306-sec-0069}

###### 

Summary of the consumer risk assessment for fenpropimorph

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                          | Chronic exposure assessment                                                                                                                                                                                                                                                                                   | Comments on JMPR exposure assessment                                                                                                |
+====================================================================================================================================================================================================================================================================================================================================================+===============================================================================================================================================================================================================================================================================================================+=====================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                | **RA assumptions:**                                                                                                                                                                                                                                                                                           | **Specific comments**                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               |                                                                                                                                     |
| The short‐term dietary risk assessment was performed for banana, barley and oats grain, wheat and rye grain, sugar beet, animal tissues, milk and eggs as outlined in Section [2](#efs25306-sec-0006){ref-type="sec"}. For bananas, the calculation was based on the HR of 0.43 mg/kg measured in the unbagged bananas (pulp).The EU ARfD was used | The most recent long‐term risk assessment (EFSA, [2015f](#efs25306-bib-0081){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for banana, barley and oats grain, wheat and rye grain, sugar beet, animal tissues, milk and eggs | The overall assessment does not consider the possible impact of plant and livestock metabolism on the isomer ratio of fenpropimorph |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                       | **Results:**                                                                                                                                                                                                                                                                                                  | **Results:**                                                                                                                        |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               |                                                                                                                                     |
| An exceedance of the ARfD was identified for banana, representing 120% of the ARfD.                                                                                                                                                                                                                                                                | No long‐term consumer health risk was identified.The overall chronic exposure accounted for 33.4% of the ADI (UK toddler).                                                                                                                                                                                    | Long‐term exposure:                                                                                                                 |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               |                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               | 1--10% of the ADI                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               |                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               | Short‐term exposure:                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               |                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               | 0--5% of the ARfD (women of childbearing age)                                                                                       |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               |                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                               | 0--9% of the ARfD (General population)                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; STMR: supervised trials median residue.

John Wiley & Sons, Ltd

4.9. Tebuconazole (189) (R) {#efs25306-sec-0070}
---------------------------

### 4.9.1. Background information (Table [35](#efs25306-tbl-0035){ref-type="table"}) {#efs25306-sec-0071}

###### 

Background information on tebuconazole

+-------------------------+--------------------------+-------------------------------------------------------------------------------------------+
|                         |                          | Comments, references                                                                      |
+=========================+==========================+===========================================================================================+
| Type of JMPR evaluation | New use                  |                                                                                           |
+-------------------------+--------------------------+-------------------------------------------------------------------------------------------+
| RMS                     | UK                       |                                                                                           |
+-------------------------+--------------------------+-------------------------------------------------------------------------------------------+
| Approval status         | Approval process ongoing |                                                                                           |
+-------------------------+--------------------------+-------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments        | EFSA ([2008d](#efs25306-bib-0011){ref-type="ref"})                                        |
|                         |                          |                                                                                           |
|                         |                          | EFSA ([2014a](#efs25306-bib-0056){ref-type="ref"}) (amendment of the approval conditions) |
|                         |                          |                                                                                           |
|                         |                          | EFSA conclusions ongoing (AIR IV)                                                         |
+-------------------------+--------------------------+-------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments        | EFSA ([2011e](#efs25306-bib-0030){ref-type="ref"})                                        |
+-------------------------+--------------------------+-------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments        | EFSA ([2017e](#efs25306-bib-0113){ref-type="ref"}) (beans with pods)                      |
|                         |                          |                                                                                           |
|                         |                          | EFSA ([2015l](#efs25306-bib-0087){ref-type="ref"}) (rye and wheat)                        |
|                         |                          |                                                                                           |
|                         |                          | EFSA ([2015c](#efs25306-bib-0078){ref-type="ref"}) (cucumbers and courgettes)             |
|                         |                          |                                                                                           |
|                         |                          | In progress olivesIn progress herbal infusion and fresh herbsUnder consideration in rice  |
+-------------------------+--------------------------+-------------------------------------------------------------------------------------------+

MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.
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### 4.9.2. Toxicological reference values -- tebuconazole (Table [36](#efs25306-tbl-0036){ref-type="table"}) {#efs25306-sec-0072}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+-----------------------+----------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | EU evaluation                                       | TRV comparable        |                                                          |     |
+========================+============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================+=======================+==========================================================+=====+
| **Tebuconazole**       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+-----------------------+----------------------------------------------------------+-----+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | JMPR, 2010(Two dog 1‐year toxicity studies, SF 100) | 0.03 mg/kg bw per day | EFSA ([2008d](#efs25306-bib-0011){ref-type="ref"})       | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       | (1‐year dog                                              |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       | supported by developmental mouse study, LOAEL with UF of |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       | 100 (dog) and                                            |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       | 300 (mouse))                                             |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+-----------------------+----------------------------------------------------------+-----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR, 2010                                          | 0.03 mg/kg bw         | EFSA ([2008d](#efs25306-bib-0011){ref-type="ref"})       | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | (Developmental rat and rabbit studies,              |                       | (Developmental mouse study, LOAEL with UF of 300)        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | supported by a rat 28‐day study (gavage), SF 100)   |                       |                                                          |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+-----------------------+----------------------------------------------------------+-----+
| **Conclusion/comment** | While the ADI values derived by JMPR and at EU level are identical, the EU ARfD is 10 times lower.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                     |                       |                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                     |                       |                                                          |     |
|                        | At EU level, TRVs were also derived for the triazole‐derivative metabolites (TDMs) 1,2,4‐triazole, triazole alanine, triazole acetic acid and triazole lactic acid to be used in consumer risk assessments for this class of compounds. However, the residues assessment for the triazole‐derivative metabolites has been discussed at the expert meeting in December 2017 and a final EFSA conclusion and a final EU agreed approach to the consumer risk assessments for all triazole pesticides have not yet been agreed. Thus, at this time, the TDMs should not have an impact on the MRLs for any triazole pesticide |                                                     |                       |                                                          |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+-----------------------+----------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values.
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### 4.9.3. Residue definitions -- tebuconazole (Table [37](#efs25306-tbl-0037){ref-type="table"}) {#efs25306-sec-0073}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
|                                                                                                               | Commodity group                                                                                                                                                                                                                                                                         | JMPR evaluation                                                                                                                                                           | EU evaluation                                    | RDs comparable |
+===============================================================================================================+=========================================================================================================================================================================================================================================================================================+===========================================================================================================================================================================+==================================================+================+
| **RD enf**                                                                                                    | Plant products                                                                                                                                                                                                                                                                          | Tebuconazole                                                                                                                                                              | Reg. 396/2005: Tebuconazole                      | Yes            |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| Peer review: Sum of enantiomers contained in tebuconazole (EFSA, [2014a](#efs25306-bib-0056){ref-type="ref"}) |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| Animal products                                                                                               | Tebuconazole                                                                                                                                                                                                                                                                            | Reg. 396/2005: Sum of tebuconazole, hydroxy‐tebuconazole and their conjugates, expressed as tebuconazole                                                                  | No                                               |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | The residue is not fat soluble                                                                                                                                                                                                                                                          | Tebuconazole + hydroxy‐tebuconazole and their conjugates (sum of enantiomers) expressed as tebuconazole (provisional) (EFSA, [2014a](#efs25306-bib-0056){ref-type="ref"}) |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         | The residue is not fat soluble                                                                                                                                            |                                                  |                |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| **RD RA**                                                                                                     | Plant products                                                                                                                                                                                                                                                                          | Tebuconazole                                                                                                                                                              | 1\. Sum of enantiomers contained in tebuconazole | Yes            |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| 2\. TDMs, harmonised for all active substances of the triazole chemical class (provisional)                   | No                                                                                                                                                                                                                                                                                      |                                                                                                                                                                           |                                                  |                |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| Animal products                                                                                               | Tebuconazole                                                                                                                                                                                                                                                                            | 1\. Tebuconazole + hydroxy‐tebuconazole and their conjugates (sum of enantiomers) expressed as tebuconazole (provisional)                                                 | No                                               |                |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| 2\. TDMs                                                                                                      |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
| (harmonised for all active substances of the triazole chemical class, provisional)                            |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| **Conclusion/comments**                                                                                       | [Plant commodities]{.ul}: JMPR derived the residue definition for enforcement and for risk assessment as tebuconazole.                                                                                                                                                                  |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | At EU level, the residue definitions for plant commodities is similar, covering parent tebuconazole (sum of enantiomers). In addition, TDMs were proposed for inclusion in a separate residue definition for risk assessment, pending the outcome of a global risk assessment approach. |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | The residue assessment for the TDMs was discussed recently in an expert meeting (December 2017). The final EFSA conclusion is not yet published.                                                                                                                                        |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | [Animal commodities]{.ul}: JMPR derived the residue definition for enforcement and for risk assessment as tebuconazole, while the EU residue definition for enforcement and for risk assessment includes the metabolite hydroxy‐tebuconazole and conjugated forms.                      |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | Since this year, only Codex MRL proposals for plant commodities are discussed; the difference for the residue definition for animal commodities is not relevant.                                                                                                                        |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | A separate residue definition for risk assessment covering the TDMs was proposed in the EU for animal products as well.                                                                                                                                                                 |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | Data on the preferential degradation and/or conversion of the two enantiomers of racemic mixture of tebuconazole in residues and the potential impact on the consumer risk assessment are not available to EFSA and have not been mentioned by JMPR.                                    |                                                                                                                                                                           |                                                  |                |
|                                                                                                               |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                           |                                                  |                |
|                                                                                                               | [Conclusion:]{.ul} For the Codex MRL proposal on beans with pods, the difference in the wording of the residue definition for products of plant origin are of no relevance. The methods of analysis used to enforce residues were not reported to be stereoselective.                   |                                                                                                                                                                           |                                                  |                |
+---------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.
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### 4.9.4. Codex MRL proposals -- tebuconazole (Table [38](#efs25306-tbl-0038){ref-type="table"}) {#efs25306-sec-0074}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------------+--------------------+--------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                               | Codex MRL proposal | EU MRL                                     | Comment                                                                                                                                                     |
+=========================================================================+====================+============================================+=============================================================================================================================================================+
| Subgroup of beans with pods (includes all commodities in this subgroup) | **3**              | 2 (+)/                                     | Critical GAP: Foliar, 3 × 200 g/ha, interval 7--21 days, PHI 7 days (Kenya), already assessed by EFSA (import tolerance request)                            |
|                                                                         |                    |                                            |                                                                                                                                                             |
|                                                                         |                    | (3)[a](#efs25306-note-0051){ref-type="fn"} | Number of trials: 8                                                                                                                                         |
|                                                                         |                    |                                            |                                                                                                                                                             |
|                                                                         |                    |                                            | Sufficiently supported by data: Yes                                                                                                                         |
|                                                                         |                    |                                            |                                                                                                                                                             |
|                                                                         |                    |                                            | Specific comments/observations: Based on the same set of trials EFSA derived a MRL proposal of 3 mg/kg (EFSA, [2017e](#efs25306-bib-0113){ref-type="ref"}). |
|                                                                         |                    |                                            |                                                                                                                                                             |
|                                                                         |                    |                                            | Conclusion: The proposed Codex MRL is acceptable                                                                                                            |
+-------------------------------------------------------------------------+--------------------+--------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Common bean (pods and/or immature seeds)                                | W 2                |                                            | Existing CXL was proposed to be withdrawn                                                                                                                   |
+-------------------------------------------------------------------------+--------------------+--------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+

CXL: Codex Maximum Residue Limit; EU MRL: European Union maximum residue limit.

(+) The European Food Safety Authority identified some information on residue trials as unavailable. When re‐viewing the MRL, the Commission will take into account the information referred to in the first sentence, if it is submitted by 25 January 2016, or, if that information is not submitted by that date, the lack of it.

The MRL of 3 mg/kg proposed recently by EFSA (EFSA, [2017e](#efs25306-bib-0113){ref-type="ref"}) has not yet been presented and voted at PAFF meeting.

John Wiley & Sons, Ltd

### 4.9.5. Consumer risk assessment -- tebuconazole (Table [39](#efs25306-tbl-0039){ref-type="table"}) {#efs25306-sec-0075}

###### 

Summary of the consumer risk assessment for tebuconazole

+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                             | Chronic exposure assessment                                                                                                                                                                                                                                                                                                  | Comments on JMPR exposure assessment                                                                                                                                                                                                                                                      |
+=======================================================================================================================================================================================================================================================================================================+==============================================================================================================================================================================================================================================================================================================================+===========================================================================================================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                   | **RA assumptions:**                                                                                                                                                                                                                                                                                                          | **Specific comments**                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                           |
| [Tebuconazole]{.ul}: The short‐term dietary risk assessment recently performed (EFSA, [2017e](#efs25306-bib-0113){ref-type="ref"}) already took into account the reported use on beans with pods in Kenya. The EU ARfD was used and no change in isomer ratio (1:1) in the final residues is assumed. | [Tebuconazole]{.ul}: The long‐term risk assessment for tebuconazole recently performed (EFSA, [2017e](#efs25306-bib-0113){ref-type="ref"}) took into account the reported use on beans with pods in Kenya, the authorised EU uses and the acceptable CXLs. It assumed no change in isomer ratio (1:1) in the final residues. | JMPR used the HR of 1.9 mg/kg for the risk assessment. EFSA selected the mean (1.5 mg/kg) from two replicates (1.9 and 1.1 mg/kg, PHI 7 days). This different approach in selecting the HR explains why the risk assessment performed in 2017 by EFSA lead to a slightly different result |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                           |
| Updated using the HR of 1.9 mg/kg.                                                                                                                                                                                                                                                                    | Update not necessary.                                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                           |
| [TDMs]{.ul}: Separate consumer risk assessment not conducted                                                                                                                                                                                                                                          | [TDMs]{.ul}: Separate consumer risk assessment not conducted                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                          | **Results:**                                                                                                                                                                                                                                                                                                                 | **Results:**                                                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                           |
| [Tebuconazole]{.ul}: No short‐term exposure concern was identified (72% of ARfD)                                                                                                                                                                                                                      | [Tebuconazole]{.ul}: No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                       | Long‐term exposure:                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                           |
| The risk assessment is affected by a non‐standard uncertainty related to the lack of information on the possible preferential metabolism of one isomer over another                                                                                                                                   | Overall long‐term exposure accounted for 3--16% of the ADI.                                                                                                                                                                                                                                                                  | 2--9% of the ADI.                                                                                                                                                                                                                                                                         |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                       | The contribution of beans with pods to the exposure was 1.18% of the ADI                                                                                                                                                                                                                                                     | Short‐term exposure:                                                                                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                              | 5% and 9% of the ARfD (0.3 mg/kg bw) for the general population and for children, respectively                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; CXL: Codex Maximum Residue Limit; HR: highest residue.
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4.10. Fenpyroximate (193) (R/T) {#efs25306-sec-0076}
-------------------------------

### 4.10.1. Background information (Table [40](#efs25306-tbl-0040){ref-type="table"}) {#efs25306-sec-0077}

###### 

Background information on fenpyroximate

+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------+
|                         |                         | Comments, references                                                                          |
+=========================+=========================+===============================================================================================+
| Type of JMPR evaluation | Periodic review         |                                                                                               |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------+
| RMS                     | AT                      |                                                                                               |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------+
| Approval status         | Renewal of the approval | Commission Directive 2008/107/EC[a](#efs25306-note-0053){ref-type="fn"} (approval)            |
|                         |                         |                                                                                               |
|                         |                         | Commission Regulation (EU) 2016/183 (renewal)                                                 |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA ([2008e](#efs25306-bib-0012){ref-type="ref"})                                            |
|                         |                         |                                                                                               |
|                         |                         | EFSA ([2013j](#efs25306-bib-0053){ref-type="ref"}) (amendment approval and confirmatory data) |
|                         |                         |                                                                                               |
|                         |                         | EFSA conclusion ongoing (AIR IV)                                                              |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments       | EFSA ([2015o](#efs25306-bib-0090){ref-type="ref"})                                            |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------+
| MRL applications        | No                      |                                                                                               |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------+

2008/107/EC: Commission Directive 2008/107/EC of 25 November 2008 amending Council Directive 91/414/EEC to include abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as active substances. OJ L 316, 26.11.2008, p. 4--11.
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### 4.10.2. Toxicological reference values -- fenpyroximate (Table [41](#efs25306-tbl-0041){ref-type="table"}) {#efs25306-sec-0078}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+-----------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                           | EU evaluation                  | TRV comparable        |                                                     |     |
+========================+===========================================================================================================================================================================================================================================================================================================================================================================================================+================================+=======================+=====================================================+=====+
| **ADI**                | 0.01 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                     | JMPR 2017;                     | 0.01 mg/kg bw per day | EFSA ([2013j](#efs25306-bib-0053){ref-type="ref"}); | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           |                                |                       |                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           | Rat, 2‐year study              |                       | Rat, 2‐year study                                   |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+-----------------------------------------------------+-----+
| **ARfD**               | 0.01 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                             | JMPR 2017;                     | 0.02 mg/kg bw         | EFSA ([2013j](#efs25306-bib-0053){ref-type="ref"}); | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           |                                |                       |                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           | Dog, 1‐day and 13‐week studies |                       | Dog, 1‐ and 5‐day study                             |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+-----------------------------------------------------+-----+
| **Conclusion/comment** | For the derivation of the [ADI]{.ul}, JMPR considered the NOAEL of 1 mg/kg bw per day in the 2‐year rat study and applying a safety factor of 100. The same derivation was adopted at EU level.                                                                                                                                                                                                           |                                |                       |                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           |                                |                       |                                                     |     |
|                        | For the derivation of the [ARfD]{.ul}, JMPR considered the induction of diarrhoea seen in a newly submitted single bolus gavage study and in a 13‐week study with dogs. An increased safety factor of 200 was applied since no NOAEL was identified in these studies.                                                                                                                                     |                                |                       |                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           |                                |                       |                                                     |     |
|                        | For the EU evaluation, it is not clear if the same data were available since a newly submitted single bolus gavage study is mentioned in JMPR 2017, and the agreed ARfD of 0.02 mg/kg bw was based (as in JMPR, 2007) on a NOAEL of 2 mg/kg bw in an acute toxicity study with dogs (1--5 days), where increased incidences of diarrhoea were observed at 5 mg/kg bw per day (and applying an UF of 100). |                                |                       |                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           |                                |                       |                                                     |     |
|                        | For the [metabolites]{.ul}, JMPR concluded that M‐1, M‐3, M‐5, M‐21, M‐22 and Fen‐OH would be covered by the reference values of the parent compound since these metabolites were also detected in rats at significant levels.                                                                                                                                                                            |                                |                       |                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                           |                                |                       |                                                     |     |
|                        | During the EU evaluation, the metabolites M‐1 and M‐12 were concluded of equal or lower toxicity than the parent compound                                                                                                                                                                                                                                                                                 |                                |                       |                                                     |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+-----------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union; NOAEL: no observed adverse effect level.
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### 4.10.3. Residue definitions -- fenpyroximate (Table [42](#efs25306-tbl-0042){ref-type="table"}) {#efs25306-sec-0079}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | JMPR evaluation                                                                                                                                                         | EU evaluation                                                                                              | RDs comparable |
+=========================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================================================================================================================+============================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Fenpyroximate                                                                                                                                                           | Reg. 396/2005: Fenpyroximate                                                                               | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         | Peer review: Fenpyroximate (fruit crops, pulses and oilseeds, only)                                        |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fenpyroximate, 2‐hydroxymethyl‐2‐propyl (E)‐4‐\[(1,3‐dimethyl‐5‐phenoxypyrazol‐4‐yl)‐methylenaminooxymethyl\]benzoate (Fen‐OH), and (E)‐4‐\[(1,3‐dimethyl‐5‐phenoxypyrazol‐4‐yl)methyleneaminooxymethyl\]benzoic acid (M‐3), expressed as fenpyroximate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Reg. 396/2005: Fenpyroximate for all animal products, except liver and kidney of ruminants:                                                                             | No                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | Liver and kidney of ruminants: metabolite M‐3                                                                                                                           |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Peer review:                                                                                                                                                            |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Metabolite M‐3 expressed as fenpyroximate                                                                                                                               |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | The residue is fat soluble                                                                                                                                              |                                                                                                            |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Sum of parent fenpyroximate and its tert‐butyl (*Z*)‐α‐(1,3‐dimethyl‐5‐phenoxypyrazol‐4‐ylmethyleneamino‐oxy)‐p‐toluate (its Z‐isomer, M‐1), expressed as fenpyroximate | Sum of fenpyroximate and its Z‐isomer, expressed as fenpyroximate (fruit crops, pulses and oilseeds, only) | Yes            |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fenpyroximate, 2‐hydroxymethyl‐2‐propyl (E)‐4‐\[(1,3‐dimethyl‐5‐phenoxypyrazol‐4‐yl)‐methylenaminooxymethyl\]benzoate(Fen‐OH), (E)‐4‐\[(1,3‐dimethyl‐5‐phenoxypyrazol‐4‐yl)methyleneaminooxymethyl\]benzoic acid(M‐3), and (E)‐4‐{\[(1,3‐dimethyl‐5‐(4‐hydroxyphenoxy)pyrazol‐4‐yl\]methyleneaminooxymethyl}benzoic acid (M‐5, free and its conjugates), expressed as fenpyroximate                                                                                                                                                                                                                                                                                                                                                                         | Sum of fenpyroximate, Fen‐OH, M‐3 and their Z‐isomers (M‐1), expressed as fenpyroximate                                                                                 | No                                                                                                         |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | **Plant:** Residue definitions for enforcement and risk assessment in plant commodities are comparable. Additional metabolism studies with fenpyroximate following foliar application to citrus, apples, grapes, snaps beans, cotton and Swiss chard were evaluated by the JMPR. These studies allowed deriving a general residue definition.                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                         |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         | **Animal:** RD enf: Fen‐OH is not included in the residue definition for enforcement established at EU level. However, according to the results of the metabolism and livestock‐feeding studies, at the calculated dietary burden, residues in livestock are mainly driven by metabolite M03 (liver and kidney) and fenpyroximate (fat). Therefore, the difference in the residue definitions for enforcement in animal commodities can be considered as minor.                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                         |                                                                                                            |                |
|                         | RD RA: Regarding the residue definition for risk assessment, metabolite M5 (free and its conjugates) is not included in the residue definition established in EU. It is noted that in the livestock‐feeding studies assessed by JMPR, M5 was not analysed in animal tissues and milk. According to the information available in the JMPR report, a conversion factor from enforcement to risk assessment was not derived to consider the exposure to this metabolite. Therefore, apparently the input values used by the JMPR for the risk assessment seem to consider only the levels of fenpyroximate, Fen‐OH and M‐3, which is in line with the EU residue definition. JMPR should be asked for clarifications as regards the metabolite M‐5 and its conjugates |                                                                                                                                                                         |                                                                                                            |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.
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### 4.10.4. Codex MRL proposals -- fenpyroximate (Table [43](#efs25306-tbl-0043){ref-type="table"}) {#efs25306-sec-0080}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                              | Codex MRL proposal                           | EU MRL                                                                                                                           | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+========================================================================================+==============================================+==================================================================================================================================+===========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Apple                                                                                  | 0.2                                          | 0.3 (ft)                                                                                                                         | Critical GAP: Belgium (1 × 76.5 g/ha, PHI: 7 days).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: Results from overdosed residue trials were scaled down according to the proportionality principle. A different GAP was assessed in the EU Article 12 review (102 g/ha; PHI: 21 days). However, the existing EU MRL was based on the old Codex MRL which is now proposed to be withdrawn.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable. The existing EU MRL should be lowered, since the old Codex MRL will be withdrawn                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Avocado                                                                                | **0.2**                                      | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Critical GAP: USA, 2 × 117 g/ha; PHI: 1 day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pear                                                                                   | 0.2                                          | 0.3 (ft)                                                                                                                         | Critical GAP: USA, 1 × 117 g/ha; PHI: 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: combined data set of trials compliant with GAP and overdosed trials. Results from overdosed residue trials were scaled down according to the proportionality principle. An acute intake concern was noted in the risk assessment performed with the JMPR ARfD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: To discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of cherries (includes all commodities in this subgroup)^(a)^                  | 2                                            | 2 (ft) (cherry)                                                                                                                  | Critical GAP: USA, 2 × 117 g/ha; PHI: 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is sufficiently supported by data. However, an acute intake concern was identified by JMPR for German and Danish children. Using the EU ARfD, no intake concern was identified by EFSA.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peach                                                                                  | **0.4**                                      | 0.3 (ft)                                                                                                                         | Critical GAP: USA, 2 × 117 g/ha; PHI: 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: an acute intake concern has been identified by the JMPR (130%) when considering the most critical GAP. An alternative GAP was not available.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is sufficiently supported by data. However, an acute intake concern was identified by JMPR for Japanese and Canadian children. Using the EU ARfD, no intake concern was identified by EFSA.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apricot                                                                                | **0.4**                                      | 0.3 (ft)                                                                                                                         | Critical GAP: USA, 2 x 117 g/ha; PHI: 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 10 trials on peaches                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: all trials were performed on peaches. According to the current EU guidelines, the extrapolation from peaches to apricots is not possible. According to the JMPR extrapolation rules, trials on peaches can be used to derive an MRL for apricots.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of plums (including fresh prunes) (includes all commodities in this subgroup) | **0.8**                                      | 0.1 (ft)                                                                                                                         | Critical GAP: USA, 2 x 117 g/ha; PHI: 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: According to the current EU guidelines, being plums a major crop, the number of trials is not sufficient to derive an MRL. In Codex, plums are classified as a major crop, for which refinement criteria applied.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | An acute intake concern has been identified by the JMPR (270%) when considering residues in dried plums. Thus, the MRL for fresh plums would not be acceptable either.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is not acceptable because it is not sufficiently supported by data. In addition, an intake concern was identified by JMPR for Australian children for processed plums. No intake concern for EU population using the EU ARfD; with the lower ARfD of JMPR, an intake concern was identified for children                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Group of citrus fruit (includes all commodities in this group)                         | **0.6**                                      | 0.5 (ft)                                                                                                                         | Critical GAP: USA, 2 x 235 g/ha; PHI: 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              | 0.01[\*](#efs25306-note-0606){ref-type="fn"} for kumquats                                                                        | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: combined data set on oranges (8), lemons (4) and grapefruits (4), extrapolation to the whole group of citrus fruits. According to the current EU guidelines, the proposed extrapolation is not fully supported by data (4 additional trials on lemons and/or mandarins would be needed). JMPR reported that trials on tangor, satsuma, Chinese citron and natsudaidai show that residues in flesh were 13% of that fruit are mentioned by the JMPR. The HR and STMR measured in the whole fruit were recalculated to an HR‐P and STMR‐P using this peeling factor of 13%. It is noted that the trials used for deriving the peeling factor are not compliant with the GAP (only 1 application of 250 g/hg). Overall, it seems that the residues in the pulp are lower, but the calculation of the peeling factor is not presented in sufficiently transparent way to verify the validity. |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is not acceptable because it is not sufficiently supported by data and because of possible intake concerns                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapes                                                                                 | 0.1                                          | 0.3 (ft) for wine and table                                                                                                      | Critical GAP: ES, 1 x 50 g/ha; PHI: 28 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The EU MRL was derived from NEU trials compliant with the DE GAP (1 × 123 g/ha, PHI 35 days).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberries                                                                           | 0.3                                          | 0.3 (ft)                                                                                                                         | Critical GAP: DE and AT, 1 x 102 g/ha; PHI: 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The EU MRL is based on the same GAP; JMPR had 8 additional trials that were not provided in the EU.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Raspberry                                                                              | 0.2                                          | 1.5 (ft)                                                                                                                         | Critical GAP: AT, 1 × 76.5 g/ha; PHI: 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The same GAP was assessed in the article 12 review. A smaller data set was available to JMPR compared to the article 12 review (4 vs. 8). In the EU, trials not analysed for the Z‐isomers were also considered.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cucumber                                                                               | **0.3**                                      | 0.08 (ft)                                                                                                                        | Critical GAP: USA, 2 x 117 g/ha; PHI: 1 day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: according to the current EU guidelines and the Codex rules, being cucumbers a major crop, the number of trials is not sufficient to derive an MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. It is noted that using the lower ARfD of JMPR, an intake concern was identified for the EU                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Squash, summer                                                                         | 0.06                                         | 0.08 (ft)                                                                                                                        | Critical GAP: DE, 1 × 46--92 g/ha, PHI: 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The trials reflect the highest application rate (92 g/ha (± 25%)). It is not specified if the trials were performed indoor or outdoor.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melons, except watermelon,                                                             | **0.2**                                      | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Critical GAP: USA, 2 × 117 g/ha; PHI: 3 days (in cantaloupe)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: combined data set with trials on melons (4, performed with one application) and cantaloupe (8, compliant with GAP) used to derive the Codex MRL proposal. Based on the 8 trials in cantaloupe that matched the GAP, a MRL proposal of 0.05 mg/kg would be derived.Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. Using the lower ARfD derived by JMPR, an acute intake concern was noted for the EU                                                                                                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Watermelon                                                                             | **0.05**                                     | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Critical GAP: USA, 2 × 117 g/ha; PHI: 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The trials were performed with 2 x 110 g/ha; PHI: 1 day. According to the current EU guidelines and the Codex rules, being watermelon a major crop, the number of trials is not sufficient to derive an MRL. An acute intake concern has been identified by the JMPR (190%). An alternative GAP was not available.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is not acceptable because the number of trials is not sufficient and the trials do not match the critical GAP; in addition, it is noted that acute intake concerns were identified by JMPR and by EFSA (only when using the lower ARfD of JMPR).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of peppers (except martynia, okra and roselle)                                | 0.2                                          | 0.3 (ft)                                                                                                                         | Critical GAP: USA, 2 × 117 g/ha; PHI: 1 day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: It seems that the residue trials used to derive the MRL proposal were not analysed for the metabolite M‐1. Thus, the HR and STMR values are likely to underestimate the total residues (sum of fenpyroximate and M‐1).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of eggplants(includes all commodities in this subgroup)                       | **0.3**                                      | 0.2 (ft)                                                                                                                         | Critical GAP: USA, 2 × 117 g/ha; PHI: 1 day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: data extrapolated from tomato.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                                                 | **0.3**                                      | 0.2 (ft)                                                                                                                         | Critical GAP: USA, 2 × 117 g/ha; PHI: 1 day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The Codex MRL derived is expected to cover both tomatoes and cherries tomatoes. Apparently, no trials on cherry tomatoes were available. An acute intake concern has been identified by the JMPR (310%) in tomato dried. An alternative GAP was not available.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is not acceptable because of intake concerns for dried tomatoes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                                          | **0.3**                                      | 0.2 (ft) (tomato)                                                                                                                | Critical GAP: USA, 2 × 117 g/ha; PHI: 1 day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | See tomatoes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of beans with pods(includes all commodities in this subgroup)                 | 0.5                                          | 0.7 (ft)                                                                                                                         | Critical GAP: ES, 1 × 102 g/ha; PHI: 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The same GAP was assessed in the article 12 review. A larger data set was available to JMPR compared to the article 12 review (16 vs. 8).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                                 | **0.05\***                                   | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Critical GAP: USA, 2 × 117 g/ha, PHI: 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: trials on potato tuber compliant with GAP.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                                                                  | 0.01[\*](#efs25306-note-0606){ref-type="fn"} | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Critical GAP: USA, 2 × 117 g/ha; PHI: 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The trials on maize grain are compliant with the GAP.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tree nut                                                                               | **0.05\***                                   | 0.01[\*](#efs25306-note-0606){ref-type="fn"} all tree nuts except almonds 0.05[\*](#efs25306-note-0606){ref-type="fn"} (ft)      | Critical GAP: USA, 2 × 117 g/ha; PHI: 14 days.Number of trials: 13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: trials on almond (5), pecan (5) and walnut (3) performed with exaggerated rate (450 g/ha; PHI: 14 days).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Coffee beans                                                                           | **0.07**                                     | 0.05[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Critical GAP: BR, 2 × 50--100 g/ha: PHI: 15 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The samples of the supervised trials were analysed only for the parent compound. Thus, the STMR/HR values may be underestimated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: To be verified if the proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Hops, dry                                                                              | 15                                           | 15 (ft)                                                                                                                          | Critical GAP: AT, 1 × 76.8--268.8 g/ha; PHI: 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: trials on hops conducted in Germany and Japan and approximating the GAP. At EU level, a less critical GAP (CZ, 1 × 125 g/ha; PHI: 21 days) was assessed which lead to the same MRL.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tea, green, black, dried                                                               | **8**                                        | 0.05[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Critical GAP: IN, 1 × 25 g/ha; PHI: 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The trials on tea leaves are approximating the GAP.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                                  | 0.01[\*](#efs25306-note-0606){ref-type="fn"} | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Max dietary burden: 3.503 mg/kg DM (Australia diet after refinement excluding bean forage).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 1 feeding study with highest dose level (10 ppm) covering the max DB.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: See comments on residue definitions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is acceptable; the different residue definition set at EU level and by JMPR is not relevant in this case                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                          | **0.1(fat)**                                 | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Max dietary burden: 3.503 mg/kg DM (Australia diet after refinement excluding bean forage).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 1 feeding study with highest dose level (10 ppm) covering the max DB.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: The MRL proposal refers to fat; it reflects the RD derived by JMPR. In muscle residues of 0.02 mg/kg were estimated for the maximum DB reported.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is not fully compatible with the EU residue definition; for muscle an appropriate MRL needs to be derived as well                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                               | **0.5**                                      | 0.09 except swine with 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                              | Max dietary burden: 3.503 mg/kg DM (Australia diet after refinement excluding bean forage).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: the feeding study covered the max DB.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: MRL proposal reflects the residue definition of JMPR which is different than the EU RD.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is not fully compatible with the EU residue definition.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                      | **0.1**                                      | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | Max dietary burden: 3.503 mg/kg DM (Australia diet after refinement excluding bean forage).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 1 feeding study with highest dose level (10 ppm) covering the max DB.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Specific comments/observations: MRL proposal reflects the residue definition of JMPR which is different than the EU RD. HR in fat is 0.089 mg/kg; thus, a MRL proposal of 0.09 mg/kg should be enough.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Conclusion: The proposed Codex MRL is not fully compatible with the EU residue definition                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apples, dried                                                                          | 1                                            |                                                                                                                                  | Derived PF of 4.4, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dried grapes (= currants, raisins and sultanas)                                        | 0.2                                          |                                                                                                                                  | Derived PF of 2, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus oil                                                                             | 25                                           | (processed)                                                                                                                      | Derived PF of 43, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize fodder                                                                           | 5                                            |                                                                                                                                  | Critical GAP: USA, 2 × 117; PHI: 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  | The MRL proposal is in line with Codex rules                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetable other than cucurbits                                                | W0.2                                         |                                                                                                                                  | The existing CXL will be replaced by the new proposed MRL for peppers, tomatoes and eggplants                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pome fruits                                                                            | W 0.3                                        | Apple and pear: 0.3 (ft) for quinces and medlars, Loquats/Japanese medlars 0.2 (ft)                                              | The existing CXL will be replaced by the new proposed MRL for apples and pears.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              |                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                        |                                              | Others 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Prunes dry                                                                             | W 0.7                                        |                                                                                                                                  | The existing CXL was proposed for withdrawal. Although a use for plums was assessed, no new MRL proposal was made, since an intake concern was identified for dried prunes (see comments on plums                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Stone fruits                                                                           | W 0.4                                        | Apricots and peach 0.3 (ft), cherries (sweet) 2 (ft), 0.1 (ft) plumes and 0.01[\*](#efs25306-note-0606){ref-type="fn"} in others | The existing CXL will be replaced by the new proposed MRL for peaches, apricots and plums.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Common beans (pod and/or immature seeds                                                | W 0.4                                        | 0.01[\*](#efs25306-note-0606){ref-type="fn"}                                                                                     | The existing CXL will be replaced by the new proposed MRL for beans with pods                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, chili, dried                                                                  | W 1.0                                        |                                                                                                                                  | The existing CXL will be replaced by the new proposed MRL for peppers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple juice                                                                            | None                                         |                                                                                                                                  | Derived PF of 0.16, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple sauce                                                                            | None                                         |                                                                                                                                  | Derived PF of 0.18, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape juice                                                                            | None                                         |                                                                                                                                  | Derived PF of 0.16, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape wine                                                                             | None                                         |                                                                                                                                  | Derived PF of 0.16, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato juice                                                                           | None                                         |                                                                                                                                  | Derived PF of 0.64, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato canned                                                                          | None                                         |                                                                                                                                  | Derived PF of 0.40, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato purée                                                                           | None                                         |                                                                                                                                  | Derived PF of 0.72, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus molasses                                                                        | None                                         |                                                                                                                                  | Derived PF of 0.07, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus juice                                                                           | None                                         |                                                                                                                                  | Derived PF of 0.03, based on two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize meal                                                                             | None                                         |                                                                                                                                  | Derived PF of 0.15, based on one processing study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize flour                                                                            | None                                         |                                                                                                                                  | Derived PF of 0.37, based on one processing study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize grits                                                                            | None                                         |                                                                                                                                  | Derived PF of 0.016, based on one processing study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize oil                                                                              | None                                         |                                                                                                                                  | Derived PF of 0.99 (refined oil, dry milling) and 0.31 (refined oil, wet milling) based on one processing study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Teas (Tea and Herb teas)                                                               | None                                         |                                                                                                                                  | Derived PF of 0.0098 for dry leaves tea infusion, based on eight processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union; PHI: preharvest interval; CXL: Codex Maximum Residue Limit; DM: dry matter.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.10.5. Consumer risk assessment -- fenpyroximate (Table [44](#efs25306-tbl-0044){ref-type="table"}) {#efs25306-sec-0081}

###### 

Summary of the consumer risk assessment for fenpyroximate

+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                    | Chronic exposure assessment                                                                                                                                                                                                                                              | Comments on JMPR exposure assessment                                                           |
+==============================================================================================================================================================================================================================================================================================================+==========================================================================================================================================================================================================================================================================+================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                          | **RA assumptions:**                                                                                                                                                                                                                                                      | **Specific comments**                                                                          |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| The short‐term dietary risk assessment was performed for all commodities assessed by JMPR.                                                                                                                                                                                                                   | The most recent long‐term risk assessment (EFSA, [2015o](#efs25306-bib-0090){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including, for those commodities having a CXL higher than the EU MRL, the STMR values derived by JMPR. | Exposure was assessed by the JMPR also for processed commodities                               |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| The EU ARfD (scenario 1) and the JMPR ARfD (scenario 2) were used.                                                                                                                                                                                                                                           | For citrus fruits, in the absence of detailed results for pulp a refinement was not possible. Therefore, residues in the whole fruits were considered.                                                                                                                   |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| For apples, a lower variability factor of 2.2, derived in the framework of the Article 12 review (EFSA, [2015o](#efs25306-bib-0090){ref-type="ref"}), was considered.The variability factor was not extrapolated to pears.                                                                                   | For peppers and coffee, the STMR values derived by JMPR do not cover the metabolite M‐1; thus, the calculated exposure may underestimate the real exposure.                                                                                                              |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| For citrus fruits, in the absence of detailed results for pulp, a refinement was not possible: therefore, residues in the whole fruits were considered. If reliable data on the residues in the edible part of citrus fruit are available, further refinements of the intake calculations might be possible. | Since Codex MRL proposals for meat are expressed on a fat basis, EFSA recalculated the corresponding median residue level for meat.                                                                                                                                      |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| For peppers and coffee, the HR values derived by JMPR do not cover the metabolite M‐1; thus, the calculated exposure may underestimate the real exposure.                                                                                                                                                    | The risk assessment for animal products is tentative, since residue definitions derived by JMPR and EU differ                                                                                                                                                            |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| Since Codex MRL proposals for meat are expressed on a fat basis, EFSA recalculated the corresponding maximum residue levels for meat.                                                                                                                                                                        |                                                                                                                                                                                                                                                                          |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| The risk assessment for animal products is tentative, since the residue definitions of JMPR differ from the EU residue definition                                                                                                                                                                            |                                                                                                                                                                                                                                                                          |                                                                                                |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------+
| **Results scenario 1:**                                                                                                                                                                                                                                                                                      | **Results (scenario 1 and 2):**                                                                                                                                                                                                                                          | **Results:**                                                                                   |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| Short‐term exposure concern were identified for the following commodities:                                                                                                                                                                                                                                   | No long‐term consumer health risk was identified.The overall chronic exposure accounted for 28% of the ADI                                                                                                                                                               | [Long‐term exposure]{.ul}:                                                                     |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Oranges** (179% of the ARfD)                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                          | No long‐term consumer health risk was identified.                                              |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Grapefruits** (120% of the ARfD)                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                          | The overall chronic exposure accounted for 10% of the ADI for the 17 GEMS/Food regional diets. |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| If reliable data on the residues in the edible part of citrus fruit are available, further refinements of the intake calculations might be possible.                                                                                                                                                         |                                                                                                                                                                                                                                                                          | [Short‐term exposure]{.ul}:                                                                    |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Results scenario 2:**                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                          | Short‐term exposure concern was identified by the JMPR for the following commodities:          |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| Short‐term exposure concern were identified for the following commodities:**Oranges** (358% of the ARfD)                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                          | **Dried tomatoes** (310% of the ARfD for general population from Australia)                    |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Grapefruits** (241% of the ARfD)                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                          | **Dried plums** (270% of the ARfD for children from Australia)                                 |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Mandarins** (150% of the ARfD)                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                          | **Watermelons** (190% of the ARfD for children from CAN)                                       |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Peaches** (148% of the ARfD)                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                          | **Peaches** (130% of the ARfD for children from Japan and CAN)                                 |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Cucumbers** (140% of the ARfD)                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                          | **Cherries** (110% of the ARfD for children from NL and DK)                                    |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Pears** (137% of the ARfD)                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                          |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Melons** (137% of the ARfD)                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                          |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Watermelons** (122% of the ARfD)                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                          |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Cherries** (121% of the ARfD)                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
|                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                          |                                                                                                |
| **Plums** (109% of the ARfD)                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                          |                                                                                                |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

4.11. Imidacloprid (206) (R) {#efs25306-sec-0082}
----------------------------

### 4.11.1. Background information (Table [45](#efs25306-tbl-0045){ref-type="table"}) {#efs25306-sec-0083}

###### 

Background information on imidacloprid

+-------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------+
|                         |                         | Comments, references                                                                                         |
+=========================+=========================+==============================================================================================================+
| Type of JMPR evaluation | New use                 |                                                                                                              |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------+
| RMS                     | DE                      |                                                                                                              |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------+
| Approval status         | Renewal of the approval | Commission Implementing Regulation (EU) No 485/2013[a](#efs25306-note-0059){ref-type="fn"}                   |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA ([2008a](#efs25306-bib-0008){ref-type="ref"})                                                           |
|                         |                         |                                                                                                              |
|                         |                         | EFSA ([2014j](#efs25306-bib-0065){ref-type="ref"})                                                           |
|                         |                         |                                                                                                              |
|                         |                         | EFSA ([2014p](#efs25306-bib-0071){ref-type="ref"})                                                           |
|                         |                         |                                                                                                              |
|                         |                         | EFSA ([2015j](#efs25306-bib-0085){ref-type="ref"})                                                           |
|                         |                         |                                                                                                              |
|                         |                         | EFSA ([2016n](#efs25306-bib-0104){ref-type="ref"})                                                           |
|                         |                         |                                                                                                              |
|                         |                         | EFSA ([2016p](#efs25306-bib-0106){ref-type="ref"})                                                           |
|                         |                         |                                                                                                              |
|                         |                         | EFSA ([2018e](#efs25306-bib-0125){ref-type="ref"}) (Art. 21 seed treatment and granules uses)                |
|                         |                         |                                                                                                              |
|                         |                         | EFSA conclusions ongoing (AIR IV)Emergency authorisations ongoing                                            |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------+
| MRL review              | No                      | Ongoing                                                                                                      |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments       | EFSA ([2010d](#efs25306-bib-0020){ref-type="ref"}) Art 10 -- various crop (ongoing, additional data request) |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

485/2013/EU Commission Implementing Regulation (EU) No 485/2013 of 24 May 2013 amending Implementing Regulation (EU) No 540/2011, as regards the conditions of approval of the active substances clothianidin, thiamethoxam and imidacloprid, and prohibiting the use and sale of seeds treated with plant protection products containing those active substances. OJ L 139, 25.5.2013, p. 12--26.

John Wiley & Sons, Ltd

### 4.11.2. Toxicological reference values -- imidacloprid (Table [46](#efs25306-tbl-0046){ref-type="table"}) {#efs25306-sec-0084}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+----------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                           | EU evaluation | TRV comparable        |                                                                                  |     |
+========================+===========================================================================================================================================================================================================================================================================================================+===============+=======================+==================================================================================+=====+
| **ADI**                | 0.06 mg/kg bw per day                                                                                                                                                                                                                                                                                     | JMPR 2015     | 0.06 mg/kg bw per day | EFSA ([2008a](#efs25306-bib-0008){ref-type="ref"}) (Rat, 2‐yr safety factor 100) | Yes |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+----------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.4 mg/kg bw                                                                                                                                                                                                                                                                                              | JMPR 2015     | 0.08 mg/kg bw         | EFSA ([2008a](#efs25306-bib-0008){ref-type="ref"}) (Dog, 90‐day                  | No  |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       |                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       | (acute effects)                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       |                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       | supported by the developmental                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       |                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       | study in the rabbit Safety factor 100)                                           |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+----------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | In 2013, EFSA assessed the developmental neurotoxicity potential for imidacloprid.                                                                                                                                                                                                                        |               |                       |                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       |                                                                                  |     |
|                        | The PPR Panel concluded that the ADI set for imidacloprid would provide adequate protection against its potential adverse effects from the developing nervous system.As regards the ARfD, the Panel recommended to conservatively lower the reference values to the level of the ADI, i.e. 0.06 mg/kg bw. |               |                       |                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                           |               |                       |                                                                                  |     |
|                        | JMPR assessed imidacloprid in 2015 where the ADI and ARfD have been confirmed. The ARfD of JMPR was based an acute neurotoxicity study in rats                                                                                                                                                            |               |                       |                                                                                  |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+----------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.11.3. Residue definitions -- imidacloprid (Table [47](#efs25306-tbl-0047){ref-type="table"}) {#efs25306-sec-0085}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                              | JMPR evaluation                                                                                             | EU evaluation                                                                                                               | RDs comparable |
+=========================+==============================================================================================================================================================================================================================================================================================================================================================================+=============================================================================================================+=============================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                               | Sum of imidacloprid and its metabolites containing the 6‐chloropyridinyl moiety, expressed as imidacloprid. | EU Reg. 396/2005: imidacloprid                                                                                              | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                             |                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                              | The residue is not fat soluble                                                                              | Peer review: No definitive decision on the residue definition for enforcement was taken.                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                             |                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                             | SCFCAH October 2009: Sum of imidacloprid, imidacloprid‐5‐ hydroxy and imidacloprid‐olefin, expressed as imidacloprid        |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Reg. 396/2005: Imidacloprid                                                                                                                                                                                                                                                                                                                                                  | No                                                                                                          |                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                             |                                                                                                                             |                |
|                         | Peer review: Sum of imidacloprid and its metabolites imidacloprid‐5‐hydroxy (M1) and imidacloprid‐olefin (M6), expressed as imidacloprid                                                                                                                                                                                                                                     |                                                                                                             |                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                             |                                                                                                                             |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                               |                                                                                                             |                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                             |                                                                                                                             |                |
|                         | SCFCAH October 2009: Sum of imidacloprid, imidacloprid‐5‐ hydroxy and imidacloprid‐olefin, expressed as imidacloprid                                                                                                                                                                                                                                                         |                                                                                                             |                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                             |                                                                                                                             |                |
|                         | Proposal RMS in ER (plant and animal products) drafted for Art. 12 review: Imidacloprid                                                                                                                                                                                                                                                                                      |                                                                                                             |                                                                                                                             |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                               | Sum of imidacloprid and its metabolites containing the 6‐chloropyridinyl moiety, expressed as imidacloprid  | Peer review: Sum of imidacloprid and its metabolites containing the 6‐chloropyridinyl moiety, all expressed as imidacloprid | Yes            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Yes                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                             |                                                                                                                             |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for risk assessment are comparable. However, residue definitions for enforcement are still under discussion in the EU. Pending a final decision taken in the framework of the MRL review, the proposed Codex MRLs need to be checked individually as to whether they can be taken over in the EU legislation or whether adaptations will be required |                                                                                                             |                                                                                                                             |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

John Wiley & Sons, Ltd

### 4.11.4. Codex MRL proposals -- imidacloprid (Table [48](#efs25306-tbl-0048){ref-type="table"}) {#efs25306-sec-0086}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

  ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **General comments**   The Meeting received supervised trial data (4) for applications of imidacloprid on pistachios. However, trials were not compliant with the GAP (Iran, 3 × 014 kg/ha; PHI: not applicable). Moreover, in these trials, residues were not analysed according to the residue definition (only levels of imidacloprid and imidacloprid olefin were measured). Therefore, no CXL could be derived from these data
  ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

GAP: Good Agricultural Practice; CXL: Codex Maximum Residue Limit.

John Wiley & Sons, Ltd

### 4.11.5. Consumer risk assessment -- imidacloprid (Table [49](#efs25306-tbl-0049){ref-type="table"}) {#efs25306-sec-0087}

###### 

Summary of the consumer risk assessment for imidacloprid

  Acute exposure assessment   Chronic exposure assessment   Comments on JMPR exposure assessment
  --------------------------- ----------------------------- --------------------------------------
  Not relevant                Not relevant                  --

John Wiley & Sons, Ltd

4.12. Cyprodinil (207) (R) {#efs25306-sec-0088}
--------------------------

### 4.12.1. Background information (Table [50](#efs25306-tbl-0050){ref-type="table"}) {#efs25306-sec-0089}

###### 

Background information on cyprodinil

                                                      Comments, references
  ------------------------- ------------------------- --------------------------------------------------------------------------------------------
  Type of JMPR evaluation   New use                   
  RMS                       FR                        
  Approval status           Renewal of the approval   Commission Implementing Regulation (EU) No 678/2014[a](#efs25306-note-0064){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2006](#efs25306-bib-0005){ref-type="ref"}) EFSA conclusions ongoing (AIR III)
  MRL review                Yes, see comments         EFSA ([2013i](#efs25306-bib-0052){ref-type="ref"})
  MRL applications          Yes, see comments         EFSA ([2015e](#efs25306-bib-0080){ref-type="ref"}) (celery)

MRL: maximum residue limit; RMS: rapporteur Member State.

678/2014/EU: Commission Implementing Regulation (EU) No 678/2014 of 19 June 2014 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clopyralid, cyprodinil, fosetyl, pyrimethanil and trinexapac. OJ L 180, 20.6.2014, p. 11--12.

John Wiley & Sons, Ltd

### 4.12.2. Toxicological reference values -- cyprodinil (Table [51](#efs25306-tbl-0051){ref-type="table"}) {#efs25306-sec-0090}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+----------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+---------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                            | EU evaluation                  | TRV comparable        |                                                   |     |
+========================+============================================================================================================================+================================+=======================+===================================================+=====+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                      | JMPR, 2003(2‐year rat, SF 100) | 0.03 mg/kg bw per day | EFSA ([2006](#efs25306-bib-0005){ref-type="ref"}) | Yes |
|                        |                                                                                                                            |                                |                       |                                                   |     |
|                        |                                                                                                                            |                                |                       | (2‐year rat, UF 100)                              |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+---------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                | JMPR, 2003                     | Not necessary         | EFSA ([2006](#efs25306-bib-0005){ref-type="ref"}) | Yes |
+------------------------+----------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+---------------------------------------------------+-----+
| **Conclusion/comment** | The TRV values derived by JMPR and at EU level are identical.                                                              |                                |                       |                                                   |     |
|                        |                                                                                                                            |                                |                       |                                                   |     |
|                        | The RMS informed EFSA that an ARfD of 1.5 mg/kg bw based on the rabbit developmental toxicity study is proposed in the RAR |                                |                       |                                                   |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+---------------------------------------------------+-----+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; RMS: rapporteur Member State; RMS: rapporteur Member State; ARfD: acute reference dose; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.12.3. Residue definitions -- cyprodinil (Table [52](#efs25306-tbl-0052){ref-type="table"}) {#efs25306-sec-0091}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                               | JMPR evaluation                                                                                             | EU evaluation | RDs comparable |
+=========================+===============================================================================================================================================================================================================================================================================================================================================================+=============================================================================================================+===============+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                | Cyprodinil                                                                                                  | Cyprodinil    | Yes            |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Cyprodinil                                                                                                                                                                                                                                                                                                                                                    | [Milk]{.ul}: Cyprodinil (sum of cyprodinil and CGA 304075 (free and conjugated), expressed as cyprodinil)   | No            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               |                                                                                                             |               |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                    | [Other animal products:]{.ul}                                                                               |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               |                                                                                                             |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               | Cyprodinil (sum of cyprodinil and CGA 304075 (free), expressed as cyprodinil)                               |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               |                                                                                                             |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               | The residue is fat soluble                                                                                  |               |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                | Cyprodinil                                                                                                  | Cyprodinil    | Yes            |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Cyprodinil                                                                                                                                                                                                                                                                                                                                                    | [Milk]{.ul}: Cyprodinil (sum of cyprodinil and CGA 304075 (free and conjugated), expressed as cyprodinil)   | No            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               |                                                                                                             |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               | [Other animal products:]{.ul} Cyprodinil (sum of cyprodinil and CGA 304075 (free), expressed as cyprodinil) |               |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------+----------------+
| **Conclusion/comments** | [Plant products]{.ul}: The residue definition for enforcement and risk assessment derived by JMPR and at EU level is identical.                                                                                                                                                                                                                               |                                                                                                             |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               |                                                                                                             |               |                |
|                         | [Animal products]{.ul}: For animal products, the EU residue definition for enforcement and risk assessment is wider as comprises the metabolite CGA304075 (4‐\[(4‐cyclopropyl‐6‐methylpyrimidin‐2‐yl)amino)\]phenol) for tissues. In the framework of the MRL review also the conjugates of CGA 304075 were also included in the residue definition for milk. |                                                                                                             |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                               |                                                                                                             |               |                |
|                         | The RMS informed EFSA that the following residue definition is proposed in the RAR (both for monitoring and risk assessment purposes): Sum of cyprodinil and CGA304075 (free form and glucuronide) expressed as cyprodinil                                                                                                                                    |                                                                                                             |               |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; RMS: rapporteur Member State; RAR: renewal assessment report.

John Wiley & Sons, Ltd

### 4.12.4. Codex MRL proposals -- cyprodinil (Table [53](#efs25306-tbl-0053){ref-type="table"}) {#efs25306-sec-0092}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                              | Codex MRL proposal                           | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+========================================================================+==============================================+==============================================+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Artichoke, globe                                                       | **4**                                        | 0.02[\*](#efs25306-note-0609){ref-type="fn"} | Critical GAP: Foliar use in USA, 4 × 366 g/ha, PHI 3 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: one trial was slightly deviating from the GAP (five applications instead of four); however, this deviation was accepted the residues were comparable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrot                                                                 | 1.5                                          | 1.5                                          | Critical GAP: Foliar use in DE, 3 × 375 g/ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: none                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | JMPR reported that the use on carrots did not have a significant impact on the dietary burden calculation for farm animals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Celery                                                                 | **30**                                       | 0.1[\*](#efs25306-note-0609){ref-type="fn"}  | Critical GAP: Foliar use in USA, 4 × 368 g/ha, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: none                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Guava                                                                  | **1.5**                                      | 0.02[\*](#efs25306-note-0609){ref-type="fn"} | Critical GAP: Foliar use in USA, 4 × 368 g/ha, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: none                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pomegranate                                                            | **10 (Po)**                                  | 0.02[\*](#efs25306-note-0609){ref-type="fn"} | Critical GAP: US post‐harvest (dip/drench) GAP, 1 × 54 g/hL before storage + 1 × 54 g/hL before trading, PHI 0 days (US)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 1 storage facility, 4 trials at different dates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: The GAP is not sufficiently defined: the interval between the first and the second treatment should be established.Metabolism studies in fruit crops are available only for foliar uses; evidence needs to be provided that the fate of residues following post‐harvest use is comparable with foliar use.The residue trials were conducted in a single facility with identical technique and variables (i.e. temperature, humidity, aeration); the trials are therefore not independent.Considering that the GAP is a post‐harvest treatment, the MRL should be calculated as 'mean + 4 SD'; thus, a MRL proposal of 5 mg/kg (unrounded 4.63 mg/kg) would be sufficient.Conclusion: The proposed Codex MRL is not acceptable. |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of beans with pods(includes all commodities in this subgroup) | 2                                            | 2                                            | Critical GAP: Spanish indoor GAP, 2 × 375 g/ha, PHI 3 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: trials with three instead of two applications. This set of trials is compliant with indoor GAP assessed in the MRL review.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Common bean (pods and/or immature seeds)                               | W 0.7                                        |                                              | Existing CXL was proposed to be withdrawn                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                 | 0.01[\*](#efs25306-note-0609){ref-type="fn"} | 0.02[\*](#efs25306-note-0609){ref-type="fn"} | Critical GAP: Foliar use in USA, 4 × 366 g/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: JMPR reported that the use on potatoes did not have a significant impact on the dietary burden calculation for farm animals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tree nuts (except almond and pistachio)                                | **0.04**                                     | 0.02[\*](#efs25306-note-0609){ref-type="fn"} | Critical GAP: Foliar use in USA, 4 × 366 g/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Specific comments/observations: extrapolation from trials on pecan (5 trials) and almond (4 trials) to tree nuts group (except almond and pistachio) is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                        |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                        |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; GAP: Good Agricultural Practice.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.12.5. Consumer risk assessment -- cyprodinil (Table [54](#efs25306-tbl-0054){ref-type="table"}) {#efs25306-sec-0093}

###### 

Summary of the consumer risk assessment for cyprodinil

+------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------+
| Acute exposure assessment                      | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                      | Comments on JMPR exposure assessment                     |
+================================================+==================================================================================================================================================================================================================================================================================================================================================================================================+==========================================================+
| **RA assumptions:**                            | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                              | **Specific comments**                                    |
|                                                |                                                                                                                                                                                                                                                                                                                                                                                                  |                                                          |
| --                                             | The long‐term risk assessment (EFSA, [2015e](#efs25306-bib-0080){ref-type="ref"}) was updated with the STMRs derived by JMPR in 2013 and 2015 for the CXLs implemented in the EU legislation and using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for tree nuts (except almond and pistachio), pomegranate, guava and celery, globe artichokes. | --                                                       |
|                                                |                                                                                                                                                                                                                                                                                                                                                                                                  |                                                          |
|                                                | Peeling factor used for cucurbits, inedible peel                                                                                                                                                                                                                                                                                                                                                 |                                                          |
+------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------+
| **Results:**                                   | **Results:**                                                                                                                                                                                                                                                                                                                                                                                     | **Results:**                                             |
|                                                |                                                                                                                                                                                                                                                                                                                                                                                                  |                                                          |
| A short‐term exposure assessment not necessary | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                                                                                | Long‐term exposure resulted by JMPR is 8--70% of the ADI |
|                                                |                                                                                                                                                                                                                                                                                                                                                                                                  |                                                          |
|                                                | The overall chronic exposure accounted for 5--40% of the ADI.The contribution of to the exposure was 3.6% ADI for celery, 0.7% ADI for globe artichokes and \< 0.4% ADI for the remaining commodities                                                                                                                                                                                            |                                                          |
+------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------+

ADI: acceptable daily intake; supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue.

John Wiley & Sons, Ltd

4.13. Trifloxystrobin (213) (R) {#efs25306-sec-0094}
-------------------------------

### 4.13.1. Background information (Table [55](#efs25306-tbl-0055){ref-type="table"}) {#efs25306-sec-0095}

###### 

Background information on trifloxystrobin

+-------------------------+-------------------------+--------------------------------------------------------------------------------------------+
|                         |                         | Comments, references                                                                       |
+=========================+=========================+============================================================================================+
| Type of JMPR evaluation | New use                 |                                                                                            |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------+
| RMS                     | UK                      |                                                                                            |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------+
| Approval status         | Renewal of the approval | Commission Implementing Regulation (EU) No 2017/841[a](#efs25306-note-0070){ref-type="fn"} |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA ([2017k](#efs25306-bib-0119){ref-type="ref"})                                         |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments       | EFSA ([2014c](#efs25306-bib-0058){ref-type="ref"})                                         |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments       | EFSA ([2016a](#efs25306-bib-0091){ref-type="ref"}) (celeriac)                              |
|                         |                         |                                                                                            |
|                         |                         | EFSA ([2014l](#efs25306-bib-0067){ref-type="ref"}) (cane fruit)                            |
|                         |                         |                                                                                            |
|                         |                         | EFSA ([2018c](#efs25306-bib-0123){ref-type="ref"}) (various crop)                          |
+-------------------------+-------------------------+--------------------------------------------------------------------------------------------+

MRL: maximum residue limit.

2017/841/EU: Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha‐cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron‐methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl‐m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s‐metolachlor, and trifloxystrobin. OJ L 125, 18.5.2017, p. 12--15.

John Wiley & Sons, Ltd

### 4.13.2. Toxicological reference values -- trifloxystrobin (Table [56](#efs25306-tbl-0056){ref-type="table"}) {#efs25306-sec-0096}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------+---------------+----------------------+----------------------------------------------------+----+
|                        | JMPR evaluation                                                                                 | EU evaluation | TRV comparable       |                                                    |    |
+========================+=================================================================================================+===============+======================+====================================================+====+
| **ADI**                | 0.04 mg/kg bw per day                                                                           | JMPR, 2004    | 0.1 mg/kg bw per day | EFSA ([2017k](#efs25306-bib-0119){ref-type="ref"}) | No |
|                        |                                                                                                 |               |                      |                                                    |    |
|                        |                                                                                                 |               |                      | (2‐year rat, UF 100)                               |    |
+------------------------+-------------------------------------------------------------------------------------------------+---------------+----------------------+----------------------------------------------------+----+
| **ARfD**               | unnecessary                                                                                     | JMPR, 2004    | 0.5 mg/kg bw         | EFSA ([2017k](#efs25306-bib-0119){ref-type="ref"}) | No |
|                        |                                                                                                 |               |                      |                                                    |    |
|                        |                                                                                                 |               |                      | (rabbit, developmental, UF 100)                    |    |
+------------------------+-------------------------------------------------------------------------------------------------+---------------+----------------------+----------------------------------------------------+----+
| **Conclusion/comment** | The EU ARfD has been established just recently in the framework of the renewal of the approval. |               |                      |                                                    |    |
+------------------------+-------------------------------------------------------------------------------------------------+---------------+----------------------+----------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.13.3. Residue definitions -- trifloxystrobin (Table [57](#efs25306-tbl-0057){ref-type="table"}) {#efs25306-sec-0097}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                          | JMPR evaluation                                                                                                                                                            | EU evaluation                                                                                                                                       | RDs comparable |
+=========================+==========================================================================================================================================================================================================================================================================================================================================+============================================================================================================================================================================+=====================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                           | Trifloxystrobin                                                                                                                                                            | Trifloxystrobin                                                                                                                                     | Yes            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of trifloxystrobin and \[(*E,E*)‐methoxyimino‐{2‐\[1‐(3‐trifluoromethylphenyl)ethylideneamino‐oxymethyl\]phenyl}acetic acid\] (CGA 321113, M5), expressed as trifloxystrobin.                                                                                                                                                        | Sum of trifloxystrobin and CGA 321113 (M5), expressed as trifloxystrobin.                                                                                                  | Yes                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                               | The residue is fat soluble                                                                                                                                                 |                                                                                                                                                     |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                           | Sum of trifloxystrobin and \[(E,E)‐methoxyimino‐{2‐\[1‐(3‐ trifluoromethylphenyl)ethylideneaminooxymethyl\]phenyl}acetic acid\] (CGA 321113), expressed as trifloxystrobin | **Primary Crops**: Sum of trifloxystrobin, its 3 isomers (CGA 357262, CGA 357261 and CGA 331409) and CGA 321113 (M5), expressed as trifloxystrobin. | No             |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            | **Processed commodities:** Sum of trifloxystrobin and CGA 321113 (M5), expressed as trifloxystrobin.                                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            | The RD RA was amended with EFSA ([2017i](#efs25306-bib-0117){ref-type="ref"}).                                                                      |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of trifloxystrobin and \[(E,E)‐methoxyimino‐{2‐\[1‐(3‐trifluoromethylphenyl)ethylideneamino‐oxymethyl\]phenyl}acetic acid\] (CGA 321113), expressed as trifloxystrobin                                                                                                                                                               | [Ruminants:]{.ul}                                                                                                                                                          | No                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          | Sum of trifloxystrobin and CGA 321113 (M5) (free and conjugated), expressed as trifloxystrobin.                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          | [Poultry:]{.ul}                                                                                                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          | Sum of trifloxystrobin and CGA 321113 (M5) (only free), expressed as trifloxystrobin.                                                                                      |                                                                                                                                                     |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | RD RA for plant products: It should be verified, if isomer specific analytical methods were used to analyse the samples of the residue trials assessed by JMPR. If this was not the case, and the results refer to the sum of isomers and M5, the different residue definitions for plant products would not have a practical relevance. |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                            |                                                                                                                                                     |                |
|                         | RD RA for animal products: Not fully compatible since the conjugates were in the EU RD for ruminant liver and kidney                                                                                                                                                                                                                     |                                                                                                                                                                            |                                                                                                                                                     |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.13.4. Codex MRL proposals -- trifloxystrobin (Table [58](#efs25306-tbl-0058){ref-type="table"}) {#efs25306-sec-0098}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+---------------------------------+----------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                       | Codex MRL proposal                           | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                   |
+=================================+==============================================+==============================================+===========================================================================================================================================================================================================================================================================================================================================+
| Cabbages, Head                  | **1.5**                                      | 0.5                                          | Critical GAP: USA, 3 × 139 g ai/ha; RTI 7--14 days, PHI 0; seasonal rate 281 g ai/ha per yr                                                                                                                                                                                                                                               |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                       |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Sufficiently supported by data: No, head cabbage is major crop, both in the EU and according to JMPR criteria.                                                                                                                                                                                                                            |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Specific comments/observations: The MRL proposal is based on head cabbage with wrapper leaves, while the STMR is derived from head cabbage without wrapper leaves. Given that consumers may eat outer leaves if they are not damaged, it would be more appropriate to use the STMR and HR being based on inclusion of the wrapper leaves. |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | A PHI of 0 days would not be acceptable for EU GAPs, but is usually acceptable for import tolerances.                                                                                                                                                                                                                                     |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs.                                                                                                                                                                                              |
+---------------------------------+----------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton seed                     | **0.4**                                      | 0.01[\*](#efs25306-note-0610){ref-type="fn"} | Critical GAP: 3 × 137 g ai/ha, RTI: 14 days, PHI 30 days, country with cGAP not reported                                                                                                                                                                                                                                                  |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Number of trials: 11                                                                                                                                                                                                                                                                                                                      |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                       |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Specific comments/observations: ‐                                                                                                                                                                                                                                                                                                         |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                         |
+---------------------------------+----------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Ginseng                         | 0.03[\*](#efs25306-note-0610){ref-type="fn"} | 0.05[\*](#efs25306-note-0610){ref-type="fn"} | Critical GAP: Republic of Korea, 3 × 3.35 g ai/ha RTI 10 days, PHI 21                                                                                                                                                                                                                                                                     |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                       |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                       |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Specific comments/observations: Residues below the LOQ of either 0.03[\*](#efs25306-note-0610){ref-type="fn"} or 0.06[\*](#efs25306-note-0610){ref-type="fn"}mg/kg.                                                                                                                                                                       |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                         |
+---------------------------------+----------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Spinach                         | **20**                                       | 0.01[\*](#efs25306-note-0610){ref-type="fn"} | Critical GAP: USA 2 × 139 g ai/ha, RTI 14 days, PHI 0                                                                                                                                                                                                                                                                                     |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                       |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                       |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Specific comments/observations: At EU level a PHI of 0 days would not be acceptable.                                                                                                                                                                                                                                                      |
|                                 |                                              |                                              |                                                                                                                                                                                                                                                                                                                                           |
|                                 |                                              |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                               |
+---------------------------------+----------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton seed refined oil, edible | none                                         |                                              | Two processing studies were available, PF = 0.02                                                                                                                                                                                                                                                                                          |
+---------------------------------+----------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

EU MRL: European Union maximum residue limit; GAP: Good Agricultural Practice; HR: highest residue; PF: processing factor; STMR: supervised trials median residue.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.13.5. Consumer risk assessment -- trifloxystrobin (Table [59](#efs25306-tbl-0059){ref-type="table"}) {#efs25306-sec-0099}

###### 

Summary of the consumer risk assessment for trifloxystrobin

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                  | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                  | Comments on JMPR exposure assessment |
+============================================================================================================================================================================================================+==============================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                        | **RA assumptions:**                                                                                                                                                                                                                                                                                                                          | **Specific comments**                |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              |                                      |
| The short‐term dietary risk assessment was performed for head cabbage, spinach, cotton seed and ginseng as outlined in Section [4.13.2](#efs25306-sec-0096){ref-type="sec"}. EU ARfD was used.             | The most recent long‐term risk assessment (EFSA, [2017k](#efs25306-bib-0119){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for spinach, cotton seed and ginseng. For head cabbage, the STMR derived from cabbage with wrapper leaves (0.42 mg/kg) was used. |                                      |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              |                                      |
| For head cabbage, the HR value was based on cabbage with wrapper leaves.                                                                                                                                   | This risk assessment is considered tentative, because of the lack of information on the metabolites included in the EU RD that were not considered in the JMPR assessment (i.e. CGA 357262, CGA 357261 and CGA 331409)                                                                                                                       |                                      |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              |                                      |
| The risk assessment is tentative, because of the lack of information on the metabolites included in the EU RD that were not considered in the JMPR assessment (i.e. CGA 357262, CGA 357261 and CGA 331409) |                                                                                                                                                                                                                                                                                                                                              |                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                               | **Results:**                                                                                                                                                                                                                                                                                                                                 | **Results:**                         |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              |                                      |
| No short‐term exposure concern was identified (45% and 6% of the ARfD for spinach and head cabbage, respectively).                                                                                         | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                            | Long‐term exposure:                  |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              |                                      |
|                                                                                                                                                                                                            | The overall chronic exposure accounted for up to 8.4% of the ADI (FR toddler).                                                                                                                                                                                                                                                               | 7% of the ADI                        |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              |                                      |
|                                                                                                                                                                                                            | The contribution of spinach and head cabbage to the exposure was up to 5.4% (FR toddler) and 0.3% of the ADI, respectively                                                                                                                                                                                                                   | Short‐term exposure:                 |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              |                                      |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                              | Not relevant for JMPR                |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

4.14. Difenoconazole (224) (R) {#efs25306-sec-0100}
------------------------------

### 4.14.1. Background information (Table [60](#efs25306-tbl-0060){ref-type="table"}) {#efs25306-sec-0101}

###### 

Background information on difenoconazole

+-------------------------+-------------------------+---------------------------------------------------------------------------------------------+
|                         |                         | Comments, references                                                                        |
+=========================+=========================+=============================================================================================+
| Type of JMPR evaluation | New use                 |                                                                                             |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------+
| RMS                     | ES                      |                                                                                             |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------+
| Approval status         | Renewal of the approval | Commission Implementing Regulation (EU) No 1100/2011[a](#efs25306-note-0076){ref-type="fn"} |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA ([2011a](#efs25306-bib-0026){ref-type="ref"})                                          |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2014r](#efs25306-bib-0073){ref-type="ref"})                                          |
|                         |                         |                                                                                             |
|                         |                         | EFSA conclusions ongoing (AIR III)                                                          |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------+
| MRL review              | No                      | In progress                                                                                 |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments       | EFSA ([2017g](#efs25306-bib-0115){ref-type="ref"}) (various crop)                           |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2014q](#efs25306-bib-0072){ref-type="ref"}) (leafy veg)                              |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2014e](#efs25306-bib-0060){ref-type="ref"}) (peppers and aubergines)                 |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2013a](#efs25306-bib-0044){ref-type="ref"}) (various crop)                           |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2012f](#efs25306-bib-0039){ref-type="ref"}) (various crop)                           |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2011c](#efs25306-bib-0028){ref-type="ref"}) (beet, artichokes, strawberry)           |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2010f](#efs25306-bib-0022){ref-type="ref"}) (peppers and aubergine)                  |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2010a](#efs25306-bib-0017){ref-type="ref"}) (swedes and turnips)                     |
|                         |                         |                                                                                             |
|                         |                         | EFSA ([2009b](#efs25306-bib-0014){ref-type="ref"}) (leafy veg)                              |
+-------------------------+-------------------------+---------------------------------------------------------------------------------------------+

MPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit.

2011/1100/EU: Commission Implementing Regulation (EU) No 1100/2011 of 31 October 2011 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substances dicamba, difenoconazole and imazaquin. OJ L 285, 1.11.2011, p. 10--14.

John Wiley & Sons, Ltd

### 4.14.2. Toxicological reference values -- difenoconazole (Table [61](#efs25306-tbl-0061){ref-type="table"}) {#efs25306-sec-0102}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

                           JMPR evaluation         EU evaluation                                                                                                                                                  TRV comparable                                                                                                     
  ------------------------ ----------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ------------------------------------------------------------------------------------------ -----
  **ADI**                  0.01 mg/kg bw per day   JMPR, 2007 (Rat, 2‐year combined toxicity and carcinogenicity study, safety factor 100)                                                                        0.01 mg/kg bw per day   EFSA ([2011a](#efs25306-bib-0026){ref-type="ref"}) (2‐year rat safety factor 100)          Yes
  **ARfD**                 0.3 mg/kg bw            JMPR, 2007 (Rat single dose neurotoxicity study, supported by maternal effects in rabbit developmental study, NOAEL 0.25 mg/kg bw/day in both cases AF: 100)   0.16 mg/kg bw           EFSA ([2011a](#efs25306-bib-0026){ref-type="ref"}) (developmental rat safety factor 100)   No
  **Conclusion/comment**   --                                                                                                                                                                                                                                                                                                        

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.14.3. Residue definitions -- difenoconazole (Table [62](#efs25306-tbl-0062){ref-type="table"}) {#efs25306-sec-0103}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+
|                         | Commodity group                                                                                                                                  | JMPR evaluation                                                                                                                                                                                                                                                                                                                 | EU evaluation                                                                                                                                                                              | RDs comparable       |
+=========================+==================================================================================================================================================+=================================================================================================================================================================================================================================================================================================================================+============================================================================================================================================================================================+======================+
| **RD enf**              | Plant products                                                                                                                                   | Difenoconazole                                                                                                                                                                                                                                                                                                                  | Difenoconazole                                                                                                                                                                             | Yes                  |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+
| Animal products         | Sum of difenoconazole and 1‐\[2‐chloro‐4‐(4‐chloro‐phenoxy)‐phenyl\]‐2‐(1,2,4‐triazol)‐1‐yl‐ethanol) (=CGA‐205375), expressed as difenoconazole. | EU Reg. 396/2005: Difenoconazole                                                                                                                                                                                                                                                                                                | Not fully compatible                                                                                                                                                                       |                      |
|                         |                                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                            |                      |
|                         | The residue is fat soluble                                                                                                                       | Peer review: Difenoconazole alcohol (CGA‐205375) expressed as difenoconazole                                                                                                                                                                                                                                                    |                                                                                                                                                                                            |                      |
|                         |                                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                            |                      |
|                         |                                                                                                                                                  | The residue is fat soluble                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                            |                      |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+
| **RD RA**               | Plant products                                                                                                                                   | Difenoconazole                                                                                                                                                                                                                                                                                                                  | Two separate residue definitions:                                                                                                                                                          | Not fully compatible |
|                         |                                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                            |                      |
|                         |                                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                 | DifenoconazoleTriazole‐derivative metabolites (TDM) (provisional, pending the definition of a common and harmonised approach for all the active substances of the triazole chemical class) |                      |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+
| Animal products         | Sum of difenoconazole and 1‐\[2‐chloro‐4‐(4‐chloro‐phenoxy)‐phenyl\]‐2‐(1,2,4‐triazol)‐1‐yl‐ethanol), expressed as difenoconazole.               | Two separate residue definitions: Difenoconazole alcohol (CGA‐205375) expressed as difenoconazoleTriazole‐derivative metabolites (provisional, pending information on metabolism of TDM in animals and pending the definition of a common and harmonised approach for all the active substances of the triazole chemical class) | Not fully compatible                                                                                                                                                                       |                      |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+
| **Conclusion/comments** | --                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                            |                      |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.14.4. Codex MRL proposals -- difenoconazole (Table [63](#efs25306-tbl-0063){ref-type="table"}) {#efs25306-sec-0104}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                    | Codex MRL proposal                           | EU MRL                                                                                                                                                                                         | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+==============================================================================+==============================================+================================================================================================================================================================================================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Pome fruits                                                                  | **4**                                        | 0.8 all group                                                                                                                                                                                  | Critical GAP: US GAP with 5 × 77 g/ha foliar + post‐harvest dip or drench 30 g ai/hL or post‐harvest spray 1.3 g ai/t                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 27 (9 for foliar + drenching, 9 for foliar + drench and 9 for foliar + post‐harvest spray)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: ‐                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is not acceptable for apples and pears because the ARfD of 0.16 mg/kg and the ADI are exceeded. Furthermore, it is noted that since the US GAP applies only to apples and pears, it is not justified to set a group tolerance                                                                                                                                                                                                                                                                                                                                                      |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Blueberries                                                                  | **4**                                        | 0.1                                                                                                                                                                                            | Critical GAP: CAN, foliar, 4 × 127 g ai/ha, RTI 6--9 days, PHI 1Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberries                                                                 | **2**                                        | 0.4                                                                                                                                                                                            | Critical GAP: USA, foliar application, 4 × 127.5 g ai/ha; RTI 7 days, PHI: 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: At EU level a PHI of 0 days would not be acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pitaya (dragon fruit)                                                        | **0.15**                                     | 0.1                                                                                                                                                                                            | Critical GAP: Indonesia, foliar, 3 × 50 g ai/ha RTI 9--11 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: Scaling was applied, as the trials were overdosed (3 × 94 g/ha).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Watermelon                                                                   | 0.02                                         | 0.2                                                                                                                                                                                            | Critical GAP: BR, 6 × 50 g ai/ha, RTI 7 days, PHI 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 4 overdosed trials which were scaled to match the GAP.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: Watermelons are considered a major crop, and therefore, 8 trials would be required.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is not compliant with the data requirements. Risk managers should discuss the need to make a reservation, considering that the existing EU MRL is higher. In general, the manufacturer should be encouraged to send a European GAP to establish a Codex MRL that covers also the European uses                                                                                                                                                                                                                                                                                     |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetables other than cucurbits                                     | W0.6                                         | Tomatoes: 2; Sweet peppers/bell peppers 0.8; Aubergines/eggplants 0.6; Okra/lady\'s fingers, sweet corns, other Solanacea and other fruiting veg. 0.05[\*](#efs25306-note-0622){ref-type="fn"} | The existing CXL is replaced by the new CXL reported below                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Group of Fruiting vegetables other than cucurbits (except peppers, chili)^a^ | 0.6                                          |                                                                                                                                                                                                | The previous CXL was maintained, excluding chili peppers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| peppers, chili                                                               | **0.9**                                      | 0.8                                                                                                                                                                                            | Critical GAP: foliar, 4 × 80 g ai/ha; RTI 10 days; PHI 2 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: EU MRL relates to sweet peppers. Peppers are a major crop, and therefore, 8 trials would be required in the EU.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, chili, dried                                                        | 5                                            |                                                                                                                                                                                                | The existing CXL for dried Chili peppers should be replaced by a new MRL proposal of 4, derived from the specific residue trials in chili peppers (see above) and the specific processing factor of 4.5                                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corn (corn on the cob) (kernels plus cob with husk removed)            | 0.01[\*](#efs25306-note-0622){ref-type="fn"} | 0.05[\*](#efs25306-note-0622){ref-type="fn"}                                                                                                                                                   | Critical GAP: USA, seed treatment 1 × 300 g ai/t seed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: residues below LOQ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry beans (except soya bean)                                     | 0.05                                         | 0.06                                                                                                                                                                                           | Critical GAP: USA, foliar, 4 × 127.5 g ai/ha, RTI 14 ± 2 days; PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: The number of trials is not sufficient to derive a MRL proposal for dry beans. However, the trials on dry beans, peas and chickpeas could be combined to derive a MRL of 0.1 mg/kg for the three crops.                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry peas(includes all commodities in this subgroup)              | **0.15**                                     | 0.1                                                                                                                                                                                            | Critical GAP: USA, foliar, 4 × 127.5 g ai/ha, RTI 14 ± 2 d; PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: see subgroup of dry beans.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Ginseng, dried                                                               | 0.8                                          | 20                                                                                                                                                                                             | Critical GAP: USA, foliar, 4 × 127.5 g ai/ha; RTI 6--8 days; PHI: 0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: The trials results refer to dried ginseng.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Globe artichoke                                                              | **1.5**                                      | 1                                                                                                                                                                                              | Critical GAP: USA, foliar; 4 × 127.5 g ai/ha; RTI 12--16 days; PHI 3 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: Based on JMPR, at least 4 trials are required for globe artichokes. The HR value proposed by JMPR was based on the highest individual analytical result (0.64 mg/kg), not the highest residue level found in the residue trial (0.57).                                                                                                                                                                                                                                                                                                                                                |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice                                                                         | **8**                                        | 3                                                                                                                                                                                              | Critical GAP: foliar, 2 × 137 g ai/ha; RTI 14 days; PHI: 35 days (USA).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: The results of the residue trials refer to rice grain, which is according to Codex classification the rice with husks. In the EU, the MRLs for rice are set for husked rice (rice without husk, brown rice) (see Commission Regulation (EU) 2018/62).                                                                                                                                                                                                                                                                                                                                 |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable, but it cannot be taken over without adjustment because of different crop description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                                               | 0.07                                         |                                                                                                                                                                                                | A processing factor of 0.0078 was reported in the JMPR report. In the JMPR Evaluation, 4 processing studies were reported with the individual PF of 0.0078, \< 0.91, 0.48 and 0.95. It is unclear why the proposed PF was based only on the first value, ignoring the three remaining results. The validity of the first PF should be verified, since the residue in the unprocessed RAC was 48 mg/kg while in the other trials the residues in the RAC, having received a similar application rate, ranged from 0.011 mg/kg to 2.9 mg/kg. Thus, it is questionable that the processing factor of 0.0078 is reliable. |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | See also comments on the dietary risk assessment performed by JMPR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice straw                                                                   | 17 (dw)                                      |                                                                                                                                                                                                | 14 trials were available                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Coffee beans                                                                 | 0.01[\*](#efs25306-note-0622){ref-type="fn"} | 0.05[\*](#efs25306-note-0622){ref-type="fn"}                                                                                                                                                   | Critical GAP: BR, foliar, 3 × 50 g ai/ha; RTI 12--16 days; PHI 30 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Specific comments/observations: Trials were overdosed, but below LOQ. Although coffee is a major crop, given the no residue situation, 4 trials are sufficient. No need to take over, as only the LOQ is lowered.                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                              |                                              |                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                              |                                                                                                                                                                                                | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corn stover                                                            | 0.01                                         | 0.05[\*](#efs25306-note-0622){ref-type="fn"}                                                                                                                                                   | 9 trials were available                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice bran, unprocessed                                                       | none                                         |                                                                                                                                                                                                | Only one processing study was available.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ADI: acceptable daily intake; CXL: Codex Maximum Residue Limit; LOQ: limit of quantification; GAP: Good Agricultural Practice.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.14.5. Consumer risk assessment -- difenoconazole (Table [64](#efs25306-tbl-0064){ref-type="table"}) {#efs25306-sec-0105}

###### 

Summary of the consumer risk assessment for difenoconazole

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                  | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                         | Comments on JMPR exposure assessment                                                                                                                                                                                                         |
+============================================================================================================================================================================================================================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================+==============================================================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                        | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                 | **Specific comments**                                                                                                                                                                                                                        |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
| The short‐term dietary risk assessment was performed for all commodities for which a CXL was sought as outlined in Section [4.14.2](#efs25306-sec-0102){ref-type="sec"}.                                                   | [Scenario 1:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                  | For the dietary risk assessment, JMPR calculated the STMR‐P for polished rice, using the PF of 0.0078. The validity of this PF is questionable. Thus, the acute and chronic dietary exposure should be recalculated, using a recalculated PF |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
| The EU ARfD was used. For pome fruits, HR values were included per commodity. Azarole and persimmon were included in the assessment, as they belong to the group of pome fruits according to the Codex food classification | The most recent long‐term risk assessment (EFSA, [2017g](#efs25306-bib-0115){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the commodities. For pome fruits, the STMR was used for the individual commodities covered by the Codex classification of pome fruit including also azaroles and persimmon. For rice, the proposed STMR‐P derived by JMPR was used. |                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                            | [Scenario 2:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                            | The same as scenario 1, except that the STMR values for apples and pears were based on the existing EU MRLs                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                               | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                        | **Results:**                                                                                                                                                                                                                                 |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
| Considering the ARfD of 0.16 mg/kg, a short‐term exposure concern was identified for apples and pears (159% and 148% of the ARfD, respectively).                                                                           | [Scenario 1:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                  | 9--80% of the ADI                                                                                                                                                                                                                            |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
| For the other commodities, the exposure was below the ARfD (highest was persimmon contributing to 64.8% of ARfD).                                                                                                          | A long‐term consumer health risk was identified, the overall chronic exposure exceeded 100% of the ADI in three diets (199% DE child, 135% NL child; 101.7% WHO Cluster diet B), apple was the major contributor in these diets (133%, 70% and 11%, respectively, except for WHO diet B, in which tomato was the major contributor).                                                                                                                | Short‐term exposure:                                                                                                                                                                                                                         |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
| If the ARfD derived by JMPR is considered, no short‐term intake concern is identified. The short‐term exposure for apples and pears would be up to 85% and 79% of the ARfD, respectively                                   | [Scenario 2:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                  | Up to 60% of the EU ARfD                                                                                                                                                                                                                     |
|                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                            | No long‐term consumer health risk identified. Chronic exposure was up to 88.9% of the ADI (WHO Cluster diet B)                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; HR: highest residue; STMR: supervised trials median residue; RD: residue definition.

John Wiley & Sons, Ltd

4.15. Azoxystrobin (229) (R) {#efs25306-sec-0106}
----------------------------

### 4.15.1. Background information (Table [65](#efs25306-tbl-0065){ref-type="table"}) {#efs25306-sec-0107}

###### 

Background information on azoxystrobin

+-------------------------+-------------------+----------------------------------------------------------------------------------------------------+
|                         |                   | Comments, references                                                                               |
+=========================+===================+====================================================================================================+
| Type of JMPR evaluation | New use           | Except rape seed                                                                                   |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------+
| RMS                     | UK                |                                                                                                    |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------+
| Approval status         | Approved          | Commission Implementing Regulation (EU) No 703/2011[a](#efs25306-note-0082){ref-type="fn"}         |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments | EFSA ([2010b](#efs25306-bib-0018){ref-type="ref"})                                                 |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments | EFSA ([2013k](#efs25306-bib-0054){ref-type="ref"})                                                 |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------+
| MRL applications        | No                | EFSA ([2016c](#efs25306-bib-0093){ref-type="ref"}) (grapes)                                        |
|                         |                   |                                                                                                    |
|                         |                   | EFSA ([2016h](#efs25306-bib-0098){ref-type="ref"}) (chervil, chervil, rhubarb, linseed, safflower) |
|                         |                   |                                                                                                    |
|                         |                   | None ongoing                                                                                       |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------+

RMS: rapporteur Member State; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

Commission Implementing Regulation (EU) No 703/2011 of 20 July 2011 approving the active substance azoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 190, 21.7.2011, p. 33--37.

John Wiley & Sons, Ltd

### 4.15.2. Toxicological reference values -- azoxystrobin (Table [66](#efs25306-tbl-0066){ref-type="table"}) {#efs25306-sec-0108}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

                           JMPR evaluation        EU evaluation                                               TRV comparable                                                                                              
  ------------------------ ---------------------- ----------------------------------------------------------- ---------------------- ------------------------------------------------------------------------------------ -----
  **ADI**                  0.2 mg/kg bw per day   JMPR 2008 (2‐year rat carcinogenicity, safety factor 100)   0.2 mg/kg bw per day   EFSA ([2010b](#efs25306-bib-0018){ref-type="ref"}) (2‐year rat, safety factor 100)   Yes
  **ARfD**                 Unnecessary            JMPR 2008                                                   Not necessary          --                                                                                   Yes
  **Conclusion/comment**   --                                                                                                                                                                                             

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.15.3. Residue definitions -- azoxystrobin (Table [67](#efs25306-tbl-0067){ref-type="table"}) {#efs25306-sec-0109}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------+--------------------------------+---------------+----------------+
|                         | Commodity group            | JMPR evaluation                | EU evaluation | RDs comparable |
+=========================+============================+================================+===============+================+
| **RD enf**              | Plant products             | Azoxystrobin                   | Azoxystrobin  | Yes            |
+-------------------------+----------------------------+--------------------------------+---------------+----------------+
| Animal products         | Azoxystrobin               | Azoxystrobin                   | Yes           |                |
|                         |                            |                                |               |                |
|                         | The residue is fat soluble | Po/w lower than 3:             |               |                |
|                         |                            |                                |               |                |
|                         |                            | The residue is not fat soluble |               |                |
+-------------------------+----------------------------+--------------------------------+---------------+----------------+
| **RD RA**               | Plant products             | Azoxystrobin                   | Azoxystrobin  | Yes            |
+-------------------------+----------------------------+--------------------------------+---------------+----------------+
| Animal products         | Azoxystrobin               | Azoxystrobin                   | Yes           |                |
+-------------------------+----------------------------+--------------------------------+---------------+----------------+
| **Conclusion/comments** | --                         |                                |               |                |
+-------------------------+----------------------------+--------------------------------+---------------+----------------+

RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice.

John Wiley & Sons, Ltd

### 4.15.4. Codex MRL proposals -- azoxystrobin (Table [68](#efs25306-tbl-0068){ref-type="table"}) {#efs25306-sec-0110}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------+--------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                     | Codex MRL proposal | EU MRL                                       | Comment                                                                                                                                              |
+===============================+====================+==============================================+======================================================================================================================================================+
| Pitaya                        | 0.3                | 0.01[\*](#efs25306-note-0625){ref-type="fn"} | Critical GAP: Vietnam and Indonesia, foliar application 3 × 0.08 kg ai/ha, RTI 10 days, PHI 7 days                                                   |
|                               |                    |                                              |                                                                                                                                                      |
| (Dragon fruit; 0162040 ‐ 001) |                    |                                              | Number of trials: 7                                                                                                                                  |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Sufficiently supported by data: Yes                                                                                                                  |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Specific comments/observations: proportionality applied, scaling factor 1.875                                                                        |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                     |
+-------------------------------+--------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugarcane                     | **0.05**           | 0.01[\*](#efs25306-note-0625){ref-type="fn"} | Critical GAP: Brazil, foliar, 5 × 0.06 kg ai/ha, RTI, PHI 30 days                                                                                    |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Number of trials: 6                                                                                                                                  |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Sufficiently supported by data: According to JMPR classification, 8 trials would be required (major crop). In the EU, it is considered a minor crop. |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Specific comments/observations: processing factors for bagasse (**7.5**), refined sugar (0.33) and molasses (0.25)                                   |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                    |
+-------------------------------+--------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rape seed                     | 0.5                | 0.5                                          | Critical GAP: USA, CAN, 3× : 0.125 kg/ha BBCH 12‐16 and 67‐79 and 0.250 BBCH 60‐63                                                                   |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Number of trials: 9                                                                                                                                  |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Sufficiently supported by data: Yes                                                                                                                  |
|                               |                    |                                              |                                                                                                                                                      |
|                               |                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                     |
+-------------------------------+--------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+

CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.15.5. Consumer risk assessment -- azoxystrobin (Table [69](#efs25306-tbl-0069){ref-type="table"}) {#efs25306-sec-0111}

###### 

Summary of the consumer risk assessment for azoxystrobin:

+-------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                     | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                    | Comments on JMPR exposure assessment |
+===============================================================================+================================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                           | **RA assumptions:**                                                                                                                                                                                                                                                                                                                            | **Specific comments**                |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                |                                      |
| The short‐term dietary risk assessment was not performed as no ARfD necessary | The most recent long‐term risk assessment (EFSA, [2016h](#efs25306-bib-0098){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for dragon fruit (Cactus fruit, 0162040) and sugar cane. Rape seed was already included in previous assessment with similar value. | --                                   |
+-------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**Not relevant                                                      | **Results:**                                                                                                                                                                                                                                                                                                                                   | **Results:**                         |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                |                                      |
|                                                                               | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                              | --                                   |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                |                                      |
|                                                                               | The overall chronic exposure accounted for 21% of the ADI.                                                                                                                                                                                                                                                                                     |                                      |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                |                                      |
|                                                                               | The contribution of dragon fruit (pitaya) and sugar cane negligible. Rape seed already included in previous assessment.                                                                                                                                                                                                                        |                                      |
+-------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; STMR: supervised trials median residue.

John Wiley & Sons, Ltd

4.16. Prothioconazole (232) (R) {#efs25306-sec-0112}
-------------------------------

### 4.16.1. Background information (Table [70](#efs25306-tbl-0070){ref-type="table"}) {#efs25306-sec-0113}

###### 

Background information on prothioconazole

                                                      Comments, references
  ------------------------- ------------------------- --------------------------------------------------------------------------------------
  Type of JMPR evaluation   New use                   
  RMS                       UK                        
  Approval status           Renewal of the approval   Commission Directive No 2008/44/EC[a](#efs25306-note-0088){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2007b](#efs25306-bib-0007){ref-type="ref"}) EFSA conclusions ongoing (AIRIII)
  MRL review                Yes, see comments         EFSA ([2014f](#efs25306-bib-0061){ref-type="ref"})
  MRL applications          Yes, see comments         EFSA ([2015h](#efs25306-bib-0083){ref-type="ref"}) (shallots)
                                                      EFSA ([2015n](#efs25306-bib-0089){ref-type="ref"}) (sunflowers)

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2008/44/EU: Commission Directive 2008/44/EC of 4 April 2008 amending Council Directive 91/414/EEC to include benthiavalicarb, boscalid, carvone, fluoxastrobin, Paecilomyces lilacinus and prothioconazole as active substances. OJ L 94, 5.4.2008, p. 13--20.

John Wiley & Sons, Ltd

### 4.16.2. Toxicological reference values -- prothioconazole (Table [71](#efs25306-tbl-0071){ref-type="table"}) {#efs25306-sec-0114}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------+-------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                       | EU evaluation | TRV comparable                          |                                                                                                 |     |
+========================+=======================================================================================================================================================================================================================================================+===============+=========================================+=================================================================================================+=====+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                                                                                                 | JMPR 2008     | 0.05 mg/kg bw per day                   | EFSA ([2007b](#efs25306-bib-0007){ref-type="ref"}) (Rat, 2 year study; dog, 1 year study        | Yes |
|                        |                                                                                                                                                                                                                                                       |               |                                         |                                                                                                 |     |
|                        | 0.01 mg/kg bw (prothioconazole‐desthio)                                                                                                                                                                                                               |               | 0.01 mg/kg bw (prothioconazole desthio) | Safety factor 100)                                                                              |     |
|                        |                                                                                                                                                                                                                                                       |               |                                         |                                                                                                 |     |
|                        |                                                                                                                                                                                                                                                       |               |                                         | Rat oncogenicity study, SF 100                                                                  |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------+-------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.8 mg/kg bw                                                                                                                                                                                                                                          | JMPR 2008     | 0.2 mg/kg bw                            | EFSA ([2007b](#efs25306-bib-0007){ref-type="ref"}) (Rat, developmental study Safety factor 100) | No  |
|                        |                                                                                                                                                                                                                                                       |               |                                         |                                                                                                 |     |
|                        | (for women of childbearing age)                                                                                                                                                                                                                       |               | 0.01 mg/kg bw (prothioconazole desthio) | Supplementary rat developmental study, SF 100                                                   |     |
|                        |                                                                                                                                                                                                                                                       |               |                                         |                                                                                                 |     |
|                        | Prothioconazole‐desthio: 0.01 mg/kg bw (for women of childbearing age);                                                                                                                                                                               |               |                                         |                                                                                                 |     |
|                        |                                                                                                                                                                                                                                                       |               |                                         |                                                                                                 |     |
|                        | 1 mg/kg bw (for general population)                                                                                                                                                                                                                   |               |                                         |                                                                                                 |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------+-------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | For prothioconazole desthio, the toxicological reference values derived by JMPR and at EU level are identical. However, it is noted that the ARfD of 0.01 mg/kg for prothioconazole‐desthio derived by JMPR refers only to women of childbearing age) |               |                                         |                                                                                                 |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------+-------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.16.3. Residue definitions -- prothioconazole (Table [72](#efs25306-tbl-0072){ref-type="table"}) {#efs25306-sec-0115}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR evaluation                                                                                                                                                                                                                      | EU evaluation                                                                                                                                                                                                | RDs comparable |
+=========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+======================================================================================================================================================================================================================================+==============================================================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Prothioconazole‐desthio                                                                                                                                                                                                              | Prothioconazole‐desthio (sum of isomers)                                                                                                                                                                     | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Prothioconazole‐desthio.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | EU Reg. 396/2005: prothioconazole‐desthio (sum of isomers                                                                                                                                                                            | Yes                                                                                                                                                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Peer review: Prothioconazole‐desthio (sum of isomers)                                                                                                                                                                                |                                                                                                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Peer review and MRL review (in case DB increases): Sum of prothioconazole‐desthio and its glucuronide conjugate, expressed as prothioconazole‐desthio (not enforced).                                                                |                                                                                                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | The residue is fat soluble                                                                                                                                                                                                           |                                                                                                                                                                                                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Prothioconazole‐desthio.                                                                                                                                                                                                             | Sum of prothioconazole‐desthio and all metabolites containing the 2‐(1‐chlorocyclopropyl)‐3‐(2‐chlorophenyl)‐2‐hydroxypropyl‐2H‐1,2,4‐triazole moiety, expressed as prothioconazole‐desthio (sum of isomers) | No             |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of prothioconazole‐desthio, prothioconazole‐desthio‐3‐hydroxy, prothioconazole‐desthio‐4‐hydroxy and their conjugates expressed as prothioconazole‐desthio.                                                                                                                                                                                                                                                                                                                                                               | MRL review: Sum of prothioconazole‐desthio and all metabolites containing the 2‐(1‐chlorocyclopropyl)‐3‐(2‐chlorophenyl)‐2‐hydroxypropyl‐2H‐1,2,4‐triazole moiety, expressed as prothioconazole‐desthio (sum of isomers) (tentative) | No                                                                                                                                                                                                           |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The EU residue definition for risk assessment for plants is more comprehensive, covering all the metabolites containing the 2‐(1‐chlorocyclopropyl)‐3‐(2‐chlorophenyl)‐2‐hydroxypropyl‐2H‐1,2,4‐triazole moiety; conversion factors for enforcement to risk assessment were derived: 2 for cereal grain, pulses and oilseeds, leafy vegetables and root and tuber vegetables; 3 for cereal straw. Since for fruit crops metabolism, data are not available, a generic conversion factor for risk assessment is not available. |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
|                         | For animal commodities, the EU and JMPR risk assessment residue definitions are not identical. From the metabolism studies presented in the 2008 JMPR report, it seems that some of the major metabolites identified in animal commodities are not covered by the JMPR residue definition. The JMPR RA residue definition reflects those metabolites which were analysed in the cow‐feeding study.                                                                                                                            |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
|                         | The potential inclusion of glucuronide conjugate in the enforcement residue definition for all livestock matrices was recommended by the MRL review in case the EU livestock DB is increasing. From livestock metabolism studies, conversion factors from enforcement to risk assessment were derived as 2 for liver and 9 for kidney and 1 for other matrices.                                                                                                                                                               |                                                                                                                                                                                                                                      |                                                                                                                                                                                                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.16.4. Codex MRL proposals -- prothioconazole (Table [73](#efs25306-tbl-0073){ref-type="table"}) {#efs25306-sec-0116}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | EU MRL                                            | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+===============================================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===================================================+==========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Cotton seed                                   | **0.3**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 0.02[\*](#efs25306-note-0659){ref-type="fn"}      | Critical GAP: USA: 3 × 0.2--0.21 kg/ha, 14 days interval, PHI 30 days                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Number of trials: 12 (USA trials)                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Six USA trials supporting the USA GAP are also available to derive residues in cotton gin by‐products (feed item).                                                                                                                                                                                                                                                                                                                                                                       |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.004[\*](#efs25306-note-0659){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 0.01[\*](#efs25306-note-0659){ref-type="fn"} (ft) | The mean and maximum dietary burden calculated for AUS dairy cattle was used to estimate the Codex MRL in milk. The feed commodities used for the calculation of DB are those referred to in the JMPR assessments in 2009 (CXL for animal matrices proposed) and 2014 (no CXLs for animal matrices proposed). Addition of prothioconazole residues in cotton seed and cotton gin by‐products slightly affect only the calculated mean DB. (See also general comments on DB calculation). |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | The existing Codex MRL for milk at the LOQ of 0.004 mg/kg is confirmed, based on no residue situation in milk at two lowest dose levels from the cow‐feeding study.                                                                                                                                                                                                                                                                                                                      |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | **0.02**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.01[\*](#efs25306-note-0659){ref-type="fn"}      | The Codex MRL proposal of 0.02 mg/kg for fat (which was proposed by the JMPR in 2008 and then withdrawn by the JMPR 2009) is confirmed, based on the residues in fat at two lowest dose levels from the cow‐feeding study.                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | See general comment on DB calculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25306-note-0659){ref-type="fn"}      | The existing Codex MRL for meat at 0.01 mg/kg is confirmed, based on residues in muscle at two lowest dose levels from the cow‐feeding study.                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | The Codex MRL refers to meat but is based on residues in muscle, thus acceptable for the EU food classification.                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | See also general comments on DB calculation.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | **0.3**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 0.5 (ft)                                          | The existing Codex MRL of 0.5 mg/kg for edible offal is lowered to 0.3 mg/kg, based on residues in liver at two lowest dose levels from the cow‐feeding study. The lowering is justified.                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | See general comments on DB calculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | The existing EU MRL is based on the CXL of 0.5 mg/kg (assessed in Art.12). Once the existing CXL is withdrawn, the EU MRL for animal products should be reconsidered, taking into account the EU uses in feed.                                                                                                                                                                                                                                                                           |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                          | 0.005[\*](#efs25306-note-0659){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 0.01[\*](#efs25306-note-0659){ref-type="fn"}      | The maximum and mean dietary burdens calculated for poultry (layers) for EU diet were used to estimate Codex MRL and STMR in eggs and poultry products.                                                                                                                                                                                                                                                                                                                                  |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | The Codex MRL proposal for eggs is estimated from the total radioactive residues (TRR) observed in eggs from the poultry metabolism study performed with prothioconazole (56N the calculated max DB).                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry edible offal                          | **0.1**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 0.01[\*](#efs25306-note-0659){ref-type="fn"}      | The Codex MRL proposal is estimated from the total radioactive residues (TRR) observed in liver from the poultry metabolism study performed with prothioconazole (56N the calculated max DB).                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | The Codex MRL in edible offal refers to prothioconazole‐desthio.                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                  | 0.01[\*](#efs25306-note-0659){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 0.01[\*](#efs25306-note-0659){ref-type="fn"}      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                  | 0.01[\*](#efs25306-note-0659){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 0.01[\*](#efs25306-note-0659){ref-type="fn"}      | The Codex MRL proposal is estimated from the total radioactive residues (TRR) observed in muscle from the poultry metabolism study performed with prothioconazole (56N the calculated max DB).                                                                                                                                                                                                                                                                                           |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | The Codex MRL refers to meat but is based on residues in muscle, thus acceptable for the EU food classification.                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| General comments                              | Errors were noted that in the dietary burden calculations performed by JMPR for beef cattle: the HR was inserted for cotton gin by‐products (1.8 mg/kg) instead of the STMR (1.1 mg/kg) (see p. 702 of the JMPR report).the input value for field corn silage/forage used was not correct (in 2017 JMPR used 3.6 mg/kg, whereas the value reported by the JMPR 2014 is 4.08 mg/kg, see p. 307 of 2014 JMPR Report).However, these mistakes are not expected to significantly change the result. |                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues**;** EU: European Union.

(ft) EFSA identified some Information on residue trials on grass (major component of the livestock dietary burden), as unavailable. When re‐viewing the MRL, the Commission will take into account the information referred to in the first sentence, if it is submitted by 27 January 2018, or, of that information is not submitted by that date, the lack of it.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.16.5. Consumer risk assessment -- prothioconazole (Table [74](#efs25306-tbl-0074){ref-type="table"}) {#efs25306-sec-0117}

###### 

Summary of the consumer risk assessment for prothioconazole

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                    | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Comments on JMPR exposure assessment                                                  |
+==============================================================================================================================================================================================================================+=============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=======================================================================================+
| **RA assumptions:**                                                                                                                                                                                                          | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | **Specific comments**                                                                 |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                       |
| The short‐term dietary risk assessment was performed for cotton seed and for those animal commodities for which higher CXLs than the existing EU MRL were derived: mammalian fat and poultry liver, kidney and edible offal. | The most recent long‐term risk assessment (EFSA, [2015n](#efs25306-bib-0089){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for cotton seed, mammalian fat and poultry liver, kidney and edible offal. The STMR values for those CXL proposals which were assessed by the JMPR in 2014 and implemented in the EU legislation in 2016 Reg. (EU) 2016/1902 were also included in the assessment (potatoes, maize, and cranberries). The input values for poultry liver and kidney were not multiplied by the default CF, as it is assumed that residues of all metabolites are already considered when deriving CXL (total TRR from metabolism studies). The STMR value for cotton seed was multiplied by the default CF of 2 | --                                                                                    |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                       |
| The ARfD for prothioconazole desthio was used.                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                       |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                 | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | **Results:**                                                                          |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                       |
| No short‐term exposure concern was identified (highest exposure 1.2% of the ARfD from intake of eggs). For cotton seed, no consumption data are available to assess the exposure                                             | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Long‐term exposure:                                                                   |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                       |
|                                                                                                                                                                                                                              | The overall chronic exposure accounted for 8% of the ADI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 3% of the ADI                                                                         |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                       |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Short‐term exposure:                                                                  |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                       |
|                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 30% for women of childbearing age, 0% of the ARfD for children and general population |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------+

HR: highest residue; STMR: supervised trials median residue; CXL: Codex Maximum Residue limit; ADI: acceptable daily intake; ARfD: acute reference dose.

John Wiley & Sons, Ltd

4.17. Spinetoram (233) (R) {#efs25306-sec-0118}
--------------------------

### 4.17.1. Background information (Table [75](#efs25306-tbl-0075){ref-type="table"}) {#efs25306-sec-0119}

###### 

Background information on spinetoram

+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
|                         |                   | Comments, references                                                                       |
+=========================+===================+============================================================================================+
| Type of JMPR evaluation | New use           |                                                                                            |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| RMS                     | UK                |                                                                                            |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| Approval status         | Approved          | Commission Implementing Regulation (EU) No 140/2014[a](#efs25306-note-0094){ref-type="fn"} |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments | EFSA ([2013f](#efs25306-bib-0049){ref-type="ref"})                                         |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| MRL review              | No                | Ongoing                                                                                    |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments | EFSA ([2017d](#efs25306-bib-0112){ref-type="ref"}) (various crop)                          |
|                         |                   |                                                                                            |
|                         |                   | EFSA ([2012e](#efs25306-bib-0038){ref-type="ref"}) (cherries, raspberry, blueberry)        |
|                         |                   |                                                                                            |
|                         |                   | EFSA ([2009d](#efs25306-bib-0016){ref-type="ref"}) (import tolerance peach and apricots)   |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+

140/2014/EU: Commission Implementing Regulation (EU) No 140/2014 of 13 February 2014 approving the active substance spinetoram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 44, 14.2.2014, p. 35--39.

John Wiley & Sons, Ltd

### 4.17.2. Toxicological reference values -- spinetoram (Table [76](#efs25306-tbl-0076){ref-type="table"}) {#efs25306-sec-0120}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                        | EU evaluation | TRV comparable         |                                                                                    |    |
+========================+========================================================================================================================================================================================================================================================================+===============+========================+====================================================================================+====+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                                                                                                                  | JMPR 2008     | 0.025 mg/kg bw per day | EFSA ([2013f](#efs25306-bib-0049){ref-type="ref"}) (1‐year dog, safety factor 100) | No |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+------------------------------------------------------------------------------------+----+
| **ARfD**               | unnecessary                                                                                                                                                                                                                                                            | JMPR 2008     | 0.1 mg/kg bw           | EFSA ([2013f](#efs25306-bib-0049){ref-type="ref"}) (1‐year dog, safety factor 100) | No |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | The active substance assessed in the peer‐review assessment (EFSA, [2013f](#efs25306-bib-0049){ref-type="ref"}) was defined as consisting of 70--90% of XDE‐175‐J and 10--30% of XDE‐J‐L.                                                                              |               |                        |                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                        |               |                        |                                                                                    |    |
|                        | The toxicological reference values derived in the peer review were based on studies complying with this specification. A change of the ratio of constituents might lead to alterations of the toxicity of the duplication of the toxicological burden of the residues. |               |                        |                                                                                    |    |
|                        |                                                                                                                                                                                                                                                                        |               |                        |                                                                                    |    |
|                        | In 2008, JMPR assessed spinetoram which was described as consisting of XDE‐175‐J and XDE‐175‐L approximately in a three to one ratio                                                                                                                                   |               |                        |                                                                                    |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.17.3. Residue definitions -- spinetoram (Table [77](#efs25306-tbl-0077){ref-type="table"}) {#efs25306-sec-0121}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                      | JMPR evaluation                                                                      | EU evaluation                                                                                                          | RDs comparable |
+=========================+======================================================================================================================================================+======================================================================================+========================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                       | Spinetoram                                                                           | Reg. 396/2005: Spinetoram (XDE‐175)                                                                                    | Yes            |
|                         |                                                                                                                                                      |                                                                                      |                                                                                                                        |                |
|                         |                                                                                                                                                      |                                                                                      | Peer review: XDE‐175 (sum of XDE‐175‐J and XDE‐175‐L)                                                                  |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Animal products                                                                                                                                      | Spinetoram                                                                           | Reg. 396/2005: Spinetoram                                                                                              | Yes            |
|                         |                                                                                                                                                      |                                                                                      |                                                                                                                        |                |
|                         |                                                                                                                                                      | The residue is fat soluble                                                           | No definition agreed upon during peer review                                                                           |                |
|                         |                                                                                                                                                      |                                                                                      |                                                                                                                        |                |
|                         |                                                                                                                                                      |                                                                                      | The residue is fat soluble                                                                                             |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                       | Spinetoram and N‐demethyl and N‐formyl metabolites of the major spinetoram component | XDE‐175 (Sum of XDE‐175‐J and XDE‐175‐L) and the N‐demethyl‐175‐J and N‐formyl‐175‐J metabolites, expressed as XDE‐175 | Yes            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Animal products                                                                                                                                      | Spinetoram and N‐demethyl and N‐formyl metabolites of the major spinetoram component | No definition agreed upon during peer review                                                                           | No             |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for plant products and the enforcement residue definition for animal products derived at EU level and by JMPR are identical. |                                                                                      |                                                                                                                        |                |
|                         |                                                                                                                                                      |                                                                                      |                                                                                                                        |                |
|                         | For animal origin commodities, no residue definition was derived under the EU process.                                                               |                                                                                      |                                                                                                                        |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.17.4. Codex MRL proposals -- spinetoram (Table [78](#efs25306-tbl-0078){ref-type="table"}) {#efs25306-sec-0122}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                                               | Codex MRL proposal                                 | EU MRL                                                                            | Comment                                                                                                                                                                                                                                                                                                                                                                                                                  |
+=========================================================================================================================+====================================================+===================================================================================+==========================================================================================================================================================================================================================================================================================================================================================================================================================+
| Subgroup of mandarin                                                                                                    | 0.15                                               | 0.2                                                                               | Critical GAP: Brazil 3 × 25--100 g/ha PHI 1 day                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: Mandarins are a major crop in Codex, and therefore, at least 8 trials would be required. All trials were scaled down to match the GAP.                                                                                                                                                                                                                                                   |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is not sufficiently supported by data                                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of cherries                                                                                                    | 0.09                                               | 2                                                                                 | Critical GAP: Italy, 1 × 100 g/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 12 residues trials from the EU, combining NEU (2 trials) and SEU.                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: The EU MRL was derived for a different GAP (2 × 75 g/ha, 3 days PHI) based on 7 SEU trials.                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable. However, the manufacturer should be encouraged to submit the most critical GAP, supported by the relevant data, to JMPR for assessment                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of plums (includesall commodities in this subgroup)                                                            | **0.09**                                           | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Italy 1 × 100 g/ha PHI 7 days.                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 10 trials approximating the GAP plus 11 trials with 3--4 applications of approximately 100 g/ha (assessed in 2012 by JMPR).                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: EFSA checked the trials reported in 2012 JMPR: in 6 of these trials, the samples did not contain quantifiable residues before the last treatment.                                                                                                                                                                                                                                        |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: To be discussed with MS if the proposed Codex MRL is acceptable, considering that not all trials exactly matched the GAP                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apricot                                                                                                                 | 0.15                                               | 0.2                                                                               | Critical GAP: Italy 1 × 100 g/ha PHI 7 days.                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 6, all trials with 2 instead of 1 application                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: For JMPR apricots are in crop category 2; thus, 4 trials are sufficient. In the EU, 8 trials would be required. 3 of the residue trials were decline studies where the residue concentration was also measured before the second application. Since the residues were below the LOQ, it was concluded that first applications do not have an impact on the final residue concentrations. |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                        |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Currant, Black, Red, White                                                                                              | **0.5**                                            | 0.4                                                                               | Critical GAP: USA 6 × 105 g/ha RTI 6 days PHI 3 days                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: The existing EU MRL was established for a different GAP (NEU/SEU, 2 × 60 g/ha, PHI 3 days)                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                        |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberry                                                                                                              | 0.15                                               | 0.20                                                                              | Critical GAP: Brazil 4 × 50 g/ha PHI 3 days                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 24, combined data set of trials from BR and EU, indoor and outdoor.                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: Although in the EU, a different policy for merging trials from indoor and outdoor as well as from different geographic regions is in place; in this case, the Codex MRL proposal is considered to be sufficiently supported by data. The same MRL proposal would be derived using only Brazilian trials.                                                                                 |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Table olives                                                                                                            | **0.07**                                           | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Greece, 2 × 25 g/ha PHI 21 days RTI 21 days                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Avocado                                                                                                                 | **0.3**                                            | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Australia 4 × 4.8 g/hL RTI 7--14 days, PHI 0 days                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: combination of residue data from Columbia and New Zealand. For all except two trials, the treatment regime in the residue trials differed significantly from the cGAP (e.g. 4 × 2.4 kg/hL, 3 × 4.0 to 3 × 7.3 kg/hL). From the information presented in the JMPR evaluation and the JMPR report, it is not clear how the scaling factors were calculated.                                |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: From the available information it cannot be concluded if the proposed MRL is valid                                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Litchi                                                                                                                  | **0.06**                                           | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Thailand, 3 × 60 g/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations:                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mango                                                                                                                   | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Thailand 3 × 60 g/ha RTI 7 days PHI 14 days                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations:                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Passion fruit                                                                                                           | **0.4**                                            | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Australia 4 × 4.8 g/hL RTI 7--14 days PHI 0 days                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: Passion fruit are a crop of category 2; thus, at least 4 trials would be required.                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is not acceptable because the minimum number of residue trials were insufficient                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leek                                                                                                                    | 0.05                                               | 0.06                                                                              | Critical GAP: EU, NL GAP 2 × 60 g/ha RTI 28 days PHI 7 days                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: The EU MRL was derived for the same GAP. The residue concentrations reported for the trials assessed in the EU are different (probably resulting from rounding/recalculation of the results).                                                                                                                                                                                            |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of fruiting vegetables, cucurbits -- cucumbers and Summer squashes (includes all commodities in this subgroup) | 0.04                                               | 0.2                                                                               | Critical GAP (cucumber): Brazil, 4 × 50 g/ha PHI 3 days Critical GAP (summer squash): Australia, 4 × 48 g/ha PHI 3 days.                                                                                                                                                                                                                                                                                                 |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    | (cucurbits with edible peel)                                                      | Number of trials: 20 for cucumber and 12 for summer squash.                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Sufficient data are available. Based on the European indoor trials on cucumbers (6 trials) and                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: MRL proposal was derived from merged data set (indoor and outdoor and Europe and Brazil trials). While merging indoor and outdoor trials is not common practice in the EU, the extrapolation from cucumbers and courgette (summer squash) to the whole group is acceptable in the EU.                                                                                                    |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: Overall, the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melons, except watermelon                                                                                               | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Brazil, 4 × 40 g/ha PHI 3 days                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: Combination of residue trials (indoor outdoor) from Brazil and Europe. Application of proportionality in the case of the European trials. However, since application rates were \> 50% higher than the maximum application rate.                                                                                                                                                         |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of peppers (except martynia, okra and roselle)                                                                 | 0.4                                                | 0.5                                                                               | Critical GAP: Brazil, 4 × 50 g/ha PHI 3 days                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: Combination of indoor and outdoor residue trials performed in the EU and in Brazil. Total of 24 residue trials.                                                                                                                                                                                                                                                                                        |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: MRL proposal was derived from merged data set (indoor and outdoor Europe and Brazil on bell pepper and non‐bell pepper). Merging indoor and outdoor trials is not common practice in the EU.                                                                                                                                                                                             |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: Overall, the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                                                                                                         | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Brazil, 2 × 18 g/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 4 slightly overdosed trials                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: Although normally 8 trials would be required, considering that the MRL proposal is at the LOQ, the deviation may be acceptable.                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                                                                  | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Brazil, 3 × 50 g/ha PHI 1 day                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: merged data set of trials from New Zealand and Brazil, reflecting slightly different application pattern. Although normally 8 trials would be required, considering that the MRL proposal is at the LOQ, the deviation may be acceptable.                                                                                                                                                |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, chili, dried                                                                                                   | 4                                                  |                                                                                   | Critical GAP: See Peppers.                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | The default processing factor of 10 was applied. It is noted that for trials on chili peppers, the default dehydration factor of 7 should have been used                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Husked rice                                                                                                             | 0.02[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: China, 2 × 27 g/ha PHI 21 days.                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: No.                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: Since rice is a major crop, at least 8 trials would be required. Considering that the MRL proposal is at the LOQ, the deviation may be acceptable. The trials did not completely match the critical GAP (shorter PHI of 14 days).                                                                                                                                                        |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                                                                                                   | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Brazil 3 × 12 g/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: No, same as above. No enough residue trials worldwide.                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations Since maize is a major crop, at least 8 trials would be required. Considering that the MRL proposal is at the LOQ, the deviation may be acceptable. Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                         |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corn (Corn on the cob) (kernels plus cob with husk removed)                                                       | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Australia, 4 × 48 g/ha PHI 3 days                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: No residue situation has been reported.Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                  |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton seed                                                                                                             | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Brazil, 4 × 18 g/ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 19.                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: combination of residue trials from Brazil matching the GAP and Greece, reflecting different use pattern (2 app at 60 g/ha). Considering that the MRL proposal is at the LOQ, the deviation of the trials may be acceptableConclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                  |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                                                                   | **0.02**                                           | 0.01[\*](#efs25306-note-0779){ref-type="fn"}                                      | The dietary burden calculation took into account the uses assessed by JMPR in 2017 and crops for which CXLs were established previously. However, JMPR should be asked for clarifications, why cabbage/kale was not included in the dietary burden calculation.                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | The Codex MRL proposal was derived from a feeding study 4N higher than the calculated dietary burden.                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk fats                                                                                                               | 0.15                                               |                                                                                   | See comments on dietary burden calculation (milks).                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                                                           | **1 (fat)**                                        | 0.01[\*](#efs25306-note-0779){ref-type="fn"}                                      | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: See comments on dietary burden calculation (milks). In the EU, an MRL should also be established for muscle. For muscle, an MRL of 0.06 mg/kg would be appropriate if the updated dietary burden does not differ significantly from the one used by JMPR in 2017.                                                                                                                        |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable. If the dietary burden calculation is verified, the proposed Codex MRL is acceptable                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                                                                | **0.08**                                           | 0.01[\*](#efs25306-note-0779){ref-type="fn"} (edible offal and kidney and liver)  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: See comments on dietary burden calculation (milks).                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                                                       | **1**                                              | 0.2                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: See comments on dietary burden calculation (milks).                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Persimmons                                                                                                              | 0.05                                               | 0.05[\*](#efs25306-note-0779){ref-type="fn"}                                      | Critical GAP: Australia 4 × 4.8 g/hL RTI 14 days PHI 0 days                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 2                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: JMPR noted that the existing CXL for pome fruit (0.05 mg/kg) covers also persimmon. Since the GAP for persimmon is different from the GAP used to derive the MRL in pomefruit, an extrapolation of the MRL is not appropriate.                                                                                                                                                           |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: To be discussed with MS whether the existing CXL for pome fruit should be taken over in the EU legislation for persimmon (e.g. in the framework of the MRL review)                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                                                                            | 0.01[\*](#efs25306-note-0779){ref-type="fn"} (fat) | 0.01                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Specific comments/observations: The Codex MRL proposal was derived from a metabolism study in poultry, performed at a significantly higher dose rate than the calculated dietary burden (160 N rate).                                                                                                                                                                                                                    |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable, since the residues may not increase proportionally to the dosing rate                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal                                                                                                   | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.01[\*](#efs25306-note-0779){ref-type="fn"} (edible offals and kidney and liver) | See comments on poultry meat                                                                                                                                                                                                                                                                                                                                                                                             |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                                                                            | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.01[\*](#efs25306-note-0779){ref-type="fn"}                                      | See comments on poultry meat                                                                                                                                                                                                                                                                                                                                                                                             |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                                                                    | 0.01[\*](#efs25306-note-0779){ref-type="fn"}       | 0.01[\*](#efs25306-note-0779){ref-type="fn"}                                      | See comments on poultry meat                                                                                                                                                                                                                                                                                                                                                                                             |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice straw and fodder, dry                                                                                              | 1.5                                                |                                                                                   | Critical GAP: China GAP                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corn fodder                                                                                                       | 0.15                                               |                                                                                   | Critical GAP: Australia GAP                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                                    |                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                                    |                                                                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+-----------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; GAP: Good Agricultural Practice; PF: processing factor; NEU: northern European Union; HR: highest residue; LOQ: limit of quantification.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.17.5. Consumer risk assessment -- spinetoram (Table [79](#efs25306-tbl-0079){ref-type="table"}) {#efs25306-sec-0123}

###### 

Summary of the consumer risk assessment for spinetoram

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                  | Chronic exposure assessment                                                                                                                                                                                                                                                                                                              | Comments on JMPR exposure assessment |
+============================================================================================================================================================================================================+==========================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                        | **RA assumptions:**                                                                                                                                                                                                                                                                                                                      | **Specific comments**                |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          |                                      |
| The short‐term dietary risk assessment was performed for those commodities where the CXLs proposal is higher than the existing EU MRL as outlined in Section [4.17.2](#efs25306-sec-0120){ref-type="sec"}. | The most recent long‐term risk assessment (EFSA, [2017d](#efs25306-bib-0112){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for those commodities that will impact in the EU consumer exposure in case that the CXL is implemented in the EU regulation. |                                      |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          |                                      |
| HR values were retrieved from the residue trials presented in the JMPR report.                                                                                                                             | Input values for meat were expressed in terms of meat (80% muscle and 20% fat).                                                                                                                                                                                                                                                          |                                      |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          |                                      |
| The EU ARfD was used                                                                                                                                                                                       | The EU ADI was used                                                                                                                                                                                                                                                                                                                      |                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                               | **Results:**                                                                                                                                                                                                                                                                                                                             | **Results:**                         |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          |                                      |
| No short‐term exposure concern was identified. (Max. 7.3% of ARfD for avocados)                                                                                                                            | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                        | Long‐term exposure:                  |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          |                                      |
|                                                                                                                                                                                                            | The overall chronic exposure accounted for approximately 50% of the ADI, being the German children the most critical diet.                                                                                                                                                                                                               | 0.2--3% of the ADI                   |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          |                                      |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          | Short‐term exposure:                 |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          |                                      |
|                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                          | Not performed. No ARfD               |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; CXL: Codex Maximum Residue Limit.

John Wiley & Sons, Ltd

4.18. Fluopyram (243) (R) {#efs25306-sec-0124}
-------------------------

### 4.18.1. Background information (Table [80](#efs25306-tbl-0080){ref-type="table"}) {#efs25306-sec-0125}

###### 

Background information on fluopyram

+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+
|                         |                   | Comments, references                                                                                                      |
+=========================+===================+===========================================================================================================================+
| Type of JMPR evaluation | New use           |                                                                                                                           |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+
| RMS                     | DE                |                                                                                                                           |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+
| Approval status         | Approved          | Commission Implementing Regulation (EU) 802/2013[a](#efs25306-note-0100){ref-type="fn"}                                   |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments | EFSA ([2013b](#efs25306-bib-0045){ref-type="ref"}) EFSA ([2018a](#efs25306-bib-0121){ref-type="ref"}) (confirmatory data) |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+
| MRL review              | No                | Ongoing                                                                                                                   |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments | EFSA ([2017i](#efs25306-bib-0117){ref-type="ref"}) (purslanes)                                                            |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+
|                         |                   | EFSA ([2016o](#efs25306-bib-0105){ref-type="ref"}) (various crop)                                                         |
|                         |                   |                                                                                                                           |
|                         |                   | EFSA ([2014t](#efs25306-bib-0075){ref-type="ref"}) (various crop)                                                         |
|                         |                   |                                                                                                                           |
|                         |                   | EFSA ([2011f](#efs25306-bib-0031){ref-type="ref"}) (import tolerance various crops)                                       |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit.

802/2013/EU: Commission Implementing Regulation (EU) No 802/2013 of 22 August 2013 approving the active substance fluopyram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 225, 23.8.2013, p. 13--16.

John Wiley & Sons, Ltd

### 4.18.2. Toxicological reference values -- fluopyram (Table [81](#efs25306-tbl-0081){ref-type="table"}) {#efs25306-sec-0126}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                    | EU evaluation | TRV comparable         |                                                                                                                      |     |
+========================+====================================================================================+===============+========================+======================================================================================================================+=====+
| **ADI**                | 0--0.01 mg/kg bw per day                                                           | JMPR 2010     | 0.012 mg/kg bw per day | EFSA ([2013b](#efs25306-bib-0045){ref-type="ref"}) (2‐yr, rat, safety factor 100)                                    | No  |
|                        |                                                                                    |               |                        |                                                                                                                      |     |
|                        |                                                                                    |               |                        | confirmed in European Commission ([2013](#efs25306-bib-0145){ref-type="ref"})                                        |     |
+------------------------+------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.5 mg/kg bw                                                                       | JMPR 2010     | 0.5 mg/kg bw           | EFSA ([2013b](#efs25306-bib-0045){ref-type="ref"}) (Acute                                                            | Yes |
|                        |                                                                                    |               |                        |                                                                                                                      |     |
|                        |                                                                                    |               |                        | neurotoxicity, rat, safety factor 100) confirmed in European Commission ([2013](#efs25306-bib-0145){ref-type="ref"}) |     |
+------------------------+------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The ADI values differ only slightly; the ARfD values of JMPR and EU are identical. |               |                        |                                                                                                                      |     |
+------------------------+------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.18.3. Residue definitions -- fluopyram (Table [82](#efs25306-tbl-0082){ref-type="table"}) {#efs25306-sec-0127}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+--------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                    | JMPR evaluation                                                                                   | EU evaluation                                          | RDs comparable |
+=========================+====================================================================================================================================================================================================================================================================================================================================================================================================================+===================================================================================================+========================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                     | Fluopyram                                                                                         | Fluopyram                                              | Yes            |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+--------------------------------------------------------+----------------+
| Animal products         | Sum of fluopyram and 2‐(trifluoromethyl) benzamide (M25), expressed as fluopyram                                                                                                                                                                                                                                                                                                                                   | Sum fluopyram, fluopyram‐benzamide (M25), expressed                                               | Yes                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                     | as fluopyram                                                                                      |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    | The residue is not fat soluble                                                                    |                                                        |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+--------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                     | Fluopyram                                                                                         | Sum fluopyram and fluopyram‐benzamide (M25), expressed | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   | as fluopyram                                           |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+--------------------------------------------------------+----------------+
| Animal products         | Sum of fluopyram, 2‐(trifluoromethyl)benzamide (M25) and the combined residues of N‐{(*E*)‐2‐\[3‐chloro‐5‐(trifluoromethyl)pyridin‐2‐yl\]ethenyl}‐2‐trifluoromethyl) benzamide (M02) and N‐{(Z)‐2‐\[3‐chloro‐5‐(trifluoromethyl)pyridin‐2‐yl\]ethenyl}‐2‐trifluoromethyl) benzamide (M03), all expressed as fluopyram.                                                                                             | Sum fluopyram, fluopyram‐benzamide (M25), fluopyram‐E/Z‐olefine (M02/M03), expressed as fluopyram | Yes                                                    |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+--------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for enforcement (plant and animal commodities) derived by JMPR and applicable in the EU are identical. Thus, the Codex MRLs are compatible with the EU legal framework.                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         | As regards the residue definition for risk assessment for plants, the EU residue definition is wider.                                                                                                                                                                                                                                                                                                              |                                                                                                   |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         | It is noted that metabolite M25 was observed at important proportions in the metabolism study in beans. At EU level, a conversion factor was derived for fruit crops (1.1), peas without pods (1.5), peas/beans with pods, oilseeds and stem vegetables (1.2).                                                                                                                                                     |                                                                                                   |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         | The lack of conversion factors introduces an uncertainty in the exposure calculations and the consumer risk assessment should be considered as tentative and may underestimate the actual exposure for plant products for which JMPR derived MRL proposals that are higher than the existing EU MRLs.                                                                                                              |                                                                                                   |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         | Rotational crop studies in cereals, leafy vegetables and roots were assessed in the peer review (EFSA, [2013b](#efs25306-bib-0045){ref-type="ref"}). Fluopyram and the metabolites resulting from the cleavage of the parent (fluopyram‐benzamide (M25) and fluopyram‐PCA (M43)) major components of the residues in rotational crops. 7‐hydroxy metabolites observed in higher proportions than in primary crops. |                                                                                                   |                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                   |                                                        |                |
|                         | Residues in rotational crops cannot be excluded. (Default MRL proposals have been made for root/tuber and leafy crops (0.1 mg/kg), cereals, oilseeds and perennial crops (0.01[\*](#efs25306-note-0789){ref-type="fn"})                                                                                                                                                                                            |                                                                                                   |                                                        |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+--------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.18.4. Codex MRL proposals -- fluopyram (Table [83](#efs25306-tbl-0083){ref-type="table"}) {#efs25306-sec-0128}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                          | Codex MRL proposal                           | EU MRL                                                                        | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+====================================================================================+==============================================+===============================================================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Artichoke, globe                                                                   | 0.4                                          | 0.5                                                                           | Critical GAP: Greek GAP 3 × 0.075 kg/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The critical GAP is reported from EU; however, the EU MRL higher than CXL proposal.                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley                                                                             | 0.2                                          | 0.2                                                                           | Critical GAP: EU GAP (Estonia) 1 × 0.078 kg/ha BBCH max 61                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 11                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The CXL proposal and the EU MRL are the same.                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley/oat forage (straw) and fodder (hay)                                         | 2                                            |                                                                               | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Basil                                                                              | **70**                                       | 8                                                                             | Critical GAP: Canada 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Basil is a category 2 crop, thus, at least 4 trials are required.                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is not acceptable because the number of trials is insufficient                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Basil, dry                                                                         | 400                                          |                                                                               | The MRL proposal was derived from 3 trials where the leaves were dried on the field.                                                                                                                                                                                                                                                                                                                                                                                                          |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Bean fodder                                                                        | 70                                           |                                                                               | Critical GAP: Canada 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Beans (dry)                                                                        | W0.07                                        |                                                                               | The previous CXL will be covered by the proposed CXL for the Subgroup of Dry Beans                                                                                                                                                                                                                                                                                                                                                                                                            |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Blackberries                                                                       | W3                                           | 3                                                                             | The previous CXL will be covered by the proposed CXL for the Subgroup of Cane berries                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                                      | 0.4                                          | 0.9                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: See tomatoes section. The EU MRL covers this residue situation.                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Chickpea (dry)                                                                     | W0.07                                        |                                                                               | The previous CXL will be covered by the CXL proposal for the grouping of Dry Peas                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cottonseed                                                                         | **0.8**                                      | 0.02[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: USA seed treatment (max. 0.35 mg/seed) combined with soil treatment and foliar treatment (max. 0.5 kg/ha), PHI 30 days                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: ‐                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton gin trash                                                                   | 30                                           |                                                                               | Critical GAP: USA GAP (above)                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dill seed                                                                          | **70**                                       | 0.05[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: ‐                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                           | **8**                                        | 0.7                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              | Kidney: 0.8 except 0.7 for equine                                             | Specific comments/observations: The maximum dietary burden for ruminants was calculated for the Australian diet. The Codex MRL proposal was based on the residues in liver expected at the calculated dietary burden.                                                                                                                                                                                                                                                                         |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              | Liver: 5 except equine 0.7                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                               | **2**                                        | 1                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The maximum dietary burden for poultry was calculated for the EU diet. Since the calculated dietary burden exceeds the highest feeding level, the MRL proposals for poultry tissues and eggs were derived from the interpolation from the residues detected in a feeding study at the highest feeding level and the residues of a metabolism study in poultry (expected residue at DB= 1.3 mg/kg). According to EFSA, a MRL of 1.5 mg/kg would be sufficient. |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: It is recommended to discuss with MS whether a lower MRL would be more appropriate                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Hops (dry)                                                                         | **50**                                       | 3                                                                             | Critical GAP: USA 2 × 0.25 kg/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: ‐                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Kidney of cattle, goats, pigs and sheep                                            | W0.8                                         | Kidney: 0.8 except 0.7 for equine                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lentil (dry)                                                                       | W0.07                                        |                                                                               | The previous CXL is suggested for withdrawal                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Liver of cattle, goats, pigs and sheep                                             | W5                                           | Liver: 5 except equine 0.7                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: See edible offal (mammalian) comment.                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lupin (dry)                                                                        | W0.07                                        |                                                                               | The previous CXL will be covered by the CXL proposal for the grouping of Dry Peas.                                                                                                                                                                                                                                                                                                                                                                                                            |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize fodder (stover)                                                              | 18                                           |                                                                               | Critical GAP: Based on the USA critical GAP for grain cereals 2 × 0.25/ha PHI 14 days. Samples for stover taken at 12--14 days.                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 14                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize forage                                                                       | 2                                            |                                                                               | Critical GAP: Based on the USA critical GAP for grain cereals 2 × 0.25/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fat                                                                      | **1.5**                                      | 0.5                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mango                                                                              | **1**                                        | 0.01[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: Malaysia 2 × 0.15 kg/hL                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Data to derive a peeling factor of 0.11 were available to derive HR and STMR for edible portion.                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                      | **1.5**                                      | 0.8                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | At the maximum dietary burden, the residues expected in muscle are 1 mg/kg.                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: Since at EU level the MRL is established for muscle and not for meat, the Codex MRL proposal is not compatible with the EU system. The feeding study would allow to derive an MRL for muscle (i.e. 1 mg/kg)                                                                                                                                                                                                                                                                       |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                              | **0.8**                                      | 0.6                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is not acceptable because it caused a exceedance of the ADI (see below chronic risk assessment)                                                                                                                                                                                                                                                                                                                                                            |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oat straw and fodder, dry                                                          | 2                                            |                                                                               | Critical GAP: EU GAP 1 × 0.078 kg/ha BBCH max 61                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oats                                                                               | 0.2                                          | 0.2                                                                           | Critical GAP: EU GAP 1 × 0.078 kg/ha BBCH max 61Number of trials: 11                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: See also barley.                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Onion, Welsh                                                                       | **2**                                        | 2                                                                             | Critical GAP: Greece 1 × 0.16 kg/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: In the EU food classification, Welsh onions and spring onions are covered by the same food code.                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pea vines, pea fodder (dry), Pea hay                                               | 100                                          |                                                                               | Critical GAP: Canada 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut                                                                             | **0.2**                                      | 0.03                                                                          | Critical GAP: USA, seed treatment (0.35 mg ai/seed) and/or foliar application (0.25 kg ai/ha).                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Treated crops should not be used to feed livestock according to the label of the critical GAP.                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut fodder (hay)                                                                | 47                                           |                                                                               | Critical GAP: Canada, 2 × 0.25 kg/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 13                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers Chili, dried                                                               | 30                                           |                                                                               | Critical GAP: USA 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 9 trials on sweet peppers                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The MRL proposal was derived applying the default dehydration factor of 10.                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: No MRLs are set in the EU for processed products.                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                             | **0.15**                                     | 0.1                                                                           | Critical GAP: USA soil application 1 in furrow soil treatment (0.25 kg/ha) + 1 foliar use (1 × 0.25 kg/ha), PHI 7 days                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 14                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fat                                                                        | **1**                                        | 0.2                                                                           | Specific comments/observations: See eggs section.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | No health concern has been identified for EU consumers                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                                       | **1.5**                                      | 0.5                                                                           | Specific comments/observations: See eggs section.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | No health concern has been identified for EU consumers.                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: Since at EU level the MRL is established for muscle and not for meat, the Codex MRL proposal is not compatible with the EU system The available feeding study would allow to derive a MRL proposal for muscle (i.e. 1 mg/kg)                                                                                                                                                                                                                                                      |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, Edible offal of                                                           | **5**                                        | 2 (edible offal and liver and kidney)                                         | Specific comments/observations: See eggs section.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | No health concern has been identified for EU consumers                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: A lower MRL of 3 mg/kg might be sufficient                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pummelo and grapefruits (including Shaddock‐like hybrids, among others grapefruit) | **0.4**                                      | 0.01[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: USA 2 × 0.25 kg/ha PHI 7 daysNumber of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Raspberries, red, black                                                            | W3                                           | 3                                                                             | The previous CXL will be covered by the proposed CXL for the Subgroup of Cane berries.                                                                                                                                                                                                                                                                                                                                                                                                        |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice                                                                               | **4**                                        | 0.01[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: Thailand 2 × 0.024 kg/hL (up to BBCH 59)                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 8 trials in rice grain                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The Codex MRL proposal refers to cereal grain (GC 0649). No processing data are available that could be used to recalculate the MRL proposal to husked rice.                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable. The MRL proposal is however not compatible with the EU food classification (MRLs are set for husked rice)                                                                                                                                                                                                                                                                                                                                   |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice straw and fodder, dry                                                         | 17                                           |                                                                               | Critical GAP: Thailand 2 × 0.024 kg/hL (up to BBCH 59)                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye                                                                                | **0.9**                                      | 0.8                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Extrapolated from wheat                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye straw and fodder, dry                                                          | 23                                           |                                                                               | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 15/16                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                                                                    | 0.3                                          | 0.2                                                                           | Critical GAP: USA/CAN, 2 × 250 g/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 20                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean fodder                                                                   | 35                                           |                                                                               | Critical GAP: Canada 2 × 0.25 kg/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Spring onion                                                                       | **15**                                       | 2                                                                             | Critical GAP: USA/Canada 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Not enough residue trials to be compliant with EU requirements; according to JMPR rules, at least 5 trials would be required.                                                                                                                                                                                                                                                                                                                                 |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is not acceptable because the number of residue trials is not sufficient. However, the MRL proposal for Welsh onions is sufficiently supported                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of bush berries (includes all commodities in this subgroup)               | **7**                                        | 3                                                                             | Critical GAP: USA/Canada 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 8 trials in blueberries                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes for JMPR; in the EU, trials on blueberries would not be used to extrapolate to the whole group of bush berries (the main crops of this group are blueberries, currants, gooseberries, rose hips); instead trials in currants or a mixed data set of currants and other small fruit trials would be required to set an MRL for the EU crop group of small fruit and berries.                                                                               |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                                   |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of cane berries(includes all commodities in this subgroup)                | **5**                                        | 3                                                                             | Critical GAP: USA/Canada 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 5 is raspberries, boysenberries and blackberries                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of cherries (includes all commodities in this subgroup)                   | **2**                                        | 1.5                                                                           | Critical GAP: USA 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Cherries are a major crop in Codex (crop for which refinement criteria applied) and in the EU. Thus, a minimum of 8 residue trials is needed.                                                                                                                                                                                                                                                                                                                 |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is not acceptable because it is not sufficiently supported by data                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry beans (except Soya bean (dry))                                     | 0.15                                         | 0.4                                                                           | Critical GAP: USA/CAN, 2 × 250 g/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: EU MRL is an import tolerance for a US/CAN GAP (6 × 250 g/ha, 14 days PHI).                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The existing EU MRL should be lowered, since it is based on a GAP that apparently is no longer valid                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry peas(includes all commodities in this subgroup)                    | **0.7**                                      | 0.4                                                                           | Critical GAP: Canada 2 × 0.25 kg/has PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Peas are considered a major crop and residue data should be supported by 8 residue trials. The existing EU MRL is an import tolerance for a US/CAN GAP (6 × 250 g/ha, 14 days PHI). It seems strange that for the less critical GAP assessed by JMPR, a significantly higher MRL was derived.                                                                                                                                                                 |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is not acceptable because of insufficient data                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of eggplants(includes all commodities in this subgroup)                   | 0.5                                          | 0.9 (eggplants) while for tomato:0.9 and Sweet peppers/bell peppers 2         | Critical GAP: USA GAP (2 × 0.25 mg/kg PHI 0 days).                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 11 trials on tomatoes                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Extrapolation from tomatoes to aubergines is also acceptable at EU level.Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                     |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of lemons and limes (includes allcommodities in this subgroup)            | **1**                                        | 0.01[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: USA 2 × 0.25 kg/ha PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of maize cereals(includes all commodities in this subgroup)               | 0.02                                         | 0.02 maize, 0.01[\*](#efs25306-note-0750){ref-type="fn"} millet, 1.5 sorghum, | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 14                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The subgroup of maize cereals covers also millet and sorghum.                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of mandarins(includes all commodities in this subgroup)                   | **0.6**                                      | 0.01[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: USA 2 × 0.25 kg/ha PHI 7 daysNumber of trials: 8 trials in oranges, 2 trials in mandarins.                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of oranges, sweet, sour (includes all commodities in this subgroup)       | **0.6**                                      | 0.01[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: USA 2 × 0.25 kg/ha PHI 7 daysNumber of trials: 8 trials on oranges, 2 trials in mandarins Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of peppers (except martynia, okra, roselle)                               | **3**                                        | 2 pepper                                                                      | Critical GAP: USA 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              | 0.01[\*](#efs25306-note-0750){ref-type="fn"} okra,                            | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The Codex MRL for subgroup of peppers covers also okra which is a separate crop in the EU food classification. Extrapolation from peppers to okra is compliant with EU extrapolation rules.                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sunflower seed                                                                     | **0.7**                                      | 0.3                                                                           | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corn (Corn on the cob) (kernels plus cob with husk removed)                  | 0.01[\*](#efs25306-note-0750){ref-type="fn"} | 0.01[\*](#efs25306-note-0750){ref-type="fn"}                                  | Critical GAP: GAP for maize and sweet corn in HU 2 × 0.125 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                                             | 0.5                                          | 0.9                                                                           | Critical GAP: USA 2 × 0.25 kg/ha PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 11                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale                                                                          | **0.9**                                      | 0.8 (wheat)                                                                   | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 15 (trials on wheat)                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: Extrapolated from residue trials on wheat which is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale straw and fodder, dry                                                    | 23                                           |                                                                               | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 15/16                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat                                                                              | **0.9**                                      | 0.8                                                                           | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat straw and fodder, dry                                                        | 23                                           |                                                                               | Critical GAP: USA 2 × 0.25 kg/ha PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 15/16                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Witloof chicory (sprouts)                                                          | 0.15                                         | 0.30                                                                          | Critical GAP: EU GAP (Belgium) including preplant root dip 0.01 kg/hL + preforcing root collar spray 0.5 g/sq. meter, PHI 21 days                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Specific comments/observations: The EU MRL was derived from 4 residue trials which seemed to be different than the trials provided to JMPR. Manufactures should be encouraged to submit all available data to avoid different conclusions at EU and JMPR level.                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs.                                                                                                                                                                                                                                                                                                                                                  |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cottonseed oil (refined)                                                           | None                                         |                                                                               | Processing factor: \< 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cottonseed meal                                                                    | None                                         |                                                                               | Processing factor: 0.022                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize bran                                                                         | None                                         |                                                                               | Processing factor: 2.7                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize flour                                                                        | None                                         |                                                                               | Processing factor: 0.85                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize grits                                                                        | None                                         |                                                                               | Processing factor: 0.51                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize meal                                                                         | None                                         |                                                                               | Processing factor: 0.81                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize oil (dry milled)                                                             | None                                         |                                                                               | Processing factor: \< 0.36                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize oil (wet milled)                                                             | None                                         |                                                                               | Processing factor: 0.58                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize starch                                                                       | None                                         |                                                                               | Processing factor: 0.36                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange juice                                                                       | None                                         |                                                                               | Processing factor: 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange oil, edible                                                                 | None                                         |                                                                               | Processing factor: 16                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange peel                                                                        | None                                         |                                                                               | Processing factor: 1.8                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange flesh                                                                       | None                                         |                                                                               | Processing factor: 0.16                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut butter                                                                      | None                                         |                                                                               | Processing factor: 0.22                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut meal                                                                        | None                                         |                                                                               | Processing factor: 0.19                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut oil                                                                         | None                                         |                                                                               | Processing factor: 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato (peeled)                                                                    | None                                         |                                                                               | Processing factor: \< 0.64                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato chips (crisps)                                                              | None                                         |                                                                               | Processing factor: \< 0.64                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato flakes                                                                      | None                                         |                                                                               | Processing factor: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato wet peel                                                                    | None                                         |                                                                               | Processing factor: 4.3                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice bran, unprocessed                                                             | None                                         |                                                                               | Processing factor: 1.1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 2                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice hulls                                                                         | None                                         |                                                                               | Processing factor: 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF:2                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, cooked                                                                       | None                                         |                                                                               | Processing factor: 0.04                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF:2                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, Polished                                                                     | None                                         |                                                                               | Processing factor: 0.11                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 2                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean asp grain fraction                                                       | None                                         |                                                                               | Processing factor: 223                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean flour                                                                    | None                                         |                                                                               | Processing factor: 0.04                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean meal                                                                     | None                                         |                                                                               | Processing factor: 0.05                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean milk                                                                     | None                                         |                                                                               | Processing factor: \< 0.02                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean oil                                                                      | None                                         |                                                                               | Processing factor: 0.02                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sunflower seed oil (refined)                                                       | None                                         |                                                                               | Processing factor: \< 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sunflower seed meal                                                                | None                                         |                                                                               | Processing factor: 0.02                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato juice                                                                       | None                                         |                                                                               | Processing factor: 0.36                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato paste                                                                       | None                                         |                                                                               | Processing factor: 0.46                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato preserve                                                                    | None                                         |                                                                               | Processing factor: 0.21                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato puree                                                                       | None                                         |                                                                               | Processing factor: 0.73                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato pulp                                                                        | None                                         |                                                                               | Processing factor: 0.1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat bran, Processed                                                              | None                                         |                                                                               | Processing factor:2.7                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF:1                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat flour                                                                        | None                                         |                                                                               | Processing factor: 0.12                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat germ                                                                         | None                                         |                                                                               | Processing factor: 2.4                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                    |                                              |                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                    |                                              |                                                                               | Number of studies to derive the PF: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; MRL: maximum residue limit; PHI: preharvest interval.

\* Indicates that the input value is proposed at the limit of quantification.
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### 4.18.5. Consumer risk assessment -- fluopyram (Table [84](#efs25306-tbl-0084){ref-type="table"}) {#efs25306-sec-0129}

###### 

Summary of the consumer risk assessment for fluopyram

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                      | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | Comments on JMPR exposure assessment               |
+================================================================================================================================================================================================================================================================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+====================================================+
| **RA assumptions:**                                                                                                                                                                                                                                            | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | **Specific comments**                              |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
| The short‐term dietary risk assessment was performed for those plant and animal origin commodities for which higher Codex MRL proposals than the existing EU MRLs were derived, as outlined in Section [4.18.2](#efs25306-sec-0126){ref-type="sec"}.           | The most recent long‐term risk assessment (EFSA, [2017i](#efs25306-bib-0117){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for those commodities were the CXL is higher than the existing EU MRL. I.e. Basil, cottonseeds, dill seeds, mammals tissues, milk, poultry tissues, eggs, hops, mango, peanuts, potatoes, citrus fruits, rye, bush berries, cane fruits, cherries, peas, peppers, sunflower seeds, triticale and wheat. | None                                               |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
| HR residue values were used for the exposure calculations.                                                                                                                                                                                                     | STMR values for those commodities under the fruit crop group were converted into the risk assessment residue definition to perform a more accurate risk assessment. Due to the lack of reliable conversion factors for the rest of the food commodities, the risk assessment needs to be considered in tentative basis.                                                                                                                                                                                             |                                                    |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
| Conversion factors have been used to accommodate residue values in the PRIMo according to the risk assessment residue definition (1.1 for fruit, 1.2 for oilseeds)                                                                                             | Where EU MRL and the CXL proposal are the same, but STMR values differ, the STMRs derived during the EU process have been used for the exposure calculations and risk assessment. Those cases were peppers and oat/barley.                                                                                                                                                                                                                                                                                          |                                                    |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
| The residues conversion from enforcement to risk assessment residue definitions has not been done for the rest of the plant origin commodities due to the lack of reliable CFs. In those cases, the risk assessment needs to be considered in tentative basis. | The EU ADI was used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                    |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
| The EU ARfD was used                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                   | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | **Results:**                                       |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
| No short‐term exposure concern was identified (max. 18% of the ARfD; peppers).                                                                                                                                                                                 | A long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Long‐term exposure:                                |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
| For dill seeds, no consumption data are available; therefore, the exposure was no calculated. Risk not assessed                                                                                                                                                | The overall chronic exposure accounted for 205% of the ADI.                                                                                                                                                                                                                                                                                                                                                                                                                                                         | Max. 80% of the ADI                                |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
|                                                                                                                                                                                                                                                                | The food item contributing the most to the most critical diet and for which a CXL has been proposed was milk representing the 158% of the ADI                                                                                                                                                                                                                                                                                                                                                                       | Short‐term exposure:                               |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 10% of the ARfD (milk)                             |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                    |
|                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 100% of the ARfD (lettuce) -- not under assessment |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; HR: highest residue; STMR: supervised trials median residue; EU MRL: European Union maximum residue limit.
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4.19. Acetamiprid (246) (T) {#efs25306-sec-0130}
---------------------------

### 4.19.1. Background information (Table [85](#efs25306-tbl-0085){ref-type="table"}) {#efs25306-sec-0131}

###### 

Background information on acetamiprid

+-------------------------+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                         |                         | Comments, references                                                                                                                                                   |
+=========================+=========================+========================================================================================================================================================================+
| Type of JMPR evaluation | New use                 |                                                                                                                                                                        |
+-------------------------+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                     | NL                      |                                                                                                                                                                        |
+-------------------------+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status         | Renewal of the approval | Commission Implementing Regulation (EU) 2016/2016[a](#efs25306-note-0106){ref-type="fn"}                                                                               |
+-------------------------+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA ([2016q](#efs25306-bib-0107){ref-type="ref"})                                                                                                                     |
+-------------------------+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments       | EFSA ([2011d](#efs25306-bib-0029){ref-type="ref"})                                                                                                                     |
+-------------------------+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments       | EFSA ([2016b](#efs25306-bib-0092){ref-type="ref"}) (various crops)                                                                                                     |
|                         |                         |                                                                                                                                                                        |
|                         |                         | EFSA ([2015k](#efs25306-bib-0086){ref-type="ref"}) (leafy Brassicacea)                                                                                                 |
|                         |                         |                                                                                                                                                                        |
|                         |                         | EFSA ([2014o](#efs25306-bib-0070){ref-type="ref"}) (banana)                                                                                                            |
|                         |                         |                                                                                                                                                                        |
|                         |                         | EFSA ([2013l](#efs25306-bib-0055){ref-type="ref"}) (apricots and tree nuts)                                                                                            |
|                         |                         |                                                                                                                                                                        |
|                         |                         | EFSA ([2012j](#efs25306-bib-0043){ref-type="ref"}) (in purslane, legume vegetables and pulses) Ongoing for: Art. 10 barley and oatsArt. 10 Table olives and oilArt. 43 |
+-------------------------+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue limit; RMS: rapporteur Member State.

2016/2016/EU: Commission Implementing Regulation (EU) 2016/2016 of 17 November 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, benzoic acid, flazasulfuron, mecoprop‐P, mepanipyrim, mesosulfuron, propineb, propoxycarbazon, propyzamide, propiconazole, Pseudomonas chlororaphis Strain: MA 342, pyraclostrobin, quinoxyfen, thiacloprid, thiram, ziram, zoxamide. OJ L 312, 18.11.2016, p. 21--23.

John Wiley & Sons, Ltd

### 4.19.2. Toxicological reference values -- acetamiprid (Table [86](#efs25306-tbl-0086){ref-type="table"}) {#efs25306-sec-0132}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

                           JMPR evaluation                                                                                                                                             EU evaluation   TRV comparable                                                                                                                                 
  ------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ------------------------ --------------------------------------------------------------------------------------------------------------------- ----
  **ADI**                  0.07 mg/kg bw per day                                                                                                                                       JMPR, 2011      0.025 mg/kg bw per day   EFSA ([2016q](#efs25306-bib-0107){ref-type="ref"}) (rat, developmental neurotoxicity study, uncertainty factor 100)   No
  **ARfD**                 0.1 mg/kg bw                                                                                                                                                JMPR, 2011      0.025 mg/kg bw           EFSA ([2016q](#efs25306-bib-0107){ref-type="ref"}) (rat, developmental neurotoxicity study, uncertainty factor 100)   No
  **Conclusion/comment**   Following a request from CCPR, acetamiprid was on the agenda for follow‐up evaluation for toxicology. However, no relevant new data were provided to JMPR                                                                                                                                                                  

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.19.3. Residue definitions -- acetamiprid (Table [87](#efs25306-tbl-0087){ref-type="table"}) {#efs25306-sec-0133}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+---------------+----------------+
|                         | Commodity group                                                                               | JMPR evaluation                                                                              | EU evaluation | RDs comparable |
+=========================+===============================================================================================+==============================================================================================+===============+================+
| **RD enf**              | Plant products                                                                                | Acetamiprid                                                                                  | Acetamiprid   | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Sum of acetamiprid and metabolite IM‐2‐1 (N‐desmethyl‐acetamiprid), expressed as acetamiprid. | Reg. 396/2005: Acetamiprid                                                                   | No            |                |
|                         |                                                                                               |                                                                                              |               |                |
|                         | The residue is not fat soluble                                                                | Peer review: Metabolite IM‐2‐1 (N‐desmethyl‐acetamiprid), expressed as acetamiprid           |               |                |
|                         |                                                                                               |                                                                                              |               |                |
|                         |                                                                                               | The residue is not fat soluble                                                               |               |                |
+-------------------------+-----------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                | Acetamiprid                                                                                  | Acetamiprid   | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Sum of acetamiprid and metabolite IM‐2‐1 (N‐desmethyl‐acetamiprid), expressed as acetamiprid  | Sum of acetamiprid and metabolite IM‐2‐1 (N‐desmethyl‐acetamiprid), expressed as acetamiprid | Yes           |                |
+-------------------------+-----------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+---------------+----------------+
| **Conclusion/comments** | --                                                                                            |                                                                                              |               |                |
+-------------------------+-----------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.19.4. Codex MRL proposals -- acetamiprid (Table [88](#efs25306-tbl-0088){ref-type="table"}) {#efs25306-sec-0134}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity            | Codex MRL proposal                                                                                                                                                | EU MRL | Comment                                                                                                                                                                                                                                                                                                                                                                                  |
+======================+===================================================================================================================================================================+========+==========================================================================================================================================================================================================================================================================================================================================================================================+
| Pistachios           | --                                                                                                                                                                | 0.07   | Critical GAP: Iran -- Foliar spray, 3 × 0.05 kg a.s./ha (Interval between applications: 20--30 days), PHI not specified.                                                                                                                                                                                                                                                                 |
|                      |                                                                                                                                                                   |        |                                                                                                                                                                                                                                                                                                                                                                                          |
|                      |                                                                                                                                                                   |        | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                      |
|                      |                                                                                                                                                                   |        |                                                                                                                                                                                                                                                                                                                                                                                          |
|                      |                                                                                                                                                                   |        | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                       |
|                      |                                                                                                                                                                   |        |                                                                                                                                                                                                                                                                                                                                                                                          |
|                      |                                                                                                                                                                   |        | Specific comments/observations: The submitted residue trials were not compliant with the supported GAP; these were performed with 3 applications at 0.05 kg a.s./ha (time interval: 29--60 days) and a PHI of 28--30 days. No Codex MRL was proposed. It is noted that, in 2011, a CXL of 0.06 mg/kg was established for tree nuts (including pistachios) for the same GAP as the EU MRL |
+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments** | Further clarification on the proposed GAP on pistachio nuts should be provided either on the BBCH growth stage at which the applications take place or on the PHI |        |                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice.

John Wiley & Sons, Ltd

### 4.19.5. Consumer risk assessment -- acetamiprid {#efs25306-sec-0135}

No risk assessment was required since JMPR did not derive a MRL proposal.

4.20. Isopyrazam (249) (R) {#efs25306-sec-0136}
--------------------------

### 4.20.1. Background information (Table [89](#efs25306-tbl-0089){ref-type="table"}) {#efs25306-sec-0137}

###### 

Background information on isopyrazam

+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+
|                         |                   | Comments, references                                                                                                                        |
+=========================+===================+=============================================================================================================================================+
| Type of JMPR evaluation | New use           |                                                                                                                                             |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                     | NO                |                                                                                                                                             |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status         | Approved          | Commission Implementing Regulation (EU) 2015/1106[a](#efs25306-note-0111){ref-type="fn"} \[candidate for substitution -- two PBT criteria\] |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments | EFSA ([2012c](#efs25306-bib-0036){ref-type="ref"})                                                                                          |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review              | No                | On‐going                                                                                                                                    |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments | EFSA ([2015b](#efs25306-bib-0077){ref-type="ref"}) (fruiting vegetables)                                                                    |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+
|                         |                   | EFSA ([2013h](#efs25306-bib-0051){ref-type="ref"}) (various vegetables)                                                                     |
|                         |                   |                                                                                                                                             |
|                         |                   | EFSA ([2013c](#efs25306-bib-0046){ref-type="ref"}) (various crops)                                                                          |
|                         |                   |                                                                                                                                             |
|                         |                   | EFSA ([2011b](#efs25306-bib-0027){ref-type="ref"}) (banana)                                                                                 |
|                         |                   |                                                                                                                                             |
|                         |                   | EFSA ([2010g](#efs25306-bib-0023){ref-type="ref"}) (cereals and animal origin)                                                              |
+-------------------------+-------------------+---------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2015/1106/EU: Commission Implementing Regulation (EU) 2015/1106 of 8 July 2015 amending Implementing Regulations (EU) No 540/2011 and (EU) No 1037/2012 as regards the conditions of approval of the active substance isopyrazam. OJ L 181, 9.7.2015, p. 70--71.

John Wiley & Sons, Ltd

### 4.20.2. Toxicological reference values -- isopyrazam (Table [90](#efs25306-tbl-0090){ref-type="table"}) {#efs25306-sec-0138}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation       | EU evaluation | TRV comparable                                                                                                                                                        |                                                                                                                                                                             |    |
+========================+=======================+===============+=======================================================================================================================================================================+=============================================================================================================================================================================+====+
| **ADI**                | 0.06 mg/kg bw per day | JMPR, 2011    | 0.03 mg/kg bw/day,                                                                                                                                                    | EFSA ([2012c](#efs25306-bib-0036){ref-type="ref"}) (rat, 2‐year study, safety factor of 200) confirmed by European Commission ([2012b](#efs25306-bib-0143){ref-type="ref"}) | No |
|                        |                       |               |                                                                                                                                                                       |                                                                                                                                                                             |    |
|                        |                       |               | applicable to isopyrazam containing up to 50% anti‐isomers and to metabolites CSCD656800, CSCD459488, CSCD459489, CSCD465008, CSCD591489 and CSCD563692               |                                                                                                                                                                             |    |
+------------------------+-----------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 0.3 mg/kg bw          | JMPR, 2011    | 0.2 mg/kg bw, applicable to isopyrazam containing up to 50% anti‐isomers and to metabolites CSCD656800, CSCD459488, CSCD459489, CSCD465008, CSCD591489 and CSCD563692 | EFSA ([2012c](#efs25306-bib-0036){ref-type="ref"}) (rat, developmental toxicity study, safety factor of 100) confirmed by                                                   | No |
|                        |                       |               |                                                                                                                                                                       |                                                                                                                                                                             |    |
|                        |                       |               |                                                                                                                                                                       | European Commission ([2012b](#efs25306-bib-0143){ref-type="ref"})                                                                                                           |    |
+------------------------+-----------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | --                    |               |                                                                                                                                                                       |                                                                                                                                                                             |    |
+------------------------+-----------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.20.3. Residue definitions -- isopyrazam (Table [91](#efs25306-tbl-0091){ref-type="table"}) {#efs25306-sec-0139}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR evaluation                                                                                                                                                                                    | EU evaluation                                                                            | RDs comparable |
+=========================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================+====================================================================================================================================================================================================+==========================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                          | Isopyrazam (sum of syn‐isomer and anti‐isomer)                                                                                                                                                     | Isopyrazam (sum of isomers)                                                              | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------+----------------+
| Animal products         | Isopyrazam (sum of syn‐isomer and anti‐isomer).                                                                                                                                                                                                                                                                                                                                                                                         | Isopyrazam (sum of isomers)                                                                                                                                                                        | Yes                                                                                      |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                    |                                                                                          |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                              | The residue is fat soluble                                                                                                                                                                         |                                                                                          |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                          | Sum of isopyrazam and 3‐difluoromethyl‐1‐methyl‐1H‐pyrazole‐4‐carboxylic acid \[9‐(1‐hydroxyl‐1‐methylethyl)‐(1*RS*, 4RS, 9RS)‐1,2,3,4‐tetrahydro‐1,4‐methanonaphthalen‐5‐yl\] amide (CSCD459488), | Isopyrazam (sum of isomers) plus its metabolite                                          | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                    |                                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                         | expressed as isopyrazam                                                                                                                                                                            | CSCD459488 \[*syn*‐ hydroxyl isopyrazam\] (free and conjugated), expressed as isopyrazam |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------+----------------+
| Animal products         | Isopyrazam (sum of syn‐isomer and anti‐isomer).                                                                                                                                                                                                                                                                                                                                                                                         | Isopyrazam (sum of isomers) plus all its metabolites containing the CSAA798670 moiety \[3‐(difluromethyl)‐1‐methyl‐pyrazole‐4‐methanoic acid\] expressed as Isopyrazam                             | No                                                                                       |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for enforcement are identical. Due to the difference of the residue definitions for risk assessment derived by JMPR and applicable in the EU, the dietary exposure/risk assessment is affected by uncertainties and allows only a tentative risk assessment. However, considering that the existing EU MRLs are in general higher than the proposed Codex MRL proposals, this uncertainty is of minor relevance |                                                                                                                                                                                                    |                                                                                          |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.20.4. Codex MRL proposals -- isopyrazam (Table [92](#efs25306-tbl-0092){ref-type="table"}) {#efs25306-sec-0140}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                      | Codex MRL proposal                           | EU MRL                                                      | Comment                                                                                                                                                                                                                                                                                                                                     |
+================================================================+==============================================+=============================================================+=============================================================================================================================================================================================================================================================================================================================================+
| Group of Pome fruits(includes all commodities in this group)   | 0.4                                          | 0.7 (EU pome fruit group);                                  | Critical GAP: 2 foliar applications of 150 g ai/ha with a PHI of 21 days (Chile)                                                                                                                                                                                                                                                            |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              | 0.01[\*](#efs25306-note-0720){ref-type="fn"} kaki, azaroles | Number of trials: 16 trials on apples                                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: The Codex MRL proposal for pome fruit applies also to azaroles and kaki, which do not belong in the pome fruit category according to the EU classification.                                                                                                                                                 |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cucumber                                                       | 0.06                                         | 0.4                                                         | Critical GAP: 2 foliar applications at a rate of 12.5 g ai/hL, up to 1,000 L/ha (maximum of 125 g ai/ha) with a PHI of 1 day (protected -- indoor use, United Kingdom)                                                                                                                                                                      |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8                                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: The trials were conducted in cucumber (indoor).                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melon, except watermelon                                       | 0.15                                         | 0.3                                                         | Critical GAP: 2 foliar applications at rate of 12.5 g ai/hL, up to 1,000 L/ha (maximum of 125 g ai/ha) with a PHI of 7 days (protected -- indoor use, United Kingdom)                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8                                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Trials conducted in melons (indoor). Residues of isopyrazam were analysed in the whole fruit (n = 8) and melons flesh (n = 8). STMR of 0.015 mg/kg and HR of 0.015 mg/kg for melon flesh were estimated.                                                                                                    |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, sweet (including pimento or pimiento)                 | 0.09                                         | 0.09                                                        | Critical GAP: 2 foliar applications at rate of 12.5 g ai/hL, up to 1,000 L/ha (maximum of 125 g ai/ha) with a PHI of 3 days (protected -- indoor use, United Kingdom)                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8                                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Trials conducted in peppers (indoor).                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                  | 0.4                                          | 0.5 (tomato)                                                | Critical GAP: 2 foliar applications at rate of 12.5 g ai/hL, up to 1000 L/ha (maximum of 125 g ai/ha) with a PHI of 1 day (protected -- indoor use, United Kingdom)                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8 (trials conducted in cherry tomato)                                                                                                                                                                                                                                                                                     |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Trials were done in cherry tomato (indoor). In the EU, no separate MRLs are established for cherry tomatoes. Thus, this MRL proposal would be applicable to all tomatoes.                                                                                                                                   |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                           |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                         | 0.4                                          | 0.5                                                         | Critical GAP: 2 foliar applications at rate of 12.5 g ai/hL, up to 1,000 L/ha (maximum of 125 g ai/ha) with a PHI of 1 day (protected -- indoor use, United Kingdom)                                                                                                                                                                        |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8 (trials conducted in cherry tomato)                                                                                                                                                                                                                                                                                     |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: The MRL proposal derived for cherry tomatoes was extrapolated tomatoes.                                                                                                                                                                                                                                     |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of Eggplants (includes all commodities in this group) | 0.4                                          | 0.5                                                         | Critical GAP: 2 foliar applications at rate of 12.5 g ai/hL, up to 1,000 L/ha (maximum of 125 g ai/ha) with a PHI of 1 day (protected -- indoor use, United Kingdom)                                                                                                                                                                        |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8 (trials conducted in cherry tomato)                                                                                                                                                                                                                                                                                     |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: The MRL proposal derived for cherry tomatoes was extrapolated to the subgroup of eggplants. The extrapolation from tomatoes to eggplants is also possible according to the current EU guidance document. However, residue trials on cherry tomatoes are expected to overestimate the residues in eggplants. |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable, although it may overestimate the residues                                                                                                                                                                                                                                                 |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrot                                                         | 0.15                                         | 0.2                                                         | Critical GAP: 2 foliar applications at rate of 125 g ai/ha with a PHI of 14 days (United Kingdom)                                                                                                                                                                                                                                           |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 16                                                                                                                                                                                                                                                                                                                        |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: --                                                                                                                                                                                                                                                                                                          |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley                                                         | 0.6                                          | 0.6                                                         | Critical GAP: 2 foliar applications at rate of 125 g ai/ha before beginning of flowering (first anthers visible, BBCH 61) (United Kingdom)                                                                                                                                                                                                  |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8                                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Residues measured in barley grain.                                                                                                                                                                                                                                                                          |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                           |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat                                                          | 0.03                                         | 0.2                                                         | Critical GAP: 2 foliar applications at a rate of 125 g ai/ha before grain watery ripe stage (BBCH 71) (United Kingdom)                                                                                                                                                                                                                      |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8 trials in wheat                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: --                                                                                                                                                                                                                                                                                                          |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                           |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye                                                            | 0.03                                         | 0.2                                                         | Critical GAP: UK, 2 foliar applications at a rate of 125 g ai/ha before grain watery ripe stage (BBCH 71) (United Kingdom)                                                                                                                                                                                                                  |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8 (trials on wheat)                                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Extrapolated from trials on wheat.                                                                                                                                                                                                                                                                          |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                           |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale                                                      | 0.03                                         | 0.2 (wheat)                                                 | Critical GAP: UK, 2 foliar applications at a rate of 125 g ai/ha before grain watery ripe stage (BBCH 71) (United Kingdom)                                                                                                                                                                                                                  |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 8 (trials on wheat)                                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Extrapolated from trials no wheat.                                                                                                                                                                                                                                                                          |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rape seed                                                      | 0.2                                          | 0.4                                                         | Critical GAP: 1 foliar application at rate of 125 g ai/ha up to the end of flowering (BBCH 71) (United Kingdom)                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 20                                                                                                                                                                                                                                                                                                                        |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations:                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peanut                                                         | 0.01                                         | 0.01[\*](#efs25306-note-0720){ref-type="fn"}                | Critical GAP: 2 foliar application at rate of 100--125 g ai/ha with PHI of 7 days (Nicaragua)                                                                                                                                                                                                                                               |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 4 (conducted at 3 × 125 g ai/ha, PHI not reported)                                                                                                                                                                                                                                                                        |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                          |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Residues measured in peanuts and peanuts seed. According to the JMPR, peanuts belong to the minor crops category 3, for which a minimum of 5 residue trials are necessary to propose a CXL.                                                                                                                 |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                               |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple, dry                                                     | 3                                            |                                                             | Processing Factor (PF) of 6.03 derived by JMPR and used to propose the CXL. The same PF was derived by EFSA ([2015b](#efs25306-bib-0077){ref-type="ref"})                                                                                                                                                                                   |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato, dry                                                    | 5                                            |                                                             | PF of 11 derived by JMPR and used to propose the CXL. The same value was derived by EFSA ([2015b](#efs25306-bib-0077){ref-type="ref"})                                                                                                                                                                                                      |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder, dry                                   | 15 (dw)                                      |                                                             | Critical GAP: 2 foliar applications at rate of 125 g ai/ha before beginning of flowering up to BBCH 61 (United Kingdom)                                                                                                                                                                                                                     |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 13 (barley straw) + 8 (wheat straw)                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Combined data set of residues of isopyrazam in barley straw and wheat straw were combined to derive the proposed CXL.                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: For feed items no MRLs are established in the EU                                                                                                                                                                                                                                                                                |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye straw and fodder, dry                                      | 15 (dw)                                      |                                                             | Critical GAP: 2 foliar applications at rate of 125 g ai/ha before beginning of flowering up to BCH 71 (United Kingdom)                                                                                                                                                                                                                      |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 13 (barley straw) + 8 (wheat straw)                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Combined data set of residues of isopyrazam in barley straw and wheat straw were combined to derive the proposed CXL.                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: For feed items no MRLs are established in the EU.                                                                                                                                                                                                                                                                               |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale straw and fodder, dry                                | 15 (dw)                                      |                                                             | Critical GAP: 2 foliar applications at rate of 125 g ai/ha before beginning of flowering up to BCH 71 (United Kingdom)                                                                                                                                                                                                                      |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 13 (barley straw) + 8 (wheat straw)                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Combined data set of residues of isopyrazam in barley straw and wheat straw were combined to derive the proposed CXL.                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: For feed items no MRLs are established in the EU                                                                                                                                                                                                                                                                                |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat straw and fodder, dry                                    | 15 (dw)                                      |                                                             | Critical GAP: 2 foliar applications at rate of 125 g ai/ha before beginning of flowering up to BCH 71 (United Kingdom)                                                                                                                                                                                                                      |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Number of trials: 13 (barley straw) + 8 (wheat straw)                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                         |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Specific comments/observations: Combined data set of residues of isopyrazam in barley straw and wheat straw were combined to derive the proposed CXL.                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: For feed items no MRLs are established in the EU                                                                                                                                                                                                                                                                                |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                              | **0.03**                                     | 0.01[\*](#efs25306-note-0720){ref-type="fn"}                | Max Dietary burden is 22 ppm (equivalent to mg/kg DM)                                                                                                                                                                                                                                                                                       |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Feeding study with highest dose level (127 ppm) covering the max DB.                                                                                                                                                                                                                                                                        |
|                                                                |                                              |                                                             |                                                                                                                                                                                                                                                                                                                                             |
|                                                                |                                              |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                  | **0.03 (fat)**                               | 0.01[\*](#efs25306-note-0720){ref-type="fn"}                | Specific comments/observations: At EU level, an MRL for muscle should be established. Based on the feeding studies, no quantifiable residues are expected in muscle and the existing EU MRL would be appropriate                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                       | **0.02**                                     | 0.01[\*](#efs25306-note-0720){ref-type="fn"}                | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                          | 0.01[\*](#efs25306-note-0720){ref-type="fn"} | 0.01[\*](#efs25306-note-0720){ref-type="fn"}                | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk fats                                                      | 0.02                                         |                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple juice                                                    | None                                         |                                                             | PF of 0.02 derived by JMPR has the same value as the PF derived by EFSA (EFSA, [2013h](#efs25306-bib-0051){ref-type="ref"},[c](#efs25306-bib-0046){ref-type="ref"})                                                                                                                                                                         |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Canned apple                                                   | None                                         |                                                             | PF of 0.05 derived by JMPR has the same value as the PF derived by EFSA ([2013h](#efs25306-bib-0051){ref-type="ref"},[c](#efs25306-bib-0046){ref-type="ref"})                                                                                                                                                                               |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple sauce                                                    | None                                         |                                                             | PF of 0.18 derived by JMPR has the same value as the PF derived by EFSA ([2013h](#efs25306-bib-0051){ref-type="ref"},[c](#efs25306-bib-0046){ref-type="ref"})                                                                                                                                                                               |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley malt                                                    | None                                         |                                                             | PF of 0.55 derived by JMPR has the same value as the PF derived by EFSA ([2010g](#efs25306-bib-0023){ref-type="ref"})                                                                                                                                                                                                                       |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley beer                                                    | None                                         |                                                             | PF of \< 0.13 derived by JMPR has the same value as the PF derived by EFSA ([2010g](#efs25306-bib-0023){ref-type="ref"})                                                                                                                                                                                                                    |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pot barley                                                     | None                                         |                                                             | PF of 0.37 derived by JMPR has the same value as the PF derived by EFSA ([2010g](#efs25306-bib-0023){ref-type="ref"})                                                                                                                                                                                                                       |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rape seed oil, edible                                          | None                                         |                                                             | PF of 1.81 derived by JMPR. It was not possible to confirm if a PF was derived at the EU level by EFSA                                                                                                                                                                                                                                      |
+----------------------------------------------------------------+----------------------------------------------+-------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; GAP: Good Agricultural Practice; STMR: supervised trials median residue; PF: processing factor; MRL: maximum residue limit; CXL: Codex Maximum Residue Limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.20.5. Consumer risk assessment -- isopyrazam (Table [93](#efs25306-tbl-0093){ref-type="table"}) {#efs25306-sec-0141}

###### 

Summary of the consumer risk assessment for isopyrazam

+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                       | Chronic exposure assessment                                                                                                                                                                                                                                       | Comments on JMPR exposure assessment                                                                   |
+=================================================================================================================================================================================================================================================+===================================================================================================================================================================================================================================================================+========================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                             | **RA assumptions:**                                                                                                                                                                                                                                               | **Specific comments:**                                                                                 |
|                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                   |                                                                                                        |
| A tentative short‐term dietary risk assessment was performed for all commodities assessed by JMPR. The risk assessment is tentative, because of the different residue definitions for risk assessment derived by JMPR and applicable in the EU. | The most recent long‐term risk assessment (EFSA, [2015b](#efs25306-bib-0077){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for rye grain, wheat grain and livestock commodities. | Acute exposure for cereals is assessed with STMR and/or STMR‐p, which is a different approach from EU. |
|                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                   |                                                                                                        |
| Contribution of cereals was assessed with the STMR RAC. No refinement was performed with STMR‐p. For wheat, the higher STMR of triticale was used in the calculation                                                                            | The risk assessment is tentative, because of the different residue definitions for risk assessment derived by JMPR and applicable in the EU.                                                                                                                      | Detailed RA values can be assessed for wheat and triticale, which is not possible with the EU PRIMo    |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                    | **Results:**                                                                                                                                                                                                                                                      | **Results:**                                                                                           |
|                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                   |                                                                                                        |
| No short‐term exposure concern was identified (apples: 12% of the ARfD)                                                                                                                                                                         | No long‐term consumer health risk was identified.                                                                                                                                                                                                                 | Long‐term exposure:                                                                                    |
|                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                   |                                                                                                        |
|                                                                                                                                                                                                                                                 | The overall chronic exposure accounted for 13% of the ADI.                                                                                                                                                                                                        | 0--1% of the ADI                                                                                       |
|                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                   |                                                                                                        |
|                                                                                                                                                                                                                                                 | The contribution of apples to the exposure was 12% of the ADI                                                                                                                                                                                                     | Short‐term exposure:                                                                                   |
|                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                   |                                                                                                        |
|                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                   | 6--10% of the ARfD                                                                                     |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; STMR: supervised trials median residue; RA: risk assesment.

John Wiley & Sons, Ltd

4.21. Propylene oxide (250) (R/T) {#efs25306-sec-0142}
---------------------------------

### 4.21.1. Background information (Table [94](#efs25306-tbl-0094){ref-type="table"}) {#efs25306-sec-0143}

###### 

Background information on propylene oxide

                                      Comments, references
  ------------------------- --------- ------------------------
  Type of JMPR evaluation   New use   
  RMS                       --        
  Approval status           --        Not assessed in the EU
  EFSA conclusion           No        --
  MRL review                No        --
  MRL applications          No        --
                                      

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

John Wiley & Sons, Ltd

### 4.21.2. Toxicological reference values -- propylene oxide (Table [95](#efs25306-tbl-0095){ref-type="table"}) {#efs25306-sec-0144}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                             | EU evaluation                                                       | TRV comparable |                  |     |
+========================+=============================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================================+================+==================+=====+
| **ADI**                | 0.04 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                       | JMPR, 2011, 2017;                                                   | --             | No EU assessment | N/A |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Rat, chronic inhalation supported by reproductive toxicity study    |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| **ARfD**               | 0.04 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR, 2011, 2017;                                                   | --             | N/A              |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Rat, chronic inhalation supported by reproductive toxicity study    |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| Propylene chlorohydrin |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| **ADI**                | 0.3 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR, 2017;                                                         | --             | No EU assessment | N/A |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Rat, acute neurotoxicity supported by reproductive toxicity studies |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR, 2017;                                                         | --             | N/A              |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Rat acute neurotoxicity, supported by developmental toxicity study  |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| Propylene bromohydrin  |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                       | JMPR, 2017;                                                         | --             | No EU assessment | N/A |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Same as propylene chlorohydrin                                      |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| **ARfD**               | 0.03 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR, 2017;                                                         | --             | N/A              |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             | Same as propylene chlorhydrin                                       |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+
| **Conclusion/comment** | For **propylene oxide**, the ADI was derived with an additional factor of 10 (to the default SF of 100) to address the limitations in the available database and ensure a margin of 100 to the LOAEL of 4.3 mg/kg bw per day in the gavage carcinogenicity study. The ARfD was derived on the same basis.                                                                                                                                   |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        | EFSA: Considering that propylene oxide is classified as mutagen (cat 1B) and carcinogen (cat 1B) according to EU CLP Regulation (EC) No. 1272/2008, the conclusions on genotoxicity and carcinogenicity and the derivation of reference values from JMPR might not be supported in an EU evaluation.                                                                                                                                        |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        | For **propylene chlorohydrin**, the ADI was derived on the basis of reduced motor activity observed in the rat acute neurotoxicity study (NOAEL 25 mg/kg bw) and applying a safety factor of 100. This is supported by parental, offspring and embryo/foetal toxicity in the reproductive toxicity studies. The ARfD was also derived on the basis of the rat acute neurotoxicity study, supported by the rat developmental toxicity study. |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        | For **propylene bromohydrin**, JMPR considered a read across from propylene chlorohydrin. Considering the uncertainties and the available evidence that propylene bromohydrin was of greater potency than propylene chlorohydrin, an extra safety factor of 10 was applied to the derivation of the ADI and ARfD.                                                                                                                           |                                                                     |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                     |                |                  |     |
|                        | EFSA: Considering the same uncertainties related to the genotoxic potential than for propylene oxide, the JMPR conclusion and derivation of reference values for the 2 metabolites might not be supported in an EU evaluation                                                                                                                                                                                                               |                                                                     |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.21.3. Residue definitions -- propylene oxide (Table [96](#efs25306-tbl-0096){ref-type="table"}) {#efs25306-sec-0145}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+---------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                   | JMPR evaluation                                                                                    | EU evaluation | RDs comparable |
+=========================+===================================================================================================================================================================================================================================================================================================================================+====================================================================================================+===============+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                    | Propylene oxide                                                                                    | --            | N/A            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Not reported                                                                                                                                                                                                                                                                                                                      | --                                                                                                 | N/A           |                |
|                         |                                                                                                                                                                                                                                                                                                                                   |                                                                                                    |               |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                    |                                                                                                    |               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                    | Propylene oxide, propylene chlorohydrin and propylene bromohydrin.                                 | --            | N/A            |
|                         |                                                                                                                                                                                                                                                                                                                                   |                                                                                                    |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                   | Propylene chlorohydrin and propylene bromohydrin to be considered separately from propylene oxide. |               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Not reported                                                                                                                                                                                                                                                                                                                      | --                                                                                                 | N/A           |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+---------------+----------------+
| **Conclusion/comments** | The data assessed by JMPR in 2011 to derive the residue definitions was very limited. The residue definitions were derived by analogy based on the similarity in reactions and chemistry between ethylene oxide and propylene oxide. The database is considered insufficient to derive residue definitions for propylenoxide uses |                                                                                                    |               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.21.4. Codex MRL proposals -- propylene oxide (Table [97](#efs25306-tbl-0097){ref-type="table"}) {#efs25306-sec-0146}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+--------------------+------------+-------------------------------------------------------------------------------+
| Commodity            | Codex MRL proposal | EU MRL     | Comment                                                                       |
+======================+====================+============+===============================================================================+
| Almonds, walnuts     | No proposal        | No EU MRLs | Critical GAP: USA, post‐harvest fumigation at 2 g ai/L in a sealed chamber.   |
|                      |                    |            |                                                                               |
|                      |                    |            | JMPR considered the residue data not valid. No Codex MRL proposal was derived |
+----------------------+--------------------+------------+-------------------------------------------------------------------------------+
| **General comments** | --                 |            |                                                                               |
+----------------------+--------------------+------------+-------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 4.21.5. Consumer risk assessment -- propylene oxide (Table [98](#efs25306-tbl-0098){ref-type="table"}) {#efs25306-sec-0147}

###### 

Summary of the consumer risk assessment for propylene oxide

  Acute exposure assessment
  ---------------------------
  Not relevant

John Wiley & Sons, Ltd

4.22. Saflufenacil (251) (R/T) {#efs25306-sec-0148}
------------------------------

### 4.22.1. Background information (Table [99](#efs25306-tbl-0099){ref-type="table"}) {#efs25306-sec-0149}

###### 

Background information on saflufenacil

+-------------------------+-------------------+----------------------------------------------------------------------------------------------------------------------------------------------+
|                         |                   | Comments, references                                                                                                                         |
+=========================+===================+==============================================================================================================================================+
| Type of JMPR evaluation | New use           |                                                                                                                                              |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                     | --                |                                                                                                                                              |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status         | Not approved      | --                                                                                                                                           |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion         | No                | --                                                                                                                                           |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review              | No                | --                                                                                                                                           |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments | Import tolerances on a wide range of food commodities: EFSA ([2012b](#efs25306-bib-0035){ref-type="ref"})                                    |
|                         |                   |                                                                                                                                              |
|                         |                   | Various crops, considering the risk related to the metabolite trifluoroacetic acid (TFA): EFSA ([2014b](#efs25306-bib-0057){ref-type="ref"}) |
|                         |                   |                                                                                                                                              |
|                         |                   | Import tolerance assessment ongoing (data requested)                                                                                         |
+-------------------------+-------------------+----------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

John Wiley & Sons, Ltd

### 4.22.2. Toxicological reference values -- saflufenacil (Table [100](#efs25306-tbl-0100){ref-type="table"}) {#efs25306-sec-0150}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

                                   JMPR evaluation         EU evaluation   TRV comparable                                                                                                                                
  -------------------------------- ----------------------- --------------- ------------------------ -------------------------------------------------------------------------------------------------------------------- -----
  **ADI**                          0.05 mg/kg bw per day   JMPR, 2011      0.046 mg/kg bw per day   EFSA ([2012b](#efs25306-bib-0035){ref-type="ref"}) (Mouse, 18‐month carcinogenicity)                                 Yes
  **ARfD**                         Unnecessary             JMPR, 2011      0.05 mg/kg bw            EFSA ([2012b](#efs25306-bib-0035){ref-type="ref"}) (Rat, developmental toxicity with an uncertainty factor of 100)   No
  **TFA (Trifluoroacetic acid)**                                                                                                                                                                                         
  ADI                              --                      --              0.05 mg/kg bw per day    (90‐day oral rat study with an uncertainty factor of 200) EFSA ([2014b](#efs25306-bib-0057){ref-type="ref"})         N/A
  ARfD                             --                      --              0.05 mg/kg bw            (90‐day oral rat study with a safety factor 200) EFSA ([2014b](#efs25306-bib-0057){ref-type="ref"})                  N/A
  **Conclusion/comment**           --                                                                                                                                                                                    

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.22.3. Residue definitions -- saflufenacil (Table [101](#efs25306-tbl-0101){ref-type="table"}) {#efs25306-sec-0151}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+
|                         | Commodity group                | JMPR evaluation                                                                                                                                | EU evaluation                                                       | RDs comparable |
+=========================+================================+================================================================================================================================================+=====================================================================+================+
| **RD enf**              | Plant products                 | Saflufenacil                                                                                                                                   | Sum of saflufenacil, M800H11 and M800H35, expressed as saflufenacil | No             |
+-------------------------+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+
| Animal products         | Saflufenacil                   | Saflufenacil                                                                                                                                   | Yes                                                                 |                |
|                         |                                |                                                                                                                                                |                                                                     |                |
|                         | The residue is not fat soluble | Metabolite M800H10 to be considered if poultry feed might be affected by saflufenacil uses (EFSA, [2012b](#efs25306-bib-0035){ref-type="ref"}) |                                                                     |                |
|                         |                                |                                                                                                                                                |                                                                     |                |
|                         |                                | The residue is not fat soluble                                                                                                                 |                                                                     |                |
+-------------------------+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                 | Saflufenacil                                                                                                                                   | Sum of saflufenacil, M800H11 and M800H35, expressed as saflufenacil | No             |
+-------------------------+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+
| Animal products         | Saflufenacil                   | Saflufenacil.                                                                                                                                  | Yes                                                                 |                |
|                         |                                |                                                                                                                                                |                                                                     |                |
|                         |                                | Metabolite M800H10 to be considered if poultry feed might be affected by saflufenacil uses                                                     |                                                                     |                |
+-------------------------+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+
| **Conclusion/comments** | --                             |                                                                                                                                                |                                                                     |                |
+-------------------------+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.22.4. Codex MRL proposals -- saflufenacil (Table [102](#efs25306-tbl-0102){ref-type="table"}) {#efs25306-sec-0152}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+--------------+--------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity    | Codex MRL proposal | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+==============+====================+==============================================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Mustard seed | **0.6**            | 0.03[\*](#efs25306-note-0705){ref-type="fn"} | Critical GAP for rape seed (JMPR, 2011): single late‐season application, as harvest aid/desiccant at 0.049--0.051 kg ai/ha, PHI 3 days (allowing up to 7 days for optimum desiccation effect depending on environmental conditions)                                                                                                                                                                                                                     |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | Number of trials: 14 trials in rape seed, to be extrapolated to mustard seeds.                                                                                                                                                                                                                                                                                                                                                                          |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                     |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | The extrapolation from rape seed trials to mustard seed is also accepted in the EU. The previously established CXL for rape seed has been taken over in the EU legislation, although the residue definitions set by JMPR and in the EU were different (in the EU, the residue definition was provisionally proposed in the framework of the import tolerance application. The residue definition was amended in the same period as the CXL was adopted. |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs.                                                                                                                                                                                                                                                                                                            |
+--------------+--------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Linseed      | **0.6**            | 0.03[\*](#efs25306-note-0705){ref-type="fn"} | Critical GAP for rape seed (JMPR, 2011): single late‐season application, as harvest aid/desiccant at 0.049--0.051 kg ai/ha, PHI 3 days (allowing up to 7 days for optimum desiccation effect depending on environmental conditions)                                                                                                                                                                                                                     |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | Number of trials: 14 trials in rape seed, to be extrapolated to mustard seeds.                                                                                                                                                                                                                                                                                                                                                                          |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                     |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | Specific comments/observations: accepted EU extrapolation from rape seed trials to linseed taken by EU legislation. See comments on mustard seeds.                                                                                                                                                                                                                                                                                                      |
|              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|              |                    |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                             |
+--------------+--------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; CXL: Codex Maximum Residue Limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.22.5. Consumer risk assessment -- saflufenacil (Table [103](#efs25306-tbl-0103){ref-type="table"}) {#efs25306-sec-0153}

###### 

Summary of the consumer risk assessment for saflufenacil

+--------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                              | Chronic exposure assessment                                                                                                                                                                                                              | Comments on JMPR exposure assessment                                                                                                                                                                       |
+========================================================================================================================================================+==========================================================================================================================================================================================================================================+============================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                    | **RA assumptions:**                                                                                                                                                                                                                      | **Specific comments:**                                                                                                                                                                                     |
|                                                                                                                                                        |                                                                                                                                                                                                                                          |                                                                                                                                                                                                            |
| The short‐term dietary risk assessment was performed for mustard seed and linseed as outlined in Section [4.22.2](#efs25306-sec-0150){ref-type="sec"}. | The most recent long‐term risk assessment (EFSA, [2014b](#efs25306-bib-0057){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for mustard seed and linseed | In 2017 JMPR report, no livestock exposure assessment was conducted including 'Flaxseed/Linseed meal' which could be fed to animal.                                                                        |
|                                                                                                                                                        |                                                                                                                                                                                                                                          |                                                                                                                                                                                                            |
| The EU ARfD was used                                                                                                                                   |                                                                                                                                                                                                                                          | In 2011, JMPR livestock exposure assessment conducted was incomplete not taken crops that were fed to item and considering MRLs taken by CODEX.                                                            |
|                                                                                                                                                        |                                                                                                                                                                                                                                          |                                                                                                                                                                                                            |
|                                                                                                                                                        |                                                                                                                                                                                                                                          | Livestock assessment has been done for CODEX items and for EU items. For CODEX as well as for EU, no differences on the outcome if linseed is taken or not. However, there are concerns for sheep and beef |
+--------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                           | **Results:**                                                                                                                                                                                                                             |                                                                                                                                                                                                            |
|                                                                                                                                                        |                                                                                                                                                                                                                                          |                                                                                                                                                                                                            |
| No short‐term exposure concern was identified (0.9% of the ARfD for linseed and 0.2% of the ARfD for mustard seed)                                     | No long‐term consumer health risk was identified.                                                                                                                                                                                        |                                                                                                                                                                                                            |
|                                                                                                                                                        |                                                                                                                                                                                                                                          |                                                                                                                                                                                                            |
|                                                                                                                                                        | The overall chronic exposure accounted for 4% of the ADI.                                                                                                                                                                                |                                                                                                                                                                                                            |
|                                                                                                                                                        |                                                                                                                                                                                                                                          |                                                                                                                                                                                                            |
|                                                                                                                                                        | The contribution of rape seed to the exposure was 0.017% of the ADI for linseed and 0.002% of the ADI for mustard seed                                                                                                                   |                                                                                                                                                                                                            |
+--------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

4.23. Picoxystrobin (258) (R) {#efs25306-sec-0154}
-----------------------------

### 4.23.1. Background information (Table [104](#efs25306-tbl-0104){ref-type="table"}) {#efs25306-sec-0155}

###### 

Background information on picoxystrobin

+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
|                         |                   | Comments, references                                                                       |
+=========================+===================+============================================================================================+
| Type of JMPR evaluation | New use           |                                                                                            |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| RMS                     | CZ                |                                                                                            |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| Approval status         | Not approved      | Commission Implementing Regulation (EU) No 2017/438[a](#efs25306-note-0401){ref-type="fn"} |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments | EFSA ([2016l](#efs25306-bib-0102){ref-type="ref"})                                         |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| MRL review              | Yes, see comments | EFSA ([2011h](#efs25306-bib-0033){ref-type="ref"})                                         |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments | Ongoing in rice                                                                            |
|                         |                   |                                                                                            |
|                         |                   | EFSA ([2014h](#efs25306-bib-0063){ref-type="ref"}) (sugar beet)                            |
+-------------------------+-------------------+--------------------------------------------------------------------------------------------+

2017/438/EU: Commission Implementing Regulation (EU) 2017/438 of 13 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance abamectin. OJ L 67, 14.3.2017, p. 67--69.

John Wiley & Sons, Ltd

### 4.23.2. Toxicological reference values -- picoxystrobin (Table [105](#efs25306-tbl-0105){ref-type="table"}) {#efs25306-sec-0156}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                         | EU evaluation | TRV comparable                                                                                                                                            |                                                                                                        |    |
+========================+=========================================================================================================================================================================================================================================================================================================================================================+===============+===========================================================================================================================================================+========================================================================================================+====+
| **ADI**                | 0.09 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                   | JMPR          | **No toxicological reference values could be derived.** (previous ADI was 0.043 mg/kg bw European Commission, [2003](#efs25306-bib-0137){ref-type="ref"}) | Setting of reference values was postponed until conclusion on the genotoxic potential of picoxystrobin | No |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 0.09 mg/kg bw                                                                                                                                                                                                                                                                                                                                           | JMPR          | **No toxicological reference values could be derived**                                                                                                    | Setting of reference values was postponed until conclusion on the genotoxic potential of picoxystrobin | No |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | During the renewal process, no toxicological references were proposed since a genotoxic potential of picoxystrobin could not be excluded (picoxystrobin was positive in the *in vitro* mammalian gene mutation assay).                                                                                                                                  |               |                                                                                                                                                           |                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                         |               |                                                                                                                                                           |                                                                                                        |    |
|                        | In addition for several metabolites relevant for the risk assessment residue definition in plant, a conclusion on the toxicological profile could not be derived (IN‐H8612 a clastogenic/aneugenic potential cannot be excluded, while for IN‐K2122, IN‐QGU64 no toxicological data were provided) (EFSA, [2016l](#efs25306-bib-0102){ref-type="ref"}). |               |                                                                                                                                                           |                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                         |               |                                                                                                                                                           |                                                                                                        |    |
|                        | In 2012, JMPR established the ADI and ARfD listed above. However, no conclusion was reached on the toxicological relevance of IN‐H8612 and IN‐QGU64, both metabolites have structural alerts for genotoxicity.                                                                                                                                          |               |                                                                                                                                                           |                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                         |               |                                                                                                                                                           |                                                                                                        |    |
|                        | For IN‐H8612, JMPR concluded in 2013, on the basis of a mouse micronucleus study and an estimate of the exposure using TTC that this metabolite is of no concern for dietary exposure. In 2016, JMPR concluded that further information was required for IN‐QGU64, because a possible interconversion of IN‐H8612 and IN‐QGU64 cannot be excluded       |               |                                                                                                                                                           |                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                         |               |                                                                                                                                                           |                                                                                                        |    |
|                        | In 2017, JMPR assessed the new metabolism studies in soybeans, tomatoes and potatoes; in none of them, IN‐QGU64 was not observed. With this information, the meeting concluded that in the 2006 soybean metabolism study, IN‐H8612 had been incorrectly characterised as IN‐QGU64                                                                       |               |                                                                                                                                                           |                                                                                                        |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.23.3. Residue definitions -- picoxystrobin (Table [106](#efs25306-tbl-0106){ref-type="table"}) {#efs25306-sec-0157}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                              | JMPR evaluation                                                                                                             | EU evaluation                                                                                                     | RDs comparable |
+=========================+==============================================================================================================================================================================================================================================================================================+=============================================================================================================================+===================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                               | Picoxystrobin                                                                                                               | EU Reg. 396/2005: picoxystrobin                                                                                   | Yes            |
|                         |                                                                                                                                                                                                                                                                                              |                                                                                                                             |                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                              |                                                                                                                             | Picoxystrobin (pending conclusion on the toxicological profile of picoxystrobin and its main plant metabolites)   |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Picoxystrobin                                                                                                                                                                                                                                                                                | EU Reg. 396/2005: Picoxystrobin                                                                                             | Yes                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                              |                                                                                                                             |                                                                                                                   |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                   | Peer review:                                                                                                                |                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                              |                                                                                                                             |                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                              | Picoxystrobin (pending conclusion on the toxicological profile of picoxystrobin and its main plant metabolites)             |                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                              |                                                                                                                             |                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                              | The residue is fat soluble                                                                                                  |                                                                                                                   |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                               | Picoxystrobin                                                                                                               | **Not proposed,** pending conclusion on the toxicological profile of picoxystrobin and its main plant metabolites | Not applicable |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Picoxystrobin                                                                                                                                                                                                                                                                                | **Not proposed**, pending conclusion on the metabolites to be included in the plant residue definition for risk assessment. | Not applicable                                                                                                    |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The EU residue definitions for enforcement derived under the peer review are provisional.                                                                                                                                                                                                    |                                                                                                                             |                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                              |                                                                                                                             |                                                                                                                   |                |
|                         | For metabolites IN‐K2122, IN‐QGU64, (both relevant for risk assessment), insufficient toxicological information was available to conclude on their toxicological profile; for IN‐H8612, a clastogenic potential cannot be exclude. Thus, no risk assessment residue definitions were derived |                                                                                                                             |                                                                                                                   |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.23.4. Codex MRL proposals -- picoxystrobin (Table [107](#efs25306-tbl-0107){ref-type="table"}) {#efs25306-sec-0158}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                         | Codex MRL proposal                           | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                      |
+===================================================================+==============================================+==============================================+==============================================================================================================================================================================================================================================================================================================+
| Barley                                                            | 0.3                                          | 0.3                                          | Critical GAP: 3 × 0.22 kg/ha, PHI 45 days                                                                                                                                                                                                                                                                    |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Number of trials: 17                                                                                                                                                                                                                                                                                         |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Conclusion: Although a sufficient number of residue trials are available, the proposed Codex MRL is not acceptable since a consumer risk assessment cannot be conducted. The existing EU MRL for barley should be reconsidered, taking into account that the approval for picoxystrobin has not been renewed |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder, dry                                      | 7 (dw)                                       |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                          | **0.02**                                     | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | The Codex MRL proposal was derived from a feeding study where at the estimated dietary burden residues at 0.012 mg/kg were calculated for liver. In kidney, no residues were found.                                                                                                                          |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | The CXL proposal is not acceptable since a consumer risk assessment cannot be conducted                                                                                                                                                                                                                      |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                              | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | From the feeding study, it was concluded that at the expected dietary burden, no quantifiable residues are expected in eggs and other poultry products                                                                                                                                                       |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                                             | **0.015**                                    | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | Critical GAP: 3 × 0.22 kg/ha, PHI 7 days                                                                                                                                                                                                                                                                     |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Number of trials: 15                                                                                                                                                                                                                                                                                         |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Conclusion: Although a sufficient number of residue trials are available, the proposed Codex MRL is not acceptable since a consumer risk assessment cannot be conducted.                                                                                                                                     |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize fodder                                                      | 20 (dw)                                      |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize oil, edible                                                 | 0.15                                         |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                 | **0.02**                                     | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | The Codex MRL proposal was derived from a feeding study; at the calculated burden, residues of 0.015 mg/kg are expected in fat. The proposed Codex MRL is not acceptable since a consumer risk assessment cannot be conducted                                                                                |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) (fat)               | **0.02**                                     | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | Since picoxystrobin is fat soluble, the MRL proposal for fat is applied to meat (fat). The proposed Codex MRL is not acceptable since a consumer risk assessment cannot be conducted                                                                                                                         |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                             | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | 0.01                                         | From the feeding study, it was concluded that at the expected dietary burden no quantifiable residues are expected in milk                                                                                                                                                                                   |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oats                                                              | 0.3                                          | 0.3                                          | See comment on barley                                                                                                                                                                                                                                                                                        |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oat straw and fodder, dry                                         | 7 (dw)                                       |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pea hay or pea fodder (dry)                                       | 150 (dw)                                     |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Popcorn                                                           | 0.015                                        |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                                          | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | See the comment on eggs                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                      | 0.01                                         | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | See the comment on eggs                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                      | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | See the comment on eggs                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye                                                               | 0.04                                         | 0.05                                         | See the wheat                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye straw and fodder, dry                                         | 7 (dw)                                       |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean fodder                                                  | 5 (dw)                                       |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean oil, refined                                            | 0.2                                          |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry beans (includes all commodities in this subgroup) | **0.06**                                     | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | Critical GAP: 2 × 0.22 kg/ha, PHI 14 days                                                                                                                                                                                                                                                                    |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Number of trials: 11                                                                                                                                                                                                                                                                                         |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Conclusion: Although a sufficient number of residue trials are available, the proposed Codex MRL is not acceptable since a consumer risk assessment cannot be conducted.                                                                                                                                     |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry peas(includes all commodities in this subgroup)   | **0.06**                                     | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | Critical GAP: 2 × 0.22 kg/ha, PHI 14 days                                                                                                                                                                                                                                                                    |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Number of trials: 11                                                                                                                                                                                                                                                                                         |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Conclusion: Although a sufficient number of residue trials are available, the proposed Codex MRL is not acceptable since a consumer risk assessment cannot be conducted.                                                                                                                                     |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corn (corn on the cob) (kernels plus cob with husk removed) | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | 0.01[\*](#efs25306-note-0919){ref-type="fn"} | Critical GAP: 4 × 0.22 kg/ha, PHI 7 days                                                                                                                                                                                                                                                                     |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Number of trials: 11 (all below 0.01 mg/kg)                                                                                                                                                                                                                                                                  |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Conclusion: Although a consumer risk assessment cannot be conducted (see below), it is not necessary to raise a reservation, since the proposed MRL is at the LOQ                                                                                                                                            |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale                                                         | 0.04                                         | 0.05 (wheat)                                 | See the comment on wheat                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale straw and fodder, dry 7(dw)                             | 7 (dw)                                       |                                              |                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat                                                             | 0.04                                         | 0.05                                         | Critical GAP: 3 × 0.22 kg/ha, PHI 45 days                                                                                                                                                                                                                                                                    |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Number of trials: 23                                                                                                                                                                                                                                                                                         |
|                                                                   |                                              |                                              |                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                              |                                              | Conclusion: Although a sufficient number of residue trials are available, the proposed Codex MRL is not acceptable since a consumer risk assessment cannot be conducted. The existing EU MRL for barley should be reconsidered, taking into account that the approval for picoxystrobin has not been renewed |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat bran, processed                                             | 0.15                                         |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat germ                                                        | 0.15                                         |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat straw and fodder, dry                                       | 7 (dw)                                       |                                              | --                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------+----------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; MRL: maximum residue limit; LOQ: limit of quantification.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.23.5. Consumer risk assessment -- picoxystrobin (Table [108](#efs25306-tbl-0108){ref-type="table"}) {#efs25306-sec-0159}

###### 

Summary of the consumer risk assessment for picoxystrobin

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                              | Chronic exposure assessment                                                                                                                                                                                                           | Comments on JMPR exposure assessment |
+========================================================================================================================================================================================================================================+=======================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                    | **RA assumptions:**                                                                                                                                                                                                                   | **Specific comments**                |
|                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                       |                                      |
| No short‐term consumer intake exposure could be conducted since in the EU, no toxicological reference values and no residue definitions for risk assessment could be derived in the peer review process on the renewal of the approval | No long‐term consumer intake exposure could be conducted since in the EU, no toxicological reference values and no residue definitions for risk assessment could be derived in the peer review process on the renewal of the approval |                                      |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                           | **Results:**                                                                                                                                                                                                                          | **Results:**                         |
|                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                       |                                      |
| **--**                                                                                                                                                                                                                                 | --                                                                                                                                                                                                                                    | 0--0.1% of ADI                       |
|                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                       |                                      |
|                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                       | 0--3% of ARfD                        |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union; RA: risk assesment.

John Wiley & Sons, Ltd

4.24. Fluensulfone (265) (R) {#efs25306-sec-0160}
----------------------------

### 4.24.1. Background information (Table [109](#efs25306-tbl-0109){ref-type="table"}) {#efs25306-sec-0161}

###### 

Background information on fluensulfone

                                      Comments, references
  ------------------------- --------- ------------------------
  Type of JMPR evaluation   New use   
  RMS                       --        
  Approval status           --        Not assessed in the EU
  EFSA conclusion           No        --
  MRL review                No        --
  MRL applications          No        --

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; EU: European Union.

John Wiley & Sons, Ltd

### 4.24.2. Toxicological reference values -- fluensulfone (Table [110](#efs25306-tbl-0110){ref-type="table"}) {#efs25306-sec-0162}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | EU evaluation | TRV comparable |                  |     |
+========================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+================+==================+=====+
| **ADI**                | 0.01 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR, 2013    | --             | No EU assessment | N/A |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+-----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | JMPR, 2013    | N/A            |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+-----+
| **Conclusion/comment** | No new information. Comments were provided by EU for 2016 and 2017 CCPR.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |               |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                |                  |     |
|                        | At its meeting in 2013, WHO/JMPR evaluated the toxicology of fluensulfone and a monograph was published in 2014 (FLUENSULFONE 271--315 JMPR, 2013). Following chronic oral administration, the substance showed carcinogenic effects in lungs of mice and led to proliferative changes in the respiratory epithelium of rats. The JMPR meeting concluded that fluensulfone would be unlikely to be genotoxic *in vivo* and that there would be a threshold for lung tumours in mice. Accordingly, an ARfD of 0.3 mg/kg bw and an ADI of 0--0.01 mg/kg bw were derived                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |               |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                |                  |     |
|                        | At the request of CCPR, JMPR reviewed existing and new information of the mode of action for lung tumours at its meeting in 2016 (FAO, [2016](#efs25306-bib-0151){ref-type="ref"}). According to the published meeting report from JMPR, 2016, induction of carcinoma in mice was linked to Cyp2f2‐mediated metabolic activation of fluensulfone in Clara cells of the lung and increased cell proliferation. Based on the lack of genotoxicity in the available studies, the earlier conclusion from 2013 on the likely existence of a threshold for carcinogenicity in rodents was confirmed by the meeting. Based on the previous meetings, conclusion that fluensulfone is unlikely to be genotoxic *in vivo* and that the mode of action for lung tumours in mice will exhibit a threshold and is unlikely to be relevant to humans, the present meeting concluded that fluensulfone is unlikely to pose a carcinogenic risk to humans from the diet.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                |                  |     |
|                        | The reference values derived by JMPR are associated with a significant level of uncertainty. This uncertainty arises from the observation of lung tumours in mice and the assumption of a threshold with regard to genotoxicity in the Cyp2f competent target tissue and an incomplete understanding of the mode(s) of action involved: Following chronic oral administration, **the substance showed carcinogenic effects in lungs of mice from doses of 39 mg/kg bw/d** and led to proliferative changes in the respiratory epithelium of rats. JMPR reviewed information on the mode of action for these lung tumours at its meeting in 2016 (FAO, [2016](#efs25306-bib-0151){ref-type="ref"}). The respective revised monograph is not yet publicly available. According to the meeting report, experts postulated that induction of carcinoma in mice results from Cyp2f2‐mediated metabolic activation of fluensulfone in Clara cells of the lung into an unidentified reactive intermediate, cell‐specific toxicity and regenerative epithelial cell proliferation. The meeting excluded an alternative genotoxic mode‐of‐action based on the lack of genotoxicity in the available studies, and the likely existence of a threshold for carcinogenicity of fluensulfone in rodents was concluded. However, this conclusion is uncertain as the genotoxicity test methods used for fluensulfone are lacking sufficient Cyp2f metabolic activity. |               |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                |                  |     |
|                        | An uncertainty for genotoxicity was already identified by the first JMPR meeting in 2013 (FLUENSULFONE 271--315 JMPR, 2013, refer to page 288: 'Alternative modes of action have not been addressed. There are no specific genotoxicity data on lung tissue/cells.'). An equivocal finding was noted for chromosome damage *in vitro*. The negative *in vivo* micronucleus assay addressed genotoxicity in bone marrow is to be considered irrelevant, as bone marrow cells are known not to express Cyp2f2 (e.g. Wong, [2009](#efs25306-bib-0157){ref-type="ref"}) In its most recent publication on the subject matter, the manufacturer confirmed that site‐specific genotoxicity in the lung was not yet investigated (Strupp, [2016](#efs25306-bib-0156){ref-type="ref"}). Therefore, there is still a data gap for genotoxicity in the appropriate (target) tissue. Accordingly, the conclusion on the existence of a threshold and the current reference values are associated with substantial uncertainty.                                                                                                                                                                                                                                                                                                                                                                                                                                     |               |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                |                  |     |
|                        | In their Global Joint Review, Australian OCS, US EPA and Canadian PMRA also concluded 'The evidence to support the proposed MoA is currently insufficient due to uncertainties, inconsistencies and gaps in the currently available data.' (APVMA, [2015](#efs25306-bib-0001){ref-type="ref"}).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                |                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                |                  |     |
|                        | When assessing acceptability of this uncertainty, it could be taken into account that Cyp2F activity in human lung (Cyp2F1) is approximately 100 fold lower than in mouse lung (Cyp2f2). From the toxicological perspective, the uncertainty on genotoxicity should be addressed using a Cyp2f competent test system and/or target tissue.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                |                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.24.3. Residue definitions -- fluensulfone (Table [111](#efs25306-tbl-0111){ref-type="table"}) {#efs25306-sec-0163}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------+----------------------------------------------------------------------------------------------------------------+---------------+----------------+
|                         | Commodity group                  | JMPR evaluation                                                                                                | EU evaluation | RDs comparable |
+=========================+==================================+================================================================================================================+===============+================+
| **RD enf**              | Plant products                   | Sum of fluensulfone and 3,4,4‐trifluorobut‐3‐ene‐1‐sulfonic acid (BSA), expressed as fluensulfone equivalents. | --            | N/A            |
+-------------------------+----------------------------------+----------------------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Fluensulfone                     | --                                                                                                             | N/A           |                |
|                         |                                  |                                                                                                                |               |                |
|                         | The residue is fat soluble       |                                                                                                                |               |                |
+-------------------------+----------------------------------+----------------------------------------------------------------------------------------------------------------+---------------+----------------+
| **RD RA**               | Plant products                   | Fluensulfone                                                                                                   | --            | N/A            |
+-------------------------+----------------------------------+----------------------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Fluensulfone                     | --                                                                                                             | N/A           |                |
+-------------------------+----------------------------------+----------------------------------------------------------------------------------------------------------------+---------------+----------------+
| **Conclusion/comments** | No new information in JMPR, 2017 |                                                                                                                |               |                |
+-------------------------+----------------------------------+----------------------------------------------------------------------------------------------------------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.24.4. Codex MRL proposals -- fluensulfone (Table [112](#efs25306-tbl-0112){ref-type="table"}) {#efs25306-sec-0164}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments** | [Plant commodities:]{.ul}                                                                                                                                                                                                                                                                         |
|                      |                                                                                                                                                                                                                                                                                                   |
|                      | The Meeting received supervised trial data for applications of fluensulfone to citrus, soya beans, sugarcane, coffee and black pepper. However, no evidence on approval of the GAP was provided. Therefore, JMPR did not assess the studies.                                                      |
|                      |                                                                                                                                                                                                                                                                                                   |
|                      | [Animal commodities:]{.ul}                                                                                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                   |
|                      | Of the uses under consideration by the Meeting, citrus, soya bean and sugarcane have significant livestock feed items. JMPR had no GAPs available for the data considered by the meeting, and therefore, previous dietary burdens and recommendations from the 2016 Meeting were not re‐evaluated |
+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit.

John Wiley & Sons, Ltd

### 4.24.5. Consumer risk assessment -- fluensulfone (Table [113](#efs25306-tbl-0113){ref-type="table"}) {#efs25306-sec-0165}

###### 

Summary of the consumer risk assessment for fluensulfone

  Acute exposure assessment   Chronic exposure assessment   Comments on JMPR exposure assessment
  --------------------------- ----------------------------- --------------------------------------
  Not relevant                Not relevant                  --

John Wiley & Sons, Ltd

4.25. Imazapyr (267) (R) {#efs25306-sec-0166}
------------------------

### 4.25.1. Background information (Table [114](#efs25306-tbl-0114){ref-type="table"}) {#efs25306-sec-0167}

###### 

Background information on imazapyr

                                                Comments, references
  ------------------------- ------------------- --------------------------------------------------------------------------------------------------------------------
  Type of JMPR evaluation   New use             
  RMS                       --                  
  Approval status           Not approved        Commission Regulation (EC) No 2076/2002[a](#efs25306-note-0134){ref-type="fn"}
  EFSA conclusion           No                  --
  MRL review                No                  --
  MRL applications          Yes, see comments   EFSA ([2014k](#efs25306-bib-0066){ref-type="ref"}) (genetically modified soya bean and other oilseeds and lentils)

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2076/2002: Commission Regulation (EC) No 2076/2002 of 20 November 2002 extending the time period referred to in Article 8(2) of Council Directive 91/414/EEC and concerning the non‐inclusion of certain active substances in Annex I to that Directive and the withdrawal of authorisations for plant protection products containing these substances. OJ L 319, 23.11.2002, p. 3--11.

John Wiley & Sons, Ltd

### 4.25.2. Toxicological reference values -- imazapyr (Table [115](#efs25306-tbl-0115){ref-type="table"}) {#efs25306-sec-0168}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------+------------------------------------+----------------------+------------------------------------------------------------------------------+----------------+
|                        | JMPR evaluation                                                                                      | EU evaluation                      | TRV comparable       |                                                                              |                |
+========================+======================================================================================================+====================================+======================+==============================================================================+================+
| **ADI**                | 3 mg/kg bw per day                                                                                   | JMPR, 2013 (1 year oral dog study) | 2.5 mg/kg bw per day | EFSA ([2014k](#efs25306-bib-0066){ref-type="ref"})Dog, 1‐year study and rat, | Yes, see below |
|                        |                                                                                                      |                                    |                      |                                                                              |                |
|                        |                                                                                                      |                                    |                      | 2‐year study safety factor 100                                               |                |
+------------------------+------------------------------------------------------------------------------------------------------+------------------------------------+----------------------+------------------------------------------------------------------------------+----------------+
| **ARfD**               | Unnecessary                                                                                          | JMPR, 2013                         | Not necessary        | Yes                                                                          |                |
+------------------------+------------------------------------------------------------------------------------------------------+------------------------------------+----------------------+------------------------------------------------------------------------------+----------------+
| **Conclusion/comment** | Although the ADI values are established at different levels, they are in the same order of magnitude |                                    |                      |                                                                              |                |
+------------------------+------------------------------------------------------------------------------------------------------+------------------------------------+----------------------+------------------------------------------------------------------------------+----------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values.

John Wiley & Sons, Ltd

### 4.25.3. Residue definitions -- imazapyr (Table [116](#efs25306-tbl-0116){ref-type="table"}) {#efs25306-sec-0169}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+---------------+----------------+
|                         | Commodity group                                                                                                                                                                           | JMPR evaluation | EU evaluation | RDs comparable |
+=========================+===========================================================================================================================================================================================+=================+===============+================+
| **RD enf**              | Plant products                                                                                                                                                                            | Imazapyr        | Imazapyr      | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+---------------+----------------+
| Animal products         | Imazapyr                                                                                                                                                                                  | Imazapyr        | Yes           |                |
|                         |                                                                                                                                                                                           |                 |               |                |
|                         | The residue is not fat soluble                                                                                                                                                            | No fat soluble  |               |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                            | Imazapyr        | Imazapyr      | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+---------------+----------------+
| Animal products         | Imazapyr                                                                                                                                                                                  | Imazapyr        | Yes           |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+---------------+----------------+
| **Conclusion/comments** | The residue definitions derived in the framework of the import tolerance application (EFSA, [2014k](#efs25306-bib-0066){ref-type="ref"}) are identical with the JMPR residue definitions. |                 |               |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.25.4. Codex MRL proposals -- imazapyr (Table [117](#efs25306-tbl-0117){ref-type="table"}) {#efs25306-sec-0170}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                    | Codex MRL proposal                           | EU MRL                                                                                                 | Comment                                                                                                                                                                                                           |
+==============================+==============================================+========================================================================================================+===================================================================================================================================================================================================================+
| Barley                       | 0.7                                          | 0.01[\*](#efs25306-note-0909){ref-type="fn"} (default MRL, no specific MRL mentioned in Reg. 396/2005) | Critical GAP: AUS (use on imidazolidone‐tolerant barley); 0.025 kg/ha at early growth stage (between 5 leaf stage to 1st node stage).                                                                             |
|                              |                                              |                                                                                                        |                                                                                                                                                                                                                   |
|                              |                                              |                                                                                                        | Number of trials: 6                                                                                                                                                                                               |
|                              |                                              |                                                                                                        |                                                                                                                                                                                                                   |
|                              |                                              |                                                                                                        | Sufficiently supported by data: No, for barley, at least 8 residue trials would be required at EU level.                                                                                                          |
|                              |                                              |                                                                                                        |                                                                                                                                                                                                                   |
|                              |                                              |                                                                                                        | Specific comments/observations: It should be verified if the import of imidazolidone tolerant barley to the EU is approved.                                                                                       |
|                              |                                              |                                                                                                        |                                                                                                                                                                                                                   |
|                              |                                              |                                                                                                        | Conclusion: To be discussed with MS whether the proposed Codex MRL is not acceptable considering the limited number of trials                                                                                     |
+------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder, dry | 0.05[\*](#efs25306-note-0909){ref-type="fn"} |                                                                                                        | Critical GAP: see above                                                                                                                                                                                           |
|                              |                                              |                                                                                                        |                                                                                                                                                                                                                   |
|                              |                                              |                                                                                                        | Number of trials: 6                                                                                                                                                                                               |
|                              |                                              |                                                                                                        |                                                                                                                                                                                                                   |
|                              |                                              |                                                                                                        | Specific comments/observations: At EU level, no MRLs are set for feed.                                                                                                                                            |
|                              |                                              |                                                                                                        |                                                                                                                                                                                                                   |
|                              |                                              |                                                                                                        | Conclusion: The residues in barley straw and fodder were taken into account in an updated dietary burden calculation in livestock. No amendment of MRLs for animal commodities is required. No comments required. |
+------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; EU: European Union.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.25.5. Consumer risk assessment -- imazapyr (Table [118](#efs25306-tbl-0118){ref-type="table"}) {#efs25306-sec-0171}

###### 

Summary of the consumer risk assessment for imazapyr

+--------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                  | Chronic exposure assessment                                                                                                                                                                                                | Comments on JMPR exposure assessment |
+============================================+============================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                        | **RA assumptions:**                                                                                                                                                                                                        | **Specific comments**                |
|                                            |                                                                                                                                                                                                                            |                                      |
| Not relevant since no ARfD was established | The most recent long‐term risk assessment (EFSA, [2014k](#efs25306-bib-0066){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for rape seed. |                                      |
+--------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                               | **Results:**                                                                                                                                                                                                               | **Results:**                         |
|                                            |                                                                                                                                                                                                                            |                                      |
| --                                         | No long‐term consumer health risk was identified.                                                                                                                                                                          | Long‐term exposure:                  |
|                                            |                                                                                                                                                                                                                            |                                      |
|                                            | The overall chronic exposure accounted for 0.05% of the ADI.                                                                                                                                                               | 0% of the ADI                        |
|                                            |                                                                                                                                                                                                                            |                                      |
|                                            | The contribution of barley to the exposure was insignificant (\< 0.01%).                                                                                                                                                   |                                      |
+--------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

4.26. Imazamox (276) (R) {#efs25306-sec-0172}
------------------------

### 4.26.1. Background information (Table [119](#efs25306-tbl-0119){ref-type="table"}) {#efs25306-sec-0173}

###### 

Background information on imazamox

                                                      Comments, references
  ------------------------- ------------------------- -----------------------------------------------------------------------------------------
  Type of JMPR evaluation   New use                   
  RMS                       FR                        
  Approval status           Renewal of the approval   Commission Implementing Regulation (EU) 2016/950[a](#efs25306-note-0140){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2016f](#efs25306-bib-0096){ref-type="ref"})
  MRL review                Yes, see comments         EFSA ([2013g](#efs25306-bib-0050){ref-type="ref"})
  MRL applications          No                        

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2016/950/EU: Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4‐DB, beta‐cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91‐08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid‐P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin. OJ L 159, 16.6.2016, p. 3--5.

John Wiley & Sons, Ltd

### 4.26.2. Toxicological reference values -- imazamox (Table [120](#efs25306-tbl-0120){ref-type="table"}) {#efs25306-sec-0174}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | EU evaluation | TRV comparable     |                                                                                                                                                                                                                                                                                  |     |
+========================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+====================+==================================================================================================================================================================================================================================================================================+=====+
| **ADI**                | 3 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR, 2014    | 3 mg/kg bw per day | European Commission ([2002](#efs25306-bib-0136){ref-type="ref"}) not confirmed in EFSA ([2016f](#efs25306-bib-0096){ref-type="ref"}) AIR III (Rabbit developmental study, uncertainty factor 100) confirmed in European Commission ([2017b](#efs25306-bib-0148){ref-type="ref"}) | Yes |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR, 2014    | 3 mg/kg bw         | European Commission ([2002](#efs25306-bib-0136){ref-type="ref"}) not confirmed in EFSA ([2016f](#efs25306-bib-0096){ref-type="ref"}) AIR III (Rabbit developmental study, uncertainty factor 100) confirmed in European Commission ([2017b](#efs25306-bib-0148){ref-type="ref"}) | Yes |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The toxicological reference values derived for the active substance are fully comparable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | Toxicological properties of metabolites:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | [EU assessment: The metabolite]{.ul} **CL 263284** was of low acute oral toxicity to rats. The metabolite showed positive results in the *in vitro* MN test and negative results in the *in vivo* MN test; however, there was no sufficient evidence that the target tissue, i.e. bone marrow, was reached in the *in vivo* MN test. The experts agreed that target tissue exposure needs to be further demonstrated (data gap). The agreed NOAEL in the 28‐day rat study on CL 263284 is 333 mg/kg bw per day.                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | The glucose conjugate CL 189215 was not genotoxic in a standard *in vitro* test battery. However, EFSA considered that the genotoxic potential of CL 189215 should be reconsidered once the genotoxic potential of the aglycon metabolite CL 263284 is finally addressed since hydrolysis of the metabolite is expected *in vivo*.                                                                                                                                                                                                                                                                                                 |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | Once the genotoxicity of CL 263284 and its glucose conjugate (CL 189215) is addressed, the relative toxicity profile and possible derivation of reference values for metabolite CL 263284 and its glucose conjugate CL 189215 should be reconsidered.                                                                                                                                                                                                                                                                                                                                                                              |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | [JMPR, 2014:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | **CL 263284** was tested for genotoxicity in an adequate range of assays *in vitro* and *in vivo*. It gave a positive response in the *in vitro* micronucleus assay, but was negative in the *in vivo* micronucleus assay.                                                                                                                                                                                                                                                                                                                                                                                                         |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | **CL 263284** is an O‐demethylation product of imazamox and is a common metabolite with imazapic. Although there is some indication of slightly higher toxicity of this metabolite when compared with imazamox in a 28‐day toxicity study in rats, the effects observed were mild changes in body weight gain in males only. Taking into account the close structural similarity to imazamox and the effects and effect levels observed in the developmental toxicity study in rats with imazamox, JMPR concluded that CL 263284 is of similar toxicity to imazamox and that it would be covered by the ADI and ARfD for imazamox. |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                    |                                                                                                                                                                                                                                                                                  |     |
|                        | Considering that there are still open issues as regards the toxicological properties of the metabolites, the risk assessment is considered as tentative                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                    |                                                                                                                                                                                                                                                                                  |     |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.26.3. Residue definitions -- imazamox (Table [121](#efs25306-tbl-0121){ref-type="table"}) {#efs25306-sec-0175}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR evaluation                                                                                                                          | EU evaluation                                                                                                                                                                                       | RDs comparable                |
+=========================+========================================================================================================================================================================================================================================================================================================================================================================================================================================================+==========================================================================================================================================+=====================================================================================================================================================================================================+===============================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                         | Imazamox                                                                                                                                 | Reg. 396/2005: (imazamox and its salts, expressed as imazamox)                                                                                                                                      | Yes (for RD in Reg. 396/2005) |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          | Peer review: Sum of imazamox and CL 263284, expressed as imazamox                                                                                                                                   |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          | (limited to the cereal/grass and Oilseeds/pulses crop groups) -- Provisional pending the conclusions on the toxicological properties of metabolite CL 263284                                        |                               |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
| Animal products         | Imazamox                                                                                                                                                                                                                                                                                                                                                                                                                                               | Reg. 396/2005: Imazamox (Sum of imazamox and its salts, expressed as imazamox)                                                           | Yes                                                                                                                                                                                                 |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                         | Peer review: Imazamox                                                                                                                    |                                                                                                                                                                                                     |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        | The residue is not fat soluble                                                                                                           |                                                                                                                                                                                                     |                               |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                         | Sum of imazamox and 5‐(hydroxymethyl)‐2‐(4‐isopropyl‐4‐methyl‐5‐oxo‐2‐imazazolin‐2‐yl) nicotinic acid (CL 263284), expressed as imazamox | Sum of imazamox, CL 263284, and CL 189215, expressed as imazamox (Provisional, pending the conclusions on the toxicological properties of metabolite CL 263284 and its glucose conjugate CL 189215) | No                            |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
| Animal products         | Sum of imazamox and 5‐(hydroxymethyl)‐2‐(4‐isopropyl‐4‐methyl‐5‐oxo‐2‐imazazolin‐2‐yl) nicotinic acid (CL 263284), expressed as imazamox                                                                                                                                                                                                                                                                                                               | Imazamox                                                                                                                                 | No                                                                                                                                                                                                  |                               |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
| **Conclusion/comments** | Basically, the residue definitions for enforcement derived by JMPR and at EU level (Reg. 396/2005) are comparable.                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         | The residue definition derived in the peer review has not yet been implemented.                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                          |                                                                                                                                                                                                     |                               |
|                         | The risk assessment residue definitions differ; the different residue definition for animal products is of no relevance, since no MRL proposals were made by JMPR. The fact that the glucose conjugate of metabolite CL 263284 is not included in the JMPR residue definition may lead to an underestimation of the dietary exposure if the STMR/HR values derived by JMPR are used in the risk assessment, resulting in some additional uncertainties |                                                                                                                                          |                                                                                                                                                                                                     |                               |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.26.4. Codex MRL proposals -- imazamox (Table [122](#efs25306-tbl-0122){ref-type="table"}) {#efs25306-sec-0176}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------+--------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                    | Codex MRL proposal | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+==============================+====================+==============================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Barley                       | 0.02               | 0.05[\*](#efs25306-note-2000){ref-type="fn"} | Critical GAP: AUS (use on imidazolidone‐tolerant barley); 0.025 kg/ha at early growth stage (between 5 leaf stage to 1st node stage).                                                                                                                                                                                                                                                                                                                                                                                         |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | Sufficiently supported by data: No; for barley, at least 8 residue trials would be required.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | Specific comments/observations: It should be verified if the import of imidazolidone tolerant barley to the EU is approved.                                                                                                                                                                                                                                                                                                                                                                                                   |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | Conclusion: Although the number of trials is not compliant with the EU requirements, there is currently no need to make a reservation, since the existing EU MRL is higher.                                                                                                                                                                                                                                                                                                                                                   |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | However, if the residue definition will be modified as proposed in the peer review (including metabolite CL263284), the Codex MRL proposal would not be compatible with the EU legislation and a higher would be required. The RMS noted that metabolism data show that in wheat, parent imazamox is higher than CL263284; however, for a number of commodities, including, maize, oilseeds and rice, the metabolite is higher than the parent, which justified its inclusion in the enforcement residue definition in the EU |
+------------------------------+--------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder, dry | 0.05               |                                              | Critical GAP: see above                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | Specific comments/observations: At EU level, no MRLs are set for feed.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                              |                    |                                              | Conclusion: The residues in barley straw and fodder were taken into account in an updated dietary burden calculation in livestock. No amendment of MRLs for animal commodities is required. No comments required                                                                                                                                                                                                                                                                                                              |
+------------------------------+--------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

EU MRL: European Union maximum residue limit; GAP: Good Agricultural Practice; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.26.5. Consumer risk assessment -- imazamox (Table [123](#efs25306-tbl-0123){ref-type="table"}) {#efs25306-sec-0177}

###### 

Summary of the consumer risk assessment for imazamox:

+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                     | Chronic exposure assessment                                                                                                                                                                                                        | Comments on JMPR exposure assessment |
+===============================================================================================================================================================================================================================================================================================+====================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                           | **RA assumptions:**                                                                                                                                                                                                                | **Specific comments**                |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    | --                                   |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Considering that there are still open issues as regards the toxicological properties of the metabolites, the risk assessment is considered as tentative                                                                                                                                       |                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    |                                      |
| The risk assessment is affected by non‐standard uncertainties due to the fact that the EU RD for RA comprises an additional metabolite. However, considering the low exposure (see results below), this difference will not result in a significant underestimation of a consumer health risk |                                                                                                                                                                                                                                    |                                      |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| The short‐term dietary risk assessment was performed for barley                                                                                                                                                                                                                               | The most recent long‐term risk assessment (MRL review, EFSA, [2013g](#efs25306-bib-0050){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for barley |                                      |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                  | **Results:**                                                                                                                                                                                                                       | **Results:**                         |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    |                                      |
| No short‐term exposure concern was identified (0.002% of the ARfD)                                                                                                                                                                                                                            | No long‐term consumer health risk was identified.                                                                                                                                                                                  | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                                                                                                                                                                               | The overall chronic exposure accounted for 0.013% of the ADI.                                                                                                                                                                      | 0% of the ADI                        |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                                                                                                                                                                               | The contribution of barley to the exposure was 0.002% of the ADI                                                                                                                                                                   | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                    | 0%of the ARfD                        |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue; HR: highest residue.

John Wiley & Sons, Ltd

4.27. Flonicamid (283) (R) {#efs25306-sec-0178}
--------------------------

### 4.27.1. Background information (Table [124](#efs25306-tbl-0124){ref-type="table"}) {#efs25306-sec-0179}

###### 

Background information on flonicamid

+-------------------------+-------------------------+------------------------------------------------------------------------+
|                         |                         | Comments, references                                                   |
+=========================+=========================+========================================================================+
| Type of JMPR evaluation | New use                 |                                                                        |
+-------------------------+-------------------------+------------------------------------------------------------------------+
| RMS                     | FI                      | FR was the previous RMS                                                |
+-------------------------+-------------------------+------------------------------------------------------------------------+
| Approval status         | Renewal of the approval | Commission Directive 2010/29/EU[a](#efs25306-note-0146){ref-type="fn"} |
+-------------------------+-------------------------+------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA ([2010e](#efs25306-bib-0021){ref-type="ref"}) Ongoing AIR IV      |
+-------------------------+-------------------------+------------------------------------------------------------------------+
| MRL review              | Yes, see comments       | EFSA ([2014i](#efs25306-bib-0064){ref-type="ref"})                     |
+-------------------------+-------------------------+------------------------------------------------------------------------+
| MRL applications        | Yes, see comments       | EFSA ([2017a](#efs25306-bib-0109){ref-type="ref"}) (various crops)     |
|                         |                         |                                                                        |
|                         |                         | EFSA ([2016i](#efs25306-bib-0099){ref-type="ref"}) (herbs)             |
|                         |                         |                                                                        |
|                         |                         | EFSA ([2015g](#efs25306-bib-0082){ref-type="ref"}) (several crops)     |
|                         |                         |                                                                        |
|                         |                         | In progress for radishes and various crops                             |
+-------------------------+-------------------------+------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2010/29/EU: Commission Directive 2010/29/EU of 27 April 2010 amending Council Directive 91/414/EEC to include flonicamid (IKI‐220) as active substance. OJ L 106, 28.4.2010, p. 9--11.

John Wiley & Sons, Ltd

### 4.27.2. Toxicological reference values -- flonicamid (Table [125](#efs25306-tbl-0125){ref-type="table"}) {#efs25306-sec-0180}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------+---------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation       | EU evaluation | TRV comparable         |                                                                                                                                                                           |    |
+========================+=======================+===============+========================+===========================================================================================================================================================================+====+
| **ADI**                | 0.07 mg/kg bw per day | JMPR, 2015    | 0.025 mg/kg bw per day | European Commission ([2010a](#efs25306-bib-0139){ref-type="ref"},[b](#efs25306-bib-0140){ref-type="ref"}) confirmed in EFSA ([2014i](#efs25306-bib-0064){ref-type="ref"}) | No |
|                        |                       |               |                        |                                                                                                                                                                           |    |
|                        |                       |               |                        | (Rabbit development, with safety factor 100)                                                                                                                              |    |
+------------------------+-----------------------+---------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | unnecessary           | JMPR, 2015    | 0.025 mg/kg bw         | No                                                                                                                                                                        |    |
+------------------------+-----------------------+---------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | --                    |               |                        |                                                                                                                                                                           |    |
+------------------------+-----------------------+---------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.27.3. Residue definitions -- flonicamid (Table [126](#efs25306-tbl-0126){ref-type="table"}) {#efs25306-sec-0181}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                          | JMPR evaluation                                        | EU evaluation                                             | RDs comparable |
+=========================+==========================================================================================================================================================================================================================================================================================+========================================================+===========================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                           | Flonicamid                                             | Sum of flonicamid, TFNA and TFNG, expressed as flonicamid | No             |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------+----------------+
| Animal products         | Flonicamid and the metabolite TFNA‐AM, expressed as flonicamid.                                                                                                                                                                                                                          | Sum of flonicamid and TFNA‐AM, expressed as flonicamid | Yes                                                       |                |
|                         |                                                                                                                                                                                                                                                                                          |                                                        |                                                           |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                           | The residue is not fat soluble                         |                                                           |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                           | Flonicamid                                             | Sum of flonicamid, TFNA and TFNG expressed as flonicamid  | No             |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------+----------------+
| Animal products         | Flonicamid and the metabolite TFNA‐AM, expressed as flonicamid                                                                                                                                                                                                                           | Sum of flonicamid and TFNA‐AM expressed as flonicamid  | Yes                                                       |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions derived by JMPR for plant commodities (enforcement and risk assessment) do not cover the metabolites TFNA and TFNG while these compounds were major components of the metabolism studies in cereals and root crops (less in fruits).                             |                                                        |                                                           |                |
|                         |                                                                                                                                                                                                                                                                                          |                                                        |                                                           |                |
|                         | The current EU MRLs include these compounds as they were considered relevant marker compounds (ratio of parent, TFNA and TFNG are not stable enough to derive robust conversion factors). Therefore, the Codex MRL proposals derived by JMPR are not compatible with the EU legislation. |                                                        |                                                           |                |
|                         |                                                                                                                                                                                                                                                                                          |                                                        |                                                           |                |
|                         | In 2017 CCPR, the EU made a reservation for the Codex MRL proposals presented because the residue definitions were not compatible                                                                                                                                                        |                                                        |                                                           |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.
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### 4.27.4. Codex MRL proposals -- flonicamid (Table [127](#efs25306-tbl-0127){ref-type="table"}) {#efs25306-sec-0182}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------------------+--------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                     | Codex MRL proposal | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+===============================================================================+====================+==============================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Subgroup of beans with pods (except soya bean (succulent seeds in pods))      | 0.7                | 1.5                                          | Critical GAP: 3 × 100 g a.s./ha; PHI : 7 days (Canada, USA)                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Sufficiently supported by data: No; as major crop in EU, 8 trials would be needed. According to JMPR rules, the number of trials is sufficient.                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Specific comments/observations: The EU rules for extrapolations allow extrapolating trials from beans with pods to peas with pods and vice versa. As the same GAP is authorised on both crops, it is not understood why a combined data set was not proposed. This would allow deriving a common robust MRL on both commodities.                                                                                                                                                              |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because the residue definitions for enforcement are not compatible                                                                                                                                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------------+--------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of Peas with pods                                                    | 0.8                | 1.5                                          | Critical GAP: 3 × 100 g a.s./ha; PHI : 7 days (Canada, USA)                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Specific comments/observations: The EU rules for extrapolations allow extrapolating trials from beans with pods to peas with pods and vice versa. As the same GAP is authorised on both crops, it is not understood why a combined data set was not proposed. This would allow deriving a common robust MRL on both commodities.                                                                                                                                                              |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because the residue definitions for enforcement are not compatible                                                                                                                                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------------+--------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of Succulent beans without pods (except soya bean (succulent seeds)) | 0.3                | 0.03[\*](#efs25306-note-2002){ref-type="fn"} | Critical GAP: 3 × 100 g a.s./ha; PHI : 7 days (Canada, USA)                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Sufficiently supported by data: No; as major crop in EU, 8 trials would be needed; however, for Codex, the number of trials is sufficient (crop category 3, 6 trials are required).                                                                                                                                                                                                                                                                                                           |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Specific comments/observations: The EU rules for extrapolations allow extrapolating trials from beans without pods to peas without pods and vice versa. As the same GAP is authorised on both crops, it is not understood why a combined data set was not proposed. This would allow deriving a common robust MRL on both commodities.                                                                                                                                                        |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because the residue definitions for enforcement are not compatible                                                                                                                                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------------+--------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of succulent peas without pods                                       | 0.4                | 0.7                                          | Critical GAP: 3 × 100 g a.s./ha; PHI : 7 days (Canada, USA Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Specific comments/observations: In Codex peas without pods are crop category 3; thus, the number of trials is sufficient for JMPR. The EU rules for extrapolations would allow extrapolating trials from beans without pods to peas without pods and vice versa. As the same GAP is authorised on both crops, it is not understood why a combined data set was not proposed. This would allow deriving a common robust MRL on both commodities. 6 trials for peas without pods are sufficient |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because the residue definitions for enforcement are not compatible                                                                                                                                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------------+--------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry beans (except soya bean (dry))                                | 0.15               | 0.03[\*](#efs25306-note-2002){ref-type="fn"} | Critical GAP: 3 × 100 g a.s./ha; PHI : 7 days (Canada, USA Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Specific comments/observations: The EU rules for extrapolations allow combining trials performed on dry beans and dry peas. However, considering that residue levels in these commodities were found to be highly different, it is approved not to pool both data sets.                                                                                                                                                                                                                       |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because the residue definitions for enforcement are not compatible                                                                                                                                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------------+--------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of dry peas                                                          | 1                  | 0.03[\*](#efs25306-note-2002){ref-type="fn"} | Critical GAP: 3 × 100 g a.s./ha; PHI : 7 days (Canada, USA Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Sufficiently supported by data: No; as major crop in EU and in Codex, 8 trials would be needed.                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Specific comments/observations: The EU rules for extrapolations allow combining trials performed on dry beans and dry peas. However, considering that residue levels in these commodities were found to be highly different, it is not appropriate to pool both data sets.                                                                                                                                                                                                                    |
|                                                                               |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because the residue definitions for enforcement are not compatible and because of insufficient trials                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------+--------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI:preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice; CXL: Codex Maximum Residue Limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.27.5. Consumer risk assessment -- flonicamid (Table [128](#efs25306-tbl-0128){ref-type="table"}) {#efs25306-sec-0183}

###### 

Summary of the consumer risk assessment for flonicamid

+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                           | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Comments on JMPR exposure assessment                                                                                                                            |
+=====================================================================================================================================================================================================================================================================================+==========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                 | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | **Specific comments**                                                                                                                                           |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
| The short‐term dietary risk assessment was performed for commodities assessed by JMPR (beans and peas with and without pods, dry beans and dry peas).                                                                                                                               | The most recent long‐term risk assessment (EFSA, [2017a](#efs25306-bib-0109){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for dry beans and dry peas. For beans with and without pods and for peas with and without pods, where the STMR derived from EU assessments (EFSA, [2016i](#efs25306-bib-0099){ref-type="ref"}, [2017a](#efs25306-bib-0109){ref-type="ref"}) were higher than the STMR derived by JMPR, no changes were done. | The chronic exposure assessment only considers uses on legume vegetables and dry beans and beans assessed in this report.                                       |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
| Although they may be considered as bulked products, the consumer exposure was assessed considering HR of each crop. No refinement considering STMR was performed.                                                                                                                   | The EU ADI was used. The JMPR ADI is less critical                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | JMPR should have performed the chronic risk assessment, taking into account all commodities (including also those for which CXLs have been established earlier) |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
| It is noted that residue trials did not analyse for metabolites TFNA and TFNG which are expected to be significant part of the residues. No conversion factor is available to consider these metabolites in the risk assessment. Therefore, the risk assessment is indicative only. |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
| The EU ARfD was used. There is no JMPR ARfD                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                        | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | **Results:**                                                                                                                                                    |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
| No short‐term exposure concern was identified (Max 18.6% of the ARfD for beans with pods)                                                                                                                                                                                           | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Long‐term exposure:                                                                                                                                             |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
|                                                                                                                                                                                                                                                                                     | The overall chronic exposure accounted for 18.1% of the ADI.                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 0--10% of the ADI                                                                                                                                               |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
|                                                                                                                                                                                                                                                                                     | The contribution of commodities assessed in this report did not exceed 1.5% of the ADI (beans with pods)                                                                                                                                                                                                                                                                                                                                                                                                                 | Short‐term exposure:                                                                                                                                            |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                 |
|                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Was not assessed as JMPR 2015 decided that an ARfD for flonicamid was not necessary                                                                             |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue.

John Wiley & Sons, Ltd

4.28. Flupyradifurone (285) (R) {#efs25306-sec-0184}
-------------------------------

### 4.28.1. Background information (Table [129](#efs25306-tbl-0129){ref-type="table"}) {#efs25306-sec-0185}

###### 

Background information on flupyradifurone

+-------------------------+-------------------+------------------------------------------------------------------------------------------------+
|                         |                   | Comments, references                                                                           |
+=========================+===================+================================================================================================+
| Type of JMPR evaluation | New use           |                                                                                                |
+-------------------------+-------------------+------------------------------------------------------------------------------------------------+
| RMS                     | NL                |                                                                                                |
+-------------------------+-------------------+------------------------------------------------------------------------------------------------+
| Approval status         | Approved          | Commission Implementing Regulation (EU) 2015/2084[a](#efs25306-note-0152){ref-type="fn"}       |
+-------------------------+-------------------+------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments | EFSA ([2015d](#efs25306-bib-0079){ref-type="ref"})                                             |
|                         |                   |                                                                                                |
|                         |                   | EFSA ([2017c](#efs25306-bib-0111){ref-type="ref"}) (conf. data M‐Tox and Phys/chem)            |
+-------------------------+-------------------+------------------------------------------------------------------------------------------------+
| MRL review              | No                | --                                                                                             |
+-------------------------+-------------------+------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments | Strawberries, blackberries and raspberries: EFSA ([2016e](#efs25306-bib-0095){ref-type="ref"}) |
+-------------------------+-------------------+------------------------------------------------------------------------------------------------+
|                         |                   | Art. 10 in progress (various crop)                                                             |
+-------------------------+-------------------+------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2015/2084: Commission Implementing Regulation (EU) 2015/2084 of 18 November 2015 approving the active substance flupyradifurone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 302, 19.11.2015, p. 89--92.
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### 4.28.2. Toxicological reference values -- flupyradifurone (Table [130](#efs25306-tbl-0130){ref-type="table"}) {#efs25306-sec-0186}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                             | EU evaluation | TRV comparable         |                                                       |     |
+========================+=============================================================================================================================================================================================================================================================+===============+========================+=======================================================+=====+
| **ADI**                | 0.08 mg/kg bw per day                                                                                                                                                                                                                                       | JMPR, 2015    | 0.064 mg/kg bw per day | EFSA ([2015d](#efs25306-bib-0079){ref-type="ref"})    | Yes |
|                        |                                                                                                                                                                                                                                                             |               |                        |                                                       |     |
|                        |                                                                                                                                                                                                                                                             |               |                        | (Rat, two‐generation study, with safety factor 100)   |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------+-----+
| **ARfD**               | 0.2 mg/kg bw                                                                                                                                                                                                                                                | JMPR, 2015    | 0.15 mg/kg bw          | EFSA ([2015d](#efs25306-bib-0079){ref-type="ref"})    | Yes |
|                        |                                                                                                                                                                                                                                                             |               |                        |                                                       |     |
|                        |                                                                                                                                                                                                                                                             |               |                        | (Rabbit, developmental study, with safety factor 100) |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------+-----+
| **Conclusion/comment** | The EU pesticides peer review concluded that the reference values of parent flupyradifurone are also applicable to the metabolite difluoroacetic acid (DFA, found in plants, livestock and environment; EFSA, [2015d](#efs25306-bib-0079){ref-type="ref"}). |               |                        |                                                       |     |
|                        |                                                                                                                                                                                                                                                             |               |                        |                                                       |     |
|                        | Although the ADI and ARfD values derived by JMPR are not exactly the same as the ones derived by EFSA, they are in the same range and therefore considered comparable                                                                                       |               |                        |                                                       |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.
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### 4.28.3. Residue definitions -- flupyradifurone (Table [131](#efs25306-tbl-0131){ref-type="table"}) {#efs25306-sec-0187}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | JMPR evaluation                                                                                                                   | EU evaluation                                                 | RDs comparable         |
+=========================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===================================================================================================================================+===============================================================+========================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Flupyradifurone                                                                                                                   | **EU Reg. 396/2005:**                                         | No, see comments below |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   |                                                               |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   | Difluoroacetic acid (DFA)Flupyradifurone                      |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+------------------------+
| Animal products         | Sum of flupyradifurone and difluoroacetic acid, expressed as parent equivalents                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | **EU Reg. 396/2005:**                                                                                                             | No, see comments below                                        |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   |                                                               |                        |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Difluoroacetic acid (DFA)Flupyradifurone                                                                                          |                                                               |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   |                                                               |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | The residue is not fat soluble                                                                                                    |                                                               |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+------------------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Sum of flupyradifurone, difluoroacetic acid (DFA) and 6‐chloropyridine‐3‐carboxylic acid (6‐CNA), expressed as parent equivalents | **EFSA (** [2015d](#efs25306-bib-0079){ref-type="ref"} **):** | No                     |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   |                                                               |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   | Sum flupyradifurone and DFA, expressed as flupyradifurone     |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+------------------------+
| Animal products         | Sum of flupyradifurone and difluoroacetic acid, expressed as parent equivalents                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | **EFSA (** [2015d](#efs25306-bib-0079){ref-type="ref"} **):**                                                                     | Yes                                                           |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   |                                                               |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | Sum flupyradifurone and DFA, expressed as flupyradifurone                                                                         |                                                               |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+------------------------+
| **Conclusion/comments** | The enforcement residue definitions for plant and animal products derived by the JMPR evaluation are not fully compatible with the residue definitions established in the EU. In addition to the RD for enforcement as 'flupyradifurone', specific EU MRLs are also set for the metabolite difluoroacetic acid (DFA) in order to monitor DFA residues expected in rotational crops (EFSA, [2015d](#efs25306-bib-0079){ref-type="ref"}). Although the Codex MRLs for the parent compound could be taken over in the EU legislation, corresponding MRLs for DFA are not proposed by JMPR. Since detailed information on the DFA residues are reported in the JMPR evaluation, it would be possible to derive MRL proposals for DFA to be established in the EU. However, this needs to be discussed with risk managers. |                                                                                                                                   |                                                               |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                   |                                                               |                        |
|                         | The risk assessment residue definition for plant products derived by the JMPR evaluation is wider than the respective EU residue definition, covering also the metabolite 6‐chloropyridine‐3‐carboxylic acid (synonym: 6‐chloronicotinic acid; 6‐CNA), a metabolite that is not specific for flupyradifurone (this metabolite is also observed in metabolism of other neonicotinoids)                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                   |                                                               |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.
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### 4.28.4. Codex MRL proposals -- flupyradifurone (Table [132](#efs25306-tbl-0132){ref-type="table"}) {#efs25306-sec-0188}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                          | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                           | EU MRL                                                                  | Comment                                                                                                                                                                                                                                                                                                                                                                                                                               |
+====================================================================================================+==============================================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Subgroup of cherries (includes all commodities in this subgroup)                                   | **2**                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Flupyradifurone: 0.01[\*](#efs25306-note-2003){ref-type="fn"}           | Critical GAP: USA 2 × 205 g/ha, interval 10 days, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Difluoroacetic acid (DFA): 0.02[\*](#efs25306-note-2003){ref-type="fn"} | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Specific comments/observations: Residues of flupyradifurone ranged from 0.014 to 0.94 mg/kg (STMR‐Mo = 0.36 mg/kg). Total residues of flupyradifurone, DFA and 6‐CNA expressed as parent equivalents ranged from 0.40 to 1.1 mg/kg (STMR‐RA = 0.555 mg/kg).                                                                                                                                                                           |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs and how to precede for setting the MRL for DFA. In the JMPR evaluation, the results for DFA are reported separately, but it is not so obvious which of the 16 residue trials have been selected for deriving the MRL proposal                                                             |
+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of peaches (including nectarine and apricots) (includes all commodities in this subgroup) | **1.5**                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Flupyradifurone: 0.01[\*](#efs25306-note-2003){ref-type="fn"}           | Critical GAP: USA 2 × 205 g/ha, interval 10 days, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Difluoroacetic acid (DFA): 0.02[\*](#efs25306-note-2003){ref-type="fn"} | Number of trials: 11 trials on peaches                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Sufficiently supported by data: Yes, according to JMPR rules. At EU level, in addition to the trials on peaches, trials on apricots would be required to extrapolate to the whole group.                                                                                                                                                                                                                                              |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Specific comments/observations: Residues of flupyradifurone ranged from 0.13 to 0.73 mg/kg (STMR‐Mo = 0.31 mg/kg). Total residues of flupyradifurone, DFA and 6‐CNA expressed as parent equivalents ranged from 0.16 to 1.1 mg/kg (STMR‐RA = 0.39 mg/kg). In the JMPR evaluation, the results for DFA are reported separately, but it is not so obvious which of the residue trials have been selected for deriving the MRL proposal. |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs and how to precede for setting the MRL for DFA                                                                                                                                                                                                                                            |
+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of plums (including fresh prunes) (includes all commodities in this subgroup)             | **0.4**                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Flupyradifurone: 0.01\*                                                 | Critical GAP: USA 2 × 205 g/ha, interval 10 days, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Difluoroacetic acid (DFA): 0.02[\*](#efs25306-note-2003){ref-type="fn"} | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Specific comments/observations: Residues of flupyradifurone ranged from 0.037 to 0.26 mg/kg (STMR‐Mo = 0.09 mg/kg). In the JMPR evaluation, the results for DFA are reported separately, but it is not so obvious which of the 16 residue trials have been selected for deriving the MRL proposal.                                                                                                                                    |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs and how to precede for setting the MRL for DFA                                                                                                                                                                                                                                            |
+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Prunes, dried                                                                                      | **3**                                                                                                                                                                                                                                                                                                                                                                                                                                                        | --                                                                      | The JMPR estimated a processing factor for flupyradifurone (parent only, i.e. the residue definition for enforcement) of 5.3 for prunes. Information on the number of processing studies is not provided in the available data.                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | See also comments on plums                                                                                                                                                                                                                                                                                                                                                                                                            |
+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Canned peaches                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Based on one processing study, a PF of 0.43 was derived for canned peaches (based on residue definition for risk assessment)                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cooked cherries                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         | Based on one processing study, a PF of 0.35 was derived for cooked cherries (based on residue definition for risk assessment)                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Conclusion/**                                                                                    | The use in the USA is for the stone fruit group; however, the JMPR recommended MRLs for the individual subgroups of stone fruit, as there are sufficient trials for each subgroup which is acceptable.                                                                                                                                                                                                                                                       |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| **comments**                                                                                       | The residue definition for enforcement in plant products derived by the JMPR evaluation is not fully compatible with the residue definitions established in the EU with regard to the metabolite DFA. The Codex MRL proposal is only 'Flupyradifurone' and the JMPR did not propose a specific Codex MRL for DFA. Specific information on DFA residues is not provided in the available residue trials data, but is probably reported in the JMPR evaluation |                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.28.5. Consumer risk assessment -- flupyradifurone (Table [133](#efs25306-tbl-0133){ref-type="table"}) {#efs25306-sec-0189}

###### 

Summary of the consumer risk assessment for flupyradifurone

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                       | Chronic exposure assessment                                                                                                                                                                                                                  | Comments on JMPR exposure assessment                                                                                                                                                                      |
+=================================================================================================================================================================================================================================+==============================================================================================================================================================================================================================================+===========================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                             | **RA assumptions:**                                                                                                                                                                                                                          | **Specific comments**                                                                                                                                                                                     |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              |                                                                                                                                                                                                           |
| The short‐term dietary risk assessment was performed for cherries, peaches and plums as outlined in Section [4.28.2](#efs25306-sec-0186){ref-type="sec"}.                                                                       | The most recent long‐term risk assessment (EFSA, [2015d](#efs25306-bib-0079){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for cherries, peaches and plums. | The JMPR exposure assessment is more comprehensive than the EU assessment because the JMPR RD‐RA is wider than the respective EU residue definition, which results in a more conservative risk assessment |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              |                                                                                                                                                                                                           |
| The EU ARfD was used.                                                                                                                                                                                                           | The EU ADI was used.                                                                                                                                                                                                                         |                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              |                                                                                                                                                                                                           |
| The HR values used for the crops under consideration are according to the RD‐RA for plant products derived by the JMPR evaluation, which is wider than the respective EU residue definition, covering also the metabolite 6‐CNA | The STMR values used for the crops under consideration are according to the RD‐RA for plant products derived by the JMPR evaluation, which is wider than the respective EU residue definition, covering also the metabolite 6‐CNA            |                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                    | **Results:**                                                                                                                                                                                                                                 | **Results:**                                                                                                                                                                                              |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              |                                                                                                                                                                                                           |
| No short‐term exposure concern was identified (peaches: 44% of the ARfD; plums: 13% of the ARfD; cherries: 9% of the ARfD)                                                                                                      | No long‐term consumer health risk was identified.                                                                                                                                                                                            | Long‐term exposure:                                                                                                                                                                                       |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              |                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                 | The overall chronic exposure accounted for up to 13% of the ADI (WHO Cluster diet B).                                                                                                                                                        | 6--20% of the ADI                                                                                                                                                                                         |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              |                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                 | The contributions of cherries, peaches and plums to the exposure were 0.3%, 0.3% and 0.1% of the ADI, respectively                                                                                                                           | Short‐term exposure:                                                                                                                                                                                      |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              |                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                              | 0--30% of the ARfD                                                                                                                                                                                        |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; HR: highest residue; STMR: supervised trials median residue.

John Wiley & Sons, Ltd

4.29. Quinclorac (287) (R) {#efs25306-sec-0190}
--------------------------

### 4.29.1. Background information (Table [134](#efs25306-tbl-0134){ref-type="table"}) {#efs25306-sec-0191}

###### 

Background information on quinclorac

                                           Comments, references
  ------------------------- -------------- ---------------------------------------------------------------------------
  Type of JMPR evaluation   New use        
  RMS                       --             
  Approval status           Not approved   Commission Decision of 2004/129/EC[a](#efs25306-note-0158){ref-type="fn"}
  EFSA conclusion           No             --
  MRL review                No             --
  MRL applications          No             --

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2004/19/EC: Commission Decision of 30 January 2004 concerning the non‐inclusion of certain active substances in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing these substances. OJ L 37, 10.2.2004, p. 27--31.

John Wiley & Sons, Ltd

### 4.29.2. Toxicological reference values -- quinclorac (Table [135](#efs25306-tbl-0135){ref-type="table"}) {#efs25306-sec-0192}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-----+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                        | EU evaluation | TRV comparable |     |     |
+========================+========================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+================+=====+=====+
| **ADI**                | 0.04 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                  | JMPR, 2015    | --             | --  | N/A |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-----+-----+
| **ARfD**               | 2 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR, 2015    | --             | N/A |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-----+-----+
| **Conclusion/comment** | No EU evaluation of the active substance.                                                                                                                                                                                                                                                                                                                                                                                              |               |                |     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                |     |     |
|                        | In 2015, JMPR assessed the active substance and its metabolites. JMPR concluded that the methyl ester is 10‐fold more toxic than quinclorac and that a 10‐fold potency factor should be applied to the residue levels for use in both the acute and chronic exposure assessments for quinclorac and that these should be added to the dietary exposures for quinclorac and compared with the ARfD and ADI for quinclorac, respectively |               |                |     |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-----+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.29.3. Residue definitions -- quinclorac (Table [136](#efs25306-tbl-0136){ref-type="table"}) {#efs25306-sec-0193}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------+-----------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR evaluation                                                                           | EU evaluation   | RDs comparable |
+=========================+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===========================================================================================+=================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Quinclorac plus quinclorac conjugates                                                     | Quinclorac      | No             |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------+-----------------+----------------+
| Animal products         | Quinclorac plus quinclorac conjugates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Quinclorac                                                                                | No              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                           |                 |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------+-----------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Quinclorac plus quinclorac conjugate plus quinclorac methyl ester expressed as quinclorac | Not established | N/A            |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------+-----------------+----------------+
| Animal products         | Quinclorac plus quinclorac conjugates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Not established                                                                           | N/A             |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------+-----------------+----------------+
| **Conclusion/comments** | In 2015, JMPR derived the above‐reported residue definitions. They were based on metabolism studies in rice, wheat, rape seed, sorghum and strawberries. The metabolite quinclorac methyl ester was a significant residue in rape seeds (occurring in the same amount as parent compound) and was a minor residue in other primary and subsequent rotational crops; parent quinclorac was the major residue in all examined crops.                                                                                                                                                                             |                                                                                           |                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | In 2016, when Codex MRL proposals were discussed in CCPR for fruit crops, the EU expressed a reservation on the advancement of these proposed draft MRLs because of concerns as regards the residue definition for enforcement, since the more toxic metabolite was not included.                                                                                                                                                                                                                                                                                                                              |                                                                                           |                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | In 2017, JMPR reassessed residue definitions; JMPR did not see a need to modify them.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                           |                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | Considering that in 2017 JMPR assessed the setting of MRLs for rape seed, a crop where the methyl ester occurred in higher concentrations than expected from the metabolism studies, i.e. up to 400% of the parent compound, it would be more appropriate to include the more toxic metabolite in the residue definition. Parent quinclorac is considered to be not a good marker substance for rape seed.                                                                                                                                                                                                     |                                                                                           |                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | Since the metabolite quinclorac methyl ester has a toxicological potency up to 10 times higher than that of quinclorac, this potency factor needs to be taken into account when deriving the risk assessment values (STMR/HR value), i.e. calculating according to the following equation: (quinclorac + quinclorac conjugate, expressed as quinclorac) + 10 × quinclorac methyl ester, expressed as quinclorac).                                                                                                                                                                                              |                                                                                           |                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | In 2017, JMPR reported several analytical methods that were used in the residue trials (rape seed) and were considered suitable for enforcement purpose. It needs to be verified whether routine enforcement methods are also covering quinclorac conjugates. Apparently, no hydrolysis step is included to release the conjugates. Without a routine enforcement method, the proposed Codex MRLs for the plant products are not acceptable.                                                                                                                                                                   |                                                                                           |                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | A method for animal commodities was reported in 2015 JMPR. The method foresees a hydrolysis step; thus, the quinclorac residues derived with this method seem to include quinclorac released from conjugates. However, in 2015, JMPR noted that it is not clear whether identified quinclorac represents quinclorac only or also includes quinclorac released from conjugates by the alkaline extraction method used. Thus, a confirmation needs to be provided that appropriate analytical methods are available to monitor residues in animal commodities complying with the enforcement residue definition. |                                                                                           |                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                           |                 |                |
|                         | The results of the feeding studies do not provide any evidence that the residues in animal commodities should be considered as fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                           |                 |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------+-----------------+----------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.29.4. Codex MRL proposals -- quinclorac (Table [137](#efs25306-tbl-0137){ref-type="table"}) {#efs25306-sec-0194}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                                 | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+===============================================+====================================================+==============================================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Edible offal (mammalian)                      | 0.1                                                |                                              | Specific comments/observations: From the presentation of the input values used for the dietary burden calculation, it is not so clear whether the calculations are based on the residue definition for risk assessment or for the residue definition for enforcement or a mixture, depending on the feed item. The critical dietary burden was calculated for Australia. It should be confirmed that an analytical method suitable for the enforcement residue definition is available. |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                          | 0.05[\*](#efs25306-note-2004){ref-type="fn"}       |                                              | Specific comments/observations: It should be confirmed that an analytical method suitable for the enforcement residue definition is available.                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | 0.05[\*](#efs25306-note-2004){ref-type="fn"}       |                                              | Specific comments/observations: It should be confirmed that an analytical method suitable for the enforcement residue definition is available.                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | 0.05[\*](#efs25306-note-2004){ref-type="fn"}(fat)  |                                              | Specific comments/observations: It should be confirmed that an analytical method suitable for the enforcement residue definition is available. Considering the results of the feeding study, the residues should not be classified as fat soluble.                                                                                                                                                                                                                                      |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.05[\*](#efs25306-note-2004){ref-type="fn"}       | --                                           | Specific comments/observations: It should be confirmed that an analytical method suitable for the enforcement residue definition is available.                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, Edible offal of                      | 0.05[\*](#efs25306-note-2004){ref-type="fn"}       | --                                           | Specific comments/observations: From the presentation of the input values used for the dietary burden calculation, it is not so clear whether the calculations are based on the residue definition for risk assessment or for the residue definition for enforcement or a mixture, depending on the feed item. The critical dietary burden was calculated for Australia. It should be confirmed that an analytical method suitable for the enforcement residue definition is available. |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                  | 0.05[\*](#efs25306-note-2004){ref-type="fn"}       | --                                           | Specific comments/observations: It should be confirmed that an analytical method suitable for the enforcement residue definition is available.                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                  | 0.05[\*](#efs25306-note-2004){ref-type="fn"} (fat) | --                                           | Specific comments/observations: It should be confirmed that an analytical method suitable for the enforcement residue definition is available. Considering the results of the feeding study, the residues should not be classified as fat soluble.                                                                                                                                                                                                                                      |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rape seed                                     | **0.15**                                           | 0.02[\*](#efs25306-note-2004){ref-type="fn"} | Critical GAP: CAN/USA, 0.1 kg ai/ha, PHI 60 days                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Specific comments/observations: The residue trials were analysed with a method that allowed a separate measurement of parent quinclorac and quinclorac methyl. These analyses demonstrate that the methyl ester occurred in higher concentrations than expected from the metabolism studies, i.e. up to 400% of the parent compound.                                                                                                                                                    |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable, taking into account the fact that the residue definition for enforcement has not been revised as suggested by the EU.                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice                                          | **10**                                             |                                              | Critical GAP: USA, 1 × 0.5 kg/ha (from 2‐leaf stage to before heading), PHI 40 days                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Sufficiently supported by data: Yes, but see comments below.                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Specific comments/observations: The samples were only analysed for parent quinclorac and for quinclorac conjugate; to be verified in JMPR evaluation. To derive the risk assessment value (STMR), a conversion factor was used which was derived from metabolism studies in cereals (rice, wheat, sorghum). In addition, the toxicological potency factor of 10 was applied.                                                                                                            |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Considering the high residues in rice, and the fact that there is only a slight reduction in residues during processing (husked rice, polished rice), the approach to use an indicative conversion factor from metabolism studies to estimate the residues of the more toxic metabolite is leading to a high uncertainty.                                                                                                                                                               |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because the samples of the supervised field trials were not analysed for the full residue definition. The approach used by JMPR to estimate the residues of quinclorac methyl is expected to lead to a high uncertainty. Considering that the dietary exposure to residues via rice is close to the ARfD, this high level of uncertainty is not acceptable                                                                         |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, husked                                  | 10                                                 | 5                                            | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Specific comments/observations: Only 1 study is available which is not sufficient to derive a robust‐processing factor. The samples of unprocessed and processed rice were analysed only for parent quinclorac. No reduction of residues occurred during the processing to produce husked rice.                                                                                                                                                                                         |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | The proposed MRL for husked rice is not acceptable.                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                | 8                                                  |                                              | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                               |                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                    |                                              | Specific comments/observations: Only 1 study is available which is not sufficient to derive a robust‐processing factor. Apparently, the reduction of residues during the processing to produce polished rice is low.                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice straw and fodder, dry                    | 8 (dw)                                             |                                              | Specific comments/observations: The residue levels of quinclorac and quinclorac conjugates measured in rice straw was used to calculate the dietary burden of livestock. Quinclorac methyl was not taken into account. Metabolism studies do not allow concluding whether quinclorac methyl is an important component of the residue trials, since the extraction regime used did not allow a separate quantification of parent and methyl ester.                                       |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rape seed oil, edible                         |                                                    |                                              | Specific comments/observations: Based on 4 processing study, a PF of 1.3 was derived (applicable to the RD enforcement).                                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice bran, unprocessed                        |                                                    |                                              | Specific comments/observations: Based on 1 trial, a PF of 1.3 was derived (applicable to the RD enforcement).                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+----------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

EU MRL: European Union maximum residue limit; PF: processing factor; PHI: preharvest interval; MRL: maximum residue limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.29.5. Consumer risk assessment -- quinclorac (Table [138](#efs25306-tbl-0138){ref-type="table"}) {#efs25306-sec-0195}

###### 

Summary of the consumer risk assessment for quinclorac

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                            | Chronic exposure assessment                                                                                                                                                                                                                      | Comments on JMPR exposure assessment |
+======================================================================================================================================================================================================================+==================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                  | **RA assumptions:**                                                                                                                                                                                                                              | **Specific comments**                |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
| A tentative short‐term dietary risk assessment was performed for the commodities for which Codex MRL proposals were derived, using the approach as outlined in Section [4.29.2](#efs25306-sec-0192){ref-type="sec"}. | The long‐term risk assessment was performed using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the commodities under assessment. For the remaining commodities, the existing EU MRL was used. |                                      |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
| The HR/STMR values derived by JMPR were used as input values.                                                                                                                                                        | The JMPR ADI was used, since no EU reference value is available                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
| For rice, in addition, a scenario was calculated using the HR reported for the risk assessment residue definition (16 mg/kg) instead of the STMR (1.45 mg/kg).                                                       |                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
| The JMPR ARfD was used, lacking a toxicological reference value derived in the EU                                                                                                                                    |                                                                                                                                                                                                                                                  |                                      |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                         | **Results:**                                                                                                                                                                                                                                     | **Results:**                         |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
| No short‐term exposure concern was identified (0.9% of the ARfD for rice based on the STMR);                                                                                                                         | No long‐term consumer health risk was identified.                                                                                                                                                                                                | Long‐term exposure:                  |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
| Using the HR for rice (16 mg/kg), the acute exposure accounted for 10%                                                                                                                                               | The overall chronic exposure accounted for 0.8% of the ADI.                                                                                                                                                                                      | 1% of the ADI                        |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                      | The contribution of rice to the exposure was 0.2% of the ADI                                                                                                                                                                                     | Short‐term exposure:                 |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                  | 2% of the ARfD                       |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; HR: highest residue; STMR: supervised trials median residue.
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4.30. Bicyclopyrone (295) (R/T) {#efs25306-sec-0196}
-------------------------------

### 4.30.1. Background information (Table [139](#efs25306-tbl-0139){ref-type="table"}) {#efs25306-sec-0197}

###### 

Background information on bicyclopyrone

                                                      Comments, references
  ------------------------- ------------------------- ------------------------
  Type of JMPR evaluation   New compound evaluation   
  RMS                       --                        
  Approval status           Not approved              Not assessed in the EU
  EFSA conclusion           No                        --
  MRL review                No                        --
  MRL applications          No                        --

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

John Wiley & Sons, Ltd

### 4.30.2. Toxicological reference values -- bicyclopyrone (Table [140](#efs25306-tbl-0140){ref-type="table"}) {#efs25306-sec-0198}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                 | EU evaluation | TRV comparable |                  |    |
+========================+=================================================================================================================================================================================================================================================================================+===============+================+==================+====+
| **ADI**                | 0.003 mg/kg bw per day                                                                                                                                                                                                                                                          | JMPR, 2017    | --             | No EU assessment | -- |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+----+
| **ARfD**               | 0.01 mg/kg bw                                                                                                                                                                                                                                                                   | JMPR, 2017    | --             | --               |    |
|                        |                                                                                                                                                                                                                                                                                 |               |                |                  |    |
|                        | (women of childbearing age)                                                                                                                                                                                                                                                     |               |                |                  |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+----+
| **Conclusion/comment** | JMPR established an ADI on the basis of the effect of thyroid hyperplasia in the 2‐year carcinogenicity study in rats, applying an overall safety factor of 100 (with decreased factor for toxicodynamic interspecies differences and increased factor for the use of a LOAEL). |               |                |                  |    |
|                        |                                                                                                                                                                                                                                                                                 |               |                |                  |    |
|                        | The refinements of the safety factor as presented might be considered differently at EU level on the basis of a more detailed assessment.                                                                                                                                       |               |                |                  |    |
|                        |                                                                                                                                                                                                                                                                                 |               |                |                  |    |
|                        | According to JMPR, the ADI and ARfD for bicyclopyrone could be applied to all structurally related metabolites of SYN503780 and CSCD686480, the common moieties included in the residue definitions.                                                                            |               |                |                  |    |
|                        |                                                                                                                                                                                                                                                                                 |               |                |                  |    |
|                        | EFSA is not in a position to derive a final position based on the available assessment                                                                                                                                                                                          |               |                |                  |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.30.3. Residue definitions -- bicyclopyrone (Table [141](#efs25306-tbl-0141){ref-type="table"}) {#efs25306-sec-0199}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                           | JMPR evaluation                                                                                                                                                                                                                                                                                                      | EU evaluation | RDs comparable |
+=========================+===========================================================================================================================================================================================================================================================================================================================================================================================================+======================================================================================================================================================================================================================================================================================================================+===============+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                            | Sum of bicyclopyrone and its structurally related metabolites determined as the sum of the common moieties 2‐(2‐methoxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (SYN503780) and (2‐(2‐hydroxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (CSCD686480), expressed as bicyclopyrone | --            | N/A            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Sum of bicyclopyrone and its structurally related metabolites determined as the sum of the common moieties 2‐(2‐methoxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (SYN503780) and 2‐(2‐hydroxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (CSCD686480), expressed as bicyclopyrone.                                                                                      | --                                                                                                                                                                                                                                                                                                                   | N/A           |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                      |               |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                      |               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                            | Sum of bicyclopyrone and its structurally related metabolites determined as the sum of the common moieties 2‐(2‐methoxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (SYN503780) and (2‐(2‐hydroxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (CSCD686480), expressed as bicyclopyrone | --            | N/A            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Sum of bicyclopyrone and its structurally related metabolites determined as the sum of the common moieties 2‐(2‐methoxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (SYN503780) and 2‐(2‐hydroxyethoxymethyl)‐6‐(trifluoromethyl)pyridine‐3‐carboxylic acid (CSCD686480), expressed as bicyclopyrone                                                                                       | --                                                                                                                                                                                                                                                                                                                   | N/A           |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+
| **Conclusion/comments** | In the EU, no specific residue definition has been established. Thus, currently, the default enforcement residue definition is the parent compound.                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                      |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                      |               |                |
|                         | Residue definition for plant commodities: JMPR proposed a common moiety residue definition for plant commodities which would cover a number of metabolites which individually did not occurs in concentrations \< 10%.                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                      |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                      |               |                |
|                         | RD for animal commodities: According to the metabolism in lactating goats, bicyclopyrone was found in all animal matrices; in addition, a metabolite was found in liver and milk in concentrations exceeding the parent compound that would be covered by the common moiety residue definition. In poultry, the parent compound was the main residue, but a number of metabolites occurred in low levels. |                                                                                                                                                                                                                                                                                                                      |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                      |               |                |
|                         | Risk managers to decide whether a specific residue definition should be established under Regulation (EC) No 396/2005 for plant and animal commodities. The RD proposed by JMPR is more comprehensive and should be considered as an alternative to the default EU RD                                                                                                                                     |                                                                                                                                                                                                                                                                                                                      |               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.30.4. Codex MRL proposals -- bicyclopyrone (Table [142](#efs25306-tbl-0142){ref-type="table"}) {#efs25306-sec-0200}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                | Codex MRL proposal                                | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+==========================================================+===================================================+==============================================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Sweet corn (corn on the cob) (kernels plus cob with husk | **0.03**                                          | 0.01[\*](#efs25306-note-2005){ref-type="fn"} | Critical GAP: USA, preplant pre‐emergence 50 g ai/ha, PHI 45 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| removed)                                                 |                                                   |                                              | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley                                                   | **0.04**                                          | 0.01[\*](#efs25306-note-2005){ref-type="fn"} | Critical GAP: USA, foliar application, 50 g ai/ha, PHI 60 days                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                                    | **0.02** [\*](#efs25306-note-2005){ref-type="fn"} | 0.01\*                                       | Critical GAP: Uruguay, 1 × 200 g ai/ha (pre‐emergence)                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Number of trials: 26 trials from Brazil and USA                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Specific comments/observations: residue trials partially overdosed, but acceptable since residues were below LOQ                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat                                                    | **0.04**                                          | 0.01[\*](#efs25306-note-2005){ref-type="fn"} | Critical GAP: USA, CAN; 50 g ai/ha, PHI 60 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Number of trials: 22                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar cane                                               | **0.02** [\*](#efs25306-note-2005){ref-type="fn"} | 0.01\*                                       | Critical GAP: Belize, 1 × 262.5 g ai/ha at BBCH 00 to BBCH 08 (pre‐emergence) or at BBCH 11 to BBCH 14 (early post‐emergence), PHI not required                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Number of trials: 17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Specific comments/observations: Additional overdosed residue trials (3‐5N) were reported, all with residues below the LOQ.                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                          |                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                          |                                                   |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                 | **3**                                             | 0.01[\*](#efs25306-note-2005){ref-type="fn"} | In the feeding study in lactating dairy cows, residues were less than the LOQ in milk, fat and muscle. However, in kidney and liver, significant residues were found at 0.6N and 2N dose levels; residues were not dose dependent. The residue levels in the feeding study expected in liver and kidney (1N max. dietary burden) were in the same order of magnitude as the residues found in the metabolism study (lactating goats), which was performed at 25N dose rate of the maximum calculated dietary burden |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk of cattle, goats and sheep                          | **0.02** [\*](#efs25306-note-2005){ref-type="fn"} | 0.01[\*](#efs25306-note-2005){ref-type="fn"} | The proposed Codex MRL is sufficiently supported by data and is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                        | **0.02** [\*](#efs25306-note-2005){ref-type="fn"} | 0.01[\*](#efs25306-note-2005){ref-type="fn"} | The proposed Codex MRL is sufficiently supported by data and is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)            | **0.02** [\*](#efs25306-note-2005){ref-type="fn"} | 0.01[\*](#efs25306-note-2005){ref-type="fn"} | The proposed Codex MRL is sufficiently supported by data and is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat, bran processed                                    | 0.1                                               |                                              | A PF of 2.3 was derived from two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat, germ                                              | 0.06                                              |                                              | A PF of 1.4 was derived from two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley bran, processed                                   | 0.1                                               |                                              | The proposed Codex MRL for barley bran was derived by extrapolation from wheat bran. Considering morphological differences between wheat and barley, such an extrapolation, does not seem appropriate                                                                                                                                                                                                                                                                                                               |
+----------------------------------------------------------+---------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; GAP: Good Agricultural Practice; PF: processing factor; MRL: maximum residue limit; PHI: preharvest interval.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.30.5. Consumer risk assessment -- bicyclopyrone (Table [143](#efs25306-tbl-0143){ref-type="table"}) {#efs25306-sec-0201}

###### 

Summary of the consumer risk assessment for bicyclopyrone

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                          | Chronic exposure assessment                                                                                                                                                                                                                                                 | Comments on JMPR exposure assessment                                         |
+====================================================================================================================================================================================+=============================================================================================================================================================================================================================================================================+==============================================================================+
| **RA assumptions:**                                                                                                                                                                | **RA assumptions:**                                                                                                                                                                                                                                                         | **Specific comments**                                                        |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
| The short‐term dietary risk assessment was performed for the commodities for which JMPR derived MRL proposals as outlined in Section [4.29.2](#efs25306-sec-0198){ref-type="sec"}. | A tentative long‐term risk assessment was performed, using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the commodities listed in the table above. For the remaining commodities, the default MRL of 0.01 mg/kg was used | JMPR calculated the acute risk assessment only for women of childbearing age |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
| The HR values derived for ruminant liver was also used for other edible offal, except kidney (for kidney, a separate HR was reported by MPR which was used in the calculations).   |                                                                                                                                                                                                                                                                             |                                                                              |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
| The JMPR ARfD was used for both children and adults.                                                                                                                               |                                                                                                                                                                                                                                                                             |                                                                              |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
| The risk assessment is tentative, as no EU reference values are available                                                                                                          |                                                                                                                                                                                                                                                                             |                                                                              |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                       | **Results:**                                                                                                                                                                                                                                                                | **Results:**                                                                 |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
| An exceedance of the ARfD was noted for children for bovine liver (221% of the ARfD) and edible offal of bovine (200% of the ARfD).                                                | No long‐term consumer health risk was identified.                                                                                                                                                                                                                           | Long‐term exposure:                                                          |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
| For adults, the highest exposure was calculated for bovine edible offal and bovine liver (81% and 74% of the ARfD, respectively)                                                   | The overall chronic exposure accounted for 42% of the ADI.                                                                                                                                                                                                                  | 20% of the ADI                                                               |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
|                                                                                                                                                                                    | The highest contributor was milk (26% of the ADI)                                                                                                                                                                                                                           | Short‐term exposure:                                                         |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             |                                                                              |
|                                                                                                                                                                                    |                                                                                                                                                                                                                                                                             | 100% of the ARfD (for women of childbearing age)                             |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; HR: highest residue; STMR: supervised trials median residue.

John Wiley & Sons, Ltd

4.31. Cyclaniliprole (296) (R/T) {#efs25306-sec-0202}
--------------------------------

### 4.31.1. Background information (Table [144](#efs25306-tbl-0144){ref-type="table"}) {#efs25306-sec-0203}

###### 

Background information on cyclaniliprole

                                                      Comments, references
  ------------------------- ------------------------- -----------------------------------------------------------------------------------------
  Type of JMPR evaluation   New compound evaluation   
  RMS                       AT                        
  Approval status           Not approved              Commission Implementing Regulation (EU) 2017/357[a](#efs25306-note-0169){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2016g](#efs25306-bib-0097){ref-type="ref"})
  MRL review                No                        
  MRL applications          No                        

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2017/357: Commission Implementing Regulation (EU) 2017/357 of 28 February 2017 concerning the non‐approval of the active substance cyclaniliprole, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market. OJ L 54, 1.3.2017, p. 4--5.

John Wiley & Sons, Ltd

### 4.31.2. Toxicological reference values -- cyclaniliprole (Table [145](#efs25306-tbl-0145){ref-type="table"}) {#efs25306-sec-0204}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | EU evaluation                                                    | TRV comparable          |                                                                                               |     |
+========================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==================================================================+=========================+===============================================================================================+=====+
| **ADI**                | 0.04 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR, 2017 (90‐day and 1‐year dog study, uncertainty factor 100) | 0.0043 mg/kg bw per day | EFSA ([2016g](#efs25306-bib-0097){ref-type="ref"}) (1‐year dog study, uncertainty factor 300) | No  |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR, 2017                                                       | --                      | Not allocated                                                                                 | Yes |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | Regarding the ADI setting, the **JMPR** selected an overall NOAEL for the 90‐day and 1‐year dog studies of 4.07 mg/kg bw per day based on a consistent increase in alkaline phosphatase (ALP) activity, a slight but consistent decrease in albumin and increased liver weight at and above 1,000 ppm (equal to 26.8/27.2 mg/kg bw per day, respectively) and using a 100‐fold safety factor.                                                                                                                                                                                                                                           |                                                                  |                         |                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                  |                         |                                                                                               |     |
|                        | The JMPR considered that the ADI of the parent apply to the metabolites YT‐1284, NSY‐28 (present in the rat metabolism) and NK‐1375 (based on an acute oral toxicity study, an Ames test and structural comparison with cyclaniliprole using Toxtree).                                                                                                                                                                                                                                                                                                                                                                                  |                                                                  |                         |                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                  |                         |                                                                                               |     |
|                        | In establishing the ADI for cyclaniliprole, the **EU** assessment interpreted differently the same effects observed on the same studies, identifying a LOAEL in both studies, and in the 1‐year study, at 1.29 mg/kg bw per day for hepatotoxicity. In general, an increase in relative liver weights above 20% is considered to be adverse in the European peer review. The overall LOAEL was based on increases in liver weights (above 20% in both studies) in combination of induction of ALP and reduction of albumin in females. The basis of a LOAEL to set the ADI implied an additional uncertainty factor of 3 (overall 300). |                                                                  |                         |                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                  |                         |                                                                                               |     |
|                        | The ADI of the parent applies to metabolite NSY‐28, since it was found to be a major rat metabolite. Additional metabolites were discussed for their toxicological relevance: i.e. NK‐1375 which was found in significant levels in primary crops and YT‐1327, BCPBA and BPQO which were found in processing studies, primarily under conditions representing sterilisation.                                                                                                                                                                                                                                                            |                                                                  |                         |                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                  |                         |                                                                                               |     |
|                        | The data provided on metabolites NK‐1375, YT‐1327, BCPBA and BPQO was considered insufficient by the peer review to conclude on their toxicity profile.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                  |                         |                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                  |                         |                                                                                               |     |
|                        | In the EU, the acute oral toxicity study and the Ames test for NK‐1375 were also assessed. In the acute oral study, there was no response to treatment at 2,000 mg/kg bw/day and the bacterial reverse mutation study showed no evidence of mutagenic activity in this bacterial system. QSAR analyses have been submitted as additional information but were considered not sufficient to finalise the complete genotoxicity package of NK‐1375 including chromosome aberration and mammalian gene mutation                                                                                                                            |                                                                  |                         |                                                                                               |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union; NOAEL: no observed adverse effect level.

John Wiley & Sons, Ltd

### 4.31.3. Residue definitions -- cyclaniliprole (Table [146](#efs25306-tbl-0146){ref-type="table"}) {#efs25306-sec-0205}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                              | JMPR evaluation                                                                                                                                                                                     | EU evaluation                                                                                                                                                                                             | RDs comparable                       |
+=========================+==============================================================================================================================================================================================================================================================================================================================================================================+=====================================================================================================================================================================================================+===========================================================================================================================================================================================================+======================================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                               | Cyclaniliprole                                                                                                                                                                                      | Reg. 396/2005: Default residue definition                                                                                                                                                                 | Yes                                  |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     | Peer review: Cyclaniliprole (for RAC;                                                                                                                                                                     |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     | For processed commodities, assessment not finalised)                                                                                                                                                      |                                      |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Animal products         | Cyclaniliprole                                                                                                                                                                                                                                                                                                                                                               | Reg. 396/2005: Default residue definition                                                                                                                                                           | Yes                                                                                                                                                                                                       |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                   | Peer review: Cyclaniliprole                                                                                                                                                                         |                                                                                                                                                                                                           |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              | The residue is fat soluble                                                                                                                                                                          |                                                                                                                                                                                                           |                                      |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                               | Cyclaniliprole + 3‐bromo‐2‐((2‐bromo‐4H‐pyrazolo\[1,5‐d\]pyrido\[3,2‐b\]‐\[1,4\]oxazin‐4‐ylidene)amino)‐5‐chloro‐N‐(1‐cyclopropylethyl)benzamide (NK‐1375), expressed as cyclaniliprole equivalents | Peer review: provisional RD for RAC: Cyclaniliprole and metabolite NK 1375 (pending information on the toxicity of metabolite NK‐1375)                                                                    | N/A, since EU RD is only provisional |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              | Note: The molecular weight conversion factor to express NK‐1375 in cyclaniliprole equivalents = 1.064                                                                                               | Processed commodities: Assessment is not finalised; a separate residue definition for processed commodities may be proposed, possible inclusion of the compounds YT‐1327, BCPBA and BPQO to be considered |                                      |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Animal products         | Cyclaniliprole                                                                                                                                                                                                                                                                                                                                                               | Cyclaniliprole and metabolites NSY‐28 and NK‐1375; provisionally and pending the submission of data to address the metabolism of NK‐1375 in livestock and its toxicological properties.             | No                                                                                                                                                                                                        |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              | For NSY‐28, reference values of parent may be used                                                                                                                                                  |                                                                                                                                                                                                           |                                      |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Conclusion/comments** | In the EU Peer Review of cyclaniliprole, several data gaps were identified (e.g. toxicological assessment, including genotoxic potential of metabolites NK‐1375, YT‐1327, BCPBA and BPQO relevant to the consumer risk assessment; the occurrence of YT‐1327, BCPBA and BPQO in processed commodities and finalisation of the residue definition for processed commodities). |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         |                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
|                         | Thus, the residue definitions for consumer risk assessment, and consequently, the consumer risk assessment could not finalised because of the data gaps with regard to the toxicological relevance of metabolites NK‐1375, YT‐1327, BCPBA and BPQO in food commodities                                                                                                       |                                                                                                                                                                                                     |                                                                                                                                                                                                           |                                      |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 4.31.4. Codex MRL proposals -- cyclaniliprole (Table [147](#efs25306-tbl-0147){ref-type="table"}) {#efs25306-sec-0206}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                           | Codex MRL proposal                                                                                                                                                                                                                                                                                                                            | EU MRL (default MRLs) | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+=====================================================================================================+===============================================================================================================================================================================================================================================================================================================================================+=======================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Subgroup of cherries                                                                                | **0.9**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP: USA, 1 × 60 + 3 × 80 g ai/ha (max. 300 g ai/ha per season), RTI 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| (includes all commodities in this subgroup)                                                         |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The residue trials were performed with 3 × 100 g/ha, interval 6--8 days, PHI 7 days. Thus, the trials did not match with the critical GAP. JMPR used a new tool that was developed to model the residue behaviour and would allow to predict residue concentrations for a given GAP from residue trials that differ in terms of application rates, treatment intervals, PHI.                                                                                                                                    |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                                                       | **0.1**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | See comments on tomatoes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of cucumbers and                                                                           | **0.06**                                                                                                                                                                                                                                                                                                                                      | 0.01                  | Critical GAP for fruiting vegetables, cucurbits: USA, 4 × 60 g ai/ha (max. 240 g ai/ha per season), RTI 5 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Summer squashes                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 9 trials in cucumbers and 9 in summer squash.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| (includes all commodities in this subgroup)                                                         |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (cucumber trials: 3 × 76--84 g ai/ha, interval 6--8 days, PHI 1 day; summer squash: 3 × 77--83, interval 6--8 days, PHI 1 day). Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in fruiting vegetables.                                                                                                                                          |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The number of trials is insufficient. Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato, dried                                                                                       | **0.4**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | The proposed MRL was derived from tomatoes, using processing factor of 3.3                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                                            | 0.01[\*](#efs25306-note-2006){ref-type="fn"}                                                                                                                                                                                                                                                                                                  | 0.01                  | For the calculation of dietary burden, JMPR used the crops for which MRL proposals were derived, its by‐products and crops where residues may be expected due to rotational crops. However, the calculations were modified, taking into account that in certain geographical regions, the use on certain crops is not approved. N this modified dietary burden calculation, Australian dietary burden was the basis for deriving MRL proposals for livestock. At the calculated dietary burden, residues were below 0.01 mg/kg in all matrices. |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The proposed Codex MRL is similar to the current default EU MRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of eggplants (includes all commodities in this subgroup)                                   | **0.1**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Specific comments/observations: The proposed MRL was derived by extrapolation from tomatoes, see comments on tomatoes.                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of flowerhead brassicas(includes all commodities in this subgroup)                         | **1**                                                                                                                                                                                                                                                                                                                                         | 0.01                  | Critical GAP: USA, 4 × 60 g ai/ha (max. 240 g ai/ha per season), RTI 5 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3×61--87 g ai/ha, interval 6--8 days, PHI 1 day. Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in flower head brassica.                                                                                                                                                                                                                       |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The number of trials is insufficient. Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of head brassicas (includes all commodities in this subgroup)                              | **0.7**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP: USA, 4 × 60 g ai/ha (max. 240 g ai/ha per season), RTI 5 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3×61--102 g ai/ha, interval 6--8 days, PHI 1 day. Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in head brassicas.                                                                                                                                                                                                                            |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The number of trials is insufficient. Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of leaves of *Brassicaceae Brassica* spp. (includes all commodities in this subgroup)      | **15**                                                                                                                                                                                                                                                                                                                                        | 0.01                  | Critical GAP for mustard greens: USA, 4 × 60 g ai/ha (max. 240 g ai/ha per season), RTI 5 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3 × 60--81 g ai/ha, interval 6--8 days, PHI 1 days. Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in peaches. Although the number of trials is sufficient for mustard greens (crop category 2), 5 trials are not sufficient to extrapolate to the whole group of leaves of Brassicaceae which comprises also major crops.                     |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. In addition, the number of trials is insufficient to extrapolate to the whole subgroup of Leaves of brassica. See also other general comments                                                                                                                                                                                               |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                                       | 0.01[\*](#efs25306-note-2006){ref-type="fn"} (fat)                                                                                                                                                                                                                                                                                            | 0.01                  | See comments on Edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of melons, pumpkins and Winter squashes (includes all commodities in this group)           | **0.15**                                                                                                                                                                                                                                                                                                                                      | 0.01                  | Critical GAP for fruiting vegetables, cucurbits: USA, 4 × 60 g ai/ha (max. 240 g ai/ha per season), RTI 5 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 10 trials in melons                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3 × 76--85 g ai/ha, interval 6--8 days, PHI 1 day); summer squash: 3 × 77--83, interval 6--8 days, PHI 1 day). Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in melons and pumpkins.                                                                                                                                                          |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The number of trials is insufficient. Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                                   | 0.01[\*](#efs25306-note-2006){ref-type="fn"}                                                                                                                                                                                                                                                                                                  | 0.01                  | See comments on Edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                                               | 0.01[\*](#efs25306-note-2006){ref-type="fn"}                                                                                                                                                                                                                                                                                                  | 0.01                  | See comments on Edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk fats                                                                                           | 0.01[\*](#efs25306-note-2006){ref-type="fn"}                                                                                                                                                                                                                                                                                                  | 0.01                  | See comments on Edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of peaches (including apricots and nectarines) (includes all commodities in this subgroup) | **0.3**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP: USA, 1 × 60 + 3 × 80 g ai/ha (max. 300 g ai/ha per season), RTI 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3 × 55--103 g ai/ha, interval 6--8 days, PHI 7 days. Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in peaches. Furthermore, residue trials in peaches would not be acceptable in the EU to extrapolate to apricots.                                                                                                                           |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of peppers (except martynia, okra and roselle)                                             | **0.2**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP for sweet peppers: USA, 4×60 g ai/ha (max. 240 g ai/ha per season), RTI 5 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 9 trials in bell peppers, 3 trials in non‐bell peppers                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3 × 60--82 g ai/ha, interval 6--8 days, PHI 1 day). Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in peppers.                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The number of trials is insufficient. Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, Chili, dried                                                                               | **2**                                                                                                                                                                                                                                                                                                                                         | 0.01                  | The proposed MRL was derived from peppers using the default dehydration factor of 10. See comments on peppers.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Group of pome fruits (includes all commodities in this group)                                       | **0.3**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP: USA, 1 × 60 + 3 × 80 g ai/ha (max. 300 g ai/ha per season), RTI 10 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 16 in apples, 9 in pears                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3 × 59--107 g ai/ha, interval 13--15 days, PHI 7 days). Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in pome fruit.                                                                                                                                                                                                                          |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of plums (includes all commodities in this subgroup)                                       | **0.2**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP: USA, 1 × 60 + 3 × 80 g ai/ha (max. 300 g ai/ha per season), RTI 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3 × 40--102 g ai/ha, interval 6--8 days, PHI 7 days. Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in plums. Furthermore, for plums, being a major crop according to Codex rules, at least 8 trials would be required.                                                                                                                        |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The number of trials is insufficient. Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Prunes, dried                                                                                       | **0.8**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | The proposed MRL was derived from plums using a processing factor that was derived from one processing study. See comments on plums                                                                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapes                                                                                              | **0.8**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP: USA, 1 × 60 + 3 × 80 g ai/ha (max. 300 g ai/ha per season), RTI 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (3 × 97--105 g ai/ha, interval 6--8 days, PHI 7 days. Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in grapes.                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                                                              | **0.1**                                                                                                                                                                                                                                                                                                                                       | 0.01                  | Critical GAP for fruiting vegetables (covering tomatoes and eggplants): USA, 4 × 60 g ai/ha (max. 240 g ai/ha per season), RTI 5 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Number of trials: 22                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Specific comments/observations: The conditions of the residue trials did not match with the critical GAP (tomatoes, including cherry tomatoes: 3 × 60--97 g ai/ha, interval 6--8 days, PHI 1 day). Thus, the trials did not match with the critical GAP. JMPR used the new tool (see general comments) to predict residue concentrations in tomatoes.                                                                                                                                                                                           |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       | Conclusion: The number of trials is insufficient. Since this model used by JMPR to predict the residues for the cGAP was never presented before, and no reliable validation of the tool is available, the proposed MRL is not acceptable. See also other general comments                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Straw and fodder, dry of cereal grains                                                              | **0.45 (dw)**                                                                                                                                                                                                                                                                                                                                 | 0.01                  | No MRLs are established at EU level for straw and fodder of cereals                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                                | The tool used by JMPR to decide whether residue trials that differed with regard to the number of applications and the application rate from the critical GAP was reported under point 2.4 of the General Considerations. The validity of the calculation method has not been sufficiently demonstrated and therefore may lead to wrong MRLs. |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                                                                                                                                                                                                                                                                                                                                               |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     | These data gaps and open issues identified in the EU peer review (see comments/conclusions on toxicological reference values and residue definitions) are also valid for the proposed Codex MRLs                                                                                                                                              |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-----------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice; EU: European Union.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.31.5. Consumer risk assessment -- cyclaniliprole (Table [148](#efs25306-tbl-0148){ref-type="table"}) {#efs25306-sec-0207}

###### 

Summary of the consumer risk assessment for cyclaniliprole

+-----------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------+
| Acute exposure assessment               | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                  | Comments on JMPR exposure assessment   |
+=========================================+==============================================================================================================================================================================================================================================================================================================================================================+========================================+
| **RA assumptions:**                     | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                          | **Specific comments**                  |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
| Not relevant since no ARfD was derived. | A tentative short‐term dietary risk assessment was performed for the commodities reported above as outlined in Section [4.31.2](#efs25306-sec-0204){ref-type="sec"}.                                                                                                                                                                                         |                                        |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
|                                         | The EU ADI was used.                                                                                                                                                                                                                                                                                                                                         |                                        |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
|                                         | The calculation is tentative because of the data gaps as regards the toxicological relevance of metabolites/degradation products (see comments on toxicological reference values and residue definitions). Furthermore, the input values for risk assessment derived by JMPR are not reliable, since they were not based on residue trials matching the GAP. |                                        |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
|                                         | EFSA used the default EU MRLs and the STMR values derived by JMPR, noting the concerns raised in the previous sections                                                                                                                                                                                                                                       |                                        |
+-----------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------+
| **Results:**                            | **Results:**                                                                                                                                                                                                                                                                                                                                                 | **Results:**                           |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
| --                                      | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                                            | Long‐term exposure:                    |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
|                                         | The overall chronic exposure accounted for 48% of the ADI.                                                                                                                                                                                                                                                                                                   | 0--7% of the ADI                       |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
|                                         | The highest contributor was Chinese cabbage (20% of the ADI).                                                                                                                                                                                                                                                                                                | Short‐term exposure:                   |
|                                         |                                                                                                                                                                                                                                                                                                                                                              |                                        |
|                                         |                                                                                                                                                                                                                                                                                                                                                              | Not relevant since no ARfD was derived |
+-----------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice; MRL: maximum residue limit.

John Wiley & Sons, Ltd

4.32. Fenazaquin (297) (R/T) {#efs25306-sec-0208}
----------------------------

### 4.32.1. Background information (Table [149](#efs25306-tbl-0149){ref-type="table"}) {#efs25306-sec-0209}

###### 

Background information on fenazaquin

+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------+
|                         |                         | Comments, references                                                                                                  |
+=========================+=========================+=======================================================================================================================+
| Type of JMPR evaluation | New compound evaluation | --                                                                                                                    |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------+
| RMS                     | DE                      | --                                                                                                                    |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------+
| Approval status         | Approved                | Commission Implementing Directive 2011/39/EU[a](#efs25306-note-0175){ref-type="fn"}                                   |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion         | Yes, see comments       | EFSA ([2010i](#efs25306-bib-0025){ref-type="ref"}) (approval restricted to use on ornamentals in greenhouses)         |
|                         |                         |                                                                                                                       |
|                         |                         | EFSA ([2013d](#efs25306-bib-0047){ref-type="ref"}) (application for amendment of approval conditions)                 |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------+
| MRL review              | No                      | Ongoing                                                                                                               |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------+
| MRL applications        | Yes, see comments       | EFSA ([2010c](#efs25306-bib-0019){ref-type="ref"}) in tea (dried or fermented leaves and stalks of Camellia sinensis) |
+-------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

2011/39/EU: Commission Implementing Directive 2011/39/EU of 11 April 2011 amending Council Directive 91/414/EEC to include fenazaquin as active substance and amending Commission Decision 2008/934/EC OJ L 97, 12.4.2011, p. 30--33.

John Wiley & Sons, Ltd

### 4.32.2. Toxicological reference values -- fenazaquin (Table [150](#efs25306-tbl-0150){ref-type="table"}) {#efs25306-sec-0210}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | EU evaluation                                                               | TRV comparable         |                                                                                                                                                               |     |
+========================+===================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=============================================================================+========================+===============================================================================================================================================================+=====+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR, 2017,                                                                 | 0.005 mg/kg bw per day | EFSA ([2010i](#efs25306-bib-0025){ref-type="ref"}) confirmed by EFSA ([2013d](#efs25306-bib-0047){ref-type="ref"}) (2‐year oral rat study, UF 100)            | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (NOAEL combined chronic toxicity and carcinogenicity study in rats, UF 100) |                        |                                                                                                                                                               |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.1 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | JMPR, 2017                                                                  | 0.1 mg/kg bw           | EFSA ([2010i](#efs25306-bib-0025){ref-type="ref"}) confirmed by EFSA ([2013d](#efs25306-bib-0047){ref-type="ref"}) (rat developmental toxicity study, UF 100) | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | NOAEL of rat developmental toxicity study, UF 100)                          |                        |                                                                                                                                                               |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | For [fenazaquin]{.ul}, the EU and JMPR ADI are both derived from the same study, but using a different NOAEL, resulting in a 10 times lower EU ADI.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        | In the EFSA conclusion, the increased incidence of focal hepatocellular atypia was considered adverse, whereas in the JMPR assessment, this effect was considered of uncertain significance as the incidence of this lesion is highly variable in this strain and no other pathological changes were observed. In the absence of a more detailed assessment justifying the non‐relevance of this finding, EFSA is not in a position to change the NOAEL into a higher value. The RMS noted that, from a scientific point of view, the ADI derived from JMPR is supported. The existing EU value should be discussed considering the more recent evaluation by JMPR in a post annex I procedure or latest in the renewal procedure for fenazaquin. |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        | [Metabolites:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        | For the plant metabolite **TBPE**, in the EFSA conclusion (2013d), it was concluded that it is of higher toxicity than fenazaquin, based on its classification for reproductive toxicity (Repr 2) and repeated dose toxicity (STOT 2). Reference values were derived on the basis of a specific 4‐week rat study and additional uncertainty factors to cover the extrapolation to chronic toxicity and the uncertainties over reproductive toxicity and damage after prolonged exposure (total UF 10 000), resulting in a value of 0.002 mg/kg bw (per day).                                                                                                                                                                                      |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        | For the metabolite **M34** (2‐\[4‐(carboxymethyl)phenyl\]‐2‐methylpropanoic acid), insufficient data were available during the EU peer review to conclude on its toxicity profile (EFSA, [2013d](#efs25306-bib-0047){ref-type="ref"}).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        | The metabolite **4‐OHQ** (quinazolin‐4‐ol) was concluded of lower toxicity than fenazaquin, but no reference values were mentioned. The conclusion of JMPR that the reference values of fenazaquin can be applied seems reasonable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        | For the metabolite **2‐oxy**‐fenazaquin (identified in groundwater), no toxicological data were available.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                             |                        |                                                                                                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                             |                        |                                                                                                                                                               |     |
|                        | For the metabolite 2‐hydroxyfenazaquin acid, a major metabolite in livestock, no toxicological data were available, neither to JMPR nor to EFSA. JMPR considered that its toxicological properties are covered by studies on parent compound since it was present as a major metabolite in faeces. In EU assessments, metabolites in faeces are not considered to be covered by the parent, since they might not have been absorbed (i.e. bioavailable). As a consequence, EFSA would not support the approach of JMPR for this metabolite                                                                                                                                                                                                        |                                                                             |                        |                                                                                                                                                               |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.32.3. Residue definitions -- fenazaquin (Table [151](#efs25306-tbl-0151){ref-type="table"}) {#efs25306-sec-0211}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+-------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR evaluation                     | EU evaluation                                               | RDs comparable |
+=========================+===================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================+=============================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Fenazaquin                          | Reg. 396/2005: Fenazaquin                                   | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     | Peer review: Fenazaquin (applicable to fruit);              |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+-------------------------------------------------------------+----------------+
| Animal products         | Sum of fenazaquin and the metabolite 2‐hydroxy‐fenazaquin acid expressed as fenazaquin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Reg. 396/2005: Fenazaquin           | No                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Peer review: Fenazaquin (ruminants) |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | The residue is fat soluble          |                                                             |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+-------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Fenazaquin                          | Peer review: Fenazaquin;                                    | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     | TBPE                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     | These RD are applicable to unprocessed and processed fruit. |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+-------------------------------------------------------------+----------------+
| Animal products         | Sum of fenazaquin and the metabolite 2‐hydroxy‐fenazaquin acid expressed as fenazaquin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Fenazaquin (ruminants)              | No                                                          |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+-------------------------------------------------------------+----------------+
| **Conclusion/comments** | The proposed enforcement RD for plants of JMPR is identical with the current EU residue definition established in the MRL legislation.                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         | The other residue definitions are not fully compatible. The difference in residue definition for animal products is currently of no relevance as regards the proposed Codex MRLs (MRL proposals only for plant products).                                                                                                                                                                                                                                                                                                                                                         |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         | For plants products, the peer review suggested two separate RA RDs (see above) based on a metabolism study in grapes.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         | Rationale (EFSA, [2013d](#efs25306-bib-0047){ref-type="ref"}): For fenazaquin and metabolite TBPE, separate risk assessments are conducted due to the different toxicological reference values (TBPE is of higher toxicity than fenazaquin).                                                                                                                                                                                                                                                                                                                                      |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         | JMPR assessed two metabolism studies in apples, one in oranges, grapes and maize. TBPE was not considered as a relevant metabolite by JMPR. It accounted for 2--5% of TRR in apples, \< 6% of TRR in grapes (\< 0.16 mg eq./kg): In oranges and maize, it was not identified. (This information should be verified in the JMPR evaluation).                                                                                                                                                                                                                                       |                                     |                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                     |                                                             |                |
|                         | As regards the separate RD RA for plants (TBPE), the RMS noted that no further in‐depth evaluation could be conducted on the continued need for setting of a 2nd RD for TBPE, and the EU position stands as it is. However, for benefits of aligning RD between JMPR and EU as much as possible it is strongly recommended to revisit this question as soon as possible, thereby taking into account potentially new data and new tools (QSAR) which were not available in the course of the peer review in order to decide whether such a high UF of 10 000 is further justified |                                     |                                                             |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+-------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.32.4. Codex MRL proposals -- fenazaquin (Table [152](#efs25306-tbl-0152){ref-type="table"}) {#efs25306-sec-0212}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity            | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | EU MRL                                       | Comment                                                                                                                                                                                                |
+======================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==============================================+========================================================================================================================================================================================================+
| Subgroup of cherries | **2**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.3                                          | Critical GAP: USA, 1 × 504 g/ha, 3 days PHI                                                                                                                                                            |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
| (inc                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              | Number of trials: 5                                                                                                                                                                                    |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              | Sufficiently supported by data: For import tolerances in the EU at least 8 trials would be required. In Codex, cherries are also considered a major crop (crop for which refinement criteria applied). |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU legislative system, considering the different RA RDs                              |
+----------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Hops, dry            | **30**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25306-note-2009){ref-type="fn"} | Critical GAP: USA, 1 × 504 g/ha, PHI 7 days.                                                                                                                                                           |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              | Number of trials: 7                                                                                                                                                                                    |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              | Sufficiently supported by data: Yes                                                                                                                                                                    |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              | Specific comments/observations:                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU legislative system, considering the different RA RDs                              |
+----------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| General comment:     | In the light of the outcome of the peer review, the existing EU MRL for fenazaquin in tea should be reconsidered. It has been established in 2010 following an import tolerance request. At that time, the risk assessment was only performed for fenazaquin. The second RD (TBPE) has been derived later in the framework of the peer review.                                                                                                                                                                                                                        |                                              |                                                                                                                                                                                                        |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                              |                                                                                                                                                                                                        |
|                      | The RMS proposed to perform an indicative risk assessment for TBPE, based on information on the expected proportion of this metabolite observed in metabolism studies. This type of tentative calculation could be performed by EFSA at a later stage. However, for the chronic risk assessment, the conclusions of an indicative risk assessment will be of low reliability, since currently no comprehensive information is available on all approved GAPs to decide whether the data from metabolism studies are sufficiently representative for all existing uses |                                              |                                                                                                                                                                                                        |
+----------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

EU MRL: European Union maximum residue limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.32.5. Consumer risk assessment -- fenazaquin (Table [153](#efs25306-tbl-0153){ref-type="table"}) {#efs25306-sec-0213}

###### 

Summary of the consumer risk assessment for fenazaquin

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                      | Chronic exposure assessment                                                                                                                                                                                                                                                                                               | Comments on JMPR exposure assessment |
+================================================================================================================================================================================================+===========================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                            | **RA assumptions:**                                                                                                                                                                                                                                                                                                       | **Specific comments**                |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           |                                      |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           | --                                   |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| The risk assessment could be only performed for the parent compound. For the second EU RD (TBPE), no residue data are reported by JMPR. Thus, the outcome of the risk assessment is tentative. |                                                                                                                                                                                                                                                                                                                           |                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| The short‐term dietary risk assessment was performed for the crops for which JMPR derived MRL proposals as outlined in Section [4.32.2](#efs25306-sec-0210){ref-type="sec"}.                   | The most recent long‐term risk assessment (EFSA, [2010c](#efs25306-bib-0019){ref-type="ref"} in tea (dried or fermented leaves and stalks of Camellia sinensis)) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for hops and cherries. The EU ADI was used |                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                   | **Results:**                                                                                                                                                                                                                                                                                                              | **Results:**                         |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           |                                      |
| The short‐term exposure did not exceed the ARfD (cherries: 11.8% of the ARfD, hops: 1.6% of the ARfD)                                                                                          | The calculated long‐term consumer for fenazaquin did not exceed the ADI (90.2%). The contribution of cherries and hops was 4% and 1.1%, respectively                                                                                                                                                                      | Long‐term exposure:                  |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           |                                      |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           | 0.2% of the ADI                      |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           |                                      |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           | Short‐term exposure:                 |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           |                                      |
|                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                           | 10% of the ARfD                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.
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4.33. Fenpyrazamine (298) (R/T) {#efs25306-sec-0214}
-------------------------------

### 4.33.1. Background information (Table [154](#efs25306-tbl-0154){ref-type="table"}) {#efs25306-sec-0215}

###### 

Background information on fenpyrazamine

                                                      Comments, references
  ------------------------- ------------------------- ---------------------------------------------------------------------------------------------------------------------------------
  Type of JMPR evaluation   New compound evaluation   
  RMS                       AT                        
  Approval status           Approved                  Commission Implementing Regulation (EU) No 2012/595[a](#efs25306-note-0181){ref-type="fn"}
  EFSA conclusion           Yes, see comments         EFSA ([2012a](#efs25306-bib-0034){ref-type="ref"})
  MRL review                Yes, see comments         EFSA ([2017l](#efs25306-bib-0120){ref-type="ref"})
  MRL applications          Yes, see comments         EFSA ([2018f](#efs25306-bib-0126){ref-type="ref"}) (in lettuce and salads plants, escarole, spinach and similar (leaves) group)

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

595/2012/EU: Commission Implementing Regulation (EU) No 595/2012 of 5 July 2012 approving the active substance fenpyrazamine, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 OJ L 176, 6.7.2012, p. 46--49.

John Wiley & Sons, Ltd

### 4.33.2. Toxicological reference values -- fenpyrazamine (Table [155](#efs25306-tbl-0155){ref-type="table"}) {#efs25306-sec-0216}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | EU evaluation                                                    | TRV comparable        |                                                                                                                                                                  |    |
+========================+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==================================================================+=======================+==================================================================================================================================================================+====+
| **ADI**                | 0.3 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | JMPR, 2017 (Overall NOAEL of 25 mg/kg bw per day in dog studies) | 0.13 mg/kg bw per day | EFSA ([2012a](#efs25306-bib-0034){ref-type="ref"}) (2 years rat, uncertainty factor 100) as in European Commission ([2012a](#efs25306-bib-0142){ref-type="ref"}) | No |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 0.8 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR, 2017 (Acute neurotoxicity study in rats)                   | 0.3 mg/kg bw          | EFSA ([2012a](#efs25306-bib-0034){ref-type="ref"}) (Developmental                                                                                                | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                  |                       |                                                                                                                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                  |                       | study rabbit, uncertainty factor 100) as in European Commission ([2012a](#efs25306-bib-0142){ref-type="ref"})                                                    |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | The JMPR and EFSA used a different study for setting the ADI. EFSA considered more appropriate to use the 2‐year rat study than the dog studies. This was because EFSA set a lower NOAEL of 12.7 mg/kg bw per day in the 2‐year rat study than JMPR (i.e. NOAEL of 52 mg/kg bw per day). JMPR identified decreased body weight as critical effect for setting the NOAEL of 52 mg/kg bw per day. It is not clear to EFSA why JMPR disregarded liver toxicity for setting the NOAEL, and therefore, EFSA still support the ADI as set during the peer review.                                                                                                                                    |                                                                  |                       |                                                                                                                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                  |                       |                                                                                                                                                                  |    |
|                        | The JMPR and EFSA used a different study for setting the ARfD. EFSA considered more appropriate to use the developmental rabbit study where a lower NOAEL was set compared to the acute neurotoxicity study. It is not clear to EFSA why JMPR disregarded the developmental rabbit study for setting the ARfD. As explained by the RMS dose‐related premature deliveries/abortions were observed, which might derive from complete food refusal of these dams for several days prior to the premature delivery. Since it is not clear why the dams refused to feed and at which time point of the pregnancy these effects might be induced, this was considered relevant for setting the ARfD. |                                                                  |                       |                                                                                                                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                  |                       |                                                                                                                                                                  |    |
|                        | The data available indicated that the metabolite S‐2188‐OH is probably of comparable toxicity as the precursor S‐2188‐DC and parent compound fenpyrazamine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                  |                       |                                                                                                                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                  |                       |                                                                                                                                                                  |    |
|                        | The toxicological profile of MPPZ and S‐2188‐CH~2~‐OH‐DC was not discussed during the EFSA peer review. JMPR identified these metabolites in laying hen and goat, respectively, noting that these compounds occurred in the rat metabolism. EFSA would support that metabolites MPPZ and S‐2188‐CH~2~‐OH‐DC can be considered covered by parent on the basis of rat metabolism studies                                                                                                                                                                                                                                                                                                         |                                                                  |                       |                                                                                                                                                                  |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; NOAEL: no observed adverse effect level.

John Wiley & Sons, Ltd

### 4.33.3. Residue definitions -- fenpyrazamine (Table [156](#efs25306-tbl-0156){ref-type="table"}) {#efs25306-sec-0217}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                     | JMPR evaluation                                                                                                           | EU evaluation                                    | RDs comparable |
+=========================+=====================================================================================================================================================================+===========================================================================================================================+==================================================+================+
| **RD enf**              | Plant products                                                                                                                                                      | Fenpyrazamine                                                                                                             | Fenpyrazamine                                    | Yes            |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| Animal products         | Sum of fenpyrazamine and 5‐amino‐1,2‐dihydro‐2‐isopropyl‐4‐(o‐tolyl)pyrazol‐3‐one (S‐2188‐DC), expressed as fenpyrazamine                                           | Reg. 396/2005: fenpyrazamine                                                                                              | No, but JMPR RD is comparable proposed new EU RD |                |
|                         |                                                                                                                                                                     |                                                                                                                           |                                                  |                |
|                         | The residue is not fat soluble                                                                                                                                      | EFSA conclusion: Sum fenpyrazamine and S‐2188‐DC, expressed as fenpyrazamine                                              |                                                  |                |
|                         |                                                                                                                                                                     |                                                                                                                           |                                                  |                |
|                         |                                                                                                                                                                     | The residue is not fat soluble                                                                                            |                                                  |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                      | Sum of fenpyrazamine and 5‐amino‐1,2‐dihydro‐2‐isopropyl‐4‐(o‐tolyl)pyrazol‐3‐one (S‐2188‐DC), expressed as fenpyrazamine | Sum fenpyrazamine and S‐2188‐DC, expressed as    | Yes            |
|                         |                                                                                                                                                                     |                                                                                                                           |                                                  |                |
|                         |                                                                                                                                                                     |                                                                                                                           | fenpyrazamine                                    |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| Animal products         | Sum of fenpyrazamine and 5‐amino‐1,2‐dihydro‐2‐isopropyl‐4‐(o‐tolyl)pyrazol‐3‐one (S‐2188‐DC), expressed as fenpyrazamine                                           | Sum of fenpyrazamine, S‐2188‐DC, S‐2188‐CH~2~OH‐DC and MPPZ (provisional)                                                 | No                                               |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for plant commodities are comparable.                                                                                                       |                                                                                                                           |                                                  |                |
|                         |                                                                                                                                                                     |                                                                                                                           |                                                  |                |
|                         | MPPZ was found in metabolism study in poultry (15.9--34.1% TRR), while S‐2188‐CH~2~OH‐DC was a metabolite found in goat muscle, kidney and liver (12.7--29.2% TRR). |                                                                                                                           |                                                  |                |
|                         |                                                                                                                                                                     |                                                                                                                           |                                                  |                |
|                         | According to JMPR, the two metabolites were found at low concentrations and were found in rats                                                                      |                                                                                                                           |                                                  |                |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.
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### 4.33.4. Codex MRL proposals -- fenpyrazamine (Table [157](#efs25306-tbl-0157){ref-type="table"}) {#efs25306-sec-0218}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                            | Codex MRL proposal                                | EU MRL                                                                                                                                       | Comment                                                                                                                                                                                                                                                                                                                                                  |
+======================================================================+===================================================+==============================================================================================================================================+==========================================================================================================================================================================================================================================================================================================================================================+
| Subgroup of cherries (includes all commodities in this subgroup)     | 3                                                 | 4                                                                                                                                            | Critical GAP: Austria 3 × 600 g ai/ha, interval 7 days; PHI 1 day                                                                                                                                                                                                                                                                                        |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 12                                                                                                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: The EU MRL is based on the same GAP and data (8 NEU and 4 SEU trials) (EFSA, [2017l](#efs25306-bib-0120){ref-type="ref"}). JMPR has merged the NEU and SEU data, while in the EU, the MRL was derived from the NEU data set only.                                                                                        |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: Based on the NEU trials, an MRL of 4 mg/kg would be needed for NEU.                                                                                                                                                                                                                                                                          |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of plums (includes all 2 commodities in this subgroup)      | 2                                                 | 3                                                                                                                                            | Critical GAP: Austria 3 × 600 g ai/ha, interval 7 days; PHI=1 day.                                                                                                                                                                                                                                                                                       |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 16                                                                                                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: The 16 trials are derived from 8 NEU and 8 SEU trials (2017l)                                                                                                                                                                                                                                                            |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL should be reconsidered. Based on the NEU trials, an MRL of 3 mg/kg would be required.                                                                                                                                                                                                                                 |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of peaches (includes all commodities in this subgroup)      | 4                                                 | 4                                                                                                                                            | Critical GAP: Austria 3 × 600 g ai/ha, interval 7 days; PHI=1 day                                                                                                                                                                                                                                                                                        |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   | Art 12 proposal (not yet implemented)                                                                                                        | Number of trials: 6 on apricots (2 NEU + 4 SEU); 12 on peaches (4 NEU + 8 SEU)                                                                                                                                                                                                                                                                           |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   | 5 (peaches)                                                                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   | 5 (apricots)                                                                                                                                 | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                       |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: Based on the SEU trials, an MRL proposal of 5 mg/kg was derived for peaches and apricots. Thus, the proposed Codex MRL should be reconsidered                                                                                                                                                                                                |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of cane berries (includes all commodities in this subgroup) | 5                                                 | 5                                                                                                                                            | Critical GAP: USA 3 × 560 g ai/ha, interval 7 days; PHI = 0 day                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 4 trials on blackberries and raspberries                                                                                                                                                                                                                                                                                               |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: EU import tolerance was based on the same GAP.                                                                                                                                                                                                                                                                           |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of bush berries (includes all commodities in this subgroup) | **4**                                             | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Critical GAP: USA 3 × 560 g ai/ha, interval 7 days; PHI = 0 day                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   | Art. 12 proposals                                                                                                                            | Number of trials: 8                                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   | 4 blueberries; no proposals for other crops listed under 'bush berries', i.e. currants, gooseberries, rose hips, mulberries and elderberries | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Same trials (7 GAP compliant and 1 overdosed trials on blueberries) as evaluated by EFSA (EFSA, [2017l](#efs25306-bib-0120){ref-type="ref"}).                                                                                                                                                                            |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable for blueberries. According to the EU extrapolation rules, blueberry trials cannot be used for extrapolation to the other crops listed under the Codex group of bushberries. It is noted that the Codex group of bushberries does not comprise cranberries and azaroles                                  |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapes                                                               | **4**                                             | 3                                                                                                                                            | Critical GAP: FR, foliar spray 3 × 560 g ai/ha, interval not specified; PHI = 3 days                                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 14                                                                                                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: the meeting used North American data set. It is noted that using the OECD calculator, an MRL of 3 mg/kg is derived.                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is should be aligned with the result of the OECD calculator (3 mg/kg)                                                                                                                                                                                                                                                 |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dried grapes                                                         | 12                                                |                                                                                                                                              | A processing factor was derived for dried grapes (best estimate 3.1)                                                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: This proposal needs to be reconsidered, taking into account the conclusions on grapes. If the MRL for grapes is agreed to be set at a level of 3 mg/kg, the MRL for dried grapes would be 9 mg/kg.                                                                                                                                           |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberry                                                           | 3                                                 | 3                                                                                                                                            | Critical GAP: USA foliar spray 4 × 560 g ai/ha, interval 7--14 days; PHI = 0 days; in addition, EU indoor and outdoor GAP                                                                                                                                                                                                                                |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 7 for US GAP, 7 for EU indoor, 7 EU outdoor.                                                                                                                                                                                                                                                                                           |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Although JMPR considered 1 trial less than EFSA, the overall MRL, HR and STMR are more or less the same.                                                                                                                                                                                                                 |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cucumber                                                             | 0.7                                               | 0.7                                                                                                                                          | Critical GAP: France indoor 3 × 600 g ai/ha, interval 10 days; PHI = 1 day                                                                                                                                                                                                                                                                               |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Same trials (8 GAP compliant on cucumber) were evaluated by EFSA.                                                                                                                                                                                                                                                        |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, sweet (including pimento or pimiento)                       | 3                                                 | 3                                                                                                                                            | Critical GAP: France indoor 3 × 600 g ai/ha, interval 10 days; PHI = 1 day                                                                                                                                                                                                                                                                               |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Same trials (8 GAP compliant on sweet peppers) as evaluated by EFSA.                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                               | 3                                                 | 3                                                                                                                                            | Critical GAP: France indoor 3 × 600 g ai/ha, interval 10 days; PHI = 1 day                                                                                                                                                                                                                                                                               |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Same trials (8 GAP compliant on cherry tomatoes) as evaluated by EFSA.                                                                                                                                                                                                                                                   |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                        | 3                                                 | 3                                                                                                                                            | Same GAP and trials as for tomatoes.                                                                                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of eggplants(includes all commodities in this subgroup)     | 3                                                 | 3                                                                                                                                            | Critical GAP: France indoor 3 × 600 g ai/ha, interval 10 days; PHI = 1 day                                                                                                                                                                                                                                                                               |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Same trials (8 GAP compliant on cherry tomatoes) as evaluated by EFSA were used to extrapolate to eggplants.                                                                                                                                                                                                             |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lettuce, Head                                                        | **1.5**                                           | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Critical GAP: USA 3 × 560 g ai/ha, interval 7--10 days, PHI = 14 days                                                                                                                                                                                                                                                                                    |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 8 + 8                                                                                                                                                                                                                                                                                                                                  |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Combined residues for head and leaf lettuce (n = 16) were pooled to derive the proposed MRL.                                                                                                                                                                                                                             |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lettuce, Leaf                                                        | **1.5**                                           | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Critical GAP: USA 3 × 560 g ai/ha, interval 7--10 days, PHI = 14 days                                                                                                                                                                                                                                                                                    |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 8 + 8                                                                                                                                                                                                                                                                                                                                  |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: Combined residues for head and leaf lettuce (n = 16) were pooled to derive the proposed MRL.                                                                                                                                                                                                                             |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Ginseng                                                              | **0.7**                                           | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Critical GAP: USA 4 × 560 g ai/ha, interval 7--10 days, PHI = 2 days                                                                                                                                                                                                                                                                                     |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 3                                                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: according to JMPR rules, 3 trials are sufficient.                                                                                                                                                                                                                                                                        |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: HR of 3 trials compliant to US GAP was taken                                                                                                                                                                                                                                                                             |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. It is noted that in the EU classification, ginger root is in the group of herbal infusions (dried roots). Thus, a dehydration factor would be required if the Codex MRL is taken over in the EU legislation |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Almond                                                               | 0.01[\*](#efs25306-note-2008){ref-type="fn"}      | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Critical GAP: USA GAP 3 × 420 g ai/ha, interval: not defined, PHI = 21 days                                                                                                                                                                                                                                                                              |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Number of trials: 3 (1 GAP compliant, 2 with 2 applications)                                                                                                                                                                                                                                                                                             |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Sufficiently supported by data: No, at least 4 trials would be required according to JMPR rules.                                                                                                                                                                                                                                                         |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Specific comments/observations: A tentative EU MRL was derived from 5 GAP compliant trials (EFSA, [2017l](#efs25306-bib-0120){ref-type="ref"}).                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: Considering that the proposed MRL is at the LOQ, the MRL is acceptable                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                    | **0.02** [\*](#efs25306-note-2008){ref-type="fn"} | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Maximum and mean dietary burden were calculated using the mean residues for grape wet pomace.                                                                                                                                                                                                                                                            |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | No feeding study on cattle. MRL proposal was derived from goat metabolism study with 7.2 ppm in diet.                                                                                                                                                                                                                                                    |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable. It refers to the RD derived by JMPR                                                                                                                                                                                                                                                                    |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                        | **0.02** [\*](#efs25306-note-2008){ref-type="fn"} | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Maximum and mean dietary burden were calculated using the mean residues for grape wet pomace.                                                                                                                                                                                                                                                            |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | No feeding study on cattle. MRL proposal was derived from goat metabolism study with 7.2 ppm in diet.                                                                                                                                                                                                                                                    |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable. It refers to the RD derived by JMPR                                                                                                                                                                                                                                                                    |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                | 0.01[\*](#efs25306-note-2008){ref-type="fn"}      | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | No feeding study on cattle (goat metabolism study).                                                                                                                                                                                                                                                                                                      |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                             | **0.05**                                          | 0.01[\*](#efs25306-note-2008){ref-type="fn"}                                                                                                 | Maximum and mean dietary burden were calculated using the mean residues for grape wet pomace.                                                                                                                                                                                                                                                            |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | No feeding study on cattle. Residues in liver of goat metabolism study were scaled to the expected DB (AUS)                                                                                                                                                                                                                                              |
|                                                                      |                                                   |                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                          |
|                                                                      |                                                   |                                                                                                                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------+---------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue limit; PHI:preharvest interval; NEU: northern European Union; HR: highest residue; STMR: supervised trials median residue.

\* Indicates that the input value is proposed at the limit of quantification.
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### 4.33.5. Consumer risk assessment -- fenpyrazamine (Table [158](#efs25306-tbl-0158){ref-type="table"}) {#efs25306-sec-0219}

###### 

Summary of the consumer risk assessment for fenpyrazamine

+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                 | Chronic exposure assessment                                                                                                                                                                                                                                                   | Comments on JMPR exposure assessment |
+===========================================================================================================================================================================================================================================================+===============================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                       | **RA assumptions:**                                                                                                                                                                                                                                                           | **Specific comments**                |
|                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                               |                                      |
| The short‐term dietary risk assessment was performed with the PRIMO used for the Art. 12 review (EFSA, [2017l](#efs25306-bib-0120){ref-type="ref"}) by including higher JMPR proposals for blueberries, grapes, lettuces, ginseng and animal commodities. | The most recent long‐term risk assessment (EFSA, [2017l](#efs25306-bib-0120){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for blueberries, grapes, lettuces, ginseng and animal commodities | --                                   |
|                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                               |                                      |
| The EU ARfD was used.                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                               |                                      |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                              | **Results:**                                                                                                                                                                                                                                                                  | **Results:**                         |
|                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                               |                                      |
| No short‐term exposure concern was identified (74.2% of the ARfD for table grapes)                                                                                                                                                                        | No long‐term consumer health risk was identified.                                                                                                                                                                                                                             | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                               |                                      |
|                                                                                                                                                                                                                                                           | The overall chronic exposure accounted for 5.6% of the ADI (WHO Cluster diet B).                                                                                                                                                                                              | 0.3% of the ADI                      |
|                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                               |                                      |
|                                                                                                                                                                                                                                                           | The contribution of wine and table grapes to the exposure was 74.2% of the ADI                                                                                                                                                                                                | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                               |                                      |
|                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                               | 40% of the ARfD                      |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; EU: European Union.

John Wiley & Sons, Ltd

4.34. Isoprothiolane (299) (R/T) {#efs25306-sec-0220}
--------------------------------

### 4.34.1. Background information (Table [159](#efs25306-tbl-0159){ref-type="table"}) {#efs25306-sec-0221}

###### 

Background information on isoprothiolane

                                                      Comments, references
  ------------------------- ------------------------- --------------------------------------------------------------------------------
  Type of JMPR evaluation   New compound evaluation   
  RMS                       --                        
  Approval status           Not approved              Commission Regulation (EC) No 2076/2002[a](#efs25306-note-0186){ref-type="fn"}
  EFSA conclusion           No                        
  MRL review                No                        
  MRL applications          Yes, see comments         EFSA ([2012d](#efs25306-bib-0037){ref-type="ref"})

2076/2002: Commission Regulation (EC) No 2076/2002 of 20 November 2002 extending the time period referred to in Article 8(2) of Council Directive 91/414/EEC and concerning the non‐inclusion of certain active substances in Annex I to that Directive and the withdrawal of authorisations for plant protection products containing these substances. OJ L 319, 23.11.2002, p. 3--11.

John Wiley & Sons, Ltd

### 4.34.2. Toxicological reference values -- isoprothiolane (Table [160](#efs25306-tbl-0160){ref-type="table"}) {#efs25306-sec-0222}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+----------------------+-------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                    | EU evaluation                     | TRV comparable       |                                                                   |     |
+========================+====================================================================================================================================================================================================================================================================================================================================================================+===================================+======================+===================================================================+=====+
| **ADI**                | 0.1 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                               | JMPR, 2018,                       | 0.1 mg/kg bw per day | EFSA ([2012d](#efs25306-bib-0037){ref-type="ref"}),               | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                    |                                   |                      |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                    | 2‐year rat supported by 1‐yr dog, |                      | 1‐year and 2‐year dog studies; 2‐year rat, uncertainty factor 100 |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                    |                                   |                      |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                    | safety factor 100                 |                      |                                                                   |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+----------------------+-------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                        | JMPR, 2018                        | 0.12 mg/kg bw        | EFSA ([2012d](#efs25306-bib-0037){ref-type="ref"}),               | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                    |                                   |                      |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                    |                                   |                      | Rat developmental toxicity, uncertainty factor 100                |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+----------------------+-------------------------------------------------------------------+-----+
| **Conclusion/comment** | During the EU evaluation of isoprothiolane, it was considered that an ARfD should be derived since adverse effects were observed during the early phases of several studies. It was agreed to set an ARfD of 0.12 mg/kg bw based on increased incidences of unossified vertebral bodies in foetuses in the rat developmental study.                                |                                   |                      |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                    |                                   |                      |                                                                   |     |
|                        | For the metabolites M3 (4‐hydroxy isoprothiolane), M5 (1‐hydroxypropan‐2‐yl propan‐2‐yl 1,3‐dithiolan‐2‐ylidenemalonate) and M2 (monoester glucuronide conjugate), the JMPR assessment concluded that they are unlikely to be more toxic than the parent.                                                                                                          |                                   |                      |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                    |                                   |                      |                                                                   |     |
|                        | During the EU evaluation (EFSA, [2012d](#efs25306-bib-0037){ref-type="ref"}), limited toxicological data (acute and/or genotoxicity studies, no repeated dose study) were provided for two metabolites (didehydro isoprothiolane (M‐4) and 4‐hydroxy‐isoprothiolane (M‐3)) and no conclusion was derived on the reference values that could be applicable to them. |                                   |                      |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                    |                                   |                      |                                                                   |     |
|                        | For metabolite M‐2, EFSA cannot fully support the JMPR assessment based on the available data (considering that the genotoxic potential of the metabolite might be excluded on the basis of structural considerations, the extrapolation of the whole toxicity profile from the parent needs to be supported by more robust data)                                  |                                   |                      |                                                                   |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+----------------------+-------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.34.3. Residue definitions -- isoprothiolane (Table [161](#efs25306-tbl-0161){ref-type="table"}) {#efs25306-sec-0223}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                    | JMPR evaluation                                                                                                                                                                                                                                               | EU evaluation                                                                                                                                      | RDs comparable |
+=========================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============================================================================================================================================================================================================================================================+====================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Isoprothiolane                                                                                                                                                                                                                                                | Reg. 396/2005:                                                                                                                                     | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                               |                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                               | Isoprothiolane                                                                                                                                     |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of isoprothiolane and 2‐(1,3‐dithiolan‐2‐ylidene)‐3‐oxo‐3‐(propan‐2‐yloxy)propanoic acid (M‐2), expressed as isoprothiolane                                                                                                                                                                                                                                                                                                                                    | Reg. 396/2005: Isoprothiolane                                                                                                                                                                                                                                 | No                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                               |                                                                                                                                                    |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                     | The residue is not fat soluble                                                                                                                                                                                                                                |                                                                                                                                                    |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Rice: isoprothiolane                                                                                                                                                                                                                                          | EFSA ([2012d](#efs25306-bib-0037){ref-type="ref"}):                                                                                                | Yes (for rice) |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                               |                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Plants other than rice: Sum of isoprothiolane, diisopropyl‐4‐hydroxy‐1,3‐dithiolan‐2‐ylidenemalonate (M‐3); free and conjugated, and 1‐hydroxypropan‐2‐yl propan‐2‐yl 1,3‐dithiolan‐2‐ylidenemalonate (M‐5); free and conjugated, expressed as isoprothiolane | Isoprothiolane (residues in commodities of plant origin other than rice were not assessed in the framework of the EU import tolerance application) |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of isoprothiolane and 2‐(1,3‐dithiolan‐2‐ylidene)‐3‐oxo‐3‐(propan‐2‐yloxy)propanoic acid (M‐2), expressed as isoprothiolane                                                                                                                                                                                                                                                                                                                                    | EFSA ([2012d](#efs25306-bib-0037){ref-type="ref"}):                                                                                                                                                                                                           | No                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                               |                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Residues in livestock were not assessed in the framework of the EU import tolerance application                                                                                                                                                               |                                                                                                                                                    |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The paddy rice metabolism studies did not allow for the identification of potential metabolites due to the low application rate; no metabolites exceeded 0.01 mg eq/kg in rice grain at either 7 or 28 DALA. However, the potential contribution of isoprothiolane metabolites to the total consumer intake is covered by a wide safety margin of the calculated consumer exposure to isoprothiolane residues (EFSA, [2012d](#efs25306-bib-0037){ref-type="ref"}). |                                                                                                                                                                                                                                                               |                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                               |                                                                                                                                                    |                |
|                         | JMPR noted that metabolites M‐3 and M‐5 did not occur in rice grain; however, since these metabolites were the major residue in rotational crops at the 30‐day plant back interval, they were included in the residue definition for crops other than rice                                                                                                                                                                                                         |                                                                                                                                                                                                                                                               |                                                                                                                                                    |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.34.4. Codex MRL proposals -- isoprothiolane (Table [162](#efs25306-tbl-0162){ref-type="table"}) {#efs25306-sec-0224}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                                                                                                                                                                                                                                  | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                        |
+===============================================+=====================================================================================================================================================================================================================================================+==============================================+================================================================================================================================================================================================================================================================================================================================================================================================+
| Rice, husked                                  | **6**                                                                                                                                                                                                                                               | 5                                            | Critical GAP: Japan 9 g/box granule formulation application followed by 2 × 600 g/ha foliar application, PHI 14 days                                                                                                                                                                                                                                                                           |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Specific comments/observations: The EU import tolerance assessed the same Japanese GAP (granule formulation broadcast application 9 g a.s. to 5 L nursery box in combination with 2 × 600 g/ha ground spray application (EFSA, [2012d](#efs25306-bib-0037){ref-type="ref"})). Two trials were rejected (dust application not matching the cGAP). These trials, however, were accepted by JMPR. |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | The Codex MRL proposal refers to husked rice which corresponds to the part of the product to which the EU MRL applies for rice. Husked rice (stripped of the husk) is synonymous with brown rice, defined as rice after the removal of the hull from paddy rice.                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Conclusion: The proposed MRL is not acceptable, since only 6 GAP compliant trials were available. Two trials (the trails that were scaled by JMPR) do not reflect the GAP (dusting application instead of spray)                                                                                                                                                                               |
+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                | **1.5**                                                                                                                                                                                                                                             | --                                           | The JMPR derived a processing factor (PF) for polished rice of 0.25 on the basis of one study                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | 0.01[\*](#efs25306-note-2010){ref-type="fn"}                                                                                                                                                                                                        | 0.01[\*](#efs25306-note-2010){ref-type="fn"} | Only husked rice was considered as a livestock feed commodities by the JMPR, using the STMR of rice grain in the dietary burden calculation. For RD, see general comments below.                                                                                                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.01[\*](#efs25306-note-2010){ref-type="fn"}                                                                                                                                                                                                        | 0.01[\*](#efs25306-note-2010){ref-type="fn"} | For RD, see general comments below.                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | 0.01[\*](#efs25306-note-2010){ref-type="fn"}                                                                                                                                                                                                        | 0.01[\*](#efs25306-note-2010){ref-type="fn"} | For RD, see general comments below.                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | 0.01[\*](#efs25306-note-2010){ref-type="fn"}                                                                                                                                                                                                        | 0.01[\*](#efs25306-note-2010){ref-type="fn"} | For RD, see general comments below.                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| General comments                              | Considering that an MRL proposal was derived only for rice, the residue definition covering also M‐3 and M‐5 is currently not relevant.                                                                                                             |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               | For animal products, the residue definitions applicable in the EU and set by JMPR are different. A revision of the current EU residue definition should be considered, taking over the residue definition for animal products derived by JMPR.      |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
|                                               | It is noted that in the livestock dietary burden calculation, rice bran and rice straw were not included (data insufficient for rice straw). However, without these by‐products, the dietary burden might underestimate the actual dietary exposure |                                              |                                                                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; STMR: supervised trials median residue.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.34.5. Consumer risk assessment -- isoprothiolane (Table [163](#efs25306-tbl-0163){ref-type="table"}) {#efs25306-sec-0225}

###### 

Summary of the consumer risk assessment for isoprothiolane

+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                          | Chronic exposure assessment                                                                                                                                                                                           | Comments on JMPR exposure assessment |
+====================================================================================================================================+=======================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                | **RA assumptions:**                                                                                                                                                                                                   | **Specific comments**                |
|                                                                                                                                    |                                                                                                                                                                                                                       |                                      |
| The short‐term dietary risk assessment was performed for rice as outlined in Section [4.34.2](#efs25306-sec-0222){ref-type="sec"}. | The most recent long‐term risk assessment (EFSA, [2012d](#efs25306-bib-0037){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for rice. | --                                   |
|                                                                                                                                    |                                                                                                                                                                                                                       |                                      |
| The EU ARfD was used.                                                                                                              | The risk assessment assumes that no significant reduction of residues occurs during processing.                                                                                                                       |                                      |
|                                                                                                                                    |                                                                                                                                                                                                                       |                                      |
| The risk assessment assumes that no significant reduction of residues occurs during processing                                     | For animal products, the existing/proposed Codex MRLs were used                                                                                                                                                       |                                      |
+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                       | **Results:**                                                                                                                                                                                                          | **Results:**                         |
|                                                                                                                                    |                                                                                                                                                                                                                       |                                      |
| No short‐term exposure concern was identified (17% of the ARfD)                                                                    | No long‐term consumer health risk was identified.                                                                                                                                                                     | Long‐term exposure:                  |
|                                                                                                                                    |                                                                                                                                                                                                                       |                                      |
|                                                                                                                                    | The overall chronic exposure accounted for 1.7% of the ADI.                                                                                                                                                           | 2% of the ADI                        |
|                                                                                                                                    |                                                                                                                                                                                                                       |                                      |
|                                                                                                                                    | The contribution of rice to the exposure was 1.0% of the ADI                                                                                                                                                          | Short‐term exposure:                 |
|                                                                                                                                    |                                                                                                                                                                                                                       |                                      |
|                                                                                                                                    |                                                                                                                                                                                                                       | Not relevant                         |
+------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

John Wiley & Sons, Ltd

4.35. Natamycin (300) (R/T) {#efs25306-sec-0226}
---------------------------

### 4.35.1. Background information (Table [164](#efs25306-tbl-0164){ref-type="table"}) {#efs25306-sec-0227}

###### 

Background information on natamycin

                                                               Comments, references
  ------------------------- ---------------------------------- -------------------------------------------------------------
  Type of JMPR evaluation   New compound evaluation            
  RMS                       --                                 
  Approval status           --                                 Not assessed in the EU
  EFSA conclusion           No                                 
  MRL review                No                                 
  MRL applications          No                                 
  Other EFSA assessment     Yes, assessment as food additive   EFSA ANS Panel ([2009](#efs25306-bib-0108){ref-type="ref"})

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

John Wiley & Sons, Ltd

### 4.35.2. Toxicological reference values -- natamycin (Table [165](#efs25306-tbl-0165){ref-type="table"}) {#efs25306-sec-0228}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

                           JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                EU evaluation   TRV comparable        
  ------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ---------------- ---- -----
  **ADI**                  Not established                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                JMPR, 2017      --               --   N/A
  **ARfD**                 Not established                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                JMPR, 2017      --               --   N/A
  **Conclusion/comment**   No EU evaluation as pesticide. As food additive, the EFSA Panel on Food Additives and Nutrient Sources added to Food (EFSA ANS Panel, [2009](#efs25306-bib-0108){ref-type="ref"}) considered that the available data are not sufficiently robust for the purpose of deriving an ADI because of the limitations of the present database on natamycin (design of the animal studies, limited number of animals, lack of a carcinogenicity study) and in view of the inadequate description of the human data. This is line with JMPR assessment as a pesticide                                         

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.35.3. Residue definitions -- natamycin (Table [166](#efs25306-tbl-0166){ref-type="table"}) {#efs25306-sec-0229}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+---------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR evaluation                   | EU evaluation | RDs comparable |
+=========================+========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===================================+===============+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | Natamycin                         | --            | N/A            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                   |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | (for plant commodities and fungi) |               |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+---------------+----------------+
| Animal products         | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | --                                | N/A           |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | Natamycin                         | --            | N/A            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                   |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | (for plant commodities and fungi) |               |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+---------------+----------------+
| Animal products         | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | --                                | N/A           |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+---------------+----------------+
| **Conclusion/comments** | At EU level, natamycin has not been assessed for use in PPPs and no residue definition for use on plants has been set. Natamycin is not listed in any Annex of Regulation (EC) No 396/2005.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                   |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                   |               |                |
|                         | Natamycin is listed in the veterinary MRL Regulation (EU) No 37/2010[a](#efs25306-note-0193){ref-type="fn"}. Its use is restricted to topical application on bovine and equidae and does not require setting of an MRL and residue marker.                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                   |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                   |               |                |
|                         | In 2009, EFSA assessed natamycin as food additive. The highest potential exposure to natamycin was estimated to be below 0.1 mg/kg bw/day for children (97.5th percentile). Considering that this conservative estimate would provide an adequate margin of safety from the effect level seen from the long‐term animal studies and the human study used by JECFA to establish an ADI, the Panel considered that the proposed use levels of natamycin are not of safety concern if it is only used for the surface treatment of the rind of semihard and semisoft cheese and on the casings of certain sausages.                                                                       |                                   |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                   |               |                |
|                         | The residue definition as parent natamycin of JMPR is not based on metabolism studies in plants, but was derived based considerations that for the GAPs under consideration (post‐harvest uses in citrus and pineapples and uses in mushrooms) no degradation is expected. EFSA is of the opinion that the residue definition is not sufficiently supported by experimental data. Considering that the residue trials show a transfer from the peel to the pulp in citrus, the theoretical conditions on the residue behaviour on the surface are not sufficient. The nature of residues needs to be investigated in metabolism studies in representative crops for the intended uses. |                                   |               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                   |               |                |
|                         | Furthermore, the possible development and/or transfer of resistance may need to be addressed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                   |               |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

37/2010: Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 015 20.1.2010, p. 1.

John Wiley & Sons, Ltd

### 4.35.4. Codex MRL proposals -- natamycin (Table [167](#efs25306-tbl-0167){ref-type="table"}) {#efs25306-sec-0230}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+---------------------------------+--------------------+--------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                       | Codex MRL proposal | EU MRL | Comment                                                                                                                                                                                                                                                                                                                                                                                                                          |
+=================================+====================+========+==================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Group of Citrus fruit (includes | 5(Po)              | --     | A Codex MRL proposal was reported (5 mg/kg) only in the JMPR report (p. 307), but this MRL proposal is not mentioned in the Annex 1 (p. 440). On p. 307, JMPR concluded that the residue trials are suitable for establishing an MRL. However, since no toxicological reference values were derived, the dietary risk assessment could not be completed.                                                                         |
|                                 |                    |        |                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| all commodities in this group)  |                    |        | EFSA noted a number of deficiencies related to the MRL proposal (e.g. lack of storage stability data, nature of residues in edible part of the crop is expected to be different due to hydrolytic degradation under acidic conditions, method to calculate the MRL for post‐harvest uses is 'mean + 4 SD' for Po, which leads to a MRL proposal of 4 mg/kg; lack of toxicological reference values to perform a risk assessment) |
|                                 |                    |        |                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                 |                    |        | Conclusion: The proposed Codex MRL is not acceptable due to the deficiencies listed above and due to the residue definition that is not sufficiently supported by data                                                                                                                                                                                                                                                           |
+---------------------------------+--------------------+--------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue limit.

John Wiley & Sons, Ltd

### 4.35.5. Consumer risk assessment -- natamycin (Table [168](#efs25306-tbl-0168){ref-type="table"}) {#efs25306-sec-0231}

###### 

Summary of the consumer risk assessment for natamycin

+---------------------------+-----------------------------+---------------------------------------------------+
| Acute exposure assessment | Chronic exposure assessment | Comments on JMPR exposure assessment              |
+===========================+=============================+===================================================+
| **RA assumptions:**       | **RA assumptions:**         | **Specific comments**                             |
|                           |                             |                                                   |
| --                        | --                          | JMPR has not conducted a consumer risk assessment |
+---------------------------+-----------------------------+---------------------------------------------------+
| **Results:**              | **Results:**                | **Results:**                                      |
|                           |                             |                                                   |
| N/A                       | N/A                         | **--**                                            |
+---------------------------+-----------------------------+---------------------------------------------------+

RA: risk assessment.

John Wiley & Sons, Ltd

4.36. Phosphonic acid (301) (R/T) {#efs25306-sec-0232}
---------------------------------

### 4.36.1. Background information (Table [169](#efs25306-tbl-0169){ref-type="table"}) {#efs25306-sec-0233}

###### 

Background information on phosphonic acid

                                                      Comments, references
  ------------------------- ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type of JMPR evaluation   New compound evaluation   
  RMS                       FR                        
  Approval status           Not approved              Assessed as metabolite of fosetyl, potassium phosphonate and disodium phosphonate
  EFSA conclusion           Yes, see comments         Fosetyl (EFSA, [2005b](#efs25306-bib-0004){ref-type="ref"} -- corrigendum 2013), Disodium phoshonate (EFSA, [2013e](#efs25306-bib-0048){ref-type="ref"}), Potassium phosphonate (EFSA, [2012h](#efs25306-bib-0041){ref-type="ref"}, corrigendum 2013)
  MRL review                --                        See fosetyl
  MRL applications          --                        See fosetyl

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

John Wiley & Sons, Ltd

### 4.36.2. Toxicological reference values -- phosphonic acid (Table [170](#efs25306-tbl-0170){ref-type="table"}) {#efs25306-sec-0234}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | EU evaluation | TRV comparable        |                                                                                                                                                                                                                                                                                                                                                                              |     |
+========================+===================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+==============================================================================================================================================================================================================================================================================================================================================================================+=====+
| **ADI**                | 1 mg/kg bw per day (Applies to fosetyl‐aluminium and phosphonic acid, expressed as fosetyl‐aluminium)                                                                                                                                                                                                                                                                                                                                                                             | JMPR, 2017    | 2.25 mg/kg bw per day | EFSA ([2012h](#efs25306-bib-0041){ref-type="ref"}, [2012i](#efs25306-bib-0042){ref-type="ref"}, [2012j](#efs25306-bib-0043){ref-type="ref"}, [2013a](#efs25306-bib-0044){ref-type="ref"}, [2013b](#efs25306-bib-0045){ref-type="ref"}, [2013c](#efs25306-bib-0046){ref-type="ref"}, [2013d](#efs25306-bib-0047){ref-type="ref"}--[e](#efs25306-bib-0048){ref-type="ref"})    | No  |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | JMPR, 2017    | Unnecessary           | EFSA ([2012h](#efs25306-bib-0041){ref-type="ref"}, [2012i](#efs25306-bib-0042){ref-type="ref"}, [2012j](#efs25306-bib-0043){ref-type="ref"}, [2013a](#efs25306-bib-0044){ref-type="ref"}, [2013b](#efs25306-bib-0045){ref-type="ref"}, [2013c](#efs25306-bib-0046){ref-type="ref"}, [2013d](#efs25306-bib-0047){ref-type="ref"}--[2013e](#efs25306-bib-0048){ref-type="ref"} | Yes |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | For the ADI of phosphonic acid, considered as the major metabolite of fosetyl‐Al and fosetyl, JMPR has proposed to use the ADI of fosetyl‐Al. During the EU evaluations, it has been considered more relevant to use the 2‐year rat study performed with the hydrated monosodium phosphonate, with a correction for the content of water (25.9%) and for the molecular weight of monosodium phosphonate vs. phosphonic acid. The resulting ADI is 2.25 mg/kg bw per day (UF 100). |               |                       |                                                                                                                                                                                                                                                                                                                                                                              |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |               |                       |                                                                                                                                                                                                                                                                                                                                                                              |     |
|                        | In the renewal dossier for Fosetyl‐Al, no change has been proposed (to be confirmed in an experts' meeting in February 2018)                                                                                                                                                                                                                                                                                                                                                      |               |                       |                                                                                                                                                                                                                                                                                                                                                                              |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.36.3. Residue definitions -- phosphonic acid (Table [171](#efs25306-tbl-0171){ref-type="table"}) {#efs25306-sec-0235}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------+-------------------------------------------------------------------------------+----------------+----------------+
|                         | Commodity group                | JMPR evaluation                                                               | EU evaluation  | RDs comparable |
+=========================+================================+===============================================================================+================+================+
| **RD enf**              | Plant products                 | Sum of fosetyl, phosphonic acid and their salts, expressed as phosphonic acid | See fosetyl Al | No             |
+-------------------------+--------------------------------+-------------------------------------------------------------------------------+----------------+----------------+
| Animal products         | Phosphonic acid                | See fosetyl Al                                                                | No             |                |
|                         |                                |                                                                               |                |                |
|                         | The residue is not fat soluble |                                                                               |                |                |
+-------------------------+--------------------------------+-------------------------------------------------------------------------------+----------------+----------------+
| **RD RA**               | Plant products                 | Sum of fosetyl, phosphonic acid and their salts, expressed as phosphonic acid | See fosetyl Al | Yes            |
+-------------------------+--------------------------------+-------------------------------------------------------------------------------+----------------+----------------+
| Animal products         | Phosphonic acid                | See fosetyl Al                                                                | Yes            |                |
+-------------------------+--------------------------------+-------------------------------------------------------------------------------+----------------+----------------+
| **Conclusion/comments** |                                |                                                                               |                |                |
+-------------------------+--------------------------------+-------------------------------------------------------------------------------+----------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.36.4. Codex MRL proposals -- phosphonic acid {#efs25306-sec-0236}

See fosetyl.

### 4.36.5. Consumer risk assessment -- phosphonic acid {#efs25306-sec-0237}

See fosetyl.

4.37. Fosetyl Al (302) (R/T) {#efs25306-sec-0238}
----------------------------

### 4.37.1. Background information (Table [172](#efs25306-tbl-0172){ref-type="table"}) {#efs25306-sec-0239}

###### 

Background information on fosetyl Al

+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+
|                                                                                   |                         | Comments, references                                                                              |
+===================================================================================+=========================+===================================================================================================+
| Type of JMPR evaluation                                                           | New compound evaluation | --                                                                                                |
+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+
| RMS                                                                               | FR                      | --                                                                                                |
+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+
| Approval status                                                                   | Renewal of the approval | Commission Implementing Regulation (EU) No 678/2014[a](#efs25306-note-0200){ref-type="fn"}        |
+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                   | Yes, see comments       | EFSA ([2005b](#efs25306-bib-0004){ref-type="ref"}) (corrigendum 2013)                             |
|                                                                                   |                         |                                                                                                   |
|                                                                                   |                         | EFSA ([2014g](#efs25306-bib-0062){ref-type="ref"}) (Statement dietary RA proposed temporary MRLs) |
|                                                                                   |                         |                                                                                                   |
|                                                                                   |                         | EFSA conclusions ongoing (AIR III)                                                                |
+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+
| MRL review                                                                        | Yes, see comments       | EFSA ([2012g](#efs25306-bib-0040){ref-type="ref"})                                                |
+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+
| MRL applications                                                                  | Yes, see comments       |                                                                                                   |
+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+
| EFSA ([2015m](#efs25306-bib-0088){ref-type="ref"}) (various crop)                 |                         |                                                                                                   |
|                                                                                   |                         |                                                                                                   |
| EFSA ([2012i](#efs25306-bib-0042){ref-type="ref"}) (potato, kiwi)                 |                         |                                                                                                   |
|                                                                                   |                         |                                                                                                   |
| EFSA ([2018d](#efs25306-bib-0124){ref-type="ref"}) (tree nuts, peaches, potatoes) |                         |                                                                                                   |
+-----------------------------------------------------------------------------------+-------------------------+---------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

678/2014/EU: Commission Implementing Regulation (EU) No 678/2014 of 19 June 2014 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clopyralid, cyprodinil, fosetyl, pyrimethanil and trinexapac. OJ L 180, 20.6.2014, p. 11--12.

John Wiley & Sons, Ltd

### 4.37.2. Toxicological reference values -- fosetyl Al (Table [173](#efs25306-tbl-0173){ref-type="table"}) {#efs25306-sec-0240}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                | EU evaluation | TRV comparable                                                     |                                                                                                                                                                                                        |     |
+========================+================================================================================================================================================================================================================================================================================================================================================================+===============+====================================================================+========================================================================================================================================================================================================+=====+
| **ADI**                | 1 mg/kg bw per day (Applies to fosetyl‐aluminium and phosphonic acid, expressed as fosetyl‐aluminium)                                                                                                                                                                                                                                                          | JMPR, 2017    | 3 mg/kg bw per day                                                 | European Commission ([2012c](#efs25306-bib-0144){ref-type="ref"}) confirmed in EFSA ([2005b](#efs25306-bib-0004){ref-type="ref"}) (corrigendum 2013) (2‐year dog and 2‐year rat, safety factor of 100) | No  |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                    | JMPR, 2017    | Unnecessary as low acute toxicity and lack of severe acute effects | --                                                                                                                                                                                                     | Yes |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | For **fosetyl**, a new ADI of 1 mg/kg bw per day based on the rabbit developmental toxicity study is proposed in the RAR and will be discussed in the pesticide peer review meeting in February 2018.                                                                                                                                                          |               |                                                                    |                                                                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                |               |                                                                    |                                                                                                                                                                                                        |     |
|                        | An ARfD for fosetyl of 1 mg/kg bw based on the rabbit developmental toxicity study is proposed in the RAR considering the developmental NOAEL of 100 mg/kg bw per day based on increased incidence of dilated ureter at the high dose and an uncertainty factor of 100. This proposal will be discussed in the pesticide peer review meeting in February 2018. |               |                                                                    |                                                                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                |               |                                                                    |                                                                                                                                                                                                        |     |
|                        | Concerning **phosphonic acid**, a specific ADI was proposed in the EFSA Conclusion in corrigendum 2013 at 2.25 mg/kg per day based on the 2‐year rat study with an uncertainty factor of 100 and the same is proposed in the RAR (to be confirmed in February 2018).                                                                                           |               |                                                                    |                                                                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                |               |                                                                    |                                                                                                                                                                                                        |     |
|                        | For phosphonic acid, no ARfD has been established and no proposal is made in the RAR.                                                                                                                                                                                                                                                                          |               |                                                                    |                                                                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                |               |                                                                    |                                                                                                                                                                                                        |     |
|                        | For details on **phosphonic acid**, see section above                                                                                                                                                                                                                                                                                                          |               |                                                                    |                                                                                                                                                                                                        |     |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+--------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.37.3. Residue definitions -- fosetyl Al (Table [174](#efs25306-tbl-0174){ref-type="table"}) {#efs25306-sec-0241}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | JMPR evaluation                                                                                                                                                                  | EU evaluation                                                                                                                                                                                                                 | RDs comparable |
+=========================+============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==================================================================================================================================================================================+===============================================================================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Sum of fosetyl, phosphonic acid and their salts, expressed as phosphonic acid                                                                                                    | EU Reg. 365/2005: Fosetyl‐Al (sum of fosetyl, phosphonic acid and their salts, expressed as fosetyl)                                                                                                                          | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  | MRL review: Phosphonic acid; risk managers to decide whether a separate residue definition for fosetyl should be established (EFSA, [2012h](#efs25306-bib-0041){ref-type="ref"})                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  | Peer review: Sum of fosetyl, phosphonic acid and their salts expressed as phosphonic acid (not enforced) (EFSA corrigendum 2013), confirmed in expert meeting (February 2018)                                                 |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Phosphonic acid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | EU Reg. 365/2005: Fosetyl‐Al (sum of fosetyl, phosphonic acid and their salts, expressed as fosetyl)                                                                             | No                                                                                                                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Peer review: Sum of fosetyl, phosphonic acid and their salts expressed as phosphonic acid                                                                                        |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | (not enforced) (EFSA corrigendum 2013)                                                                                                                                           |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | The residue is not fat soluble                                                                                                                                                   |                                                                                                                                                                                                                               |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Sum of fosetyl, phosphonic acid and their salts, expressed as phosphonic acid                                                                                                    | Sum of fosetyl, phosphonic acid and their salts expressed as phosphonic acid                                                                                                                                                  | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  | MRL review: Phosphonic acid; risk managers to decide whether a separate residue definition for fosetyl should be established (EFSA, [2012h](#efs25306-bib-0041){ref-type="ref"}), confirmed by expert meeting (February 2018) |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Phosphonic acid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Sum of fosetyl, phosphonic acid and their salts expressed as phosphonic acid                                                                                                     | Yes                                                                                                                                                                                                                           |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | MRL review: Phosphonic acid; risk managers to decide whether a separate residue definition for fosetyl should be established (EFSA, [2012h](#efs25306-bib-0041){ref-type="ref"}) |                                                                                                                                                                                                                               |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for enforcement in plant and animal commodities are expressed differently, i.e., as fosetyl or as phosphonic acid. The conversions between both compounds using conversion factors derived from molecular weights are possible.                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         | For animal products, different residue definitions for enforcement are established. In the EU RD, fosetyl is included while JMPR restricted the RD to phosphonic acid. However, fosetyl is rapidly degrading to phosphonic acid in plants and in animals. Thus, the difference of the enforcement residue definitions for animal products is of low practical relevance. The RMS noted that in the RAR the same residue definition as the one set by JMPR was proposed.                                                                                                                                                                                    |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         | The proposal to set the residue definitions for both risk assessment and monitoring as phosphonic acid only and to let risk managers decide to set a separate residue definition for fosetyl was discussed during the Standing Committee on the food chain and animal health held in Brussels on February 2014. Member States agreed to the proposal to set the residue definition as 'phosphonic acid'. Nevertheless, pending modification of the existing enforcement residue definition (set in Regulation (EC) No 396/2005), the Article 10 MRL applications submitted to EFSA have been assessed in a way to accommodate various residue definitions. |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         | The renewal of the approval of fosetyl‐Al at the European level is currently ongoing where the residue definitions for fosetyl‐Al in plant and animal matrices will be agreed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         | When CXLs for plant and animal commodities are taken over in the EU MRL legislation, they need to be converted to fosetyl by applying the molecular weight conversion factor of 1.34.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
|                         | Alternatively, if the EU residue definition is amended as proposed in the peer review, the CXLs can be taken over without recalculation, with a minor discrepancy for the MRLs for animal products                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                  |                                                                                                                                                                                                                               |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.37.4. Codex MRL proposals -- fosetyl Al (Table [175](#efs25306-tbl-0175){ref-type="table"}) {#efs25306-sec-0242}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                    | Codex MRL proposal                     | EU MRL                                                                                                   | Comment                                                                                                                                                                                                                                                                                                                                                                                                                       |
+==============================================================================+========================================+==========================================================================================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================+
| Avocado                                                                      | 20                                     | 50                                                                                                       | Critical GAP: ES (fosetyl‐Al): 3 × 0.24 kg/hL, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: 1 trial matching GAP, rest of trials scaled down. Values ranging from 2.7 to 3.4 mg/kg, except one value at 10 mg/kg. MRL expressed as fosetyl would be 30 mg/kg.                                                                                                                                                                                                                             |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cucumber                                                                     | 60 (**80** expressed as fosetyl)       | 75                                                                                                       | Critical GAP: EL (fosetyl‐Al): 4 × 4.8 kg/ha, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 7 (indoor)                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: No; cucumbers are considered a major crop both by JMPR and at EU level. Thus, at least 8 trials would be required.                                                                                                                                                                                                                                                                            |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: It is not reported whether the GAP is indoor or outdoor. The MRL expressed as fosetyl would be 80 mg/kg.                                                                                                                                                                                                                                                                                      |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is not supported by a sufficient number of trials. However, the EU MRL is established at a similar level, which is based on a sufficient number of trials (MRL proposal under Art. 12: 70 mg/kg for cucumbers and courgette for phosphonic acid for the indoor use (not yet enforced)                                                                                                      |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                     | 0.5                                    | 0.5[\*](#efs25306-note-2011){ref-type="fn"}                                                              | Based on the mean/max DB calculated for dairy and beef cattle in Australia (31 mg/kg DM) following the intake of grape wet pomace, apple wet pomace and dried citrus pulp.                                                                                                                                                                                                                                                    |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Residues determined in kidney and liver based on the feeding study performed with lactating cows at the dose level 32 mg/kg DM phosphonic acid. The Codex MRL refers to phosphonic acid                                                                                                                                                                                                                                       |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapes                                                                       | 60                                     | 100                                                                                                      | Critical GAP: CZ (fosetyl‐Al): 3 × 2 kg/ha, PHI 21 days                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 22                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The MRL expressed as fosetyl would be 80 mg/kg.                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Group of pome fruits (includes all commodities in this group)                | 50                                     | 75 pome fruit;                                                                                           | Critical GAP: FR (fosetyl‐Al): 3 × 3 kg/ha, PHI 28 days                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        | 2\*kaki/                                                                                                 | Number of trials: 15 (7 apples + 8 pears)                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        | Japanese persimmon, 2[\*](#efs25306-note-2011){ref-type="fn"} azaroles                                   | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: MRL expressed as fosetyl would be 60 mg/kg. The Codex MRL would apply also to kaki/Japanese persimmon and azaroles, which according to EU food classification is included in the group 'Miscellaneous fruit (edible peel)' and 'Other small fruit and berries'. An extrapolation from apple/pear trials to Japanese persimmon is acceptable (the existing EU MRL for persimmon is 2\* mg/kg). |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Hops (dry)                                                                   | 1500 (**2000** expressed as fosetyl)   | 1500                                                                                                     | Critical GAP: DE (fosetyl‐Al): 8 × 8 kg/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The MRL expressed as fosetyl would be 2,000 mg/kg.                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lettuce, head                                                                | **200**                                | 75                                                                                                       | Critical GAP: FI (fosetyl‐Al): 4 × 2.4 kg/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 7 indoor,                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes (according the JMPR rules); at EU level lettuce the trials on head and leaf lettuce would be combined. Thus, overall, the number of trials would be sufficient.                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The MRL expressed as fosetyl would be 300 mg/kg. Conclusion: Due to a different policy of pooling data on leaf and head lettuce, and considering indoor and outdoor trials separately, a different MRL would be derived                                                                                                                                                                       |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lettuce, leaf                                                                | 40                                     | 75                                                                                                       | Critical GAP: FI (fosetyl‐Al): 4 × 2.4 kg/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 18 (8 indoor + 10 outdoor)                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The indoor and outdoor residue trials were combined to derive CXL. The Codex MRL for the indoor use alone would be 60 mg/kg (or 70 mg/kg, expressed as fosetyl) and 30 mg/kg for the outdoor use (or 40 mg/kg expressed as fosetyl).                                                                                                                                                          |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: See conclusion on lettuce, head                                                                                                                                                                                                                                                                                                                                                                                   |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                            | 0.2                                    | 0.5[\*](#efs25306-note-2011){ref-type="fn"}                                                              | Based on the mean/max DB calculated for dairy and beef cattle in Australia (31 mg/kg DM) following the intake of grape wet pomace, apple wet pomace and dried citrus pulp.                                                                                                                                                                                                                                                    |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Residues determined in fat based on the feeding study performed with lactating cows at the dose level 32 mg/kg DM phosphonic acid. The Codex MRL refers to phosphonic acid                                                                                                                                                                                                                                                    |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                | 0.15                                   | 0.5\* (muscle)                                                                                           | Based on the mean/max DB calculated for dairy and beef cattle in Australia (31 mg/kg DM) following the intake of grape wet pomace, apple wet pomace and dried citrus pulp.                                                                                                                                                                                                                                                    |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Residues determined in meat based on the feeding study performed with lactating cows at the dose level 32 mg/kg DM phosphonic acid. The Codex MRL refers to phosphonic acid                                                                                                                                                                                                                                                   |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melon (except water melon)                                                   | 60                                     | 75                                                                                                       | Critical GAP: FR (fosetyl‐Al): 2 × 3.2 kg/ha, PHI 3 days                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 14 (8 indoor + 6 outdoor)                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes for indoor, no for outdoor                                                                                                                                                                                                                                                                                                                                                                |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: Indoor and outdoor residue trials were combined. The Codex MRL for indoor use alone would be 50 mg/kg (and 70 mg/kg, expressed as fosetyl); the outdoor use is not sufficiently supported by residue data (additional 2 trials would be required).                                                                                                                                            |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: Although at EU level, the indoor and outdoor trials would not be combined, the proposed Codex MRL might be acceptable to risk managers                                                                                                                                                                                                                                                                            |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                        | 0.1                                    | 0.1\*                                                                                                    | Based on the mean/max DB calculated for dairy and beef cattle in Australia (31 mg/kg DM) following the intake of grape wet pomace, apple wet pomace and dried citrus pulp.                                                                                                                                                                                                                                                    |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Residues determined in meat based on the feeding study performed with lactating cows at the dose level 32 mg/kg DM phosphonic acid. The Codex MRL refers to phosphonic acid                                                                                                                                                                                                                                                   |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, sweet, (including pimento or pimiento)                              | 7                                      | 130                                                                                                      | Critical GAP: HU (fosetyl): indoor 18.6 kg/ha + 9.3 kg/ha (seeding drench) + 4 × 0.93 kg/ha (drip irrigation), PHI 3 days                                                                                                                                                                                                                                                                                                     |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The MRL expressed as fosetyl would be 9 mg/kg.                                                                                                                                                                                                                                                                                                                                                |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable. The manufacturer should be encouraged to submit the EU GAP and residue trials to JMPR set a Codex MRL that covers the EU uses                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Spinach                                                                      | 20                                     | 75                                                                                                       | Critical GAP: BE (fosetyl): outdoor 1 × 0.775 kg/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                              |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The MRL expressed as fosetyl would be 30 mg/kg.                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable. The proposed Codex MRL is acceptable. The manufacturer should be encouraged to submit the EU GAP and residue trials to JMPR set a Codex MRL that covers the EU uses                                                                                                                                                                                                         |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberries                                                                 | 70                                     | 75                                                                                                       | Critical GAP: FR (fosetyl‐Al): 3 × 4 kg/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              | (**100** expressed as fosetyl)         |                                                                                                          | Number of trials: 16 (8 indoor + 8 outdoor)                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The Codex MRL for the outdoor use alone would be 80 mg/kg (150 mg/kg, expressed as fosetyl) and 60 mg/kg for indoor use (80 mg/kg, expressed as fosetyl).                                                                                                                                                                                                                                     |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: Although at EU level, indoor and outdoor trials would not be combined, the proposed Codex MRL may be acceptable for risk managers                                                                                                                                                                                                                                                                                 |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of Mandarins(includes all commodities in this subgroup)             | 50                                     | 75                                                                                                       | Critical GAP: USA (fosetyl‐Al): 4 × 4.48 kg/ha, PHI 12 h                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations:.JMPR used EU trials on mandarins scaled down for USA GAP. The MRL expressed as fosetyl would be 60 mg/kg. In the Art. 12 review, an MRL of 50 mg/kg for phosphonic acid for mandarins was proposed for an EU use (not yet enforced).                                                                                                                                                          |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: To be discussed, whether the proposed Codex MRL is not acceptable since it is based on EU trials to support US GAP                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Subgroup of oranges, sweet, sour (includes all commodities in this subgroup) | 20                                     | 75                                                                                                       | Critical GAP: USA (fosetyl‐Al): 4 × 4.48 kg/ha, PHI 12 h                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: EU trials on oranges were scaled down for USA GAP. The MRL expressed as fosetyl would be 30 mg/kg. In the Art. 12 review, an MRL of 20 mg/kg for phosphonic acid for oranges was proposed for an EU use (not yet enforced).                                                                                                                                                                   |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: To be discussed, whether the proposed Codex MRL is not acceptable since it is based on EU trials to support US GAP                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Summer squash                                                                | 70                                     | 75                                                                                                       | Critical GAP: EL (fosetyl‐Al): 4 × 4.8 kg/ha, PHI 3 days                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              | (**100** expressed as fosetyl)         |                                                                                                          | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes (according to JMPR rules); at EU level, 2 additional trials would be required.                                                                                                                                                                                                                                                                                                            |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: Trials were scaled up for the GAP. The MRL expressed as fosetyl would be 100 mg/kg.                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is not acceptable because 2 more trials would be required. However, the Art. 12 review, an MRL of 70 mg/kg for phosphonic acid was proposed based on indoor GAP for EU uses (not yet enforced)                                                                                                                                                                                             |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                                       | 8                                      | 100                                                                                                      | Critical GAP: HU (fosetyl): indoor 2 × 9.3 kg/ha (seedling drench)+ 4 × 0.93 kg/ha (drip irrigation); PHI 3 days                                                                                                                                                                                                                                                                                                              |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The residue values range from 0.21 to 0.47, apart from a single value at 5.2 mg/kg. The MRL expressed as fosetyl would be 10 mg/kg.                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tree nuts (includes all 400                                                  | **400** (**500** expressed as fosetyl) | 2[\*](#efs25306-note-2011){ref-type="fn"} for Brazil nuts, chestnuts, coconuts, pecans, pine nut kernels | Critical GAP: USA (phosphonic acid): 6 × 1.9 kg/ha                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
| commodities in this group)                                                   |                                        | 75 for almonds, cashew nuts, hazelnuts, macadamias, pistachios, walnuts                                  | Number of trials: 15 (5 almonds + 5 pistachio + 5 walnuts)                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Specific comments/observations: The MRL expressed as fosetyl would be 500 mg/kg and according to EU extrapolation rules would not apply to coconuts. Recent EU assessment of the same US trials was performed where 2 trials (almond/walnuts) were disregarded (deviations in number of appl.), but the MRL proposal derived was 500 mg/kg (tree nuts except coconuts).                                                       |
|                                                                              |                                        |                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                              |                                        |                                                                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+----------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; MRL: maximum residue limit; CXL: Codex Maximum Residue Limit.

\* Indicates that the input value is proposed at the limit of quantification.
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### 4.37.5. Consumer risk assessment -- fosetyl Al (Table [176](#efs25306-tbl-0176){ref-type="table"}) {#efs25306-sec-0243}

###### 

Summary of the consumer risk assessment for fosetyl Al

+-----------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+
| Acute exposure assessment                                                                                                   | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Comments on JMPR exposure assessment                               |
+=============================================================================================================================+========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+====================================================================+
| **RA assumptions:**                                                                                                         | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | **Specific comments**                                              |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                    |
| The short‐term dietary risk assessment was not performed as ARfD is established neither for fosetyl nor for phosphonic acid | The most recent long‐term risk assessment performed for total residues expressed as fosetyl (scenario1) and separately for total residues expressed as phosphonic acid (scenario 2) (EFSA, [2018d](#efs25306-bib-0124){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for those crops for which Codex MRL proposal is higher than the existing corresponding EU MRL (cucumber, hops, strawberries, courgettes (summer squash), tree nuts, persimmon, lettuce). For animal commodities, only those Codex MRL proposals were included in the RA, which were at the same level (or higher) than the corresponding EU MRL (ruminant kidney, liver, edible offal and milk). For tree nuts, the STMR values derived under EU assessment were higher and thus used in the RA. | The ADI values set at EU level and CCPR are different              |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                    |
|                                                                                                                             | To assess consumer exposure to phosphonic acid residues, the existing EU MRLs were expressed as phosphonic acid by applying the molecular weight conversion factor of 0.75 where the risk assessment values for phosphonic acid were not available.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                    |
+-----------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+
| **Results:**                                                                                                                | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | **Results:**                                                       |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                    |
|                                                                                                                             | No long‐term consumer health risk was identified.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Long‐term exposure:                                                |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                    |
|                                                                                                                             | The overall chronic exposure accounted for 43% of the ADI for fosetyl (scenario 1) and for 40% of the ADI for phosphonic acid (scenario 2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 30% of the ADI for fosetyl‐Al (applicable also to phosphonic acid) |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                    |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Short‐term exposure:                                               |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                    |
|                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | not calculated, not necessary                                      |
+-----------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; ADI: acceptable daily intake; ARfD: acute reference dose; EU: European Union.

John Wiley & Sons, Ltd

4.38. Triflumezopyrim (303) (R/T) {#efs25306-sec-0244}
---------------------------------

### 4.38.1. Background information (Table [177](#efs25306-tbl-0177){ref-type="table"}) {#efs25306-sec-0245}

###### 

Background information on triflumezopyrim

                                                      Comments, references
  ------------------------- ------------------------- ----------------------
  Type of JMPR evaluation   New compound evaluation   
  RMS                       --                        
  Approval status           Approval status           --
  EFSA conclusion           EFSA conclusion           No
  MRL review                MRL review                No
  MRL applications          MRL applications          No
                                                      

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RMS: rapporteur Member State.

John Wiley & Sons, Ltd

### 4.38.2. Toxicological reference values -- triflumezopyrim (Table [178](#efs25306-tbl-0178){ref-type="table"}) {#efs25306-sec-0246}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+----------------+------------------+----------------+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                      | EU evaluation                 | TRV comparable |                  |                |
+========================+======================================================================================================================================================================================================================================================================================================================================================================================+===============================+================+==================+================+
| **ADI**                | 0.2 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                 | JMPR, 2017;                   | --             | No EU assessment | Not applicable |
|                        |                                                                                                                                                                                                                                                                                                                                                                                      |                               |                |                  |                |
|                        |                                                                                                                                                                                                                                                                                                                                                                                      | Rat 2‐year study              |                |                  |                |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+----------------+------------------+----------------+
| **ARfD**               | 1 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                           | JMPR, 2017;                   | --             | Not applicable   |                |
|                        |                                                                                                                                                                                                                                                                                                                                                                                      |                               |                |                  |                |
|                        |                                                                                                                                                                                                                                                                                                                                                                                      | Rat acute neurotoxicity study |                |                  |                |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+----------------+------------------+----------------+
| **Conclusion/comment** | Considering the data presented in the JMPR assessment, different conclusions might be derived during an EU peer review on the basis of a more detailed evaluation (also taking into account the carcinogenic potential and the identified endocrine‐mediated effects against the approval criteria). However, for the time being, no application for EU approval has been submitted. |                               |                |                  |                |
|                        |                                                                                                                                                                                                                                                                                                                                                                                      |                               |                |                  |                |
|                        | Metabolites IN‐Y2186 and IN‐RPD47: in the absence of toxicological data, and considering that they are not major rat metabolites, the considerations given to structural similarities are not sufficient to conclude on their overall toxicity profile.                                                                                                                              |                               |                |                  |                |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+----------------+------------------+----------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values; EU: European Union.

John Wiley & Sons, Ltd

### 4.38.3. Residue definitions -- triflumezopyrim (Table [179](#efs25306-tbl-0179){ref-type="table"}) {#efs25306-sec-0247}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------+----------------+
|                         | Commodity group                                                                                                                                             | JMPR evaluation                                                                                     | EU evaluation | RDs comparable |
+=========================+=============================================================================================================================================================+=====================================================================================================+===============+================+
| **RD enf**              | Plant products                                                                                                                                              | Triflumezopyrim                                                                                     | --            | N/A            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Triflumezopyrim                                                                                                                                             | --                                                                                                  | N/A           |                |
|                         |                                                                                                                                                             |                                                                                                     |               |                |
|                         | The residue is not fat soluble                                                                                                                              |                                                                                                     |               |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------+----------------+
| **RD RA**               | Plant products                                                                                                                                              | Sum of triflumezopyrim and 3‐(trifluoromethyl)benzoic acid (IN‐Y2186), expressed as triflumezopyrim | --            | N/A            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------+----------------+
| Animal products         | Triflumezopyrim                                                                                                                                             | --                                                                                                  | N/A           |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------+----------------+
| **Conclusion/comments** | Since the substance is not specifically mentioned in Regulation (EC) No 396/2005, the default residue definition (parent compound) is currently applicable. |                                                                                                     |               |                |
|                         |                                                                                                                                                             |                                                                                                     |               |                |
|                         | For the tentative risk assessment, the residue definitions derived by JMPR for risk assessment can be used                                                  |                                                                                                     |               |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------+----------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; RD RA: residue definition for risk assessment; RD enf: residue definition for enforcement practice; EU: European Union.

John Wiley & Sons, Ltd

### 4.38.4. Codex MRL proposals -- triflumezopyrim (Table [180](#efs25306-tbl-0180){ref-type="table"}) {#efs25306-sec-0248}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                           | EU MRL (default MRLs)                        | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+===============================================+==============================================+==============================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Rice                                          | **0.2**                                      | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | Critical GAP: China, India, Thailand: 2 × 25 g ai/ha, PHI 21 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Number of trials: 23                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Specific comments/observations: The samples were analysed only for the parent compound, but not for the full‐residue definition for risk assessment which comprises also metabolite IN‐Y2186.                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Conclusion: At EU level, no MRLs are established for rice grain (rice including the husk)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, husked                                  | 0.01                                         | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | Critical GAP: see 'Rice'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Specific comments/observations: 6 slightly overdosed residue trials (2 × 37.5 g ai/ha) with husked rice were available. In none of the samples, quantifiable residues were found.                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | For risk assessment, 8 residue trials from Thailand were mentioned, that were analysed for parent triflumezopyrim and the metabolite IN‐2186. Using molecular weight conversion factors, the corresponding residue concentrations for the sum of parent + IN‐2186, expressed as parent were determined. The resulting residues were significantly higher than the residues reported for parent compound (i.e. up to 0.098 mg/kg).                                                                                                                                                                             |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Conclusion: In the EU MRL legislation, an MRL should be established for husked rice. Although only 6 trials are available, the MRL proposal of 0.01 mg/kg should be acceptable, considering that this value is similar to the current default MRL                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                | 0.01                                         | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | Specific comments/observations: No specific processing studies for polished rice are available. The results from husked rice gave an indication that no quantifiable residues are likely to occur in polished rice                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | Specific comments/observations: The calculation of the dietary burden of livestock is based on residues of parent triflumezopyrim in feed (i.e. rice straw, rice hulls, rice grain and rice bran). The contribution of residues on IN‐2186 was neglected (e.g. for rice grain, the STMR value of 0.025 mg/kg derived for parent compound was used, instead of the STMR value calculated for the risk assessment residue definition (0.053 mg/kg). The highest dietary burden was identified for the Australian livestock diet. In the feeding studies, residues were below the LOQ in all animal commodities. |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Conclusion: Although the calculation of the dietary burden is likely to underestimate the actual exposure, the proposed MRLs is acceptable, considering that no quantifiable residues were found in animal products even at significantly higher feeding levels. However, the calculation of the dietary burden calculation should be reconsidered (including all components of the risk assessment residue definition)                                                                                                                                                                                       |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | See comments on meat (mammals)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | See comments on meat (mammals)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | See comments on meat (mammals)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                  | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | Specific comments/observations: For dietary burden calculation, see comments on meat (from mammals).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | No poultry feeding study was available. The proposed MRLs were derived from the metabolism study in poultry which was performed with a significantly higher dose rate (at least 824 times higher).                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                               |                                              |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                              |                                              | Conclusion: Although the dietary burden was calculated wrongly, the MRL proposal might be acceptable, considering the evidence that even at significantly higher feeding levels no quantifiable residues were found                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                  | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | See comment on poultry meat                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                      | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | See comment on poultry meat                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                          | 0.01\*                                       | 0.01[\*](#efs25306-note-2012){ref-type="fn"} | See comment on poultry meat                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+----------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue limit.

\* Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 4.38.5. Consumer risk assessment -- triflumezopyrim (Table [181](#efs25306-tbl-0181){ref-type="table"}) {#efs25306-sec-0249}

###### 

Summary of the consumer risk assessment for triflumezopyrim

+--------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                          | Chronic exposure assessment                                                                                                                                               | Comments on JMPR exposure assessment |
+====================================================================================================================================================================+===========================================================================================================================================================================+======================================+
| **RA assumptions:**A tentative short‐term dietary risk assessment was performed for rape seed as outlined in Section [4.38.2](#efs25306-sec-0246){ref-type="sec"}. | **RA assumptions:**                                                                                                                                                       | **Specific comments**                |
|                                                                                                                                                                    |                                                                                                                                                                           |                                      |
| The JMPR ARfD was used                                                                                                                                             | A tentative long‐term risk assessment was performed, based on the existing EU MRLs and the including the STMR values derived by JMPR for the commodities under assessment |                                      |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                       | **Results:**                                                                                                                                                              | **Results:**                         |
|                                                                                                                                                                    |                                                                                                                                                                           |                                      |
| No short‐term exposure concern was identified (0.1% of the ARfD for milk and rice)                                                                                 | No long‐term consumer health risk was identified.                                                                                                                         | Long‐term exposure:                  |
|                                                                                                                                                                    |                                                                                                                                                                           |                                      |
|                                                                                                                                                                    | The overall chronic exposure accounted for 0.4% of the ADI                                                                                                                | 0.2% of the ADI                      |
|                                                                                                                                                                    |                                                                                                                                                                           |                                      |
|                                                                                                                                                                    |                                                                                                                                                                           | Short‐term exposure:                 |
|                                                                                                                                                                    |                                                                                                                                                                           |                                      |
|                                                                                                                                                                    |                                                                                                                                                                           | 0% of the ARfD                       |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ADI: acceptable daily intake; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRV: toxicological reference values.

John Wiley & Sons, Ltd

Abbreviations {#efs25306-sec-0250}
=============

ADIacceptable daily intakeARfDacute reference dosea.s.active substanceBBCHgrowth stages of mono‐ and dicotyledonous plantsbwbody weightCCPRCodex Committee on Pesticide ResiduesCFconversion factor for enforcement residue definition to risk assessment residue definitionCXLCodex Maximum Residue Limit (Codex MRL)DARDraft Assessment Report (prepared under Council Directive 91/414/EEC)DMdry matterDMSdocument management systemdwdry weightFAOFood and Agriculture Organization of the United NationsGAPGood Agricultural PracticehahectarehLhectolitreHRhighest residueIESTIInternational estimated of short‐term intakeJMPRJoint FAO/WHO Meeting on Pesticide ResiduesLOAELlowest observed adverse effect levelLODlimit of detectionLOQlimit of quantification (determination)MRLmaximum residue limitMSMember StatesMWMolecular weightNEUnorthern European UnionNOAELno observed adverse effect leveln.nnot necessaryn.anot applicableOECDOrganisation for Economic Co‐operation and DevelopmentPFprocessing factorPHIpreharvest intervalppmparts per million (10^−6^)PRIMo(EFSA) Pesticide Residues Intake ModelRArisk assessmentRACraw agricultural commodityRD‐RAresidue definition for risk assessmentRD‐ENFresidue definition for enforcement practiceRMSrapporteur Member StateRARrenewal assessment reportSEUSouthern European UnionSTMRsupervised trials median residueTTCthreshold of toxicological concernTRRtotal radioactive residuesUFUncertainty factorVFvariation factorWHOWorld Health Organization

Appendix A -- Calculations of Consumer exposure with Pesticide Residue Intake Model (Primo) {#efs25380-sec-1002}
===========================================================================================
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